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Uptake and choice of commercial weight loss products and services by 
adults in the UK 
 
Alisha Michelle Crayton 
 
Abstract 
 
Objectives: 1) To assess the use and reasons of choice of commercial weight 
loss products and services (CWLPS), 2) Critically assess the effectiveness of 
CWLPS.  
Methods: A mixed method study design was used to assess the use and 
reasons of choice of CWLPS (survey and Q-method) and investigate the 
effectiveness of CWLPS (systematic review).   
Results: Weight loss group based programmes such as Slimming World were 
the most popular type of CWLPS used. The Q-method study identified four 
different groups of participants who had similar needs for their preferred 
CWLPS, which mapped onto the different types of CWLPS available. The 
systematic review showed that CWLPS result in weight loss, although attrition 
rates are often quite high. Slimming groups such as Weight Watchers appeared 
the most effective.  
Discussion and conclusion: It is clear that most CWLPS are used, preferred, 
and effective for some people, at least for a short period of time. However, 
different users have different needs for their preferred CWLPS. The cost of a 
CWLPS is not a critical factor in its use, popularity, or effectiveness. 
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Chapter One 
Introduction 
 
1.1 Overview  
This introductory chapter outlines the rationale and components of my PhD 
thesis. It provides an overview of the background to my research, and why 
the research I did was undertaken. The aims and objectives are discussed 
prior to outlining the thesis structure.  
 
1.2 Foundation of the research proposal  
This research was undertaken during 2009 to 2012, and was funded by an 
Interdisciplinary Research Scholarship from Durham University. The topic 
area I chose to study was the effectiveness of commercial weight loss 
products and services (CWLPS), and the use of these in the North East of 
the United Kingdom.  
My previous education and employment experiences led me to choose this 
field of interest. In 2006-2007 I completed an MSc in Weight Management at 
the University of Chester. Core and optional modules were varied. During the 
course we touched on CWLPS, and I remember being surprised at the lack 
of evidence and general information on this topic (except from companies 
producing CWLPS). 
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Between 2007 and 2009 I worked as a research assistant on the Community 
Challenge Project (CCP); a Food Standards Agency funded project aimed at 
engaging adults living in the Tees Valley area to make one small change to 
diet (increasing fruit and vegetable consumption or decreasing fat intake) 
and one small increase to physical activity, for 12 months. Community 
participants discussed the use of CWLPS. A significant amount of 
participants reported positive and negative views and behaviour changes. 
Participants who reported losing weight through CWLPS stated that once 
they had stopped using CWLPS, weight gain occurred. This process of 
weight cycling is well documented in the literature and can be defined as 
“repeated loss and regain of weight although there is no standard definition 
for weight cycling” (Elfhag & Rössner, page 75, 2005). This information on 
weight cycling by CCP participants was disclosed verbally within the 
interviews and focus groups. 
When I was working on the CCP project, I read the Foresight Report (2007a) 
which estimated the value of the weight loss industry in the UK at £2 
billion/year at that time. However, I did not come across any literature on the 
popularity of CWLPS, or the stereotypical CWLPS consumer. 
My interest in commercial weight loss was strengthened in April 2009, when 
the European Commission authorized the release of the first over-the-
counter non-prescription weight loss aid (Alli; 60mg). Upon further research 
of the product, it was apparent that a large scale marketing campaign would 
complement the launch and anticipated success of this product. At the point 
of release, the manufacturers (Glaxo Smith Kline) had not published any 
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results of their randomised controlled trial for Alli. Marketing relied upon the 
published material for xenical (120mg), the sister drug of Alli that is only 
available on prescription to individuals with a Body Mass Index (BMI) of >30 
or >28 with significant co-morbidities. At this point my interest heightened in 
the variety of ‘self-help’ methods available for individuals who wanted to lose 
weight, enticing individuals to purchase their product or service with catchy 
taglines (“it can reward your hard work with 50% more weight loss, Want to 
slim down for a special occasion, and don’t have time to waste?”).  
As part of my preparations for my application for PhD funding, I collated a 
significant amount of literature. Using a simple scoping search, I found that 
there were very few randomised controlled trials which had been published in 
peer-reviewed journals (e.g. Ditschuneit et al, 1999; Foster et al, 2003; 
Heshka et al, 2003). My simple scoping search was carried out within three 
relevant databases (Medline, CINAHL, and Psych Info) using the search 
terms including ‘commercial weight loss’, and I found 44 hits. One qualitative 
research study which I found involved the investigation of individuals’ 
experiences of commercial weight loss programmes (Herriot et al, 2008). 
Herriot et al (2008) conducted a study which I found very interesting, which 
involved participants being randomised to a commercial weight loss 
programme, but free of charge. When I read this paper, I did wonder whether 
the results of this study could be of any real use (i.e. be translated to the real 
world), because people who use CWLPS need to pay for them. For those 
less well off in society, the cost of CWLPS may be a barrier to whether or not 
they use CWLPS, or may be a barrier to which CWLPS they choose. On 
reading this paper, my research plans for my PhD started to develop further, 
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and I decided I wanted to try and explore if and how views and use of 
CWLPS vary dependent on the financial status of the individual.  
In discussion with my PhD supervisors, we developed a PhD research plan, 
which was a mixed method study design, to investigate the effectiveness of 
CWLPS (by systematic review of trials), and also the use and determinants 
of choice of CWLPS by users (survey and Q-method). In all components of 
my research, I planned to try and explore whether socioeconomic status of 
participants had an impact on the effect and/or use of CWLPS.   
 
Background 
 
1.3 Epidemiology  
The 12 areas of the North East, apart from Newcastle (Gateshead, 
Darlington, Sunderland, Redcar and Cleveland, South Tyneside, 
Northumbria, North Tyneside, Newcastle, Middlesbrough, Hartlepool, and 
County Durham) observe higher obesity statistics than the current UK 
average; 24.2% (Gateshead: 30.7%, Darlington: 27.6%,: 27.7%,Sunderland: 
28.6%,Redcar and Cleveland: 29.6%,South Tyneside: 27.4%,Northumbria: 
27.3%,Tyneside: 26.6%,Newcastle: 23.9%,Middlesbrough: 
27.9%,Hartlepool: 27.5%, and County Durham: 28.6%). 
 
Gateshead’s obesity prevalence of 30.7% (Public Health England, 2013)  is 
worse than the highest UK average of 30.2%. Kumanyika et al (2008) 
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estimated that the number of overweight and obese individuals could 
increase to 1.5 billion by 2015, and using this model and in line with trends 
seen in 2013, the North East region could, in theory, observe obesity levels 
beyond 23.9%-30.7% by 2015. Data at the time of my PhD commencement 
for the North East, illustrates that obesity prevalence has increased.  In 2009, 
25.2% (APHO and Department of Health, 2010) of the North East population 
were classified as obese, this figure now ranges from 23.9% (Newcastle) to 
30.7% (Gateshead). 
 
1.3.1 Policy 
In response to the escalating prevalence of obesity and overweight in adults 
and children (although the rise in these rates have slowed down in recent 
years), and building on the two key documents described below, the UK 
government commissioned the Foresight Report (Foresight, 2007a), which 
included recommendations of how best to tailor campaigns and initiatives to 
suit national objectives. 
In 2004, the Cabinet Office published a discussion paper outlining the 
requirement for cost effective behavioural interventions over traditional 
service delivery to tackle obesity, and concluded that a patient-centred 
approach is required to support individuals in their communities to change 
their behaviour. Behavioural interventions are based on key motivational 
interviewing techniques; direct advice is only successful in 5-10% of 
healthcare consultations (Emmons & Rollnick, 2001). This discussion paper 
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did not discuss commercial weight loss programmes for some reason, which 
do have a behavioural component.  
Also in 2004, the Department of Health published a White Paper ‘Choosing 
Health: Making healthy choices easier’ (Department of Health, 2004) which 
identified obesity as one of six key priorities for the government’s Public 
Health strategy. They suggested that informed choice is essential, combined 
with co-operation and partnership from all sectors of the government, for 
successful delivery at a local level. The White Paper emphasised the need 
for individual responsibility through suitable resources, specifically in socially 
deprived areas.  
In 2006, The National Institute for Clinical Excellence produced a 
comprehensive review of the evidence and guidance on obesity 
management (National Institute for Health and Clinical Excellence, 2006). 
This guidance did contain a section in relation to ‘self-help’ for weight loss 
and commercial weight loss products and services, but the evidence base at 
that time was limited. 
The findings of the Foresight Report ‘Tackling Obesities: Future Choices’ 
(Foresight, 2007a) was purposively provocative and attracted a lot of 
attention. The report estimated that 50% of the UK population could be 
obese by 2050, potentially doubling current statistics at the time of print.  
In 2008, the Department of Health & Department for Children, Schools and 
Families produced ‘Healthy Weight, Healthy lives: A Cross-Government 
strategy for England Strategies’ which centred upon health, transport and 
planning services to work in synergy with one another to tackle obesity. The 
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proposed strategy incorporated five key themes; the healthy growth and 
development of children, promoting healthier food choices, building physical 
activity into our lives, creating incentives for better health, and personalised 
advice and support. The strategy aimed to engage individuals to make 
informed choices through local support networks. The strategy 
recommended that treatment options should be accessible for those who 
have an increased BMI, combined with assistance from specific weight 
related services. At the time of publication, the strategy acknowledged other 
treatment options outside of the NHS; however, the focus of was on bariatric 
surgery and pharmacotherapy. 
In 2009 the Department of Health supported a multimillion pound 
government and commercial sector funded social marketing programme 
designed to help tackle obesity ‘Eat Well, Move More, Live Longer’; 
Change4Life. Change4Life incorporated simple exercise and diet tips and 
tools that could be included in everyday life. Seven official sub-brands; 
Breakfast4Life, Swim4Life, Walk4Life, Bike4Life, Play4Life, Cook4Life and 
Dance4Life provided toolkits for individuals and families. Nondescript 
characters used to promote Change4Life target individuals and families 
through an extensive marketing mix of posters, TV adverts, billboards, 
information leaflets and a specifically designed website. 
At about the same time, and working in synergy with Change4Life, the 
Department of Health funded the ‘Healthy Town’ project, where nine towns 
were selected and designated as a ‘Healthy Towns’. Each ‘Healthy Town’ 
developed interesting and novel projects to encourage healthy lifestyles by 
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providing/increasing opportunities for their population to be more active and 
make healthier food choices. The Middlesbrough Healthy Town project, for 
example, developed and ran 32 projects in total. Across the Healthy Towns, 
some projects included opportunities for learning about CWLPS, but sadly 
the evaluations which are available from the Healthy Towns project are 
limited in their ability to help us know more about CWLPS.   
The National Child Measurement Programme (NCMP) was also set up seven 
years ago in line with the Governments strategy to reduce obesity 
prevalence, and also has six years of reliable data for 4-5 year olds and 10-
11 year olds. The NCMP provides height and weight data, and used to 
calculate a BMI centile. The data collected can inform initiatives at national 
and local level. Prior to March 2013, Primary Care Trusts (PCT’s) were 
responsible to collect, hold, and process the NCMP data. However, Local 
Authorities are now responsible for NCMP data collection, and a new system 
for the submission of NCMP data will be replaced for 2013/2014 school year 
(Health & Social Care Information Centre, 2013) . Since 2006/2007 and 
2011/2012 there has been a significant increase in BMI since 2010/2011, the 
trend between 2007/2008 and 2011/2012 also shows a significant increase. 
However, a decrease was observed in 4-5 year old boys since 2010/2011, 
though no significant trend was observed since the start of the NCMP.  An 
increase was observed in 4-5 year old girls since 2010/2011, though no 
significant trend was observed since the start of the NCMP.  For both age 
groups health inequalities are widening. Children in Year 6 (10-11 years) 
observe increases in obesity prevalence that are statistically significant for 
boys and girls living in the most deprived 50% of areas. Children in reception 
Chapter One Introduction 
 
9 
 
class (4-5 years) observe decreases in observe prevalence that are 
statistically significant for boys living in the least deprived 50% of areas, and 
girls in the least deprived 10% (National Obesity Observatory, 2013). It is 
unclear at present whether the change from PCT’s to Local Authorities’ 
collecting and submitting NCMP data will result in any changes. For 
example, whether parents become more resistant, and wish to withdraw their 
child from the NCMP, resulting in a smaller amount of data being collected. 
Also dependant on the training given by the health professionals collecting 
the data could affect the results. For example professionals might not be 
trained to The International Society for the Advancement of 
Kinanthropometry (ISAK) standard, whereby inter and intra reliability is 
assessed. Therefore, there could be professionals whose inter reliability 
(between colleagues) is above -/+2% technical error of measurement, or a 
professionals intra reliability (against themselves) is above -/+1.5% technical 
error of measurement 
I am aware that the National Institute for Clinical Excellence is planning to 
produce an update on its guidance on obesity, which I expect will include 
advice for commissioners of services on CWLPS, in 2013. Once my thesis is 
in the public domain, I intend to disseminate to various people and 
organisations who might find some of my research interesting and useful. 
 
1.3.2 Service  
When I started my PhD, we had PCT’s and these were responsible for 
commissioning. On 1st April 2013, the organisation of public health and 
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healthcare changed, and Public Health England is now in place. For the 
foreseeable future, Local Authorities will now commission public health 
services in England.   
As Local Authorities move towards a commissioning role, it is they who now 
need to decide whether they want to commission commercial weight loss 
programmes as part of their obesity strategies . At the time of planning my 
research, two-thirds of England’s PCT's offered a 10-12 week referral 
scheme to a commercial weight loss programme (Slimming World/Weight 
Watchers). At the time, only those commercial weight loss interventions 
which fulfilled the following criteria (National Institute for Health and Clinical 
Excellence, 2006) were allowed to be recommended and used by PCT's: 
• Be based on a balanced healthy diet  
• Encourage regular physical activity  
• Expect people to lose no more than 0.5–1 kg (1–2 lb) a week 
Beyond a primary care setting, commercial weight loss products and 
services were one of the most popular weight loss methods available for 
individuals who wanted to lose weight.  
Also, in conjunction with the changes to the NHS, bariatric surgery will be the 
responsibility of NHS England, rather than the Local Authority. Therefore, it 
could be possible that there is an increase or decrease in bariatric surgery 
provision, as more or less people could meet the criteria for bariatric surgery 
consideration (specifically for individuals who have not been 
severely/morbidly obese for at least five years).  
Chapter One Introduction 
 
11 
 
1.3.3 Issues 
Effective research and evaluation is required for healthcare providers to 
make informed decisions about products and services they wish to 
commission and deliver. The National Institute for Clinical Excellence will 
continue to endeavour to provide this information, and I hope that my 
research helps in some small way. 
 
Individuals, on the other hand, who do not seek professional assistance from 
their GP to lose weight, may be enticed by the efficient marketing strategies 
of CWLPS companies that have little or a weak evidence base to support 
their efficacy claims. Diet programmes regularly make weight loss claims 
without any supporting proper research or evidence from independent 
randomised controlled trials (Hamilton & Greenway, 2004). 
 
Individuals of lower socioeconomic status could be more susceptible to these 
marketing strategies, because I have found out during my PhD; CWLPS 
companies focus their marketing at certain groups within society. I did want 
to explore this particular issue as part of my PhD, but it would require a 
substantial amount of work. I am hopeful that I will be able to have the 
opportunity to conduct some research in this area after my PhD.  
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1.4 Aim and objectives 
 
Aim 
The aim of my research was to provide additional evidence to inform public 
health policy and practice for the provision of CWLPS, and also individual 
users (i.e. the public).  
 
Objectives: 
1. To assess the use of CWLPS in the one of the most deprived regions 
in England, and explore where usage is associated with 
socioeconomic status. 
2. To assess the reasons for choice of CWLPS in the one of the most 
deprived regions in England, and explore whether this varies by 
socioeconomic status. 
3. Critically assess the effectiveness of CWLPS.  
 
1.5 Research questions 
1. What is the uptake and reasons for choice of commercial weight loss 
products and services by adults in the UK, and is current practice 
fuelling health inequalities?   
2. What is the effectiveness of commercial weight loss products and 
services?   
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1.6 Overview of the thesis 
Succeeding this chapter is a review of the relevant literature, which includes 
an overview of the issues associated with obesity and overweight and a 
particular focus on CWLPS and health inequalities (Chapter 2). Chapters 3 
and 4 outline the methods and methodology employed for research which I 
conducted for my PhD. Chapter 5 describes the results of my research, and 
finally I have presented a discussion of my findings and conclusions in 
Chapter 6. 
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Chapter Two 
Review of the literature 
 
2.1 Introduction 
This chapter provides an overview of the methods of assessment of obesity, 
definitions of obesity, prevalence of obesity on a global, national and regional 
level, and the consequences and costs of obesity. Finally, this chapter reviews 
the treatment options available for overweight and obese adults within and 
outside of the primary care setting in England, UK.   
  
2.2 Methods of assessment 
 
2.2.1 BMI 
The BMI or Quetelet Index is the preferred measurement of predicting adiposity 
amongst adults in a primary care setting, as it is the most practical, reliable, 
valid, and a cost-effective method of choice. BMI is a measure of weight relative 
to height, calculated by dividing weight (kg) by height in metres squared (m²) 
(Foresight, 2007b). For BMI to be measured effectively it is advised that 
electronic digital weighing scales and a freestanding stadiometer to measure 
height is used. The equipment should be placed on a flat surface; individuals 
should be measured after removal of their shoes and heavy items removed 
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from their pockets. ISAK is just one organisation which provides guidance and 
training resources on the measurement of height and weight (and I have 
attended an ISAK course). 
The World Health Organization (1997) have established different cut-off points 
for the classification of overweight and obesity status amongst Caucasian 
adults, which are based on mortality data from insurance companies. Asian 
populations, for the same BMI, have an increased risk of cardiovascular disease 
(CVD) compared with Caucasians (Bell et al, 2002). As such, the World Health 
Organization have established slightly different (lower) cut-offs for Asians.  
Table 1: World Health Organization (1997) guidelines  
Classification BMI 
Underweight < 18.5 
Ideal weight 18.5–24.9 
Overweight 25.0–29.9 
Class I obesity 30.0–34.9 
Class II obesity 35.0–39.9 
Class III obesity   ≥ 40.0 
 
In public health, these BMI cut-offs are widely used amongst healthcare 
professionals as a means of categorising people for treatment options. 
Individuals who have a high muscle mass, and low fat mass, such as athletes, 
could be misclassified as obese when in actual fact they are not. This is one of 
the limitations of using BMI.  
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In 1996 the BMI index became widely used in the UK and across the world, 122 
years after Quetlet proposed the use of it. Some argue that it is not the best 
index of obesity (Bray, 1998). The use of BMI as an index of body fatness relies 
on the premise that, at any particular body weight, a set proportion of that 
weight it made up of muscle and a set proportion is made up of fat. Most 
athletes (apart from say marathon runners) would typically be classified as 
obese due to their higher than normal muscle mass. So, for these athletes, 
additional methods of assessment are needed to assess BMI.  
The general public faces confusion and controversy around the risks of obesity 
to health.  Some reports suggest that that overweight is not damaging to health, 
and should not be held up as a major public health concern (Campos et al, 
2006). However, other research is quite clear that obesity is a significant risk 
factor for health and the current high levels of obesity in some countries 
requires effective public health interventions (Kim & Popkin, 2006). 
Cohort studies have demonstrated a J-shaped or U-shaped association 
between BMI and mortality. Within these studies, the mortality rate increases in 
individuals with a higher and lower BMI compared to those with normal weight 
(Allison et al, 1997). However, research (Lewis et al, 2009) has suggested that 
thin and obese people are most likely to die than overweight persons. 
Controversy surrounds overweight status, some report that introducing 
interventions for overweight populations to reduce their weight could have 
detrimental effects (Campos et al, 2006). Though others argue that individuals 
in the overweight range could be harbouring substantial health risk (Kim and 
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Popkin, 2006), and could lead to obesity classification, therefore public health 
interventions of overweight populations are of paramount importance. Overall, 
with a raised BMI, cardiovascular risk factors increases (type 2 diabetes mellitus 
and systemic hypertension), and could benefit from weight targeted 
interventions as part of their treatment regime. 
Katzmarzyk and colleagues (2012) recent study of 10,522 adults, 18-74 years 
of age who participated in the Canadian Heart Health Surveys (1986-1995) 
were divided into five BMI categories (< 18.5, 18.5-24.9, 25-29.9, 30-34.9, and 
> or = 35 kg/m²). Between BMI and mortality at baseline a J-shaped curve was 
observed for cardiovascular and total mortality, lowest risk of mortality was 
observed in normal weight participants (18.5-24.9).after age and multivariate-
adjusted hazard ratios were undertaken significant associations between 
cardiovascular disease and cancer mortality were observed in men. However, 
cancer mortality was not apparent until a man’s BMI reached 35. In women 
cancer, mortality from all cause, and cardiovascular consequences observed a 
significant liner trend across the five BMI categories. However, excess mortality 
risk was only significant when females reached a BMI of 30-34.9, overweight 
women did not have an observed elevated risk. BMI at which the increase 
begins varies with different populations. For example, research is still trying to 
identity why Asian populations have higher weight-related risk factors at a lower 
BMI. One possible explanation is in relation to body fat. In comparison to white 
Europeans of the same BMI, Asian populations have 3-5% more body fat 
(Deurenberg et al, 2002), and are more susceptible to abdominal obesity, 
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whereby the risk of developing cardiovascular disease and type 2 diabetes 
significantly increases. 
In my personal opinion I believe that a person’s BMI can be the contributing 
cause of cardiovascular disease, cancer and mortality; specifically when an 
individual’s BMI is beyond  30. However, when BMI is assessed, all contributing 
factors should be taken into account (age, gender, ethnicity, smoking, alcohol 
consumption, physical activity, and environment). Alike health inequalities, BMI 
is a complex subject, and requires additional research, specifically in Asian 
populations. 
 
2.2.3 Waist circumference 
Waist circumference is widely accepted as a useful additional method of 
assessment of body fatness in research settings, and is used in a few clinical 
practices. A variety of different protocols can be used to measure waist 
circumference; immediately above the iliac crest (National Institute of Health 
recommendation), umbilicus, and minimal waist (International Society for the 
Advancement of Kinanthropometry-ISAK).  The World Health Organization 
(2008b) recommends that the midpoint point between the lowest rib and 
immediately above the iliac crest should be used, with hip measurement, to 
calculate the waist: hip ratio to assess metabolic syndrome. Metabolic 
Syndrome is the collection of conditions which cluster together (Table 2; 
Campbell & Haslam, 2005).  
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Table 2: Criteria levels by condition used to define the Metabolic 
Syndrome 
Condition Criteria 
BMI >30 
Waist: hip ratio >0.9 
Fasting glucose between 5.6-6mmol/L 
Triglycerides >1.7mmol/L 
High density lipoprotein <1.04 mmol/L 
High blood pressure (hypertension) >130/85mmHg 
 
Waist circumference is highly correlated with cardiovascular risk factors (high 
blood pressure, raised lipids, insulin resistance) and visceral adipose tissue. 
BMI is also commonly associated with an increased risk of developing type 2 
diabetes, certain cancers, and a reduction in overall life expectancy.  
 
Table 3: The relationship between waist circumference and odds ratios for 
risk amongst male and female adults (adapted from Han et al, 1995)    
 
 
 
Action level 1 (increased risk)  Action level 2 (high risk)  
 Men Women Men Women 
Waist (cms) 94 cm  80 cm 102 cm 88 cm 
Odds ratio for risk 2.2 1.6 4.6 2.6 
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Figure 1: Apple (Gynecoid) vs. Pear (android) illustration 
 
As illustrated in Figure 1, there are two body shapes; apple and pear. Apple 
shapes are typically observed in males; visceral and subcutaneous fat is mainly 
concentrated in the abdominal area. Pear shapes are traditionally observed in 
women; subcutaneous fat is primarily accumulated on the thighs, hips and legs. 
Greater health risks are associated with people with apple shapes, because of 
the increasing cardiovascular disease consequences and metabolic 
abnormalities that are almost exclusively related to visceral fat.  As illustrated in 
Table 2, waist circumference is a simple proxy estimate for various risk factors; 
predominately cardiovascular.  
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Independently used, waist circumference is also a reasonable predictor of total 
adipose tissue, subcutaneous adipose tissue, and increased blood pressure.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Illustration of visceral and subcutaneous fat 
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Figure 3: Subcutaneous fat illustration 
 
Subcutaneous fat is located just beneath the skin in the hypodermis, and is 
easier to reduce through weight loss attempts than intra-abdominal fat, situated 
around and within the abdominal and thoracic cavities (heart, lungs, liver, and 
kidneys).  
 
Subcutaneous 
fat 
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2.2.4 Waist: Hip ratio 
Formiguera and Canton (2004) support the requirement for waist to hip ratio to 
be conducted in individuals whose BMI is >35, stating that this measure is 
better than just waist circumference for the evaluation of fat distribution pattern. 
Waist hip ratios are used to assign health risks; above 0.82 and 0.94 for men 
and women, respectively. 
 
2.2.5 Skinfolds 
ISAK notes that the measurement of skinfold thickness has the poorest 
accuracy and precision compared with other anthropometric measurements, 
and that people who take such measurements should be trained sufficiently and 
follow a series of checks in a protocol:  
a) the calliper indicator must be on zero 
b) the calliper is held at 90 degrees at all times 
c) the skinfold is picked up at the marked site 
d) the calliper is placed 1cm below the marked site 
e) measurement is taken after two seconds, after the full pressure of the 
calliper has been applied 
f) skinfold measurements should be taken in succession to avoid experimenter 
bias 
g) inter and intra tester error should be quantified, and should be 10% at inter-
tester level and 7.5% at intra-tester level. 
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Predictive equations which were derived from skinfold thickness experiments 
have been used in clinical and epidemiological settings for decades (Durnin & 
Womersley, 1974), and they provide good correlations with body fat 
approximations from Dual energy X-ray absorptiometry (DXA), neutron 
activation analyses (doubly-labelled water), and underwater weighing. Various 
skinfold thickness prediction equations have been developed, including all or 
selected skin fold sites to estimate body fat. Garcia and colleagues (2005) have 
reported that Durnin and Womersley’s (1974) internationally recognised 
prediction equations using four skinfold sites (bicep, tricep, subscapular and 
supra-iliac) underestimate the amount of body fat in the obese. They suggest 
that prediction equations using additional skinfold sites should be used in sex-
specific equations, combining skinfold thickness measured at various sites 
(chin, biceps, triceps, subscapular, chest, abdominal, hip, thigh, knee and calf), 
various circumferences (waist, hip and thigh), and bone breadth measurements 
(chest, elbow, knee, wrist, and ankle).  Garcia and colleagues (2005) have 
shown that using these multiple measures within their equations improves the 
validity of estimates of body fatness in obese people. Hume and Marfell-Jones 
(2008) have highlighted the importance of measuring, identifying and marking 
the skinfolds, concluding that practitioners should be trained to the standards 
recommended by ISAK.  
In summary, the validity of estimation of body fat is variable between the 
different methods listed above, and the reliability of estimates for each method 
is also variable. Correct training for those carrying out these measurements can 
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increase the reliability of the measurements, and the ISAK accreditation course 
is considered a gold standard training course.   
 
2.2.6 Bioelectrical impedance 
Bioelectrical impedance is a simple and useful method for predicting body fat. 
The method involves passing a mild current through electrodes that are worn at 
various points on a person’s body, or via standing upon the electrodes with bare 
feet. The principle of this method relies on the fact that lean body mass and 
bones are good conductors, whereas body fat is a poor conductor of electricity. 
Various outlets offer weighing scales that incorporate bioelectrical impedance, 
which can be used by the public for a small nominal fee. This method of 
assessment relies upon a presumed and normal hydration status of the 
individual, and the derived equations do not take ethnicity into account.  
 
2.2.7 Doubly labelled water 
“The doubly labelled water (DLW) method is a technique used to measure the 
average daily energy expenditure of free living humans” (Trabulsi et al, page 
1370, 2003). Schoeller et al (1995) have reported that there is a high degree of 
accuracy from doubly labelled water measurements. The method involves the 
participant consuming water that is labelled with the stable isotopes deuterium 
and 18O; deuterium is eliminated through the body as water and 18O is 
eliminated through the body as water and carbon dioxide. The principle of this 
method relies measuring (in urine) and estimating the amounts of two isotopes, 
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and subtracting one from the other (Schoeller, 1999). This method is easy to 
administrate, but is very expensive.  
 
2.2.8 Air-displacement plethysomograhpy and hydrodensitometry 
Air-displacement plethysomograhpy (BOD POD) and hydrodensitometry are 
considered the ‘gold standards’ when assessing body composition. 
Hydrodensitometry requires the subject to be submerged in a tank of water, 
preferably in a tight fitting swimsuit to minimise air trapped in fibres of clothing. It 
is advised that the participant be of normal hydration (three hours after a meal, 
showered and recently urinated and defecated). The participant climbs into the 
tank, immersing him or herself and removing excess air from the skin and 
swimsuit. To measure body weight in water, the participant uses the weighing 
equipment available within the tank.  The head and shoulders are lowered into 
the water whilst exhaling for five seconds; weight is taken and repeated, taking 
the mean of the heaviest reading. The density of the body is calculated using 
the standard formula (Siri, 1961): 
Body weight (air) 
Body weight (air) - Body weight (water) 
 
Body fat percentage is calculated from body density using the Siri (1961) 
equation: 
Body fat = (4.95/body density – 4.50) x100 
 
Chapter Two Review 
of the 
literature 
 
27 
 
The BOD POD uses a similar principle of displaced volume as is used in 
hydrostatic weighing, except it uses displaced air (rather than water). The 
inverse relationship between pressure and volume is used to obtain an estimate 
of the body volume of a participant. Procedures are similar to hydrostatic 
weighing; a participant is weighed in air, has their height taken, and is advised 
to wear a tight fitting swimsuit. Body volume is derived initially by measuring the 
interior volume of the empty chamber, and subtracting that from the volume 
whilst the subject is within the BOD POD. This method of assessment is 
otherwise known as Boyle’s Law: 
P1V1 = P2V2 
P=
 
Pressure 
V= Volume 
The density of the body can be calculated using the standard formula: 
Body Density= Mass/Volume 
Mass= Body weight (kg) 
Volume= Litres (l) 
 
Air-displacement plethysomograhpy uses the same Siri (1961) equation in order 
to calculate body fat percentage of a subject. Fields et al (2000) validated the 
BOD POD against hydrostatic weighing, reporting the limitations associated 
with the type of clothing worn within the BOD POD. Agreement between both 
methods was demonstrated for body density, and body fat predictions were 
similar.  However, the authors reported that caution should be taken when 
participants wear clothing that is not a tight fitting swimsuit.   
Chapter Two Review 
of the 
literature 
 
28 
 
2.2.9 Magnetic resonance imaging (MRI) 
Magnetic resonance imaging scans are able to diagnose conditions related to 
tissue, organs and bones. Powerful magnets within the scanner produce strong 
magnetic fields and radio waves, producing a detailed image of the inside of the 
body. Basic T1 and T2 weighted MRI scans offer clinician’s accurate 
assessments of adiposity, but these type of scans can only be done in a 
number of specialist centres within the United Kingdom. Adiposity can be 
estimated from routine MRI scans, but these are less accurate (Campbell & 
Haslam, 2005). 
 
2.2.10 Computed tomography (CT) 
Rössner and colleagues (1990) have suggested that computed tomography 
(CT) scans are the most reproducible and accurate form of body fat 
assessment, specifically in relation to abdominal adipose tissue. Images 
produced of cross-sections of the body provide the practitioner with a two-
dimensional picture of specific parts of the body. Typically, CT scans are used 
in obese patients to examine endocrine organs associated with obesity related 
co-morbidities, or a more generalised examination of the abdomen. These types 
of scans are time consuming, and carry the risk of developing cancer from 
exposure to radiation, and as such have made clinicians apprehensive in 
prescribing CT scans as a method of body fat assessment.  
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2.2.11 Dual energy X-ray absorptiometry (DXA) 
DXA or DEXA scans are traditionally used to determine the bone mineral 
density of an individual, and are most commonly used to assess the risk of a 
person developing osteoporosis. In obese patients, DEXA scans are used to 
estimate the amount of fat mass. 
 
Personally, I feel that the majority of the population would assess their level of 
obesity according to their clothing size. Currently, the average clothing size for a 
woman in the UK is a size 16 (Nicholas, 2013). Therefore, I feel that women 
would only feel that they need to lose weight when they are larger than a size 
16 unless someone (family member, colleague, friend etc.) has commented that 
they should lose weight. This would also apply for men too. Men that are bigger 
than a large sizing in UK clothes (KGB answers, 2012), I feel would only lose 
weight beyond this sizing, or unless someone has commented that they should 
lose weight.  
 
2.3 Definition and health risks of obesity in adults 
Obesity can be described as an excess of fat in the subcutaneous connective 
tissue that is a threat to health and well-being. This excess of fat is associated 
with reductions in life expectancy (National Audit Office, 2001) and susceptibility 
to a number of chronic diseases, including cardiovascular, pulmonary, 
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gastroenterological and endocrine disease. Excess fat in men and women is 
associated with musculosketal problems, and also psychosocial problems. 
For any level of obesity, overweight middle-aged men (in general) have greater 
health risks compared with women because they tend to carry more of their 
excess fat around their abdomen (apple shaped), which is more detrimental to 
health than being pear shaped (described above). 
Excess fat in men is associated with a higher risk of prostate cancer, kidney 
stones and gout. Excess fat in women is associated with an increased risk of 
polycystic ovarian syndrome (PCOS) and post-menopausal breast cancer. 
 
2.4 Prevalence of obesity in adults 
The Foresight report (2007b) found one in four adults in the UK were classified 
as obese and predicted, if the then current trends continued, the prevalence 
could double by 2050. 
 
2.4.1 North East prevalence 
As previously mentioned in 1.3, the 12 areas of the North East, apart from 
Newcastle (Gateshead: 30.7%, Darlington: 27.6%,: 27.7%,Sunderland: 
28.6%,Redcar and Cleveland: 29.6%,South Tyneside: 27.4%,Northumbria: 
27.3%,Tyneside: 26.6%,Newcastle: 23.9%,Middlesbrough: 27.9%,Hartlepool: 
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27.5%, and County Durham: 28.6%) observe higher obesity statistics than the 
current UK average; 24.2% (Public Health England, 2013).  
 
Gateshead’s obesity prevalence of 30.7% is worse than the highest UK average 
of 30.2%. Kumanyika et al (2008) estimated that the number of overweight and 
obese individuals could increase to 1.5 billion by 2015, and using this model 
and in line with trends seen in 2013, the North East region could, in theory, 
observe obesity levels beyond 23.9%-30.7% by 2015. 
 
2.4.2 Global prevalence 
Globally the number of overweight and obese individuals could increase to 1.5 
billion by 2015 (Kumanyika et al, 2008). Below illustrates the difference in the 
prevalence of obesity between countries for men (Figure 4) and women (Figure 
5) in 2005, and Figure 6 shows the trends in the prevalence of obesity in 
difference countries since 1978. 
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Figure 4: The prevalence of obesity in males above 15 years of age in 2005 
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Figure 5: The prevalence of obesity in females above 15 years of age in 
2005 
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Figure 6: A line graph to illustrate trends in the prevalence of obesity 
global obesity trends from 1978 
 
2.6 Summary 
As demonstrated in Figures 4, 5 and 6, the prevalence of obesity in adults rose 
rapidly in the UK, as in many other countries, up to 2000, but since then the 
prevalence rates have slowed down although they still remain high. 
 
2.7 Costs to society 
Financial implications of obesity include costs to the state, and to the individual. 
Direct costs to the NHS for the prevention, diagnosis and treatment of obesity 
have been estimated at £10 billion per year (Campbell & Haslam, 2005). 
Chapter Two Review 
of the 
literature 
 
35 
 
However, additional (indirect) costs through increased number of sick days, 
earlier retirement; decreased performance, earnings, productivity and capability 
could equate to £49.9 billion per year for England (Campbell & Haslam, 2005).  
Table 4 illustrates the predicted of direct and indirect costs associated with 
obesity for 2050 (data taken from Foresight; Tackling Obesities: Future 
Choices—Modelling Future Trends in Obesity & Their Impact on Health, 
2007b). 
 
Table 4: Predictive costs associated with obesity in England in 2050 
Cost type 2050 projected cost 
£billion/year 
Total NHS cost of diabetes 3.5 
Total NHS costs of coronary heart disease 6.1 
Total NHS costs of stroke 5.5 
Total costs of other related diseases 7.8 
Total cost (all related diseases) 22.9 
NHS cost increase above current, due to elevated BMI 
(overweight and obesity) 
5.5 
NHS cost attributed to elevated BMI (overweight and 
obesity) 
9.7 
NHS costs attributable to obesity alone 7.1 
Projected percentage of NHS budgets at £70 billion 13.9% 
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2.8 Risks and consequences 
 
2.8.1 Cardiovascular consequences 
Obesity is associated with a range of cardiovascular problems, including 
congestive heart failure. Poirier et al (2006) suggest that obesity could lead to 
congestive heart failure by promoting diabetes, hypertension and coronary heart 
disease, and Levy et al (2002) has shown that this risk increases with 
increasing level of obesity. Gradual weight loss of 5-10% in an obese individual 
can significantly improve obesity related risk factors for coronary heart disease 
(Klein et al, 2004). 
The term ‘Syndrome X’, otherwise referred to as Metabolic Syndrome 
(mentioned above), is often present in obese adults. The diagnosis of this 
syndrome is by the presence of at least three of the criteria listed in Table 2. 
 
2.8.2 Psychological and social consequences 
Obesity is associated with a number of psychological and social problems, 
including low self-esteem, and there is some debate about whether obesity is 
the cause, or the consequence, of these problems. These problems can affect 
individuals in many ways, including their employability, and thus their potential 
to get a good job. An obese individual could also suffer lower rates of pay. 
Baum and Ford (2004) report that an obese person could suffer a wage penalty 
in the range of 0.7%-6.3%. Therefore, in relation to CWLPS, obese individuals 
could be in a ‘chicken and egg situation’. An obese person might want to lose 
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weight through a CWLPS, though cannot afford to do so as their weight has 
been reflected in their pay grade. Register and Williams’ (1990) analysis of the 
National Longitudinal Survey Youth Cohort of 8000 18-25 year old men and 
women indicated that obese women earned 12% less than their non-obese 
colleagues, and are more likely to have lower paid jobs than ‘thinner’ women. 
Typically, CWLPS is purchased by a female population, therefore obese women 
could continue to increase their weight as they cannot afford to purchase 
CWLPS based upon their lower wage than non-obese women.  Employment 
law should protect individuals from discrimination in the workplace, but there is 
evidence to suggest that this is hard to uphold.  Polinko and Popovich (2001) 
researched discrimination in the workplace, common thoughts of obese are that 
they are ‘lazy, unproductive, and unattractive’. Therefore, these misconceptions 
are still evident in society. More specifically in the context of my PhD, obese 
individuals could choose a CWLPS that is more acceptable in their workplace 
than a CWLPS that is more effective. For example Slimming World could be 
chosen as other colleagues are also following this commercial weight loss 
programme, and it is acceptable amongst peers. However, a produce like Alli 
might not be acceptable in the workplace, due to the inconvenience of the 
individual requiring additional toilet breaks, or Slim Fast could cause 
embarrassment to the individual due to the large marketing logo wrapped 
around the bottle. In my personal opinion, I believe that women would be more 
concerned about their choice of CWLPS in the workplace than a man.  
Some research (Miller and Downey, 1999) suggests that there is a relationship 
between self-esteem and weight, a moderate relationship was found for women. 
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Though self-esteem is moderated by body esteem. Friedman and colleagues 
(page 33, 2002) found that “for both men and women, body-image satisfaction 
partially mediated the relationship between degree of overweight and 
depression/self-esteem”. Weight stigma has been researched for some time, 
and is dominant in employment bias. Obese individuals also could delay seeing 
a health care professional due to bias in medial settings (Obesity Society, 
2010), and due to negative past experiences might not seek advice from a GP, 
and decide to use CWLPS instead. 
 
2.8.3 Pulmonary consequences 
Obesity is associated with sleep-associated breathing disorders, including sleep 
apnoea and Pickwicken syndrome. These disorders are associated with 
coronary heart disease (Leung & Bradley, 2001), and obese patients with 
congestive heart failure or/and sleep disorders are at increased risk of fatal 
arrhythmias, resulting in sudden death. Riley et al (1976) suggest that 
pulmonary embolism could occur if obesity-linked hypoventilation syndrome is 
apparent, resulting in death or a poor quality of life. 
There is some interesting data in the literature about asthma and obesity, 
particularly for those individuals who suffer from severe asthma who require 
regular steroid medication (Rodriguez et al, 2002); regular use of steroids 
increases visceral adiposity. 
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2.8.4 Endocrine consequences 
The most common medical condition that is associated with obesity is type 2 
diabetes. Campbell and Haslam (2005) estimate that 85% of type 2 diabetics 
are either overweight or obese. As one might expect, the primary treatment for 
type 2 diabetes in those individuals who are obese (i.e. the majority) is weight 
loss. However, where patients are unable to comply with weight loss 
programmes, they are prescribed medication. Self-management of the 
prescription drug Metformin is the current treatment option for type 2 diabetes in 
England. Treatment of type 2 diabetes for one year ranges from £23.07p-
£69.22p per individual (Department of Health, 2013a).  
 
2.8.5 Gastrointestinal consequences 
The most common gastroenterological complication of obesity is non-alcoholic 
fatty liver disease. Non-alcoholic fatty liver disease is a broad-spectrum disease 
ranging from fatty infiltration of the liver alone, or combined with inflammation. 
Early detection of the disease can be managed with diet and medication, but a 
late diagnosis might require a liver transplant. 
 
2.9 Determinants of obesity 
 
2.9.1 Socio-economic status and obesity 
Like in many other countries in Europe, obesity is positively associated with 
economic and social deprivation in England (House of Commons; Health 
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Committee, 2004; Law et al, 2007). Howard et al (2000) have explored the 
relationship between socioeconomic status and obesity, concluding that the 
relationship the positive association continues to strengthen as the level of 
obesity increases.  
As mentioned earlier (1.3), the North East region has high levels of obesity 
prevalence. The most highly disadvantaged Super Output Areas (SOAs) are 
classified as deprived on several of the seven Domain Indices that make up the 
Index of Multiple Deprivation (IMD) (Noble et al, 2006). Ten percent of the most 
deprived SOAs on the IMD are located in the North East. Specific geographical 
locations in England, including the North East, Humber and Yorkshire, and 
West and East Midlands, show significant health inequalities (White et al, 2007). 
Postcodes within the Tees Valley area (TS1-TS18) were chosen specifically as 
the initial method to recruit participants was via the Evening Gazette, which 
covered these postcodes, and these postcodes were consistently within one of 
the most deprived regions in the North East.  
My research was specifically aimed at investigating the use of commercial 
weight loss products and services in the North East, which I hope will be part of 
the preliminary work for a randomised trial in the future. Currently, I would like to 
develop a trial which aims to increase awareness and access to the best 
CWLPS options for obese individuals who live in deprived areas of the North 
East. I understand that such a trial would be challenging for a variety of 
reasons, including the likelihood of a low recruitment rate. Health promotion 
interventions targeted at individuals who live in low socioeconomic areas 
consistently attract poor participation rates (Michie et al, 2009). 
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2.9.2 Gender and obesity 
Sobal and Stunkard (1989) conducted a review of 144 epidemiological studies, 
and found that the relationship between SES and obesity was inconsistent for 
men in high income countries, but that there was a strong and consistent 
inverse relationship between SES and obesity in women in high income 
countries.  
The relationship between SES and gender in England has been looked at in 
more detail by the National Institute for Health and Clinical Excellence; no 
apparent relationship has been observed between IMD and the prevalence of 
obesity in men (National Institute for Health and Clinical Excellence, 2006). In 
contrast, the prevalence of obesity in women living in the most deprived areas 
(IMD) of England was relatively high, and the prevalence of obesity in women 
living in the least deprived areas (IMD) of England was relatively low. 
This gender differences could be due to a plethora of factors including cultural 
differences, work status and patterns, income, and pay inequality. Certainly, 
groups of women in the UK with a lower household income, who work in an 
unskilled profession, and have fewer qualifications, have higher rates of obesity 
(Wardle et al, 2002).    
It is clear from the literature that women are more likely to take part on health 
promotion research compared with men, particularly in area of deprivation. I 
was very aware that I needed to design a recruitment plan for my study which 
involved a variety of engagement opportunities that appealed to both men and 
women.  
Chapter Two Review 
of the 
literature 
 
42 
 
Reeder et al’s (2002) study of 26,293 men and women aged 18 to 74 years 
report that BMI (27+) increased with age more so in men than in women; 35% 
and 27% respectively. As age increased in men and women (55-64 years old), 
so did their BMI. However, in men after 64 years of age their BMI decreased, 
though remained unchanged in women. Men of a healthy (BMI 20-24) weight 
decreased by 24% between the youngest and oldest age groups, in comparison 
to 20% in women. Class II obesity was found to be more prominent in women 
aged 55-74. Within both males and females, as age increases, so did the high 
blood pressure, centripetal fat distribution, plasma cholesterol, triglycerides, and 
low density lipoprotein (LDL). Gender has an important role in relation to the 
storage of adipose tissue, metabolism (Power and Schulkin, 2008), and get fat 
in different ways. Women have greater adipose tissues stores, after correcting 
for BMI, have larger stores of subcutaneous fat, and adipose tissue is more 
likely to be stored on the thighs and buttocks. Men are more likely to have 
visceral of fat, and be more susceptible to abdominal obesity. Research has 
also shown that the effects of visceral fat on health vary between genders as 
well (Jensen et al, 2006). The metabolism of fat also is different between males 
and females, women are more likely to store fat than men, however, “women 
also appear to utilise fat as an energy substrate during periods of sustained 
exertion more so than do men” (Power and Schulkin, page 934, 2008. 
Therefore, gender plays a significant role in obesity and overweight prevalence.
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2.9.3 Ethnicity and obesity 
As mentioned earlier, lower BMI cut-off points for overweight and obesity are 
recommended for Asian populations (World Health Organization, 1997). A 
higher level of body fat and central fat distribution, for the same BMI as 
Caucasians, is observed, increasing the risk of cardiovascular disease 
outcomes at a lower BMI (Bell et al, 2002). Lear (2005) found higher values of 
total cholesterol, low-density lipoprotein, triglycerides, and C - reactive protein, 
and lower values of high-density lipoprotein, in Asian men compared with 
matched Caucasian men. Similar findings were observed for women.  
 
2.9.4 Age and obesity 
It is well documented that a person’s age is associated with the prevalence of 
obesity. In 16-24 year olds, the prevalence of obesity in England is at its lowest, 
and it increases steadily over the decades until the age of about 75 (Figure 
7).Research suggests that different cut-off measures should be included for a 
person’s age; specifically for waist circumference (Després et al, 2001) . Waist 
circumference and visceral fat is affected by age and menopausal status. As 
males and females age, their regressions slopes increase, and are more 
apparent in men than women at any age. When a female starts the menopause, 
the slope then starts to become similar to that of the male slope. In men and 
women over 50, abdominal obesity has been found to be a strong predictor of 
insulin resistance (Racette et al, 2006), and the cardiovascular risk profile also 
deteriorates with age. Baum and Raum (2009) report that obesity and BMI 
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prevalence grow rapidly with a person’s age. Also deprived individuals have a 
higher BMI, and the gradient steepens with a person’s age. Therefore, age is in 
important factor in obesity and overweight prevalence, and should not be 
assessed independently. Other factors including gender (see 2.9.2), physical 
activity, and SES should be reported. It is unclear as to why the prevalence of 
obesity in England varies by age, but a general decline of physical activity with 
age is likely to play a key role. In my personal opinion Figure 7 should not be 
taken at face value, due to the rise in general living costs, older individuals 
might not be obese as they cannot afford to eat sufficiently, their state pension 
might only be enough to pay for household bills, and an elderly person might 
wish to spend the rest spend of their pension on their children/grandchildren 
than on food. As a hypothetical scenario, if all age groups were given the same 
wage/pension, obesity levels would still show a marked gradient based upon 
where an individual lives, gender, whether they smoke, how much alcohol they 
drink, and so forth. Therefore, alike health inequalities, age is also a contributing 
factor to obesity and overweight prevalence. 
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Figure 7: Prevalence of obesity in England by age (Public Health England, 
2013 
 
2.9.5 Sleep and obesity 
Recent studies (Knutson, 2012) have found a relationship between the 
prevalence of obesity and sleep duration in adults. Experimental and 
observational studies have suggested that reduced sleep (<6 hours/day) could 
potentially increase the risk of obesity, but this assumes a causal mechanism, 
and this is hotly debated. Additional research on the relationship between sleep 
and obesity, especially in low socioeconomic groups where more individuals 
work shifts, would be useful.  
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2.9.6 Education and obesity 
As demonstrated in Figure 8 as the level of education increases the level of 
obesity decreases. A variety of factors could be the reason for this association. 
Education and obesity is a complex subject, whereby education is at the focal 
point of secondary variables as such as income, occupation status or 
characteristics of the area of residence.  Conclusions of the Low Income Diet 
and Nutrition Survey (Food Standards Agency, 2007) showed that the higher 
the level of education, the better the persons overall diet was, specifically fruit 
and vegetable consumption was better. An individual with poor literacy or 
numeracy skills might not be able to read nutritional labelling or understand how 
the different nutritional properties affect their health (fat, calories, sodium). Key 
policy messages might not be accessed by those with a lower education level, 
especially when messages do not demonstrate how they would be applied to a 
person’s life (how can fruit and vegetable consumption be increased when it is 
cheaper to buy unhealthy foods. Most research focuses on the health of the 
individual and socio-economic factors, or mortality, only limited evidence exists 
concerning the relationship between obesity and education. Cutler and Lleras-
Muney’s (2006) research has suggested that additional years of schooling 
reduces the likelihood of smoking, excessive drinking, illegal drugs, obesity and 
overweight. In relation to policy implications,   Cutler and Lleras-Muneys (2006) 
suggest that obesity rates could decrease by 9% in the UK if education was 
increased by 1 year. At present the casual link between obesity and education 
is not conclusive. However, within the region which this study was situated 
(North East), it is my personal opinion that the secondary variable of income 
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could be the cause of obesity prevalence. A person’s qualifications would 
determine what type of job is available, typically, a person with no qualifications 
would be in an unskilled or manual job, whereby the monthly income would be 
lower than someone who has a degree and would be in a managerial or skilled 
role. Therefore, education would be the primary cause of a person having a 
wage that reflects their qualifications, and monthly income. Dependent upon 
monthly income would determine what foods are purchased by the individual. 
Low monthly incomes could lead to the consumption of unhealthy items, as they 
are cheaper to buy than healthy items.   
 
Figure 8: Prevalence of obesity in England by educational level (Public 
Health England, 2013). 
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2.9.7 Other determinants of obesity 
For individuals who have certain rare genetic disorders, e.g. Prader-Willi 
syndrome, it is almost inevitable that those who are obese in adolescence will 
also remain obese as an adult. 
 
2.9.8 Summary of determinants of obesity 
The obesity system map (Foresight (2007b) has acknowledged that there are 
over 100 direct and indirect variables of obesity, divided into seven distinctive 
themes. 
• Biology: An individual’s genetic makeup will influence overall health and 
ill-health. 
• Activity environment: The influence of the environment on an individual’s 
activity behaviour. For example an individual might not wish to cycle due 
to their workplace due to road safety fears, inadequate shower facilities.  
• Physical Activity: Duration, intensity and type of physical activity carried 
out by individuals on a daily basis. 
• Societal influences: A variety of factors can impact on the individual 
including culture, peer pressure, education and the media 
• Individual psychology: An individual has different psychological 
triggers/drives, for example a woman might eat high calorie/high fat food 
at certain times of a menstrual cycle, consumption and physical activity 
patterns could depend upon a person’s working hours, and physical 
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activity preferences could be due to an individual’s previous experience, 
or what type of exercise they enjoy participating in. 
• Food environment:  The individual’s food environment can impact on 
food choices, for example the purchase of unhealthy food could be due 
to the location of a takeaway, and the price of their food. 
• Food consumption: Portion sizes, quality of the food, and frequency of 
eating/snacking.  
The seven themes can also be drawn upon in relation to health inequalities: 
• Biology; individuals of low SES have poorer health have less access to 
health care facilities.  
• Physical activity; individuals of low SES are less physically active. 
• Activity environment; there might be (perceived and real) barriers to 
individuals of low SES to be physically active, e.g. safety of area in which 
they live may be poor and therefore they do not want to go out alone, 
particularly at night. This could be because they are scared of gangs of 
youths, or because the environment is not pleasant, e.g. dog poo on the 
pavements and poor lighting on streets. 
• Societal influences; there is some evidence that social norms are very 
important in determining an individual’s health behaviours. So, for 
individuals of low SES who are living in a community where nobody 
walks or is physically active unless they absolutely have to be, then it is 
hard for one person in that community to engage in regular exercise to 
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simply improve their health. They might get laughed at by others, for 
example. 
• Individual psychology; as previously mentioned individuals of low SES 
are more likely to have low esteem, which in turn may be a barrier to 
them believing that they can maintain a weight loss programme and 
reduce their weight.  
• Food environment; depending on whether an individual with a low SES 
has a car or not will influence where they do their food shopping. For 
those individuals who tend to do most of their shopping in ‘corner’ shops 
in deprived areas, and because everything that they buy must be 
perceived as ‘value for money’ then they are less likely to buy fruits and 
vegetables, and more likely to buy ready-made foods.  
• Food consumption; individuals of low SES are more likely to purchase 
foods which they know their family will eat and enjoy, and avoid the risk 
of buying or making meals which may go to waste.  
 
2.10 Treatment and management of obesity 
 
2.10.1 Pharmacotherapy 
In the last decade in the UK, three drugs were licensed for the treatment of 
obesity; orlistat (xenical), sibutramine (reductil) and rimonabant (accomplia). 
The European Medicines Agency (EMEA), a European Union (EU) body, 
concluded in June 2008 that rimonobant should be withdrawn based upon 
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research that the benefits did not outweigh the risks associated with taking the 
drug. Upon that recommendation, the National Institute for Health and Clinical 
Excellence withdrew its recommendation on the use of rimonabant. The 
National Institute for Health and Clinical Excellence also suspended their 
recommendation for the prescription of sibutramine in January 2010, based 
upon the findings of a review conducted by the European Medicines Agency 
which found that the cardiovascular risks of sibutramine outweigh its benefits. 
These drugs could be reinstated in the future, if additional evidence is produced 
to support their efficacy, and long-term benefits.  
 
2.10.1.1 Performance of orlistat, sibutramine and rimonabant 
 
2.10.1.1.1 Orlistat 
Orlistat is a non-centrally acting anti-obesity agent, which acts locally in the 
gastrointestinal tract; lipase binds to triglycerides producing monoglycerides and 
free fatty acids. Brownell and Fairburn (2002) report that the recommended 
dosage of 120mg, which is required three times per day, alongside  a hypo 
caloric diet, results in inhibitory effects of dietary absorption by 30%. 
 
2.10.1.1.2 Sibutramine 
Sibutramine is a dual physiological anti-obesity drug whereby it acts upon the 
neurotransmitters; serotonin and norepinephrine as a reuptake inhibitor to 
enhance satiety. 
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2.10.1.1.3 Rimonabant 
Rimonabant blocks the CB1 receptors in the endocannabinoid system that are 
located in abdominal fat, the liver, the gastrointestinal tract, muscle, and the 
brain. 
 
2.10.1.2 Supporting studies 
 
2.10.1.2.1 Orlistat 
In Sweden a 4 year, double blind, prospective study was conducted with 3304 
randomised normal or impaired glucose tolerance patients to assess the 
effectiveness of orlistat (120mg) or placebo. Participants were obese patients at 
risk of developing type 2 diabetes. Alongside the drug, patients were advised to 
reduce their calorie intake by 800 kcal per day, engage in moderate daily 
physical activity, and attend counselling sessions. 
The XENDOS (Xenical in the Prevention of Diabetes in Obese Subjects) study 
included patients with a mean BMI of 37 and a mean age of 43 (Torgerson et al, 
2004). Results from the 4 year study demonstrated that the incidence rate of 
diabetes was considerably lower in the orlistat group compared with the placebo 
group; a risk reduction of 37.3%, p=0.0032. Improvements were observed 
(placebo vs. intervention group results) in relation to body weight; 4.1kg vs. 
6.9kg; proportion achieving a ≥5% weight loss, 37% vs. 53% and ≥10% weight 
loss; 16% vs. 26%; LDL cholesterol, -5% vs. -12.8%; systolic blood pressure, -
3.4 vs. -4.9; diastolic blood pressure, -1.9 vs. -2.6. 
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Wirth (2005) also highlight that weight loss with orlistat leads to reductions in 
medications for the treatment of co-morbidities. 26% percent of hypertensive 
patients reduced or stopped their medication during the trial. 34% of patients 
with type 2 diabetes reduced or stopped their medication during the trial, and 
40% of dyslipidaemic patients reduced or stopped medication during the trial. 
The National Institute for Health and Clinical Excellence guidance (2006) 
guidance states that only patients with a BMI of >30, or >28 with co-morbidities, 
should be prescribed orlistat. 
 
2.10.1.2.1.1 Side effects  
The primary side effect of orlistat is steatorrhea (oily, loose stools) because 
orlistat blocks 30% of the dietary fat from being absorbed by the gut, and this fat 
is excreted unchanged in the faeces, causing faecal incontinence, frequent or 
urgent bowel movements, and flatulence (Torgerson et al, 2004). 
 
2.10.1.2.2 Sibutramine 
Many studies have been conducted to illustrate the efficacy of sibutramine in 
obese patients. The well-documented STORM (Sibutramine Trail of Obesity 
Reduction and Maintenance) study was a two-year double blind, placebo 
controlled trial of 605 patients. James et al (2000) found that the STORM trial 
achieved a 12kg weight loss, which was well maintained for 2 years when 
sibutramine administration was combined with lifestyle changes. Decreases in 
waist circumference, visceral fat, triglycerides and HbA1c were found. 
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Improvements in high-density lipoprotein (HDL) cholesterol were also reported. 
However, side effects of the drug include tachycardia, palpitations, hypertension 
and vasodilatation of the cardio vascular system. Thus, frequent and regular 
monitoring of blood pressure and pulse rate is an essential part of the protocol 
for this drug. The National Institute for Health and Clinical Excellence guidance 
(2006) states that only patients with a BMI of >30, or >27 with co-morbidities, 
should be prescribed sibutramine. 
 
2.10.1.2.2.1 Side effects 
In addition to tachycardia, palpitations, hypertension and vasodilatation of the 
cardio vascular system, as mentioned above, frequent side effects from 
sibutramine include, dry mouth, increased appetite, nausea, upset stomach, 
constipation, disturbed sleep, dizziness, drowsiness,  headache, flushing, joint 
and muscle pain (National Institute for Health and Clinical Excellence, 2006). 
 
2.10.1.2.3 Rimonabant 
The Rimonabant in Obesity (RIO) study followed patients for 1 year whilst 
taking 20mg of the drug, compared with a placebo group. Patients in the 
placebo group reduced their weight by an average of 2.3kg, compared with 
8.6kg in the group taking rimonabant.  75% of patients taking rimonabant also 
lost at least 5% of their body weight in comparison to only 25% in the placebo 
group (Van Gaal et al, 2008). 
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2.10.1.2.3.1 Side effects 
Reports of severe depression (including suicidal tendencies) associated with 
taking this drug are frequent. This is thought to result from the drug being active 
in the central nervous system, an area of human physiology so complex that the 
effects of a drug are extremely difficult to predict or anticipate, varying from one 
individual to another. 
 
2.10.1.3 Costs of obesity drugs 
The cost of the drug per patient per year were estimated in 2005 as orlistat 
£533, sibutramine £455, and rimonabant £528 (Campbell & Haslem, 2005).  
 
2.10.2 Physical activity as a treatment for obesity  
It has been well documented that increased physical activity reduces the risk of 
coronary heart disease and stroke, diabetes, hypertension, colon cancer, breast 
cancer and depression (Hu et al, 2004). Moderate and vigorous physical activity 
also has other health benefits, and is associated with a reduced the risk of type 
2 diabetes, certain cancers, cardiovascular disease, and joint and bone 
problems. 
To achieve a clinically meaningful weight loss through increased physical 
activity alone, the American College of Sports Medicine (ACSM) recommends 
60 minutes of daily physical activity (Jakicic & Otto, 2005).  
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2.10.3 Fat and fitness 
Research by Ortega et al (2013) has suggested that it is possible to be obese 
and metabolically healthy, as long as that person is physically active.  This 
research has received a lot of press coverage, and a small group of researchers 
are advocating for a focus on physical activity interventions and fitness, rather 
than weight loss. 
 
2.10.4 Bariatric surgery 
Weight loss surgery, also known as bariatric surgery, is used as the last resort 
for people who are morbidly obese. There are two types of weight loss surgery, 
gastric banding, and gastric bypass. Gastric banding is when a band is fitted 
around the top of the stomach, resulting in small amounts of food being 
consumed and the feeling of fullness. Gastric bypass is when your digestive 
system is re-routed past most of your stomach, resulting in the digestion of less 
food and the patient feels full with a reduced amount of food.  Not everyone will 
be able to qualify for bariatric surgery on the NHS, unless certain criteria are 
met. A person with a BMI of 40 or above, or a person with a BMI of 35 or above 
with another co-morbidity (type 2 diabetes or high blood pressure) would be 
eligible for weight loss surgery on the NHS.  NHS waiting lists for weight loss 
surgery are increasing in England, and the numerous TV programmes which 
profile good news stories about individuals who have probably contributed to 
the length of these waiting lists. Gastric banding, on average will cost £6,500, 
and a gastric bypass will cost on average £12,250. Bariatric surgery is also 
Chapter Two Review 
of the 
literature 
 
57 
 
available privately in some countries, and is popular amongst those who are 
rich and want to be thinner, including some TV presenters and pop stars.  
Surgery of this nature will cause rapid weight loss, and could require cosmetic 
procedures to remove unwanted lose folds of skin (including an ‘apronectomy’). 
Following weight loss surgery, patients are supposed to adhere to a lifelong 
commitment of regular exercise and healthy diet. The follow up care associated 
with private surgery is of variable quality.  
 
2.10.5 Alternative methods 
Alternative methods to lose weight vary in price and duration, and have a limited 
(in number) and poor (in quality) evidence base. Examples include acupuncture, 
hypnotherapy, and reflexology, to name but a few. These alternative methods 
are normally not available on the NHS, and will not be discussed here in my 
thesis.  
 
2.10.6 Commercial weight loss products and services 
 
2.10.6.1 Primary Care setting  
Individuals in England who want to lose weight and seek advice from their GP 
may be offered, depending on their circumstances, bariatric surgery or drugs. 
However, the vast majority will only be offered a diet and/or physical activity 
product or service, which often includes a behavioural motivation component. 
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What they are offered will depend on where they live. Some of these 
diet/physical activity treatment options are delivered by the Primary Care staff 
(e.g. a weight loss clinic run by dieticians), and others are on prescription (e.g. 
Weight Watchers, Alli). The general advice is that people in the UK who are 
seeking treatment for their obesity should go to their GP first, as patients who 
are advised by their GP to lose weight are more likely to do so than those who 
are not advised (Levy & Williamson, 1988). 
However, Lowe et al (2001) have found an increasing number of individuals 
wishing to lose weight are avoiding the NHS, and instead seeking assistance 
from commercial weight loss products and services (CWLPS) which are 
available without a referral or prescription from their GP. Womble et al (2004) 
have suggested that this may be due to the fact that Primary Care offers a 
limited range of treatment options for an individual.  
 
2.10.6.2 Commercial weight loss products and services (CWLPS) and 
health inequalities  
One of the questions of my research was whether a person’s socioeconomic 
status determined if they chose (rather than it being prescribed by their GP) to 
use CWLPS, and if they did then what sort of CWLPS did they choose and why. 
At the start of my PhD, I spent a considerable amount of time looking for 
information about CWLPS and SES/health inequalities; however I was unable to 
find any useful information. I had observed that adverts for certain CWLPS were 
more commonly to be found in certain magazines and newspapers, and during 
commercial breaks of certain TV programmes but not others. Although I 
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observed that there may be an association between the SES of the typical 
reader of the magazine or newspaper, or viewer of the TV programme, and the 
CWLPS being advertised, I did not conduct a rigorous study.  
In relation to health inequalities and the research question, I personally believe 
that the reasons of choice of CWLPS and uptake of CWLPS can vary 
significantly. As described in 2.9.6, education can influence the choice of 
CWLPS, a person with a lower educational achievement, might chose a 
CWLPS based upon how easy it is to follow, in comparison to an individual 
educated at degree level (or beyond), whom might chose a CWLPS that could 
be difficult to follow, though they might know that the CWLPS is more effective 
than a similar CWLPS. Education could also impact on the type of job a person 
holds, typically as the level of education increases, the annual household 
income also rises. Therefore, a person who has a high level of educational 
achievement, could possibly have a higher annual income, and therefore might 
choose a CWLPS that is higher in cost, and could be more effective in the long-
term. As documented earlier (2.9.4), a person’s age could impact on the uptake 
and choice of CWLPS. As a person ages, their level of obesity increases, 
therefore, it could be assumed that the older the person gets the more CWLPS 
have been tried and tested in comparison to a younger person. Younger 
individuals might not be as health conscious compared to someone in their 50’s 
(see Figure 7). Therefore, the uptake of CWLPS could increase with age, as 
does their BMI. One factor that I firmly believe is the most contributor to the 
uptake and choice of CWLPS is a person’s gender (see 2.9.2). Male and female 
biology are very different, how fat is stored and where varies significantly. 
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However, the choice and uptake of CWLPS is dominated by females. This does 
not necessarily mean that men do not use CWLPS, though the choice for men 
is limited. Currently, Lighterlife, Slimming World and Weight Watchers (online), 
only cater and advertise to the male market, products like Slim Fast, Alli, 
Special K only feature females and use taglines that are more appealing to 
women. Therefore, if marketing was unisex, and commercial weight loss groups 
had the male and female only classes, might attract a larger male population. 
Men and women would possibly use a CWLPS for different reasons; a woman 
might use a CWLPS as they have put on a few lbs. and want to slim down for a 
holiday. Whereas a man might want to use a CWLPS as they have recently 
been told that they have type2 diabetes due to their weight, and losing weight 
will impact on their long-term health. 
Current practice in the provision of 12 week referral schemes could possibly fuel 
health inequalities. A low SES individual might not to in close proximity to a GP 
surgery, and would not be able to enquire about weight loss through a 12 week 
referral scheme, or the individual might be able to visit a GPs surgery via public 
transport, though this would cost money that the individual might not have. 
Whereas a high SES individual might live in closer proximity to a GP surgery (or 
have access to a car), and might possibly enquire about weight loss through a 
12 week referral scheme. Regardless of SES, access is an important factor in 
relation to weight loss. Overall it might be cheaper for a low SES individual to 
walk to their local Boots/supermarket/pharmacy, and purchase a CWLPS, than 
it is to pay for public transport/fuel. Therefore, low SES individuals could be 
benefiting from the provision of commercial weight loss 12 week referral 
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schemes via a GP due to the level of access.  Research has not been 
conducted to demonstrate this possibility. However, based upon the  changes in 
primary care and the provision of public health services in England, pharmacists 
will play a larger role in relation to accessing weight loss information. GP’s will 
be able to refer patients to pharmacists that will be closer to an individual (better 
access). This method could have better outcomes than an individual using a 
CWLPS. As previously mentioned patients who are advised by their GP to lose 
weight are more likely to do so than those who are not advised (Levy & 
Williamson, 1988). just as much weight might be lost by a pharmacist giving 
weight loss advice, as a GP. 
Within the CWLPS industry, I firmly believe that a commercial weight loss 
company targets certain audiences which they feel best fit those who they know 
normally use their products and services.   
 
2.10.6.3 Changes in primary care and the provision of public health 
services in England  
Since the commencement of the PhD in 2009, the way in which Primary Care 
operates and the provision of public health services has changed significantly, 
and on 1st April 2013 Public Health England was launched. The modernisation 
of the NHS as a commissioning system is now in place, ensuring that the 
patients’ needs are at the heart of the clinical process, and underpinned by the 
NHS constitution. Nationally, the NHS Commissioning Board will ensure the 
new system provides a clear national standard, is accountable, and is fit for 
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purpose. The five domains (Table 5) of The NHS Outcomes Framework 
(Department of Health, 2013b) is led by the Board, and took on its full statutory 
responsibilities in April 2013. Until March 31st March 2013, the NHS planning 
and delivery responsibilities were with the Department of Health, Strategic 
Health Authorities, and PCT’s. 
Table 5: The five domains of the NHS Outcomes Framework 
Domain 1  Preventing people from dying prematurely;  
Domain 2  Enhancing quality of life for people with long-term conditions;  
Domain 3  Helping people to recover from episodes of ill health or following injury;  
Domain 4  Ensuring that people have a positive experience of care; and  
Domain 5  Treating and caring for people in a safe environment; and protecting 
them from avoidable harm.  
After 1st April 2013, GP’s may be able to refer an increasing number of their 
patients to commercial weight loss groups, or prescribe a wider range of 
commercial weight loss products. GP’s will be encouraged to put the patients’ 
needs first, using their extensive knowledge on what they believe is best for the 
patient. There could, in theory, be an increased referral rate of patients to 
commercial weight loss groups (e.g. Slimming World, Weight Watchers), as the 
GP will be able to assess their patients on what they believe will work best for 
them, rather than referring a patient a routine clinic (e.g. dietician led weight 
loss clinic). 
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2.10.6.4 The difference between self-help and CWLPS 
For the purpose of my thesis, and using the approach described by Gould and 
Clum (1993), I have separated possible sources of advice and support about 
weight loss which the public could seek (without the help of their GP) into two 
categories; self-help and CWLPS. Self-help could, for example, include advice 
from a friend, or within a general (not specifically a dieting) magazine article. I 
have defined CWLPS as those which an individual would have to specifically 
pay for. Because CWLPS can be purchased by an individual, and prescribed by 
GPs, I decided that there was more value in researching CWLPS for my PhD 
than self-help methods. A number of CWLPS incorporate a screening criterion 
before a participant can proceed, particularly if the product or service is 
prescribed by a GP. Screening criteria may include BMI and age. Lowe et al 
(2001) emphasised the requirement to evaluate CWLPS, and the National 
Institute for Health and Clinical Excellence, 2006 noted the dearth in good 
quality evidence in this area. 
 
2.10.6.5 Definition of commercial weight loss products and services 
(CWLPS) 
For the purpose of my PhD, I have defined CWLPS as those which involve a 
single or continuous payment (paid by the individual, or their GP). CWLPS 
include; meal replacement programmes (e.g. Slim Fast, Special K), energy 
controlled or very low calorie diets coupled with physical activity guidance in a 
group or online environment (e.g. Slimming World, LighterLife, Weight 
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Watchers, Cambridge Diet), educational materials (e.g. DVD’s/CD’s/Websites) 
or over the pharmacological aids to reduce weight (e.g. Alli).  
Participants involved in the survey and the Q-methodology studies of my PhD 
were clearly informed that the definition of CWLPS for the purpose of these 
studies involved a one-off or continuous payment.  
To the layperson, this definition might appear too broad, but I was confident that 
to people who have used a CWLPS they would know which products and 
services this included. To help potential participants who may have been 
unclear about the definition, I provided examples within the participant 
information sheets: 
• Weight loss programmes or clubs (e.g. Slimming World, Weight 
Watchers, LighterLife, Rosemary Connelly, Diet Chef, Tony Ferguson, 
etc.) 
• Products (Alli, Slim Fast, Special K, Lipobind, Adios, etc.) 
• Other (Weight loss books, DVDs, magazines, websites, CDs, etc.) 
 
This broad context was specifically used to capture the CWLPS that have 
featured extensively in research to date, and CWLPS that have not had any 
qualitative or quantitative research conducted. The CWLPS that had not been 
included in database searches, though were marketed heavily were included to 
assess whether participants chose these CWLPS without effective research 
being conducted. 
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Within the commercial weight loss domain, companies cannot make false 
claims about the efficacy of their products or services, but they are often very 
clever in their marketing which can infer that individuals will lose significant 
amounts of weight if they use their products and services. For example, Adios 
featured a catchy strap line whereby women using their product were saying 
goodbye to the weight they did not want. Consumers can be drawn toward the 
catchy slogans and attractive packing of the products and services. 
 
Figure 9: Adios packaging 
 
Randomised controlled trails to assess the efficacy of some CWLPS have been 
conducted, and these have usually funded and conducted by the company who 
produces the CWLPS (e.g. Bye et al, 2005; Ditschuneit et al, 1999; Foster et al, 
2003; Heshka et al, 2000; Heshka et al, 2003; Lowe et al, 2008; Pallister et al, 
2009) and are systematically reviewed as part of my PhD thesis. Some 
independent (of the CWLPS company) evaluations of the efficacy of CWLPS 
have been conducted, but these are rare. Although there are benefits of funding 
and conducting a RCT of a CWLPS for the company who produces it, there are 
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also potential disadvantages. Hamilton and Greenway (2004) point out that 
some companies may not prioritise the funding of a trial if they believe that the 
results may not square with the weight loss targets of their potential clientele.  
Conflicting research surrounds weight maintenance after discontinuing with 
CWLPS.  Wadden and Foster (2000) note that programmes with a combination 
of dietary and lifestyle intervention modification result in weight regain after five 
years. However, Gosselin and Cote (2001) highlight that 38.2% of participants’ 
maintained weight lost after 5-6 years of the commercial weight loss programme 
ending.  
There is very little research in the existing literature on the general usage of 
CWLPS in the UK population, and reasons why individuals choose certain 
CWLPS. I have attempted to answer these questions as part of my PhD. 
Greater understanding of personal experiences of using commercial weight loss 
products and services would help to inform public health policy and practice. 
When PCT’s were still in existence, many offered 12-week referral schemes to 
commercial weight loss programmes, such as Slimming World and Weight 
Watchers. These companies provided feedback to the PCT primary care on the 
attendance and weight loss of the client. One high quality study has supported 
this provision compared with other forms of treatment, including dietetic-led 
clinics (Jolly et al, 2011). 
 
Slimming World and Weight Watchers were selected by PCT’s as organisations 
which they would refer patients to for weight loss because of recommendations 
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in the National Institute for Health and Clinical Excellence guidance (2006). The 
National Institute for Health and Clinical Excellence guidance stated that such 
programmes should be: 
• Based on a balanced healthy diet  
• Encourage regular physical activity  
• Expect people to lose no more than 0.5–1 kg (1–2 lb.) a week.  
When I was starting my PhD, I spent a considerable amount of time talking with 
commercial weight loss companies to determine the extent of qualitative and 
quantitative research produced internally and externally, and their sales to date. 
Although I was surprised at the time, I now realise that I was naive about the 
sensitivity of commercial data. The majority of CWLPS companies were not 
keen to share any information with me. I now understand that most of these 
companies have conducted extensive market research on their products and 
services. Marketing of CWLPS appears to me to be more of an art than a 
science where; packaging is appealing to the eye, testimonials from a handful of 
clients are featured on websites and print material; TV advertising shows the 
simplicity of the product and service alongside predicted weight loss.  
 
2.10.6.6 Marketing of CWLPS 
Throughout the nineteen nineties, the commercial marketplace for the treatment 
of overweight and obesity had been a high-profile topic among policy makers, 
the media, academia, the scientific community, and government regulators. The 
House Subcommittee on Small Business heard in 1990 that marketing of 
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commercial diet clinics, and very-low-calorie weight loss programs, failed in 
assisting consumers to lose weight and/or keep it off. The need for increased 
government inspection of the weight loss marketplace, to regulate misleading 
advertising claims, was highlighted.  
Specific codes of practice have been set out by The Committees of Advertising 
Practice (2013) and the Broadcast Committee of Advertising Practice, which are 
independently administered by the Advertising Standards Authority, for the 
marketing communications for slimming and weight control products. The 
principle components are that the claims are legal, decent, honest and trustful. 
Even with regulations, it is apparent that the marketing of some CWLPS 
includes claims of effectiveness which are not backed up by research. In 2005, 
the Advertising Standards Authority conducted a compliance report, whereby 
50% of the slimming advertisements examined (n=48) in women’s magazines 
and newspapers breached the code. The Advertising Standards Authority noted 
most breaches were for slimming pills and ingestibles, and an alarming 
proportion of the breaches occurred in regional press. 
 
2.10.6.7 Online advertising of CWLPS 
From my own observations, there has been a steady rise in the amount of 
CWLPS advertisement on the internet, and I do wonder whether the internet is 
now the most popular avenue for advertising CWLPS. 
Reviews of new CWLPS in national newspapers can be a useful marketing 
strategy. However, they can also backfire, and this case study of the OMG diet 
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describes how marketing can go horribly wrong. The OMG diet was conceived 
by British sports scientist and personal trainer Paul Khanna, who goes by the 
pen name Venice A Fulton. The diet offers controversial tips for losing weight, 
such as skipping breakfast, taking cold baths, and drinking black coffee before 
exercising. This diet was recently tried by Independent Newspaper reporter 
Emily Jupp (12 June 2012) who did not approve of the diet, particularly: 
• taking a cold shower 
• eating less fruit 
• swapping broccoli for coke 
• skipping breakfast  
 
 
She did not lose any weight on the diet. The unconventional theories of the diet 
were not approved of by a number of TV celebrity dieticians and doctors, 
including dietician and sports nutritionist Linia Patel, Dr Christian Jessen the 
presenter of the ‘Embarrassing Bodies series’, and the celebrity fitness trainer 
Jay Darrell Ingleton. However, will readers take notice of this advice from 
trained professionals, or will they be persuaded by the powerful marketing of the 
diet?. One of the key straplines in the marketing of the OMG diet was ’you can 
become skinnier than your friends’, which I found interesting psychology. 
However, one should note that only a sample size of 1 was utilised for this 
particular piece of research, and Jupp’s conclusions should not be taken 
seriously based upon this sample size. For this research to be acknowledged a 
statistician would be required to estimate the required sample size, and a 
comparison group (control and/or other CWLPS) would need to be utilised. It is 
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unknown whether readers of Jupp’s findings did not chose to use this CWLPS 
based upon her write up of the diet (not losing any weight).   
 
2.11 Health inequalities and behaviour change  
Widely acknowledged in public health, lifestyle behaviours play in important role 
in a person’s health. Many public health preventative strategies targeting 
lifestyle behaviours such as diet and physical activity are employed in the UK. 
Two UK publications were produced in 2004; a discussion paper published by 
the Cabinet Office (2004), and a White Paper “Choosing Health: Making 
Healthy Choices Easier” (Department of Health, 2004). On the back of these 
publications, the government has employed initiatives, programmes and 
campaigns to attempt to tackle adult and childhood obesity. Intervention 
strategies focus on empowering the individual to make informed choices for the 
long-term maintenance of desired behaviours. Two large scale UK initiatives 
have focused upon regional and national campaigns; Healthy Towns and 
Change4Life. Within all of these government strategies and interventions, the 
overall aim is not only to decrease the prevalence of obesity in England, but to 
reduce the inequalities in the prevalence in obesity between the richest and 
poorest in our society.  
 
2.11.1 Change4Life 
Change4Life was a multimillion pound social marketing programme designed to 
help us ‘Eat Well, Move More, Live Longer’ (Department of Health, 2009). 
Consumers, commercial organisations, and academic researchers provided 
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insights on exercise, diet, and obesity and for the scoping process.  Families 
were recommended to include simple tips and tools into their everyday life. 
These toolkits were also tied into seven official sub-brands: Breakfast4Life, 
Swim4Life, Walk4Life, Bike4Life, Play4Life, Cook4Life and Dance4Life. 
Advertising of the campaign used extensive marketing. I understand that an 
evaluation of the Change4Life was planned, but I have not been able to find it in 
the peer review literature to date. Key to the programme was a focus on health 
inequalities, but it is hard to judge whether the programme met its objectives 
given that there is very little useful data available on outcomes. 
 
2.11.2 Healthy Towns 
To work in synergy with Change4Life, nine Healthy Towns were funded by the 
Department of Health; Tewkesbury, Halifax, Thetford, Tower Hamlets, 
Manchester, Middlesbrough, Dudley, Sheffield and Portsmouth. Each Healthy 
Town commissioned an independent local evaluation, and a marketing strategy 
and logos etc.  National evaluation was also funded. Key to the programme was 
a focus on health inequalities, but it is hard to judge whether the programme 
met its objectives given that there is very little useful data available on 
outcomes in the peer review literature. However, I was lucky enough to be part 
of the research team who evaluated the Middlesbrough Healthy Towns project, 
and did get some insight into how difficult it is to engage with and change 
lifestyle behaviours in communities living in deprived areas. 
Regardless of the lack of useful information I could find about obesity and 
health inequalities from the Change4Life programme and the Healthy Towns 
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programme, there is useful information published from other similar 
programmes in other countries, particularly the USA and Australia.  
Many conventional health promotion interventions in the UK target poor diet and 
physical inactivity, and continue to be based upon traditional advice-giving 
approaches (i.e. provision of unsolicited advice and direct persuasion), which 
are appropriate for the management of many medical conditions, but can run 
into serious difficulties when the issue of behaviour change is raised in clinical 
encounters (Rollnick et al, 2008). This is demonstrated by the frustratingly small 
percentage of people who respond positively to advice on behaviour change, 
and the tendency for clinicians to label patients as ‘resistant to change’ with 
associated negative consequences for both parties (Emmons & Rollnick, 2001). 
 
Evidence illustrates that behaviour is not merely influenced by age, sex and 
constitutional factors, but is deeply embedded in the cultural context, and 
influenced by material and social factors. Attempts to change the behaviour of 
individuals have been largely unsuccessful, or particularly successful, due to 
interventions failing to recognise the need for the importance of “theories and 
principles of successful planning, delivery and evaluation” (National Institute for 
Health and Clinical Excellence, page 6, 2007). 
Typically, behavioural change interventions which aim to help obese people 
lose weight, combine treatments that aim to change dietary and physical activity 
habits. Behavioural change interventions benefit from a theoretical underpinning 
to maximise effectiveness and maintenance of weight loss after discontinuation 
of the intervention. In order for a person to take responsibility for the changes to 
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be made to their lifestyle, ‘goal directed’ modifications are increasing being 
proposed in the literature (Hillier et al, 2012), which involves participants taking 
responsibility for the changes in their lifestyle. Hillier et al (2012) conduct a 
study involved two arms; one of which was underpinned by two psychological 
models of health behaviour change (the Theory of Planned Behaviour (TPB) 
and Social Cognitive Theory (SCT), and the second arm utilised standard 
advice giving techniques that were not underpinned by TPB and SCT. Changes 
in BMI, waist circumference and weight did not show a significant difference 
between the control and intervention groups in this pilot study (which was not 
powered to assess efficacy). However, there was a definite trend that the 
participants in the intervention group lost more weight compared with the control 
groups.  
Behavioural lifestyle interventions to support obese people in their attempt to 
lose weight which are delivered via the internet have increased in number 
during the last five year. This method is, in theory, low cost, for both the 
provider and the user. In previous years individuals might not have been able to 
afford computers and internet access, and thus could have increased health 
inequalities as these individuals would not have had access to internet based 
commercial weight loss interventions.   In the past having access to the internet 
could have been a barrier, however, as internet providers are constantly 
competing for new customers, a variety of providers now offer deals that are 
reasonable for individuals of a lower SES. Therefore, the availability and access 
to the internet is narrowing the health inequality gap, and policy/service 
providers can now distribute their information cost effectively. Low SES 
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individuals could choose internet based CWLPS as a cheaper alternative, which 
could be less effective than reading a weight loss manual (Womble et al, 2004). 
   
2.11.3 Health inequalities and obesity 
The way in which society is organised creates inequalities in lifestyle behaviours 
and levels of obesity, and these in turn cause are major contributors to overall 
inequalities in health, morbidity and mortality. As demonstrated in Figure 10, 
unequal distributions of social, economic and environmental factors are the 
drivers of inequalities.  
Figure 10: Health determinants model (Dahlgren &Whitehead, 1991) 
 
These factors impact upon the risk of a person getting ill, treatment facilities, 
prevention of sickness, and other opportunities for better health. Certainly, the 
lower SES group within the English population has a reduced life expectancy 
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and a longer duration of poor health compared with other SES groups in the 
same population. 
 
2.11.4 Key documents  
The Black Report (Department of Health and Social Security, 1980) was one of 
the first key documents to detail the extent of the unequal distribution in death 
and ill health, by SES, and suggested that these inequalities had widened since 
the establishment of the National Health Service in 1948. Black did not suggest 
that the NHS was the cause of the widening in inequalities.  
Freeman (2006) outlines that The Acheson Report (1998) mirrored the findings 
of the Black Report (1980), and highlighted the fact that the primary cause of 
health inequalities was poverty. Acheson reiterated that the health gap between 
the richest and poorest in society needed to be dramatically reduced. More 
recently, the World Health Organization Commissioned report on the Social 
Determinants of Health (2008a) further supported this view. The Marmot 
Review,  ‘Fair Society Healthy Lives’ details the most effective evidence-based 
strategies for reducing health inequalities in England from 2010, and concludes 
that reducing health inequalities would require action on six policy objectives. 
The National Institute for Health and Clinical Excellence guidance (2007) on 
behaviour change at population, community and individual levels usefully 
highlights the requirement to change behaviours according to specific factors, 
and the interactions that put those of lower SES at a disadvantage. 
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In order to assess how the most deprived in our society can change their 
lifestyle behaviours, it is vital to understand what is important to them, and what 
can be done to assist them. This is what I try and do in my thesis. I 
acknowledge that weight loss is important to people, and that there are a 
plethora of weight management options available to help people lose weight in 
the UK. However, as mentioned, health inequalities can be mapped onto seven 
themes, and societal influences (which are one of those themes) could be a key 
theme in relation to how a person wishes to lose weight. For example, the 
media, and peer pressure, could be key reasons for the method of choice of 
weight loss for some people. Because of the cost of CWLPS their use could, in 
theory (assuming they are effective), be widening health inequalities in the UK. 
Dr George Cuthbert Mura M’Gonigle (1889-1939) also produced two key 
documents for the region in which this study was based. 
M’Gonigle was a public health pioneer who became the medical officer for 
Stockton-on-Tees in 1924, remaining until his death of pneumonia in 1939. At 
this period in time, Stockton suffered one of the worse unemployment rates in 
Britain, peaking at around 50%.  
Known as the Housewives Champion, M’Gonigle’s first Stockton study 
examined the impact of housing and health. Mortality rates increased when an 
unhealthy area in Stockton was divided in two. The housewife lane area was 
demolished, and people were re-housed in a self-contained housing estate 
(Mount Pleasant Estate), the other half (Riverside Area) was kept and remained 
as a comparison group. Average death rates in the new estate (Mount 
Pleasant) were higher than those who remained at Riverside, though rent was 
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double and families could not afford as much food (especially protein rich food), 
families suffered long term or sub-malnutrition. The findings of this study were 
documented in Poverty, Nutrition and the Public Health (Proceedings of the 
Royal Society of Medicine, 1933), demonstrating the strong correlation between 
death rates and income. 
His book with John Kirby also demonstrated the wider application of the 
Stockton studies in a broader context, whereby social reformers and politicians 
took notice of their work. Kirby and M’Gonigle used publicly available data 
together with empirical studies to demonstrate "poverty, not ignorance, was the 
cause of morbidity and mortality amongst the poor and this poverty was not the 
fault of the individual families but of a society that provided inadequate wages 
and welfare benefits" (Bambara, 2011). 
In the contest of this thesis, unemployment, specifically in relation to health 
inequalities is still in existence. The region in which this study is based has the 
highest rate of unemployment in the UK, at 10.2% (Parliament UK, 2013) 
compared to the UK average of 7.6%. In my personal opinion the North East 
could see obesity prevalence increasing in the future in parallel with 
unemployment rates. Similar to M’Gonigle’s Stockton study, families might not 
be able to afford to buy as much food, and could potentially suffer from 
malnutrition if cheaper unhealthy foods with little nutritional value are bought.  
Also with the restructuring of benefits (universal credit), there could be negative 
consequences. The new system of benefits is given as one lump sum to the 
individual, instead of organisations paying on their behalf people. Individuals 
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could sacrifice food as they have spent all of their money on unnecessary items 
(TV, IPad etc). However, there is no evidence at present to support this.   
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Chapter Three 
Methodology 
 
3.1 Introduction 
Mixed method research was employed for my research. This chapter will detail 
the philosophical paradigms involved in research studies, specifically positivism, 
interpretivism, and pragmatism. Strengths and weaknesses, debate, and 
progression of mixed method research are presented herein.  Justifications for 
this approach, in relation to the aims of my study are discussed in the latter part 
of this chapter. 
 
3.2 Methodology  
Sandelowski and Barroso (2003, p305), refers to methodology as ‘an overall 
approach to inquiry regularly linked to particular theoretical frameworks’ and the 
research method as a ‘synonym for the techniques for sampling, data collection, 
and data analysis with which the methodologies are implemented’. Therefore, 
methodology refers to the theoretical frameworks under investigation, using 
methods to investigate these said frameworks. Philosophical paradigms are one 
of two constructs that scaffold a research study, the second underpinned by 
theoretical investigation. 
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3.3 Research paradigms 
Paradigms are identified as a cluster of beliefs, and dictates which, for scientists 
in a particular discipline, influence that should be studied, how the research 
should be carried out, and how the results should be interpreted (Bryman, 
2001).  Paradigms are polarised worldviews or belief systems that are a 
reflection of and guide the decisions that researchers make (Tashakkori & 
Teddlie, 1998). These paradigms in the social and behavioural sciences have 
traditionally fallen into two schools of thought, with writers proposing various 
terminologies to distinguish these stances. Tashakkori and Teddlie (1998) use 
the terms “positivist” and “constructivist”, whereas Guba and Lincoln (1988) use 
different terminology for these paradigms; “scientific” and “naturalistic”.  Since 
the conception of research, fierce rivalry has occurred between the two types of 
research inquiry: quantitative and qualitative. These two paradigms differ in their 
methodological assumptions, and effect on the research process. Ontology, a 
branch of metaphysics concerned with the nature and relations of being, 
Epistemology, the study or a theory of the nature and grounds of knowledge 
especially with reference to its limits and validity, and Axiology, the study of the 
nature, types, and criteria of values and of value judgments.  
 
3.4 Positivism in quantitative research 
Auguste Comte developed positivism at the start of the 19th Century, noting key 
components of this type of research; deductive logic or reasoning, researcher 
independence, and that reality is stable and can be observed and described 
from an objective viewpoint (Johnson & Onwuegbuzie, 2004). 
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Positivists collect data systematically, and present the findings in numerical 
form to discover trends and relationships between specific variables. Methods 
of data collection using quantitative research involve large amounts of data 
being collected through surveys, questionnaires, randomised controlled trials, 
and laboratory experiments. 
Soon after the Second World War, this unchallenged approach was met with 
fierce criticism over the investigation of inquiry. Human science examination 
required a separate approach to understand social phenomena; Interpretivism.  
 
3.4.1 Postpositivism 
Personally, as a researcher I am a postpositivist. Unlike positivists, I do not 
believe that the world should merely be observed, measured, and that we 
should only describe what is seen. All measurement is fallible, as different types 
of measures can have errors no matter how conscious of intra-rater reliability 
the researcher is. For example a researcher could take multiple weight 
measurements in a variety of settings, and measurement error could creep in 
due to one surface being on a slight angle, or unconsciously a researcher could 
be testing an intervention vs. a control group whereby waist circumference is 
the primary measure, the researcher could pull the tape measure tighter in the 
intervention group without knowing. Therefore, I firmly believe in using multiple 
measures and observations to get a clear idea on the ‘bigger picture’, and 
would class myself as a postpositivist. Different observations and measurement 
techniques might have different types of error, and the use of triangulation helps 
to understand what is really going on in reality. Post-positivists commonly adopt 
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a philosophy called critical realism. Post-positivist critical realist’s recognise that 
a variety of methodological tools should be utilised that fit and answer the 
research question (Angus, 2011); and lends its hand to the use of mixed 
method data collection. I firmly believe that the use of a survey, Cochrane 
based systematic review and Q-methodology study will be the most beneficial 
methodologies to answer my objectives, and to reveal the complex nature of 
CWLPS.  
 
3.5 Interpretivism in qualitative research 
Interprevitists argue the opposite of positivists. They believe that as humans 
think and reflect, scientific methods of data collection are inappropriate for the 
study of the natural world. To understand social action, it is imperative to study 
the reasons and meanings, which that action has for people. Interpretivism and 
its philosophical underpinnings form the theoretical basis for qualitative 
research. To understand peoples' actions it is essential to understand them in 
the way that the participants do, through flexible approaches of data collection, 
ethnography, phenomenology, and case studies. Interprevitists acknowledge 
that the social world consists of and is constructed through meanings; society is 
experienced subjectively as each person interprets the world differently in the 
way we behave. Unlike quantitative research, qualitative researchers 
(Interprevitists) use small sample sizes to generate data, abundant in 
subjectivity for the generation of understanding. Theory is built from 
observations, using an inductive approach (Thomas, 2006). 
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Researchers from these different paradigms have been at odds with one 
another since the conception of these different approaches. Positivists and 
Interprevitists agreed that it was more favourable to decide upon which 
paradigm successfully addressed the research question, rather than bickering 
over the strengths and weaknesses of the two approaches.  
Since the 20th century, researchers have accepted the qualities of both 
qualitative and quantitative techniques, combining the strengths to form another 
approach, mixed method.  
Mixed method has been underpinned by the philosophical paradigm, 
pragmatism. Feilzer (2010) argued that it was more important to ascertain which 
paradigm was most helpful in answering the research question, rather than be 
stuck in pedantic debates on the superiority of any one philosophical orientation 
over another. Realists acknowledge that both methods are not failsafe, arguing 
that sociologists can be pragmatic and use whatever methods are appropriate 
for particular circumstances, drawing on one or a mixture of both positivist and 
interpretivist methods. 
 
3.6 Pragmatism in mixed method research 
The “Paradigm Wars” commenced during the 1960s, challenging singular 
methods, which resulted in the emergence of mixed methods, and 
acknowledged the mixed model in the 1990’s as a valuable research technique 
(Tashakkori & Teddlie, 1998). During this debate methodology and paradigm 
relationships were questioned, particularly by the “incompatibility theorists”, and 
the “the compatibility theorists” (Cherryholmes, 1992).  The debate of mixed 
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model, and mixed methods, led to the emergence of a third set of constructs, 
the pragmatic paradigm. Research using mixed methods has been firmly 
embedded in many disciplines; various reviews and studies have acknowledged 
the importance of the pragmatic paradigm (Morse, 1991). However, it is 
apparent that the terminology is not consistent amongst the various disciplines. 
Blended research, integrative research, multi-method research, multiple 
methods research, triangulated research, and mixed research, are all mixed 
method research terminologies. 
 
The current dialogue about how mixed methods research is defined and 
perceived by researchers will change as this methodology evolves and 
becomes a wider used instrument for data collection. The present definition has 
been identified by Johnson et al (2007) 
‘Mixed methods research is the type of research in which a researcher or team 
of researchers combine(s) elements of qualitative and quantitative research 
approaches (e.g. use of qualitative and quantitative viewpoints, data collection, 
analysis, inference techniques) for the broad purposes of breadth and depth of 
understanding and corroboration’. 
 
3.7 Research implementation of mixed methods 
It is widely acknowledged that there are three specific areas where a mixed 
methods approach is far superior to a single method (qualitative or quantitative). 
Primarily, mixed methods enable the researcher to answer several research 
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questions congruently, through the mixing of data collection.  Secondly, this 
method is able to provide a rich and deep understanding of the data being 
collected to answer the social phenomena under investigation. Lastly, the 
researcher is able to interpret the data in the most appropriate way they believe 
expresses their findings. 
In mixed methods research the collection and analysis of qualitative and 
quantitative data occur in parallel; qualitative and quantitative or quantitative 
and qualitative, or sequentially; qualitative/ quantitative or quantitative/ 
qualitative. Unlike singular forms of data collection (qualitative or quantitative), 
mixed methods studies may mix the data throughout or at certain time points 
(Tashakkori & Teddlie, 1998). Mixed methods research is an evolving 
methodology that has few weaknesses (Table 6). 
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Table 6: Strengths and weaknesses of mixed method research (adapted 
from Johnson et al, 2007) 
Strengths Weaknesses 
Can be used to increase the 
generalizability of the results. 
It is more expensive. 
Qualitative and quantitative 
research used together 
produces more complete 
knowledge, informing theory 
and practice. 
It is more time consuming. 
Can answer a broader and 
more complete range of 
research questions. 
It can be difficult for a single researcher to carry out 
both qualitative and quantitative research, 
especially if two or more approaches are expected 
to be done concurrently 
A researcher can use the 
strengths of an additional 
method to overcome the 
weaknesses in another 
method by using both in a 
research study 
The researcher has to learn about multiple methods 
and approaches and understand how to 
appropriately mix them. 
Can provide stronger evidence 
for a conclusion through 
convergence and 
corroboration of findings 
Methodological purists contend that one should 
always work within either a qualitative or a 
quantitative paradigm. 
Words, pictures, and narrative 
can be used to add meaning 
to numbers. 
Some of the details of mixed research remain to be 
fully worked out by research methodologists.  
Numbers can be used to add 
precision to words, pictures, 
and narrative. 
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To guide the research, it is essential to understand the type of research design 
that would be most appropriate for the study; implementation of data collection, 
priority given to quantitative or qualitative research, the stage in the research 
process at which integration of quantitative and qualitative research occurs, and 
theoretical perspectives. For my PhD study, the research design used was the 
sequential explanatory study design (Table 7). For my PhD study, I chose to 
use a mixed method methodology to enable me to provide a rich and deep 
understanding of the data being collected to answer the first of my two research 
questions 'What is the uptake and reasons for choice of CWLPS by adults in the 
UK'. I chose to use a sequential explanatory study design (Table 7).  
First, a survey was used to collect quantitative data from a relatively large 
number of participants to assess the range and popularity CWLPS used by the 
general public. I also felt that a survey would provide data that would suit my 
first objective (see 1.4).  
Second, Q-methodology was used to collect qualitative data from a number of 
participants in the survey who provided different choices, and different reasons 
for their choices, of CWLPS. This methodology, was conducted in several 
stages, and allowed me to better understand quantitative data through in-depth 
quantitative exploration.  I used Q-methodology study as this methodology 
allowed participants own beliefs to emerge, rather than imposing my beliefs on 
the participants. This method was employed to limit the probability of researcher 
bias of qualitative interpretation of subjective opinion and feelings, and to limit 
obsequiousness bias. The utilisation of a Likert scale would increase researcher 
bias; the questions would be imposed by the researcher, purely agreeing or 
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disagreeing. As a researcher studying a rather complex subject, I did not want 
to provide data on my personal opinions as to why individuals choose CWLPS. 
Using Q-methodology allows participants to subjectively rank order why they 
chose their favoured CWLPS, providing rich data that could inform NHS policy 
and practice (see 4.5.3), and develop interventions that relate to the complex 
relationships between behaviour (choice of CWLPS) and beliefs, which may in 
the future inform the further development of weight loss interventions. This 
methodology also suited by second objective (see 1.4).     
I chose to use a single method methodology, i.e. a systematic review of 
controlled trials, to enable me to provide a least biased estimate of the 
effectiveness of CWLPS to answer the second of my two research questions 
'What is the effectiveness of CWLPS'. The review using Cochrane formatting 
was completed throughout the thesis, gathering quantitative data of a variety of 
different study designs. This method was used to answer my third objective 
(see 1.4). The review in a Cochrane format provided a great depth of 
understanding in relation to the effectiveness of CWLPS, and whether there 
were CWLPS that were effective (and cost effective) that were not provided by 
the NHS on a referral scheme. All three methods were given an equal amount 
of priority.  
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Table 7: Mixed methods designs by four criteria (Adapted from Tashakkori 
& Teddlie, 1998)  
No. Design type  Implement
ation  
Priority  Stage of 
integration  
Theoretical 
perspective  
1 Sequential 
explanatory 
Quantitative 
followed by 
qualitative  
 
Usually 
quantitative; 
can be 
qualitative or 
equal 
Interpretation 
phase  
 
May be 
present 
 
2 Sequential 
exploratory 
Qualitative 
followed by 
quantitative  
 
Usually 
qualitative; can 
be quantitative 
or equal 
Interpretation 
phase  
 
May be 
present 
 
3 Sequential 
transformative  
 
Either 
quantitative 
followed by 
qualitative 
or 
qualitative 
followed by 
quantitative  
Quantitative, 
qualitative or 
equal 
 
Interpretation 
phase  
 
Definitely 
present 
(conceptual 
framework, 
advocacy, 
empowermen
t) 
 
4 Concurrent 
triangulation  
 
Concurrent 
collection of 
quantitative 
and 
qualitative 
data  
 
Preferably 
equal; can be 
quantitative or 
qualitative 
Interpretation 
phase or 
analysis 
phase  
 
May be 
present 
 
5 Concurrent 
nested  
 
Concurrent 
collection of 
quantitative 
and 
qualitative 
data  
Quantitative or 
qualitative 
 
Analysis 
phase  
 
May be 
present 
 
6 Concurrent 
transformative 
Concurrent 
collection of 
quantitative 
and 
qualitative 
data  
 
Quantitative, 
qualitative, or 
equal  
 
Usually 
analysis 
phase; can 
be during 
interpretation 
phase  
Definitely 
present 
(conceptual 
framework, 
advocacy, 
empowermen
t) 
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3.8 Qualitative research designs 
Phenomenology and ethnography are two qualitative methodologies (Cresswell 
et al, 2007) that could have been used instead of Q-methodology, to form the 
qualitative component of my mixed methods research. 
 
3.8.1 Phenomenology 
A phenomenological research study could have been employed to answer the 
question ‘What is it like to experience CWLPS?' by collecting rich data from the 
experiences of participants. However, this method of enquiry would have led to 
any bias which I have about CWLPS being introduced into the research. I did 
not wish to impose my personal opinions on the reasons why participants in my 
study chose CWLPS, especially when a study exploring the reasons why 
participants chose CWLPS had not been conducted at the time. Presenting, 
establishing reliability and validity, and interpreting the data can also be difficult. 
Participants who have experienced negative consequences as a result of using 
CWLPS might not wish to express these opinions in a face to face interview, in 
fear of judgement or embarrassment.  
Because of the issues mentioned above, I did not choose this method of 
research enquiry for my PhD study.  
 
3.8.2 Ethnography 
To successfully adopt an ethnographic approach it is essential to study 
participants over a prolonged period of time in their natural setting. With 
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reference to my PhD study, this could have only been achieved by observing 
participants whilst they were using CWLPS. Also, it would have been essential 
to cluster those using the same CWLPS, and conduct separate ethnographic 
studies in each cluster, in relation to the type of CWLPS. This approach could 
have only been utilised if I was investigating one method of CWLPS (at least at 
a time).  
Due to the fact that my research question was, in part, exploring comparisons 
between individuals using different CWLPS, I chose not to use this method.  
 
3.9 Summary 
After understanding the paradigms and designs in research, I concluded that a 
mixed method (pragmatism) using a sequential explanatory study design 
offered the best method to allow me to answer my research questions. A survey 
and a Cochrane systematic review were included in my research to address the 
quantitative elements of my research (usage and efficacy), and a Q-
methodology study was included to address the qualitative elements 
(preferences etc) of my research. 
In the next chapter (Chapter 4) I have described in detail the tools and 
techniques used for my PhD study. 
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Chapter Four 
Methods 
 
4.1 Introduction 
This chapter will describe the overall design and methods of my PhD study, 
which has three distinct components. Two of these components are qualitative 
(a survey and a Cochrane systematic review), and one component is 
quantitative (a Q-method study), and these are described in detail in this 
chapter. The results of the survey informed the Q-method study.  
 
4.2 Study design 
My study employed a mixed-methods (pragmatic) sequential explanatory 
design, incorporating both qualitative and quantitative methods (Figure 11), and 
involving three components. The first component included a regional survey and 
a series of focus groups and interviews, and the results of this component 
informed the design of second component which was a Q-method study which 
included interviews. The third component of my PhD study was a systematic 
review using Cochrane methods which was completed in parallel with the 
survey and Q-method study. Findings about the efficacy of CWLPS that were 
collected from the systematic review (quantitative) and the Q-method study 
(qualitative) were considered together, and are described in the discussion 
(Chapter 6).   
Chapter Four Methods 
 
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Research design flowchart 
 
 
 
 
 
 
 
 
 
 
 
 
          
Postal Survey of usage of 
CWLPS n=81 
Focus groups to 
inform Q-method, 
n=12 
Interviews to inform Q-
method, n=6 
Q-pilot method 1, 
n=11 
Q-pilot method 2, n=7 
 
Systematic 
Review 
Q-sorting, and post Q-sort interviews, 
n=19 
62 participants 
who took part 
in the survey 
did not go on to 
take part in the 
Q-method 
study. 
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Figure 12: Study location in the North East 
 
 
Given that I was particularly interested in assessing usage and views of CWLPS 
in individuals from various, and particularly low, socioeconomic backgrounds, 
the North East of England (Figure 12) was an ideal choice of location for the 
survey and Q-method study. The North East has some of the most deprived 
communities in the United Kingdom; around 10% of the most deprived Super 
Output Areas (SOA's) on the index of multiple deprivation (Noble et al, 2006) 
are located in the North East. When assessing deprivation the rank and/or 
score of an area should be considered. In general the higher the score within a 
domain the more deprived the SOA.  The North East also has relatively high 
levels of obesity. The 12 areas of the North East, apart from Newcastle 
(Gateshead, Darlington, Sunderland, Redcar and Cleveland, South Tyneside, 
Northumbria, North Tyneside, Newcastle, Middlesbrough, Hartlepool, and 
County Durham) observe higher obesity statistics than the current UK average; 
24.2% (Public Health England, 2013). There is a strong positive correlation 
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between the level of deprivation and the prevalence of obesity within 
geographical areas of the UK (House of Commons; Health Committee, 2004). 
Table 8: Health indicator profiles in the North East compared with England 
(Adapted from APHO and Department of Health, 2010) 
 
 
 
    
 
 
 
 
Indicator England North East 
Adults who smoke (%) 22.2 27.9 
Adults who binge drink (%) 20.1 30.1 
Adults who have a healthy diet (%) 28.7 21.5 
Adults who are physically active (%) 11.2 11.3 
Prevalence of obesity in adults (%) 24.2 27.8 
Early deaths: heart disease & stroke (%) 74.8 87.2 
People diagnosed with diabetes (%) 4.30 4.35 
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Poor lifestyle behaviours tend to cluster, and the data in Table 8 shows that the 
adult population living in the North East tend to have a higher prevalence of 
obesity, smoking, and binge drinking, and fewer of them have a healthy diet. 
This is played out in the increased incidence of early deaths from heart disease 
and stroke in the North East. 
 
In relation to my study design and health inequalities, I was particularly 
interested in collecting data from individuals that were deprived, though I was 
aware that I also needed to collect data from other populations as well (less 
deprived). As a junior researcher involved in a previous community and 
population health initiative I was aware that there could be recruitment issues, 
and I would therefore need a study design that enabled me to collect sufficient 
data. Recent research conducted by Demarest and colleagues (2013) 
demonstrates that survey participation was low in lower SES individuals, and 
that socio-economic inequalities can produce a bias in survey findings. 
Therefore, my study design needed to capture individuals of high and low SES. 
Previous knowledge had led me to believe that I would be able to recruit my 
required sample size from the Evening Gazette, that has a readership of 
approximately 125,000, and covers postcodes in the Tees Valley locality that 
vary in deprivation. As I was conscious of low SES not being able to afford to 
buy the Evening Gazette, or might have poor access to a Newsagent, all 
articles were also published online too. As described in 4.4.9 and Figure 13, 
initial recruitment was disappointing and led to additional methods of 
recruitment and the widening of postcodes from TS1 to TS18 to include all TS 
postcodes. Additionally, County Durham, Northumberland, and Tyne and Wear 
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postcodes were included. Within the new localities, I specifically used methods 
whereby I believed high and low SES would view posters/leaflets, and would 
register their interest in my survey. All venues to display posters and leaflets 
were carefully targeted. The IMD score for each venue was found, and I was 
satisfied that a low, medium and highly deprived individuals would be able to 
see the advertising for my survey. I was also confident that the re-launch of the 
survey in the New Year of 2010 would recruit a significant of individuals who 
had embarked on a CWLPS, through the additional Newspapers that advertised 
my study online and in print (Northern Echo, Stockton and Darlington times and 
Evening Gazette). After being on BBC Newcastle during a peak time (8am) 
when individuals would be listening to the radio whilst exercising, driving to 
work, listening to the radio whilst preparing breakfast, I was positive that I would 
be able to recruit a variety of low and high SES individuals for my survey. With 
the additional recruitment strategies (email recruitment and a commercial 
weight loss company), I felt that I had encompassed a variety of methods that 
would enable me to recruit high and low SES individuals. 
 
4.2.1 Commercial weight loss companies 
Prior to conducting my survey, and when I was originally planning the design of 
my PhD research, I contacted two of the largest commercial weight loss 
companies (Slimming World and Weight Watchers). I sought to obtain their data 
to assess what the average cost of a person using their service for a year would 
be, and whether they had data on demographics (SES, age, gender, and 
ethnicity). Weight Watchers did not wish to share any information with me. 
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Slimming World did not wish to share any information with me either, but did 
appear interested and supportive of my research. I was perhaps naive in 
thinking that they might have wanted to share their data with me, and now that I 
am at the end of my PhD studies I understand a little more about the politics 
and sensitivities regarding data held by commercial companies.  
 
4.2.2 Study site and sampling  
Originally, the study location was restricted to certain postcodes within the Tees 
Valley region (TS1 to TS18), which is covered by a local newspaper called the 
Evening Gazette. This range of postcodes includes the full range of socio-
economic spectrum. To address my research question as to how the uptake 
and reasons for choice of CWLPS vary by SES, it was essential to plan the 
sampling of participants to include the full socio-economic spectrum. Only by 
analysing data, which includes the full spectrum from all socio-economic 
spectrum backgrounds, one can understand, differentiate, and better 
understand the relationship between health inequalities and obesity. From 
previous knowledge I was aware that the Evening Gazette covered a range of 
postcodes that would cover the full socio-economic spectrum, and not just that 
of low SES individuals. After speaking with the Evening Gazette, they were also 
confident that I would be able to recruit individuals from the full socio-economic 
spectrum. 
I had initially hoped that I could recruit enough participants for my survey from 
this region by advertising in the local gazette. However, to my surprise, the 
response to the newspaper adverts disappointing, and I then extended the area 
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of recruitment to County Durham, Northumberland, and Tyne and Wear. I 
placed adverts in the relevant local papers, and even went on the radio (Radio 
Tees) at one point to try and boost recruitment.  
When I started my PhD, I honestly did not appreciate how difficult it would be to 
recruit participants to this study. In a previous research job, we had similar 
problems with recruitment to the CCP study. I have learnt a lot about 
recruitment during the course of my PhD, and understand that it is a common 
problem across many public health studies.    
 
4.2.3 Study population 
The inclusion criterion for the survey was (i) all persons who had used a 
CWLPS in the last twelve months, (ii) live in the study area, and (iii) were over 
16 years of age. It is well understood, and known, that by definition a person is 
classed as an adult at 18 years of age. However, for the purposes of this study 
16 years and over was specifically chosen as the cut off because commercial 
weight loss programmes are offered to people in the UK from the age of 16. 
 
4.3 Definition of CWLPS 
Within the survey information sheets CWLPS were defined as: 
‘Commercial weight loss products and/or services which involve a one-off or 
continuous payment/subscription to lose weight’. 
At the time of submission of my survey to the ethics committee, I extensively 
investigated commercial weight loss options that were featured in print, online 
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and advertised on the television, to define CWLPS for this study. The issue and 
problems in defining CWLPS was mirrored within the Cochrane systematic 
review process, due to the complex nature and perception of CWLPS.  
From April to May 2010, I observed that there was an increase in the level of 
advertising of CWLPS on the TV and in magazines. I assumed that this 
increase was primarily due to the summer approaching, and the population 
wishing to ‘slim down’ for a holiday. Television advertising specifically featured 
meal replacements, group weight loss programmes, and anti-obesity 
medication. Online regional and national newspapers primarily featured anti-
obesity medication, and group weight loss programmes. In print format, group 
weight loss programmes featured heavily in newspapers, which at that time 
were advertising reduced joining fees. 
 
4.3.1 Final selection of CWLPS 
The final selection of CWLPS to be included in the survey were; Slimming 
World, Weight Watchers, LighterLife, Rosemary Connelly, Diet Chef, Tony 
Ferguson, Alli, Slim Fast, Special K, Lipobind, Adios, Weight Loss book(s), 
DVD(s), Magazine(s), Website(s), and CD(s). The reason for choosing these 
specific products and services was based upon observation, personal 
experience, and products and services that had been evaluated in the academic 
literature. Within the survey, participants also had the option to list other 
CWLPS that they had used in the last twelve months (examples which were 
reported by the study participants included the use of exercise vibration plates, 
that were used as a one off or continuous payment, not via a gym, and appetite 
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suppressants that an individual had paid for privately). I chose to include 
participants who had used CWLPS within the last 12 months, and not further 
back in history, because I felt that participant recall would poor after this length 
of time. 
 
The survey sought to assess the duration, and the cost, of the CWLPS used by 
the participants, and whether any products or services which they had used had 
been provided via their GP. Duration data was collected to assess whether 
participants adhered to specific products or services more than other CWLPS. 
This data was used to compare with the attrition rates of CWLPS reported in the 
systematic review, later. Cost effectiveness is of primary concern to all 
commissioners of services. In addition, this data is of importance in assessing 
whether individuals of low SES opt to pay for a CWLPS, and if they do then 
does the price influence their decision on which one they purchase. Or do they 
instead of seek advice from their GP. 
 
4.3.1.2 Exclusion criteria 
People were excluded from taking part in the study if they had provided no 
information about using a CWLPS as defined above. 
I did receive interest from a number of people who wanted to take part in the 
study that had used cosmetic surgery (liposuction) or had been prescribed 
pharmacotherapy from their GPs. 
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4.4 The survey study 
 
4.4.1 Aims and objectives 
The aim of the survey was to assess the use and reasons for choice of CWLPS 
in the NE, and explore where usage is associated with socioeconomic status. 
The main objectives of the survey were to: 
• Describe the characteristics of participants who choose to use CWLPS 
• Describe the types, number, combinations, and cost of CWLPS used by 
participants 
• Examine the relationship between socio-economic status, and other 
determinants, and choice of CWLPS. 
 
4.4.2 Survey justification 
A survey of this type has not been conducted previously, to my knowledge. 
Knowing whether people who wish to lose weight chose to pay for CWLPS, 
instead of consulting their GP, and whether this decision is based on the SES of 
the individual, is useful information for those who commission weight loss 
services and are responsible for public health..  
 
4.4.3 Study variables 
The survey involved the collection of discrete and continuous data. The 
variables included age, postcode, highest level of educational achievement, 
ethnicity, marital status, religion, average weekly household net income (after 
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housing costs), gender, occupation, where a participant buys their bulk food 
shopping, IMD status, duration of time they used the CWLPS,  and the cost of 
each CWLPS. 
 
4.4.4 Super output area 
In terms of deprivation, postcodes were utilised to collect Index of Multiple 
Deprivation (IMD) data, at Super Output Area (SOA). A SOA is a specific and 
small geographical area on which to various statistics (e.g. health data) are 
collected and published. Data at a SOA level allows you to be reasonably 
confident that everybody in that area is comparable. Two layers account for the 
different levels of data provided; Middle Layer Super Output Area (MSOA) and 
Lower Layer Super Output Area (LSOA). To collate IMD data, Lower Layer 
Super Output Areas (LSOA’s) were utilised. LSOA’s are intended to be as 
consistent with the population size as possible. Minimum and mean population 
data is 1000 and 1500; respectively. Therefore, this dataset was utilised to 
report lower level statistics; scatter plots were performed in SPSS version 19.0 
to demonstrate the relationship between the amount an individual spent on 
CWLPS and their level of deprivation.  
Upon liaising with Dr Adeteyo Kasim (Research Statistician, Wolfson Research 
Institute for Health and Well-Being at Durham University), it was apparent that 
the IMD data which I was using do not show a relationship between level of 
deprivation and the amount an individual spent on CWLPS. Dr Kasim advised 
me to collate like-for-like data, specifically household income.  
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In conjunction with the LSOA Indices of Deprivation 2010 dataset (for IMD 
deprivation score) I also collated the required household income data from the 
MSOA April 2007-March 2008 dataset (Income: Model-Based Estimates). In 
discussion with Dr Kasim, it was decided that the MSOA using participant’s 
postcodes, was the best indicator of deprivation to use in my analysis. 
 
4.4.5 Ethical approval 
On the 23rd of September 2010, permission to undertake this research was 
granted by the School of Medicine and Health’s ethics committee at Durham 
University (Appendix 1). All participants were required to provide written 
consent (Appendix 2) before they could take part in the survey, and before they 
could take part in subsequent stages of the Q-methodology study. Within the 
information sheets, it was stressed that each participant would be given a 
specific ID number, so that data could remain anonymous. The information 
sheets stated that data collected would be stored in accordance with the Data 
Protection Act (Information Commissioners Office, 1998), and only the 
researcher (me) and named PhD supervisors would be able to access this 
information.    
 
4.4.6 Data management 
All information provided was kept strictly confidential, and was kept in locked 
filing cabinets and password-protected files on computers at Durham University 
in accordance with the Data Protection Act (Information Commissioners Office, 
Chapter Four Methods 
 
105 
 
1998). Information was not shared or viewed by anyone who was not part of the 
research team.  
 
4.4.7 Pilot survey 
As will all research studies, it was important to pilot the survey (n=5) to assess 
its acceptability and appropriateness in terms of both process and questions. 
Piloting a survey is an essential part of a good study design. The pilot survey 
was not a small-scale version of the larger study, which in an ideal world it 
should have been. Instead, participants were made up of staff members 
(administrative staff) from Durham University, in response to an email request to 
all admin staff at Queen’s campus.  
A key reason for conducting a pilot survey is to alert the researcher about where 
the weaknesses of the survey design, and particularly whether the design was 
too complicated and a burden for participants, and potential practical problems. 
In the words of De Vaus (1993, 54) "Do not take the risk. Pilot test first". 
However, pilot studies have limitations too, due to the small numbers involved, 
and of other issues might arise when the full survey/project is conducted. The 
pilot survey participant resources were assessed for low reading ability, using 
the readability statistics (Flesch-Kincaid) in Word 2007. The survey documents 
(participant information sheet, survey, additional information, useful contact 
details, letter, and registration of interest slip) were pitched at the reading age of 
an average 15 to 16 year old.  
A convenience sample of five participants was chosen, as sample size 
calculations are usually not required for pilot studies. I felt that the five 
Chapter Four Methods 
 
106 
 
participants would be enough for me to be able to assess acceptability. I was 
confident that five participants would provide useful information about the 
aspects that were being assessed for feasibility. Potential participants were 
asked to contact me via post, telephone/voicemail, or email.  
Following analysis of pilot study findings, minor changes were made to the 
design of the survey, including the additional requirement for the participant to 
state the approximate cost of the CWLPS chosen.  After minor adjustments 
were made to the survey, and after I had informed the ethics committee of these 
minor changes, I was ready to start the survey. 
 
4.4.8 Survey methods 
  
4.4.8.1 Survey design 
The survey was cross sectional in design, and collected historical data. The 
validity of the data reported by the participants was potentially prone to recall 
bias (i.e. the participants might have forgot certain things). The subsequent Q-
methodology study was conducted to collect data on why the (sub group of) 
participants chose to use certain CWLPS over others. 
The survey utilised closed tick box binary questions, inviting yes/no answers to 
state the amount of time a participant had used the CWLPS, and how much it 
cost them. Participants were invited to list any other CWLPS that they had used 
in the previous 12 months that met the definition of CWLPS (Appendix 6), 
because I was aware that the survey list was not exhaustive. I used the survey 
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design in this way, as I wanted it to be as user friendly as possible, and to 
ensure that participants completed the survey without feeling that a researcher 
was judging them. From my experiences, I believe that some people do not 
wish to take part in obesity research studies because they think that what they 
say or do will be frowned upon by the researcher. In addition, the survey was 
designed in this way to aid the analysis of data collected. 
 
4.4.8.2 Determinants of sample size 
I met with one of the medical statisticians based in the School of Medicine and 
Health at Durham University (Dr Douglas Wilson), and took advice from him 
regarding the sample size for the survey. I explained that aim of the survey, the 
statistician advised that cluster analysis would be the statistical method of 
choice, using SPSS version 19. Dr Wilson estimated that 1250 would be the 
estimated number of participants required.  
There was no exact hypothesis behind the choice of sample size. There was an 
attempt, however, to rationally find a ballpark figure. Any statistical analysis of 
proportions would involve at a minimum of testing two binomials, e.g. a 
deprivation difference of 40%, from 0.20 to 0.28 in two groups, at alpha=5%, 2-
tailed, and power of 90% would require a sample size of  495 samples per arm, 
calculated using StatXact software, which is c1000 in total. Assuming there may 
be 20% non-responders that would approximate to 1250 which, given 
information from a previous study appeared achievable. Of course, there are 
many proportions that could be used but for pragmatic and some statistical 
conjecture, 1250 samples were chosen. Also from my involved with a previous 
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study which recruited 1073 participants via the Evening Gazette, I was confident 
that I would be able to recruit a similar number of participants for my research. 
The recruitment method for the survey was adverts in The Evening Gazette, the 
local newspaper covering TS1-TS18 postcodes.  Based upon the average 
readership of the Evening Gazette (n=125,000/week), 10% of the readership 
would be required to take part in the survey to reach the sample size required. 
This was, in theory, possible since we know that more than 10% of the 
population uses some form of CWLPS at any one time (and about 50% are 
trying to lose weight at any one time).  
 
4.4.8.3 Survey recruitment  
A dedicated project contact name and address, email, and phone line was set 
up for the purpose of this survey, and this information was detailed in the advert 
(Appendix 3). A variety of methods of communication were utilised in order to 
encourage participation from a broad range of participants to meet the overall 
aims of the study. The literature suggests that different populations prefer a 
variety of study advertising and contact methods. It was hypothesised that 
individuals, who viewed the newspaper article online, would have access to a 
computer, and would contact me via email, while others may prefer postal or 
telephone communication. It was important to include participants with poor 
literacy; Weiss et al (1992) highlight the association between low 
socioeconomic status and poor literacy skills. Thus, attention was given to 
voicemail and postal contact and, as noted above, the survey was designed to 
be accessible to participants with low literacy levels.  
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Participants who were interested in taking part in the survey were able to ask for 
further details about the project in a number of ways, through postal, email or 
telephone communication. However, regardless of their chosen method of 
communication with me they were only required to supply their name and 
address, because further information was only sent to them by post. Documents 
were posted to those who stated that they were interested in taking part in the 
survey; a consent form (Appendix 2), useful contact details (Appendix 4), 
demographic information (Appendix 5), survey (Appendix 6), and information 
sheet (Appendix 7), including a return pre-paid envelope. All those who 
received information in the post were allocated a unique study ID.   
 
4.4.8.4 Contact methods 
 
4.4.8.4.1 Postal 
In the original ethics application I had intended to have a ‘cut-out’ registration of 
interest slip within the Evening Gazette, where those interested in taking part in 
the survey could write their name, address, contact telephone number, and 
postcode, and post it to the dedicated survey postal address.  
However, the Evening Gazette decided (after our initial discussions with them 
about the ‘cut-out’ form) that they would prefer to publish a full article about the 
survey and project, which was featured in their online and print formats 
(Appendix 3). This article detailed my involvement in a previous study in 
partnership with the Evening Gazette; the Get a Better Life Campaign, and it 
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described why I was undertaking the new research project, and how to contact 
me if readers were interested in participating in the survey.  
At this stage, participants were given the opportunity to participate in the survey 
and subsequent Q-method study (described later in this Chapter), or to only 
participate in the survey. Readers who were interested in participating in the 
survey (and for some of them the Q-method study too) could register their 
interest in a number of ways.  
First, readers could register their interest by sending a note in the post, 
containing their name, address and contact telephone number. A survey ID 
number was written on the paper/slip from a master list of numbers, at which 
point I deleted this number from the master list. The ID number was written on 
the documents to be sent to the potential participant; the survey, useful contact 
details, consent form, participant information sheet, additional contact details, 
and associated covering letter. These documents were sent to the potential 
participant with a pre-paid envelope. The participants who wanted to take part in 
the survey completed and returned the documents in the pre-paid envelope to 
the dedicated project address. All data was entered into a spreadsheet for 
analysis. In the survey, there was a question that asked whether they would be 
willing to be contacted at later stage to take part in another, related, study (Q-
methodology).  
 
4.4.8.4.2 Internet 
Participants who wanted to register their interest in taking part in the survey via 
email were able to do so by emailing the dedicated survey email address; 
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cwl.orbresearchgroup@durham.ac.uk. They were required to email their name, 
address and postcode. 
Once the email had been received, I printed it off, deleted it, and then deleted 
the deleted folder to maximise participant confidentiality. At this point, a unique 
ID number was hand written on the printed email from the master list of ID 
numbers available. As with the postal contacts, I deleted the ID number from 
the master list, and wrote this ID number on all documents (covering letter etc.). 
 
4.4.8.4.3 Telephone 
Participants who wanted to register their interest in taking part in the survey 
were able to call the dedicated project phone number where I would answer any 
questions and ask potential participants for their name, address and postcode. 
If I was not able to answer the phone, the answerphone message asked for 
their name, address and postcode. 
I kept a pile of blank registration interest slips by the dedicated phone line to 
transcribe the required information. I reviewed all answerphone messages 
within 24 hours. After answerphone messages had been listened to, and all the 
required details written down, the message was deleted from the answer phone. 
Data were handled as described above for email requests.   
 
Participants, who wanted to take part in the survey, returned the consent form, 
completed survey and additional information in the pre-paid envelope to the 
dedicated project address within their pre-paid envelope. 
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4.4.9 Recruitment challenges and solutions 
Unfortunately, on the day on which the article was published online and in the 
newspaper (November 19th 2010), Durham University’s phone lines were not 
operational; internal and external calls could not be received, and the specific 
email account was not functioning correctly whereby the auto response that was 
set up was looping back and forth to the Durham University’s server. After I 
spoke with the IT department, this issue was soon resolved. I was very 
disappointed at this set back, since I had spent many months planning this 
particular day.  
This situation may have resulted in a number of potential participants 
calling/emailing for more information about the study, only to receive a constant 
engaged tone on the phone, or an error message by email. It is reasonable to 
assume that potential participants might have tried to phone a number of times 
that day to contact me but, having failed a few times, then gave up. The IT 
problems at Durham University were resolved after 2 days, while the telephone 
exchange problem was resolved after 5 days. Only 12 people registered their 
interest through email and telephone communication following the advert in the 
Evening Gazette on 19th November 2010. 
After a discussion with my PhD supervisors, it was agreed to launch the survey 
again in the New Year, and the Evening Gazette agreed to republish the 
advertisement on 4th January 2011.  
Following the re-launch, recruitment was slow but steady within the first month. 
The vast majority of participants were from a small geographical area in 
relatively affluent post-codes. Thus, sampling was extended to specifically 
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target people from more deprived areas of the North East to achieve the 
objectives of the survey. In pragmatic terms, the sampling was widened from 
postcodes TS1 to TS18 to include all TS postcodes. Additionally, County 
Durham, Northumberland, and Tyne and Wear postcodes were included. The 
communication department at Durham University was approached and offered 
assistance in advertising the study, attempting to reach a wider audience. A 
press release (Appendix 9) was compiled for print and radio press release. This 
press release was later featured in other newspapers in print and online format, 
thus reaching a much wider audience than previous attempts. After the press 
release was sent to regional radio stations, I featured on a radio broadcast 
(BBC Newcastle), in which I detailed why the research was required, described 
inclusion criteria, and asked people to contact me to express their interest in 
taking part in the survey. Disappointingly, this extra effort only attracted ten 
people to register their interest, seven of whom took part in the survey. 
Therefore, once again other methods of recruitment were developed and 
conducted. I emailed all students, and all staff, at Durham University. An online 
advert describing the study was displayed on plasma screens around the 
University for six consecutive weeks. Additionally, the local PCT was contacted 
about the study and a senior health improvement specialist sent a copy of my 
recruitment email in poster format (Appendix 10) to all PCT employees. A 
neighbouring University (Teesside) also agreed to advertise the study; the same 
email was forwarded to all staff and students. 
I then gained permission to advertise the study in a large range of local libraries, 
schools, businesses, retail shops, community centres, gyms, and swimming 
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pools across the North East, which were each provided with two A4 Posters and 
25 leaflets. All venues (n=207) were followed up with a telephone call to ensure 
that the posters and leaflets had arrived, and to ask that the posters be 
appropriately displayed and leaflets made available. 
Sadly (and to my surprise), these strategies did not result in many more 
additional people being recruited to the study. Again, I sat down with my 
supervisors to develop another plan. 
The next strategy which I employed to increase participant numbers was to 
approach three senior members of commercial weight loss programmes 
(Slimming World, Weight Watchers and LighterLife) for permission to advertise 
the study. It was anticipated that these individuals would have more authority 
and influence in assisting with recruitment for my PhD than junior staff.  
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Figure 13: Research recruitment flowchart 
 
 
 
 
Evening Gazette- online and in print (19th November 2011)  
 
4th January 2011,  
Re-launch (Evening Gazette, Northern Echo, Stockton and Darlington 
times and BBC Newcastle) 
 
Email recruitment (Durham University, neighbouring university, and 
Middlesbrough PCT) 
 
Permission to advertise the study was gained from one commercial weight 
loss company. 
 
N=101 participants registered their interest.   
 
N=81 participants completed the survey after exclusions, and not wanting 
to complete the survey. 
 
Permission to advertise the study in libraries, schools, businesses, retail 
shops, community centres, gyms, swimming pools were was gained. 
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Weight Watchers declined involvement, due to concerns that participation might 
negatively influence their members and impede their weight loss. Slimming 
World staff were keen to be involved but asked for permission to be sought from 
their Head Office; despite multiple attempts to speak to a senior staff member at 
Head Office, this did not come to fruition. LighterLife were the only CWLPS 
company which agreed to help; a senior staff member emailed all LighterLife 
counsellors within the NE region, asking for them to display a poster at group 
meetings, and for the counsellors to informally mention the research at group 
sessions.  
The main negative risk of using CWLPS group members was, obviously, the 
risk of bias. A small number of participants (n=9) were recruited via LighterLife, 
which could have biased the survey results.  
I did consider a further recruitment strategy, to advertise the study in NHS 
Primary and Secondary care premises. Although this may have increased 
recruitment rates, this would have required NHS ethical approval and the 
decision was taken not to extend the study, as these permissions would have 
taken several months, potentially delaying the study timetable. 
 
At this point, I stopped recruiting participants even though I had not reached the 
sample size suggested by the statistician. I was very disappointed, but I was 
reassured by my supervisors that I should continue to the next stage of my PhD 
study. 
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4.4.10 Survey data analysis plan 
The survey data was cleaned and analysed using SPSS software version 19. 
Unfortunately, the estimated sample for multilevel analysis (n=1250) was not 
reached, therefore appropriate statistics according to the data available are 
reported in Chapter Five. Descriptive statistics are also summarised in Chapter 
five. 
 
4.4.11 Response and attrition rates 
101 participants registered their interest in taking part in the study (Figure 13), 
of which three were excluded because they had never used a CWLPS. 17 
participants expressed their interest in taking part in the survey, but were 
excluded because they did not wish to be involved further or withdrew later on. I 
telephoned participants if the data, which they supplied, was unclear. 
 
As noted previously, 1250 participants were required to demonstrate a 
statistical significant association between costs and socio-economic status. 
Despite repeated and varied attempts to engage with a range of organisations, 
and significant investment in increasing the recruitment rate, only 81 
participants were willing and able to take part in the survey. Therefore, lower 
level statistical tests were conducted on this data to explore (rather than test) 
the possible association between the level of deprivation of the individual and 
the cost of the CWLPS, weekly Household Net Income Estimate (equalised 
after housing costs), and IMD data. Scatter plots, using the line of best fit to 
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show any trends, are presented and described for hypothesis generation 
purposes (only) in Chapter five.  
 
The survey and the Q-methodology study had two separate sample size 
requirements. The survey required 1250 participants for multilevel analysis to 
be conducted, and to illustrate the relationship between cost of CWLPS and 
IMD status. However, after a disappointing recruitment rate for the survey, lower 
level statistical test were performed on the participants involved (n=81). As 
explained in detail below a sample size of 20 was sufficient for the Q-
methodology study. Webler, Danielson, Tuler (2009) suggest that a Q-
methodology study should involve 8-30 participants for the definition of factors. 
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4.5 Q-methodology study 
 
4.5.1 Aims/objectives 
• Explore the reasons why participants chose commercial weight loss 
products and services, through operant categories. 
 
4.5.2 Introduction 
The literature suggests that Q-methodology incorporates ‘qualiquantilogical’ 
research that enables the researcher to understand the level of qualitative data 
through qualitative exploration. Bi-factor analysis provides specific categories 
that have emerged though participant responses, providing greater thematic 
understanding in relation to the complexity of choices in relation to CWLPS.  
Q-methodology is most commonly applied in the fields of communication, 
political science, and the behavioural and health sciences (Brown, 1980).  
Q-methodology was developed by William Stephenson (1902-1989) whose 
educational background, and employment, influenced his work. Stephenson 
studied undergraduate physics at Durham University, and then did a PhD at 
Oxford. His interest grew in the field of psychology whereby Stephenson studied 
and worked alongside Charles Spearman (the inventor of factor analysis), and 
Cyril Burt, an educational psychologist and statistician. 
Q-methodology provides a structured means to explore a given phenomenon or 
topic of concern by allowing patterns of subjective meaning to emerge from 
participants' thoughts, beliefs, and perspectives (McKeown & Thomas, 1988). 
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As such, it is essentially a hybrid qualitative-quantitative research method. Its 
core foundation is based upon categories that are operant; in other words 
operant categories are clusters of subjectivity that have been determined by the 
participants and not pre-imposed by the researcher. 
Q-methodology is characterised by two particular elements that set it apart from 
traditional factor analysis methods. First, a characteristic of Q-methodology is its 
capacity to determine categories set by the participants rather than categories 
that have been pre-imposed by the researcher. In more traditional forms of 
factor analysis, categories would be imposed by the researcher and developed 
as an a priori element of the research protocol, usually using a Likert scale or 
other ranked scoring system. In contrast, Q-methodology begins with 
preliminary qualitative data collection as a way of defining subsequent 
categories. A variety of collection techniques can be drawn upon to collate the 
information required for concourse development; Interviews, focus groups, 
textual analysis of media outputs and popular literature. The concourse is 
further explained in this Chapter at 4.5.8.1 
The second defining characteristic of Q-methodology is the level at which factor 
analysis is focused; it is a modification of traditional factor analysis, which 
analyses (cluster) variables at the level of the group rather than the individual as 
is the case in more traditional methods. As such, Brown (1980) states that the 
Q-methodology findings are based on factor scores and will reflect the 
agreement and disagreement (perceptions) related to the individual Q-sort 
statements.  
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4.5.3 Justification 
This study aims to understand the attitudes of people who have used 
commercial weight loss products and services, in order to inform NHS policy 
and practice. I hope that the findings from my research can increase 
understanding about the complex relationships between behaviour (choice of 
CWLPS) and beliefs, which may in the future inform the further development of 
these interventions.  It was therefore important to choose a method of data 
collection for my research which allowed participants own beliefs to emerge, 
rather than impose my beliefs on the participants. Q-methodology has been 
chosen for this particular research topic as other forms of subjective research 
often rely upon categories that the researcher has determined. This method 
was employed to limit the probability of researcher bias of qualitative 
interpretation of subjective opinion and feelings, and to limit obsequiousness 
bias. The utilisation of a Likert scale would increase researcher bias; the 
questions would be imposed by the researcher, purely agreeing or disagreeing. 
In this study, Q- methodology has been chosen in order to gain an 
understanding of the attitudes associated with commercial weight loss products 
and services. This is a relatively novel method of choice within health and, in 
this particular field of interest (obesity), only one other study has used the 
application of Q-methodology. This study examined weight-control self-efficacy 
beliefs in obese women, linked to outcomes of a weight-loss program (Dennis & 
Goldberg, 1996).  
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4.5.4 Criticisms of Q-methodology 
Due to the small sample size required for a Q-methodology study, this method 
has been criticised for its reliability, and the generalisability of findings 
(Danielson, 2009). However, proponents of the method point out that any topic 
will only have a handful of viewpoints. A carefully structured Q-methodology 
study will reveal the full range of viewpoints (but not the popularity of these 
viewpoints), as long as the participants come from a variety of different sources 
(e.g. males and females, have tried different CWLPS, etc.). A Q-methodology 
study focuses on the specific subjectivities about a given topic that are operant, 
and does not focus upon the distribution of participants to each factor. 
 
4.5.5 Variables 
Q-methodology is different to traditional factor analysis, and the two methods 
can easily be distinguished. In Q-methodology, the subjects and variables are 
inverted; in other words the subjects take the place of the statements, and the 
variables take the place of the participants, particularly their Q-sorts. In 
traditional factor analysis, participants are the subjects, and the questions asked 
are the variables. Researchers using traditional factor analysis will look at the 
data for patterns in responses across the variables and whether there are any 
relationships between variables in the same individual. Q-methodology looks at 
the data the other way around. 
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4.5.6 Determinants of sample size 
In Q-methodology, a sample size of 10 or over is considered large enough to 
reveal underlying factors (Brown, 1980). Seven to twenty participants were 
involved at one or more stages of my Q-method study. 
 
4.5.7 Focus groups and interviews 
 
4.5.7.1 Aims 
The purpose of focus groups and interviews is to develop an in-depth 
understanding of the specific topic in question, which in my case were the 
weight loss experiences of participants who had used CWLPS. In my study, the 
main objective of conducting focus groups and interviews was to inform the 
development of the subsequent Q-method (described at 4.5.8.1) which sought 
to examine the relative importance of the decision-making factors regarding the 
choice, etc., of commercial weight loss products and services.   
 
4.5.7.2 Choice of method 
The focus group and interviews which I conducted were informed by the 
theoretical framework offered by Q-methodology as described in Chapter 3. 
Indeed, this is the recommended method for Q-methodology. The literature on 
Q-methodology argues that it is important to ensure knowledge of the full 
breadth of data on the research topic (in my case, the possible viewpoints on 
CWLPS from those who had used them) in advance in order to conduct a full 
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and complete interrogation of each decision-making factor.  Kitzinger (1995) 
suggests that the focus group method offers the optimum method to achieve 
this aim by virtue of bringing together relatively large numbers of people with a 
range of demographics and experiences.  
Although I had planned and would have very much liked to have restricted my 
research at this stage to focus groups, I found it very difficult to organise such 
groups across the wide geographical area of the NE. Although some people 
were keen to take part in the study, they were not willing to travel too far and/or 
meet up at set times. Therefore, I used, in addition to focus groups (held at 
Durham City and Queen’s campus), some one-to-one face-to-face interviews, 
and in a few cases one-to-one telephone interviews. Although I understand that 
using one to one interviews, particularly by telephone, was not ideal, I 
conducted them in a way which tried to maximise data depth and quality. I was 
reluctant, initially, to conduct interview by telephone, but after reading the 
relevant literature, I was reassured that it would be a satisfactory method of 
data collection to use.  For example, Aneshensel et al (1982) observed no 
important differences between data generated using telephone and face to face 
interviews in a study of 546 people. However, more recent research suggests 
that telephone interviewing does not allow for visual cues and this may affect 
the level of intimacy and responses from participants (Opdenakker, 2006). 
Others have argued that telephone interviewing may offer a level of anonymity 
that might elucidate more personal or embarrassing information (Wilson et al, 
1998). There is also a debate about the relative utility of the focus group method 
which can involve additional costs, researcher time, and participant burden. The 
potential of response bias is a contested concept in qualitative research and 
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there is no consensus about the optimum method in the more general (non-Q-
method) literature.  
 
Although I was disappointed, initially, to have to use one-to-one face-to-face 
and telephone interviews, after reading the relevant literature I was of the 
opinion that combining the results from different methods (focus groups, one-to-
one face-to-face interviews and one-to-one telephone interviews),  may offer a 
greater breadth and depth of data. I applied the principles of data saturation in 
my data collection (using all 3 methods) until no new themes emerged.   
 
4.5.7.3 Recruitment 
Participants who had stated in their survey consent form that they were happy 
for the researcher to contact them at a later date (n=80) were sent information 
sheets (Appendix 16), consent forms (Appendix 14), a pre-paid envelope to be 
returned back to the researcher, and a registration form (Appendix 15) to ask 
which venues, and times, would be most suitable for them. A range of venues 
and times (including evenings) were offered, and participants had the 
opportunity to request alternative times or venues.  
After receiving the completed registration and consent forms, focus groups 
(n=3; 12 participants), telephone interviews (n=5), and one-to-one interviews 
(n=1) were conducted over a period of three months. One participant had 
already been involved in the pilot focus group (n=2), though wished to be 
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involved in the actual study. In total, data from 19 participants were used for 
analysis.  
 
4.5.7.4 Focus group conduct 
A pilot focus group was conducted in order to assess the process of data 
collection, to ensure familiarity of the process with the neophyte researcher (i.e. 
me!), and acceptability of the experience for participants, as well as ‘testing out’ 
the pragmatics of the verbal introductions and questions, and data recording. I 
felt that it was important to conduct a pilot focus group to ensure that the 
equipment was working correctly, all questions were phrased accurately, and to 
develop questioning skills in order to build my confidence. Two participants 
attended, one who had previously used a CWLPS, and the second who was 
reflecting upon the experiences of a family member. All questions were 
acceptable, however the script required some refining to ensure that there was 
a good linkage between questions.  
Arguments for and against using pilot data in the final analysis were considered 
by me and my supervisors. Given that the interview schedule was not changed 
significantly between the pilot and full study, it was decided that we could 
analyse the pilot data with the data from the fully study. This process taught me 
a lot about the importance of doing a pilot study, regardless of what type of 
method you are using, and why you need to think carefully about whether or not 
you should combine pilot data with the data from a full study.  
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All focus groups were held in an easily accessible venue with disabled access 
within Durham University (at both the Durham City campus and Queen’s 
campus). All participants were asked for their permission for the focus group to 
be recorded. Two small electronic Dictaphones were used during each focus 
group, one as back up if the other one failed. Each focus group began me 
outlining what the focus group would cover, housekeeping rules and explaining 
the main objective of the focus group, which was to capture as many viewpoints 
about the reasons for using commercial weight loss products and services as 
possible. Because of the potentially sensitive nature of the topic, a set of ground 
rules were discussed and agreed which focused on the need for mutual respect, 
allowing each person to speak, confidentiality, a request not to discuss the 
content of the focus group with anyone, and a reminder that any disclosures of 
harm or potential harm would be acted upon by the researcher (me).  
Prior to the focus group I developed a set of potential general questions on 
three key areas, namely weight loss, obesity, and experiences of CWLPS 
(Appendix 11). Questions were open, enabling participants to think about the 
reasons they chose CWLPS, and which CWLPS. The script was only used as a 
guide, and sometimes a lively discussion developed which meant the questions 
were not answered in the order I had planned. I tried to facilitate but not lead the 
discussions, but did try and steer the conversations at certain point so that all of 
the questions I wanted answers to were covered.  
All participants were given the opportunity to ask questions, thanked for 
attending, and the Dictaphones were stopped.  
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4.5.7.5 Interviews 
The majority of interviews were conducted via telephone (n=5); one was 
conducted face-to-face. The conduct of the one-to-one face-to-face interview 
followed the same protocol as the focus group (described above), but of course 
there was only one participant.  
Prior to the commencement of the telephone interviews, all participants were 
asked whether they had had time to read the participant information sheet 
(Appendix 16), and asked whether they had any questions about their 
involvement in the telephone interview. One participant wanted to know exactly 
what the telephone interview would involve, and was keen to know more about 
the research. Similar to the conduct of the focus groups, I read from the script 
outlining what the interview would cover, and explained that the main objective 
of the interview was to capture their viewpoints regarding the reasons they used 
commercial weight loss products and services (Appendix 11). 
Participants were then asked whether they had any further questions prior to 
recording the telephone interview (using two Dictaphones). The interview was 
recorded by having the telephone on loudspeaker, and a Dictaphone either side 
of the mouthpiece. I conducted the telephone interviews in a private room, so 
nobody else could hear the conversation.  
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4.5.7.5.1 Telephone interviews 
 
4.5.7.5.1.1 Advantages 
• Telephone interviews can occur at a time that is most convenient for the 
participant. Including telephone interviews as part of the data collection 
might mean that the study includes people who are generally very busy, 
have chaotic lifestyle, and/or are very shy, and would not wish to take 
part in a focus group. Therefore, I believe that including telephone 
interviews in my study increased the chance that I included the views of 
a wide range of people who choose to use CWLPS. 
• Participants can feel relaxed and respond openly when answering 
questions related to their own personal experiences of weight loss and 
commercial weight loss methods utilised, knowing that only the 
researcher is listening. In a group setting, a participant might not feel 
comfortable in discussing these issues with strangers. 
 
4.5.7.5.1.2 Disadvantages  
• The researcher cannot detected body language and signs of 
miscommunication or misinterpretation, which could cause a breakdown 
in the flow of communication 
• The participant might forget to mention certain points, which may have 
otherwise been promoted by comments from others if they were part of a 
focus group. 
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4.5.7.6 Focus groups 
 
4.5.7.6.1 Advantages (in addition to the ‘flip-side’ of those statements for 
interviews, listed above) 
• Participants might feel that sharing their experiences with others (in 
addition to the researcher), who could be considered their peers, 
provides them with an added benefit of taking part in the study. 
• Data can be collected on a number of participants at the same, thus 
saving researcher. 
 
4.5.7.6.2 Disadvantages (in addition to the ‘flip-side’ of those statements for 
interviews, listed above) 
• It can be difficult to find a time and venue for the focus group which is 
convenient to participants, particularly if they are from a wide 
geographical area and are expected to come to one central location. 
• Transcribing data from focus groups can be a more complex process for 
the researcher, especially if many participants attend the focus group. 
• If any one participant is particularly dominant in the group, this can 
disrupt the flow of the focus group and stop the other participants 
speaking out. This is where the skills of the researcher are particularly 
important.  
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4.5.8 Q-methodology stages 
A Q-methodological study involves the following steps: (1) definition of the 
concourse; (2) development of the Q sample; (3) selection of the P set; (4) Q 
sorting; and (5) analysis and interpretation. 
 
4.5.8.1 Definition of the concourse 
Brown (1980) draws upon the definition of a concourse in a Q-methodology 
study, stating that it is “the flow of communicability surrounding any topic”. A 
verbal concourse was derived from qualitative research; focus groups, and 
telephone or face-to-face interviews. The researcher examined the emerging 
data to ensure all aspects relevant to the discourses were apparent. The 
gathered material from weight loss company websites, researcher knowledge, 
and qualitative data collection was representative of the opinions relevant to the 
choice of CWLPS. Key quotes relevant to the Q-sorting stage were extracted 
from focus groups and interviews transcriptions to form statements. I refined 
statements for readability purposes, and quotes that were less than four words 
required additional text to form a statement. After looking at commercial loss 
company websites, the researcher felt that additional statements needed to be 
created, to encompass all relevant aspects of all the discourses.   
 
4.5.8.2 Development of the Q-set 
The concourse involved inductive analysis of the focus group and interview 
transcripts. Codes were applied to the emerging themes and subthemes; 
second level coding resulted in a handful of meaningful and representative 
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categories that was a miniature version of the concourse through the application 
of a deductive sampling method. Five broad themes were identified; personal, 
emotional, mental, social and physical. All themes were examined to assess 
duplication, and whether any statement needed to be refined for readability 
purposes. After careful consideration, 111 statements were compiled before 
inductive analysis occurred 
Once the researcher felt that no more emerging themes were coming through, 
and data saturation had occurred, the Q-set was refined to a manageable set of 
59 statements for piloting. Duplications were removed, and one final statement 
was added by my primary supervisor. 
Q-methodology involves distinct stages whereby participants are involved; the 
concourse development stage was the only stage whereby telephone interviews 
were employed. 
 
4.5.8.3 Selection of the P-set 
In Q-methodology, the P-set is not selected randomly. Participants are chosen 
(from those who took part in the focus groups and interviews) based upon the 
theory that they will have a clear and distinctive viewpoint about the area or 
topic being investigated. It is expected that four or five persons should define a 
specific viewpoint; called a factor. 
At this stage, I had already selected the respondents for the P-set. I contacted 
the survey participants who had consented that they were happy for me to 
contact them at a later date within their survey consent form. Separate consent 
Chapter Four Methods 
 
133 
 
forms were required for the development of the concourse, pilot study, and Q-
sort; process consent (Appendices 14, 17 &18). This was necessary due to the 
time required for each phase to be completed; I could have found that 
participants had said ‘Yes’ to all three stages at the outset, but due to other 
commitments during the course of the study they found themselves able to only 
commit to the development of the concourse, and withdrawing from the study 
after this stage.   
 
4.5.8.4 Pilot study-Q-set 
To ensure that all statements reflected the reasons why participants choose 
CWLPS, and were readable, a pilot study was conducted. The purpose of the 
pilot was not only to text the statements for readability, but also to test the 
statements for overlap (and try and reduce the size of the Q-set). Several 
revisions of statements usually occur before the Q-sorting phase is completed.  
 
4.5.8.4.1 Recruitment 
All participants who had stated that they were happy for the researcher to 
contact them at a later date within their survey consent form (n=80, or 81) were 
sent in the post; information sheets (appendix 18), respective consent form 
(appendix 17), registration form (appendix 19)  to state which venues (Durham 
University; Main campus, Durham University; Queens Campus, and Teesside 
University), and times (Monday; 7-8pm, Wednesday; 2-3pm or Friday; 10-
11am) would be more suitable for the participants. Participants also had the 
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opportunity that state other times or venues, and pre-paid envelope to be 
returned back to the researcher. 
After receiving the completed registration and consent forms, the researcher 
organised two focus groups, each of six participants. Two separate focus 
groups were conducted at a time and date that was suitable for the participants. 
Initially one focus group was organised, however, at the last minute four 
participants could not attend this focus group, including one participant who was 
ill on the day. Therefore, only two people attended this focus group. I then sent 
the pilot exercise by post to those participants were unable to attend the focus 
groups. Within the information sent to these participants, they had the option to 
write down the statements which they felt required further work, and say if there 
were any statements that were missing. Four of six participants attended the 
second focus group, and those who did not attend were sent the information in 
the post.   All participants were asked (verbally or by letter) to read the 
instruction sheet, and think about the one CWLPS that they were most positive 
about. This was essential as the majority of participants had used one or more 
CWLPS in the past 12 months. I wanted the participants to concentrate on one 
CWLPS instead of thinking which CWLPS applied to selecting agree, disagree 
and neural from the Q-set. Participants were asked to write their favoured 
CWLPS down, carefully look at all 59 statements, and write down whether they 
agreed, disagreed or had no opinion or felt that the statement was not relevant 
to them (neutral). An audio device (Dictaphone) was used to record the 
feedback given by the participants about the statements. 
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4.5.8.4.2 Piloting the q-set: phase one 
Eleven participants piloted the 59 statements. Statements that were split 
between agree and neutral, or disagree and neutral, were removed from the Q-
set (n=11 statements). Deleting these statements was essential; participants 
were not showing preference for polar opposites, or loading between three 
piles.  Participants also expressed that they felt additional statements were 
required about the reasons why they chose CWLPS (n=13 statements), and 
four statements were separated as the participants felt that the statements were 
asking two separate questions about the reasons of choice. 
 
4.5.8.4.3 Piloting the q-set: phase two 
To ensure that the additional, and separated, statements were reflective of the 
reasons why participants chose CWLPS, another piloting exercise was 
required. In addition, I decided to include a statement that I had previously 
deleted. 
“I wanted something where there was a consistent guide to weight loss that did 
not change, which I could get from this CWLPS”. 
This statement was originally deleted as; at that point, I felt that it did not show 
an agreement, disagreement or neutral preference.  Instead, I decided to keep 
a similar statement to the deleted one in the q-set: 
“I used this CWLPS as I got confused listening to the ever changing 
government guidelines on healthy eating, and I knew the CWLPS guidelines 
would not alter”. 
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Upon observing participants take a longer amount of time in considering this 
statement, I decided that it would be better to revert to the original statement; 
participants also confirmed that this would be more appropriate.  
Seven participants piloted 63 statements (52 original statements), and this 
number was further reduced to 60 statements (Appendix 23). 
Senior researchers using Q-methodology do not pilot their Q-set before Q-
sorting. It is my opinion that piloting ensures that all statements presented are 
as representative as they can be for the Q-sorting stage. Without piloting, it is 
my opinion that a miniature version of the concourse would not be provided for 
Q-sorting. Valuable information, about the reasons why participants chose 
CWLPS could have been missed without piloting. In Q-methodology, it is the Q-
sort as a whole that is interpreted, not individual statements.  
 
4.5.8.5 Q-sorting grid 
As a Q-methodology novice, I felt that I required additional information in 
relation to the layout of the Q-sorting grid from members of a Q-methodology 
email network; Q-METHOD@LISTSERV.KENT.EDU. I explained that the P-set 
which I had been decided upon.  
Van Exel and de Graaf (2005) explain that the distribution of the grid should be 
flat to provide more room for (dis) agreement between statements. Prior to 
administering the Q-sorts, I estimated that 46 statements would be used, and 
asked whether a 2,3,4,5,6,6,6,5,4,3,2 grid would be appropriate (Figure 14). 
Literature suggests that there is not a minimum or maximum number of 
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statements that could be given to a participant. However, a large Q-set could 
cause the participant to rush their decisions, because they felt they were taking 
too long to complete the task. 
 
 
Figure 14: Q-sorting grid 
 
Senior researchers using Q- methodology responded my email, stating: 
“The platykurtic distribution described seems sensible enough”. 
“I am sure you'll get a range of responses to your question, but I think the main 
theme will be along the lines of “It makes no difference! From what I can gather 
(and I am relatively new to Q), the testing of different distributions has shown 
that they make no difference (perhaps, very little difference?) to the final factor 
scores. Having said that I think the two main tenets must be adhered to; 
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statement ordering is self-referential in that it refers to the thoughts of the 
participant, and that decisions are made in reference to the other statements in 
the Q-set, i.e. there IS an order. Presumably that means you could just have a 
continuum of statements from 1 to 50, but their order must reflect the 
participant's view of statement x being more 'important' than statement y etc” 
This information was extremely useful. Although I anticipated using only 46 
statements, I decided to 60 statements for Q-sorting after I received advice from 
others. After piloting the q-set several times, 60 statements could not be 
narrowed down any further; all participants felt that 60 statements were 
manageable. The distribution of the grid (Figure 15) was slightly altered from 
what I had originally intended, but a flatter distribution was still utilised to ensure 
that the participants had more room for the agree/disagreement statements.  
Figure 15: Sorting sheet 
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Irrespective of the structure of the grid, and the selection of statements, the 
participant employs a meaning to the statements.  
 
4.5.8.6 Recruitment 
All participants who had stated that they were happy for the researcher to 
contact them at a later date within their survey consent form (n=80, of 81) were 
sent information sheets (Appendix 20) and consent forms (Appendix 22) in the 
post, with a pre-paid envelope to be returned back to the researcher, and a 
registration form (Appendix 21) asking which venues (Durham University; Main 
campus, Durham University; Queens Campus, or Teesside University),and 
times (Monday;7-8pm, Wednesday; 2-3pm or Friday; 10-11am) which would be 
most suitable for them. Participants also had the opportunity to state other times 
or venues.  
 
4.5.8.6.1 Q-sorting 
The Q-sample systematically rank-orders each of the statements along a Q-
sorting sheet. This process differs from Likert scales as the statements are 
rated against one another, instead of on an individual basis. The overall process 
of Q-sorting reveals individual subjective opinion about the subject being 
investigated. Q-methodology does not assume what is an appropriate response; 
instead, as there are no right or wrong answers in relation to a participant’s 
viewpoint, interpretation relies on where the statements are placed on the Q-
sorting grid. 
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4.5.8.6.2 Face-to-face 
The Q-sorting process was designed to instruct participants to review the entire 
set of statements according to a condition of instruction. This condition of 
instruction was “why did you choose this particular CWLPS?”, and also the 
participant needed to review a pack of randomly numbered, individually typed 
statements on business sized cards (n=60). The participant was asked to divide 
the statements into three piles; agree, disagree and neutral, according to the 
condition of instruction. After the process of sorting, the agree pile was taken, 
and the participants was asked to think about which three statements they 
agreed with the most, and these were placed under the +5 on the Q-sorting 
sheet (Appendix 12). They were then asked which four statements they agreed 
with slightly less than +5, and placed these under +4. This process was 
continued until there were no more agree statements to be sorted and placed. 
The same process was undertaken with the disagree pile, but they were asked 
three (not four) statements that they disagreed with the most, and place them 
under the -5 on the Q-sorting sheet. The next four statements which they 
disagreed with the most (of those left in the pile) were then taken and placed 
under -4, and this process was continued until there were no more disagree 
statements. The neutral pile was then taken, placing the rest of the statements 
where the participant felt they were most appropriately positioned on the Q-
sorting sheet.  
During the exercise, the participant had the opportunity to move the statements 
on the Q-sorting grid to where they felt would be more appropriately placed. 
Once each of the participants was satisfied that his or her sort was complete, I 
recorded the results on their Q-sort answer sheet. After the Q-sort, I asked the 
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participant to comment about the placement of the statements at polar 
opposites to the Q-sorting grid, recorded on a Dictaphone to gain additional 
qualitative data. This enabled a profile to be built of each participant’s beliefs 
and opinions. Interviews also allowed for the interpretation of factors during data 
analysis.  
 
4.5.8.6.3 Postal 
Participants who were not able to attend the face-to-face Q-sorts, though had 
expressed their interest in wanting to take part in the Q-sorting exercise, were 
given the opportunity to be involved in postal Q-sorts. An instruction sheet, Q-
sorting grid, an example of a Q-sorting grid, statements and marker cards were 
forwarded to the participants, with pre-paid envelopes. Participants were asked 
to send their completed Q-sorting grid, indicating where they had placed their 
statements, back to me. 
 
4.5.8.7 Analysis and interpretation 
Statements were then subject to correlation and factor analysis, whereby 
persons were correlated against one another, rather than by tests. Individual 
likes and dislikes were factorised of significant clusters and correlations.  In 
order to assess whether there were factors that were highly correlated or 
uncorrelated with one another, factors were rotated objectively using varimax 
rotation until I was satisfied that the relationships were true to the study. 
Theoretical rotation could have been used. However, this method is used when 
the researcher has a pre-conceived idea or theory. I did not want to confirm an 
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idea or a theory, and therefore I used varimax rotation instead. Objective or 
theoretical rotation modifies the perspective from which the Q-sorts or 
relationships between Q-sorts are observed. Retained factors had an 
eigenvalue of more than one. Factor analysis reduced the data set of larger 
numbers of correlation variables to a simple structure of factors (McKeown & 
Thomas, 1988). Whilst the researcher chooses the statements, the Q-sort is 
self-referent, and the placement of statements was chosen by the participants. 
  
Data from the Q sorts was analysed using the PQMethod 2.11. This computer 
program allows the researcher to enter each participant's Q-sort in accordance 
with where the statements were placed on the grid.  
 
 
 
 
 
 
 
 
 
 
Chapter Four Methods 
 
143 
 
4.6 Cochrane review 
 
4.6.1 Background  
Prior to the commencement of the systematic review, a title and application was 
submitted to the Effective Practice of Care (EPOC) Review Group. A proposal 
which included details of the types of studies, participants, distribution of 
workload, and co-authors, were included in this application.  
The editor of the review group (Alain Mayhew) did not feel that the review was 
appropriate as an EPOC review, and felt that it was better suited to the 
Cochrane Endocrine and Metabolic Disorders review group. Alain forwarded the 
review proposal to the editor of the Endocrine and Metabolic Disorders review 
group. Before the title registration form could be fully accepted, amendments in 
relation to international perspective, definition of CWLPS, types of studies, 
outcomes, and roles and responsibilities of co-authors (see next paragraph), 
were required, and corrected. I successfully corrected the information on the 
title registration for and the systematic review title was accepted by Cochrane 
Endocrine and Metabolic Disorders review group.     
Additional co-authors who had an extensive knowledge of commercial weight 
loss products and services were invited to join the review team, on the 
recommendation of the Endocrine and Metabolic Disorders review group. 
Professor Frank Greenway, Chief of Outpatient Clinic, Pennington Biomedical 
Research Center, USA, and Tance Sonnier who works with Professor 
Greenway, accepted my invitation. I also invited Professor Harry Rutter, 
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Director of the National Obesity Observatory UK to join the review team, and he 
kindly accepted. 
I attended two Cochrane run courses; Developing a Protocol for a Review, and 
Introduction to Analysis, at York University, prior to progressing any further with 
the systematic review. I found these a great help.  
After completing of the courses, I was much more confident in conducting a 
systematic review and using the specific programme which I needed to use as 
part of the process (RevMan). I then developed the protocol for the systematic 
review, and contacted all co-authors for their comments. I wrote the search 
strategies for Medline and Embase, and these were checked by Karla 
Bergerhoff who is the Trials Search Coordinator of the Cochrane Metabolic and 
Endocrine Disorders Group. I needed to make a few revisions, and this was a 
very useful learning process. I also compiled search strings for the Cumulative 
Index to Nursing and Allied Health Literature (CINAHL) database, and PsycInfo 
database.  
I submitted the protocol to Endocrine and Metabolic Disorders review group and 
their reviewers come back with a number of queries and comments. Most of 
their comments related to outcome measures and the definition of CWLPS. The 
review group suggested that the initial diagnostic criteria of weight and BMI was 
too restrictive, and this was amended (as suggested) to include a variety of 
markers for obesity. The Cochrane review group also suggested that we collect 
data on a wide range of relevant secondary outcomes, and these are now 
included (as suggested) in the revised protocol. One of the most difficult issues I 
had with the Cochrane review group was trying to define CWLPS. CWLPS in 
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any context and setting were included within this review (e.g. face-to-face, 
group settings, and online). However, I wanted to restrict my review to CWLPS 
which focussed on diet and/or physical activity only, and I did not include 
studies of weight loss drugs, hypnotherapy or hypnosis, or nutriceuticals. The 
original definition of CWLPS which I submitted was changed, and a detailed 
explanation describing the types of products and services that would and would 
not be included within the review is now included in the protocol. 
I submitted a revised version, and this was accepted pending a small number of 
changes. I submitted a further revised version of the protocol (Appendix 13) in 
March 2013, and at the time of submitting my PhD thesis I am still waiting for 
confirmation that the protocol has been accepted.  
Although I understand that the process of doing a Cochrane review is important, 
and the steps which you must follow are there to ensure that the review 
attempts to answer an important question and is of high quality, it does take a 
long time.   
In April 2012 I made the decision, in discussion with my PhD supervisor 
Professor Carolyn Summerbell, that I would conduct the systematic review 
using Cochrane principles, but do it as a stand-alone systematic review (I refer 
to this as my PhD refer, below). I made this decision because I was worried that 
if we conducted it with the Cochrane review group that I would not be able to 
complete it in time. I was originally planning to submit my PhD in January 2013. 
However, as soon as I have submitted my PhD I will start to work on the 
Cochrane review.    
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4.6.2 Search strings 
The search strategy which was written for the Cochrane protocol produced a 
limited number of RCT's and CCT's (controls could be placebo, usual care, or 
another commercial weight loss product or service) which could be included in 
the review. At that point, I decided to include additional study designs (CBA's 
and BA's, and studies of shorter duration) in my PhD review, to capture the 
essence and breadth of intervention studies which evaluated the impact of 
commercial weight loss products and services. The Endocrine and Metabolic 
Disorders review group only accepts RCT's and CCT's in their reviews.  
I do understand that studies which do not have control groups are prone to bias 
results, and they should be viewed with caution. I do understand that most 
people who are obese who go on a weight loss diet which they believe will work 
will probably lose weight, regardless of what sort of diet it is. However, I also 
believe that good evaluations of interventions which do not have a parallel 
control group can provide useful information; although the results from these 
studies cannot be ‘lumped’ with the results form RCT's and CCT's. The result 
from RCT's and CCT's is the difference in change over time between the 
intervention and control group. The result from evaluations of interventions 
(CBA's and BA's) is just change over time in the intervention group. Because 
people in control groups do want to lose weight (otherwise they would not have 
agreed to take part in the study or stay in the study) and usually get some sort 
of weight loss advice, and lots of measurements during the study, they usually 
lose weight. Therefore, results from evaluations are likely to be greater than 
results from studies with parallel control groups.    
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Within the Cochrane protocol, only studies of 6 months, 1 year (weight change 
at 1 year is the primary outcome) and longer are included. This was a 
recommendation of one of the Cochrane reviewers. However, due to the fact 
that I was particularly interested in including studies which had evaluated 12-
week commercial weight loss interventions which PCT's had commissioned in 
the UK over recent years, I decided to include studies of 12 weeks or longer in 
my PhD review. However, I kept weight change at 1 year as the primary 
outcome for my PhD review. 
I do understand that, typically, people who go on weight loss diets lose weight 
initially, but then (at about 2 or 3 months) it starts to go back on again, and by 
six months the weight lost from the start is minimal. Perhaps this is why 
commercial weight loss companies offer PCT's 12-week courses, and often just 
present their results at 3 months.  
In addition, I only included studies from 1980 only in my PhD review. This 
specific year was chosen as the 1980’s saw a boom in the commercial weight 
loss industry, and it was about then that doctors informed the public that obesity 
was a risk to health.  
In the Cochrane protocol, participants in studies must be 18 or older. However, 
in my PhD review I have included people aged 16 years or older. I decided it 
was a good idea to reduce the age to 16 year olds since this is the minimum 
age for people who can attend commercial weight loss groups such as 
Slimming World and Weight Watchers. 
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Finally, for my PhD review, I did not collect and report the plethora of outcome 
measures which are listed in my Cochrane protocol. I have restricted the 
outcomes measures to measures or estimates of body weight and body fatness.  
 
4.6.3 Cochrane title 
Commercial weight loss products and services for overweight and obese people 
(Crayton et al, 2013). 
 
4.6.4 Cochrane protocol 
On March 28th 2013, the Cochrane protocol (Appendix 13), was checked into 
the Cochrane Library for editorial comments. I am not expecting any further 
editorial comments. After I have submitted my PhD thesis, and after the review 
has been ‘unlocked’, and I have received the approval to start the review, I will 
run the searches again from August 2012 to present, and will assess the 
additional hits for duplication and relevance. I am hopeful that I will be able to 
complete the Cochrane review quickly, and submit the review to Cochrane by 
summer 2013. 
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Chapter Five 
Results 
 
5.1 Introduction  
This section reports the findings of the first component (of three) of my 
research, the survey.  Demographics of those participating in the survey, the 
popularity of CWLPS, and the relationship between the cost of CWLPS and 
socioeconomic status of those who used them, are described in this chapter.  
Results from the Q-methodology study (the second component of my research) 
follow the results of the survey. The third component of my research is a 
systematic review, which was conducted in line with Cochrane methodology, 
with a couple of exceptions. The Cochrane review protocol (included as an 
Appendix to my thesis) has been accepted by the Cochrane Metabolic and 
Endocrine review group. For the purposes of this thesis, the systematic review, 
which I report here, includes a more inclusive inclusion criterion, as compared 
with the Cochrane review. For example, in addition to RCT's and CCT's, I 
included CBA's and ITS studies in my PhD systematic review. In addition, I 
included studies in my PhD systematic review with a minimum duration  of 12 
weeks (to reflect the same referral periods used in the NHS) and people from 
aged 16 years; in my Cochrane review the minimum  duration of study is 6 
months, and minimum age is 18 years. 
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5.2 Survey 
 
5.2.1 Participants 
Participants who were involved in the survey research (n=81), were primarily 
recruited through local publications, which have large online and print 
readerships (Evening Gazette, Northern Echo, and Darlington and Stockton 
times). As shown in Table 9, most of the participants were female (91%) and 
Caucasian (99%). About a third of the participants were in receipt of a 
postgraduate or graduate degree (37%), and over half of them were married 
(51%). The mean age of participants was 44.4 (SD 13.6). 
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Table 9: Survey participant’s (n=81) demographics 
 
 
Mean (SD) 
Age 44.4 (13.6) 
 Number of Participants (%) 
Gender     
Female 
Male 
 
74  
7    
  
(91%)  
 (9%) 
Ethnicity  
White 
Other 
 
80   
1   
  
(99%) 
  (1%) 
Highest level of educational 
achievement  
Secondary School         
BTEC/SCOTVEC        
NVQ   
HNC or HND         
CSE         
Degree        
GCSE         
Postgraduate degree             
AS or A Level   
 
  
6      
1     
10   
 2     
2 
18 
10 
11 
10 
  
 
(7%) 
(1%) 
(12%) 
(3%) 
    (3%) 
   (22%) 
   (12%) 
   (14%) 
   (12%) 
Occupation 
Full time employment 
Full time education 
Homemaker 
Other 
Part-time employment 
Retired 
Self-employed 
Unemployed 
 
39  
 8    
 3    
 1    
14 
10 
4 
2 
 
(48%) 
(10%) 
4%) 
1%) 
   (17%) 
   (12%) 
      (5%) 
    (3%) 
Religion  
Buddhism 
Catholic 
Christianity 
Church of England 
None 
Roman catholic 
Wiccan 
 
 2   
 1   
38  
3 
23 
13 
1 
  
(3%) 
1%) 
(47%) 
  (4%) 
   (28%) 
   (16%) 
      (1%) 
Marital status  
Co-habiting 
Divorced/separated 
Living with parents/guardians 
Married 
Other (widowed) 
Single 
 
19   
 5     
 7     
41 
3 
6 
 
(24%) 
(6%) 
(9%) 
  (51%) 
      (4%) 
      (7%) 
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5.2.2 Supermarket purchases 
Participants were asked where they did their bulk food purchases. Asda was 
clearly the most popular supermarket, followed by Tesco’s (Table 10).  
 
Table 10: Bulk food shopping purchases amongst survey participants   
 
 
5.2.3 Cost and duration of CWLPS purchased 
The cost and duration of use of CWLPS by the survey participants varied widely 
(Table 11).  
 
Table 11: Total cost and duration of use of CWLPS by the survey 
participants  
 
Total cost of CWLPS purchased:  
range  
(mean) 
 
£5.00 - £3,717.48 per year 
(£399.97 per year; £1.09 per day)  
Total duration of CWLPS purchased: 
range  
(mean) 
14 – 1121 days  
(327 days) 
Name of the supermarket Number (%) 
Aldi  1   1(%) 
Asda 29  (36%) 
Lidl  1   (1%) 
Local shops  1    (1%) 
Morrison’s 13   (16%) 
None  1    1(%) 
Sainsbury’s 14   (17%) 
Tesco 21   (26%) 
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5.2.4 Socio-economic status  
As shown in Table 12, the majority of participants who wanted to take part in the 
survey were not from the most deprived areas of the North East. 
 
Table 12: Participant IMD data 
Lower layer super output (2010 data) 
index of multiple deprivation:  
Range 
3.03 - 68.72 
Mean 
 (20.04)  
 
 
5.2.5 Popularity of CWLPS 
   
Figure 16: Popularity of CWLPS n=81 
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The most popular CWLPS amongst survey participants (n=81) was Slimming 
World (n=30), followed by Weight Watchers (n=21), LighterLife (n=15), Slim 
Fast (n=14), Other (n=14), DVDs (n=11), Weight Loss books (n=10),Magazines 
(n=10), Special K (n=7), Adios (n=5), Websites (n=5), Alli (n=4), Tony Ferguson 
(n=3),Diet Chef(n=2), Rosemary Conley (n=2), CDs (n=1), Lipobind (n=1),  and 
TV programmes (n=0). 
 
Others included Cambridge weight plan (n=6), Tesco ultra slim replacement 
(n=1), flabelouse machine (n=1), actislim ultra tablets (n=1), all about w8 (n=1), 
The Zoe Harcombe Diet (n=1), weight watchers meals (n=1), Paul McKenna 
(n=1), phentermine at slimming clinic (n=1). 
 
Figure 16 shows the popularity of CWLPS chosen by survey participants. 
Slimming World and Weight Watchers were the favoured CWLPS. In addition to 
looking at the popularity of CWLPS, I also assessed whether there were any 
participants who had used a combination of CWLPS, and if there were any 
participants who had only used one CWLPS.  Less than half of the participants 
(n=37) used a combination of CWLPS over a 12 month period. For those who 
used only one CWLPS (n=44), this equated to an average spend of £250.42 per 
participant, while those who used a combination of CWLPS spent more overall, 
on average £566.89 per participant. 
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Table 13: CWLPS cost per week and suggested duration of the course 
 
 
 
 
 
CWLPS Cost per week Suggested 
length of the 
course 
Slimming World £9.95 Until goal weight 
is reached 
Weight Watchers £5.50 Until goal weight 
is reached 
LighterLife £74.00 Until goal weight 
is reached 
Rosemary Conley £5 Until goal weight 
is reached 
Diet Chef £47.53 unknown 
Tony Ferguson £33.39 Unknown 
Alli £8.74 Unknown 
Slim Fast £21.70 Unknown  
Special K £2.69 Unknown 
Lipobind £5.69 Unknown 
Adios £2.43 Unknown 
Weight Loss book(s) £7.69 based upon the 
top selling weight loss 
book from Amazon (I 
Can Make You Thin by 
Paul McKenna) 
Unknown 
DVD(s) £7.44 based upon the 
top selling weight loss 
DVD from Amazon 
(Yoga For Weight Loss 
for Beginners DVD ~ 
Maggie Rhoades) 
Unknown 
Magazine(s) £2.54 Unknown 
Website(s) free Unknown 
TV Programmes free Unknown 
CD(s) £24.99 based upon 
customer rating from 
Amazon (Virtual Gastric 
Band Hypnosis - Lose 
Weight Fast!) 
Unknown 
Other 
Cambridge weight plan 
Tesco ultra slim replacement  
The Zoe Harcombe Diet 
Flabelouse machine  
Actislim ultra tablets 
Phentermine at slimming clinic  
All about W8 
Weight Watchers meals 
Paul McKenna 
 
£44.10 
£2.57 
£1.49 
£20.83 
£14.95 
£9.83 
£49 
£56.00 
£9.99 
 
Unknown 
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Table 14: Rank ordering of CWLPS according to cost and popularity 
 
CWLPS rank by cost 
(highest to lowest) 
Rank by popularity 
(most to least popular) 
LighterLife Slimming World 
Diet Chef Weight Watchers 
Tony Ferguson LighterLife 
CDs Slim Fast 
Slim Fast Other 
Other DVDs 
Slimming World Weight Loss books 
Alli Magazines 
Weight Loss books Special K 
DVDs Adios 
Lipobind Websites 
Weight Watchers Alli 
Rosemary Conley Tony Ferguson 
Special K Diet Chef 
Magazines Rosemary Conley 
Adios CDs 
Websites Lipobind 
TV programmes TV programmes 
 
TV programmes was the only CWLPS that matched according to ranking of cost 
and popularity. The most popular CWLPS amongst survey participants was 
Slimming World; however, this CWLPS was ranked as 7th according to cost.  
 
Further analysis was undertaken in relation to the most popular CWLPS; 
Slimming World. The total (of all participants) duration which this product was 
taken (6488 days) and accounted for 24.8% of overall CWLPS usage (26143 
days), though it only accounted for 10% of the total money which the 
participants spent on CWLPS during the survey period (£34129.58). Survey 
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Participants spent a considerable amount of time using CWLPS; equating to 
71.8 years. 
If one groups the different CWLPS used by the participants into; programmes, 
weight loss tablets, meals, education, it is clear that programmes are the most 
popular (Table 15). 
Table 15: Duration and cost of CWLPS   
CWLPS Total duration 
(days) 
Total cost 
(£) 
Programmes (Slimming World, Weight Watchers, 
LighterLife, Rosemary Conley, Diet Chef, Tony 
Ferguson 
14241 28848.54 
Weight loss tablets (Alli, Lipobind, Adios) 434 630.00 
Meals (Slim Fast, Special K, 1355 999.14 
Education (Weight Loss book(s), 
DVD(s),Magazine(s),Website(s),CD(s) 
8222 1429.42 
Others 
Cambridge weight plan, Tesco ultra slim replacement, 
The Zoe Harcombe Diet, Flabelouse machine , 
Actislim ultra tablets, Phentermine at slimming clinic, 
All about W8, Weight Watchers meals, and Paul 
McKenna  
1891 2204.48 
 
Of those 44 participants who used only one CWLPS, 19 used Slimming World 
and eight used Weight Watchers. One of the aims of my research was to try 
and find out why some CWLPS were more popular than others.  
 
5.2.6 Age; Survey response and CWLPS choices 
Figure 17 shows the profile of age for the participants who took part in the 
survey.  
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Figure 17: A bar chart showing the age distribution of participants of the 
survey 
 
The use of CWLPS varied by age in the participants of the survey; 16% of the 
participants who were in their 20’s had only used one (rather than a 
combination of) CWLPS in the previous year, compared with 62% of those in 
their 50’s. 
 
Table 16: Total cost of CWLPS bought by 20-29 year olds (n=16), and 50-
59 year olds (n=21), in one year (between 2010 and 2011) 
  
 
Cost 
Range (mean) 
20-29year olds £25.00-£397.00  (£144.40p) 
50-59 year olds £49.50-£3717.48  (£578.90p) 
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Participants in their 20’s spent less on CWLPS, compared with those in their 
50’s; £144.40 vs. £578.90, respectively.  
Figure 18: A scatter plot to demonstrate the relationship between age and 
total cost of commercial weight loss products and services purchased 
(2010-2011) n=81 
 
Although it appears that there is a positive relation between age and total cost 
of all CWLPS purchases, when looking at the statistics, there was no positive 
linear trend for age and CWLPS. The figure explains .020% (R²) of the 
variability of the response data around its mean. Also when observing the 
output data, there was no significance shown (see appendix 44). 
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Table 17: Total duration (days) of CWLPS bought by 20-29 (n=16), and 50-
59 year olds (n=21) from 2010-2011 
 
Range (mean) Median 
20-29year olds 14-1092.75  (361.8) 266 
50-59 year olds 84-1120.75 (356.2) 364.25 
 
Participants in their 50’s spent more money on CWLPS, and used the CWLPS 
for a shorter amount of time, compared with participants in their 20’s. 
 
Table 18: Socioeconomic factors (IMD and household net income) 
 
Range (mean Median 
Lower layer super output (2010 
data) index of multiple 
deprivation: range (mean) 
3.03-68.72  (20.04) 16.43 
Average annual household net 
income,(after housing costs) 
£14560-£26520  (£20324.94) 19760 
 
Table 18 illustrates participant’s deprivation from IMD scores and their possible 
annual household net income (after housing costs). Mean IMD participant data 
shows that the population involved was not deprived, and the average 
household net income (after housing costs) for this sample of participants was 
higher than the median North East average household net income (after 
housing costs) of £17,004 (Office for National Statistics, 2012). On average 
participants spent 2.10% of their average annual income on CWLPS. 
(£34129.58/81=£421.40;£421.40/£20324.94*100=2.10%) 
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Figure 19: A scatter plot showing the relationship between IMD data, and 
total cost of CWLPS purchased (2010-2011) n=81 
 
In general the higher the score within a domain the more deprived the SOA. 
Therefore, participants within this sample are not deprived, or very few would be 
classified as deprived. 
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Although it appears that there is a positive relation between age and total cost 
of all CWLPS purchases, when looking at the statistics, there was no positive 
linear trend for age and CWLPS. The figure explains .012% (R²) of the 
variability of the response data around its mean. Also when observing the 
output data, there was no significance shown (see appendix 44). 
Figure 20: A scatter plot to show the relationship between Average 
Weekly Household Net Income Estimate, and total cost of commercial 
weight loss products and services purchased (2010-2011) n=81 
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Using household income data as a proxy for deprivation, rather than IMD, 
Figure 20 shows that there is no relationship between the amount of money a 
participant spent on CWLPS and household income data.   
 
5.2.7 Summary 
Weight loss programmes such as Slimming World and Weight Watchers were 
clearly the most popular CWLPS used by the participants in my survey. Saying 
that, there was a wide range of CWLPS used by the participants in my survey.  
The survey clearly demonstrates that age plays an important part in relation to 
the purchase of CWLPS, especially between the ages of 20-29 and 50-59. The 
amount of money spent on CWLPS is significantly different between 20-29 year 
olds and 50-59 year olds; older participants spent more money on CWLPS. 
Also, older participants were more likely to choose just one CWLPS, rather than 
try different ones over a one-year period.   
The analysis did not show any correlations between the amount of money a 
participant spent on CWLPS and the socioeconomic status of the participants, 
but this was primarily because there were very few participants in the survey 
who were deprived. Therefore, it was necessary to establish whether cost was 
an important factor in relation to a person’s socioeconomic status through an 
additional piece of research exploration, the Q-methodology study.  
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5.3 Q-methodology analysis 
 
5.3.1 Description of Study Sample  
As previously described in 4.5.6, seven to twenty participants were involved at 
one or more stages of my Q-method study. Participants who had stated that 
they were happy for the researcher to contact them at a later date within their 
survey consent form (n=80, of 81) were sent information sheets (Appendix 20) 
and consent forms (Appendix 22) in the post, with a pre-paid envelope to be 
returned back to the researcher, and a registration form (Appendix 21) asking 
which venues (Durham University; Main campus, Durham University; Queens 
Campus, or Teesside University), and times (Monday;7-8pm, Wednesday; 2-
3pm or Friday; 10-11am) would be most suitable for them. Participants also had 
the opportunity to state other times or venues. Twenty participants replied, 
stating where and when would be suitable for them to complete the Q-sorting 
exercise. This sample size was adequate enough to reveal underlying factors in 
relation to the reasons for choosing CWLPS. 
Five subjects were male, and 15 were female. Subjects ranged in age from 21 
to 65; the mean age of participants was 45 years.  All subjects were identified 
as Caucasian (100%). Complete demographic information for can be found in 
Table 19.  
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Table 19: Sample (n=20) Q-methodology characteristics 
 
 
Mean (range) 
Age (years) 45 (21-65) 
 
Frequency (%) 
Gender 
Male 
Female 
 
5 
15 
 
(25%) 
(75%) 
Ethnicity 
White 
20  (100%) 
Occupation 
Employed fulltime 
Employed part-time 
Fulltime education 
Retired 
Self-employed 
Homemaker 
Other 
 
11  
1  
2  
3 
1 
1 
1 
 
(55%) 
(%) 
(10%) 
(15%) 
 (5%) 
 (5%) 
 (5%) 
Marital status 
Co-habiting 
Married 
Divorced/separated 
Living with parents 
Single 
Other (widow) 
 
5  
8  
1  
1 
3 
2 
 
(25%) 
(40%) 
(5%) 
(5%) 
 (15%) 
 (10%) 
Highest level of educational 
achievement 
AS or A level 
Degree 
GCSE 
HNC or HND 
Other 
Postgraduate degree 
Secondary school 
 
 
6  
2  
2  
1 
2 
4 
3 
 
 
(30%) 
(10%) 
(10%) 
 (5%) 
 (10%) 
 (20%) 
 (15%) 
Religion 
Christianity 
Buddhism 
Roman catholic 
Wiccan 
None  
 
12  
1  
1 
1 
5 
 
(60%) 
(5%) 
 (5%) 
 (5%) 
 (25%) 
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Table 20: Socioeconomic data and CWLPS usage of participants who took 
part in the Q-method study 
 
Range (mean) 
Average Weekly Household Net Income 
(after housing costs) 
£14,560 - 
£26,520 
 (£20,618) 
IMD  3.14 - 65.31  (19.62) 
CWLPS purchased £28 - £1,260  (£321) 
Duration of CWLPS purchased (days) 14 - 1121  (353) 
 
5.3.2 Review of Methods 
 
Key quotes in relation to the reasons why participants chose CWLPS were 
taken from focus groups and interviews to form statements. Prior to the 
commencement of the Q-sorting phase, the statements were piloted twice (see 
4.5.8.4.2 and 4.5.8.4.3) for readability, overlapping purposes, and to try and 
reduce the amount of statements.  
Individualized Q-Sorts were completed by 20 participants, who each rank-
ordered the Q-Set statements according to how much they agreed or disagreed 
with the statements when thinking about their favoured CWLPS. Due to time 
constraints by the participants, face-to-face (n=12) and postal (n=8) Q sorts 
were required. Participants were asked to elaborate on her/his point of view, 
expanding on the most salient statements that were placed at both extreme 
ends of the continuum on the score sheet. This information was gathered via a 
Dictaphone, or written on the postal Q-sorts. This information was extremely 
helpful for the interpretation of factors. 
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5.3.3 Correlation matrix 
The first step in the Q-analysis was to create a correlation matrix from the 20 Q-
sorts, whereby each participant's sort was correlated with every other 
participant's sort (Table 21). A correlation matrix is essential in organising the 
data to identify the underlying dominant factors.
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Table 21: Correlation Matrix Between Sorts   
 
 
 
 
 
 
 
 
 
 
 
 
 
Sorts 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 100 34 19 25 7 48 35 37 28 11 26 42 23 41 19 36 23 17 15 27 
2 34 100 34 18 30 29 58 40 36 -16 11 15 33 37 42 21 39 17 16 37 
3 19 34 100 38 34 18 49 59 23 -11 1 8 44 48 37 24 -8 2 45 -4 
4 25 18 38 100 34 39 42 32 34 20 25 9 51 30 28 37 1 14 28 14 
5 7 30 34 34 100 20 47 11 13 -17 19 6 32 6 11 9 -13 5 22 13 
6 48 29 18 39 20 100 27 42 30 34 46 36 44 42 18 53 26 43 39 34 
7 38 58 49 42 47 27 100 51 36 -8 16 25 62 43 46 18 16 14 41 12 
8 37 40 59 32 11 42 51 100 48 -1 19 20 39 63 43 45 18 7 36 13 
9 28 36 23 34 13 30 36 48 100 18 17 26 36 37 32 35 31 4 8 15 
10 11 -16 -11 20 -17 34 -8 -1 18 100 27 19 1 11 -8 15 27 30 -8 -4 
11 26 11 1 25 19 46 16 19 17 27 100 50 21 11 15 37 22 37 12 6 
12 42 15 8 9 6 36 25 20 26 19 50 100 30 16 -4 27 22 27 31 -21 
13 23 33 44 51 32 44 62 39 36 1 21 30 100 31 46 18 -2 8 56 7 
14 41 37 48 30 6 42 43 63 37 11 11 16 31 100 33 34 29 27 37 13 
15 19 42 37 28 11 18 46 43 32 -8 15 -4 46 33 100 10 5 17 18 10 
16 36 21 24 37 9 53 18 45 35 15 37 27 18 34 10 100 32 36 10 23 
17 23 39 -8 1 -13 26 16 18 31 27 22 22 -2 29 5 32 100 33 0 14 
18 17 17 2 14 5 43 14 7 4 30 37 27 8 27 17 36 33 100 5 1 
19 15 16 45 28 22 39 41 36 8 -8 12 31 56 37 18 10 0 5 100 11 
20 27 37 -4 14 13 34 12 13 15 -4 6 -21 7 13 10 23 14 1 11 100 
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5.3.4 Interpretation of the correlation matrix between sorts 
Table 21 shows all 20 Q-sorts and which participants show the agreement or 
disagreement between the factors; the closer the value to 100, the higher the 
agreement or disagreement between participant Q-sorts.  
 
Q-sorts 8 and 14 show high agreement between the factor scores, Q-sorts 12 
and 20 show a slight disagreement between the factor scores. 
 
5.3.5 Factor analysis 
The second step was to perform a factor analysis on the correlation matrix, 
using an unrotated factor matrix (Table 22), resulting in the identification of 
underlying factors, or clusters of groupings.   
Chapter Five Results 
 
170 
 
Table 22: Unrotated Factor Matrix   
 
Sorts Factor 1 Factor 2 Factor 3 
Factor 
4 
Factor 
5 
Factor 
6 
Factor 
7 
Factor 
8 
1 0.5788 0.2339 0.1399 0.0218 0.1218 0.3402 -0.2263 0.0008 
2 0.6115 -0.1656 0.4623 0.1698 0.4028 -0.1141 0.2020 
-
0.0279 
3 0.5859 -0.4892 -0.1039 -0.2556 -0.1378 0.0382 0.1446 0.2837 
4 0.5933 -0.0959 -0.2373 0.2016 -0.4591 -0.2385 -0.1271 0.0189 
5 0.3701 -0.3576 -0.2562 0.5569 0.1379 -0.1777 -0.0520 0.3082 
6 0.6994 0.3763 -0.1106 0.2319 -0.1749 0.2192 0.1223 
-
0.1243 
7 0.7304 -0.3568 -0.0225 0.0456 0.2618 -0.1692 -0.0307 
-
0.0574 
8 0.7342 -0.1587 0.1702 -0.3383 -0.1453 0.1431 -0.0448 0.1862 
9 0.5807 0.0636 0.2201 -0.1781 -0.1085 -0.2548 -0.5314 
-
0.0398 
10 0.1394 0.6193 -0.1783 -0.1212 -0.3709 -0.2622 -0.0483 
-
0.3037 
11 0.4390 0.4828 -0.3421 0.2102 0.1602 -0.1221 -0.0360 0.1171 
12 0.4370 0.3920 -0.4484 -0.1864 0.4722 0.1883 -0.2564 0.0144 
13 0.6823 -0.3113 -0.3336 0.0346 -0.0065 -0.0781 -0.0666 
-
0.3478 
14 0.6794 -0.0151 0.2196 -0.3592 -0.1344 0.1578 0.2329 0.0335 
15 0.5212 -0.3081 0.1814 -0.1236 0.0156 -0.4075 0.1871 
-
0.2049 
16 0.5678 0.3810 0.0981 0.0639 -0.2576 0.1128 -0.0151 0.4667 
17 0.3388 0.5073 0.4336 -0.1295 0.2658 -0.1264 0.0299 
-
0.0986 
18 0.3582 0.5153 -0.0734 0.0587 0.1216 -0.2573 0.5956 0.0973 
19 0.5218 -0.2803 -0.3623 -0.0534 0.0288 0.4371 0.2219 
-
0.3070 
20 0.2733 0.0212 0.5171 0.6194 -0.1967 0.2930 0.0016 
-
0.2190 
 
Eigenvalues       5.9546 2.4660 1.6002 1.2973 1.1536 1.0687 0.9598 
 % expl.Var.        30 12 8 6 6 5 5 
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5.3.6 Varimax rotation 
The third and fourth step was to conduct, using a computer-automated rotation, 
varimax, selecting which subjects to assign to each factor and how many 
factors to be considered for final analysis Table 23). Varimax produces the 
factor solution that maximizes the amount of variance explained on as few 
factors as possible. Varimax rotation was utilised. As a novice Q-methodologist, 
I felt that this analysis would be straightforward and transparent, and it is widely 
used in Q circles. I could not have used the second form of rotation in Q-
methodology for this study; judgmental rotation. Judgemental rotation looks for 
confirmation of an idea or a theory, a theoretical rotation for an acceptable 
vantage point by statistical criteria (Van Exel & de Graaf, 2005). My research 
did not set out to confirm an idea or a theory in relation to CWLPS. 
 
Various factor analyses and factor rotations were performed to identify the most 
powerful representation of factors. A four-factor solution was performed for this 
study; three and five factor solutions were also examined.  This was determined 
by assessing the factor loadings for each sorter, and evaluated for statistical 
significance (f >0.33, p<0.01). Factor loadings for each Q-sorter using a three, 
four a five factor solution were examined using the formula 2.58(1/√60). The 
auto flag feature within the Varimax option was used for subject selection, and 
to decide upon the final factor solution. Auto flagging of subjects is based on the 
rule that the rotated factor loadings must be significant at p<0.05 and the 
subject must explain more than half of the common variance for that given 
factor. 
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After examining the data for factors three, four and five, I assessed which 
solution uncovered and revealed more insight into my research question.  
 
5.3.7 Five factor solution 
Upon assessment of correlations between factor scores, I felt that there was 
some commonalty between the factors (0.1381-0.4519). Ideally the correlation 
between factor scores should be low, to increase the confidence that the factors 
are more different than alike. Also, a significant number of participants were 
loading on multiple factors (n=6). Therefore, these participants would have 
required their Q-sort to be unflagged to sharpen the meaning and 
distinctiveness of the factor, and would not be included in the final analysis. 
However, after examining the unflagged solution, factor arrays and correlations 
between factor scores, I felt that the factors were not revealing significant 
reasons why participants’ chose their favoured CWLPS. 
 
5.3.8 Three factor solution 
After examining the factor arrays, correlations between factor scores, and 
confounding Q-sorts, I felt that this solution was not sufficient in demonstrating 
the differences between the factors; correlations between factor scores were 
0.2999-0.5164. Therefore, there were significant similarities between the 
factors. However, to account for confounding Q-sorts it would have been 
essential to unflag eight Q-sorts, to show clear distinctions among the factors. 
However, I was conscious of one particular participant who had the highest Q-
sort loading on factor 4.This particular participant had chosen Slimming World 
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for men only, and I felt that this participant was unique and interesting, and 
therefore using a three factor solution would not highlight his views. 
  
5.3.9 Four factor solution 
This factor solution provided the most insight as to why people chose their 
favoured CWLPS, using 16 Q-sorts for the final analysis. Eight Q-sorts were 
confounding; however, four of these were far enough apart between the factors 
to not be considered as confounding (.1219-.3098). One Q-sort was unflagged 
as it was between one or more factors (there were a variety of reasons why this 
person chose their favoured product, or service. They did not have a clustering 
of reasons on one factor), and the remaining Q-sorts (n=3) were not included in 
the analysis as their confounding between factors was too high. 
Before, finally deciding upon a four-factor solution, I also consulted Webler et 
al’s (2009) Q-methodology study into environmental research, whereby a 
detailed explanation on deciding upon the final set of factors is given. 
1. Simplicity: All else being equal, fewer factors are better, as it makes the 
viewpoints at issue easier to understand. Of course, simplicity should not be 
taken so far that you lose important and interesting information about 
differences in people’s views. 
2. Clarity: The best factor solution is one in which each sorter loads highly on 
one, and only one, factor. You should try to minimize the number of 
“confounders” (people who load on multiple factors) and “non-loaders” (people 
who do not load on any factor). If a few confounders persist, that indicates that 
those people have truly hybrid views. 
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3. Distinctness: Lower correlations between factors are better, as highly 
correlated factors are saying similar things. Nevertheless, it is not necessarily 
bad to have high correlations, as long as the factor is otherwise satisfactory. It 
may be that two factors agree on many issues, but their points of disagreement 
are particularly important (e.g. if they disagree about a remedy that is being 
proposed as the next step at your site). 
4. Stability: As you compare the results of using different numbers of factors, 
you will notice certain groups of people tend to cluster together. This is an 
indicator that those individuals really do think similarly. 
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Table 23: Factor Matrix with an X Indicating a Defining Sort 
 
                    
Loadings 
    
 QSORT             1 2 3 4 
1 0.0922 0.4382 0.4022 0.2180 
2 0.1681 0.0492 0.5717 0.5352 
3 0.4926 -0.1265 0.6145X -0.1495 
4 0.5598X 0.2767 0.2343 0.1151 
5 0.7288X -0.0165 -0.0594 0.3250 
6 0.3138 0.6943X 0.2397 0.2423 
7 0.5656 0.5670 0.5616 0.1572 
8 0.2045 0.1465 0.8227X -0.0730 
9 0.0513 0.2603 0.5808X 0.1170 
10 0.1768 0.6214X -0.0516 -0.1713 
11 0.2650 0.7163X -0.0529 0.0309 
12 0.2194 0.6345X 0.1309 -0.3355 
13 0.7034X 0.1491 0.3934 -0.0560 
14 0.0687 0.2270 0.7634X -0.0012 
15 0.2505 -0.0661 0.5777X 0.1188 
16 0.0557 0.5703X 0.3217 0.2224 
17 -0.3968 0.4683 0.3740 0.2457 
18 -0.0118 0.6260X 0.0749 0.0712 
19 0.5926X 0.0992 0.3077 -0.1708 
20 0.0510 0.6700 0.0769 0.8445X 
     
 % expl.Var.      14 16 19 8 
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Table 23 illustrates four Q-sorts by factor 1, five by factor 2, four by factor 3, and 
one Q-sort by factor 4. The factor 4 solution accounted for 57% of the total 
variance (factor 1; 14%. factor 2; 16%, factor 3; 19% and factor 4; 8%). 
 
Table 24: Correlations between Factor Scores 
      Correlations between Factor Scores 
  1 2 3 4 
1 1.0000 0.3291 0.4863 0.1517 
2 0.3291 1.0000 0.3469 0.1027 
3 0.4863 0.3469 1.0000 0.1364 
4 0.1517 0.1027 0.1364 1.0000 
 
5.3.10 Factor scores and arrays 
 
After I had identified a four factor solution, each statement (see appendix 23) in 
the Q sample (n=60) were converted to z-scores via the Q-methodology 
software, and weighted so that the relative importance of each statement would 
be reflected in composite Q sorts representing the four factors. Webler, 
Danielson, and Tuler (2009) suggest that a Z-score is a good measure of 
salience, and allows the researcher to establish how far a statement lies from 
the middle of a distribution. For example a statement with a z-score of -1.408 is 
1.408 standard deviations below the mid-point of the distribution. Based on their 
Z-scores, the statements were ranked within each factor from the strongest 
positive z-scores to the strongest negative z-scores, demonstrating an ideal or 
hypothetical Q-sort for each factor indicating the relative importance of each 
statement in the composite.  Statements ranked in high disagreement (-5), and 
those ranked in high in agreement (+5) offered an insight into the reasons why 
participants chose their favoured CWLPS.   A weighting of the appropriate sorts 
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elicits the factor arrays. An example of the resulting factor arrays for a three-
factor solution (based on z-scores) can be found in Appendix 24. 
 
Distinguishing statements also identified which statements distinguished the 
factors from one another, and aided the interpretation of the factors, and the 
consensus statements that are not distinguished amongst the factors. 
 
5.3.10.1 Interpretation of the factors 
 
5.3.10.1.1 Factor 1- “Effortless self-management”.  
The Q-sorts of 4 participants all showed statistically significant loadings on 
factor 1, all of whom had chosen different favoured CWLPS when conducting 
the Q-sort; LighterLife, Special K, Slim fast, and Weight Watchers online. 
Proceeding tables demonstrate the highest and lowest ranked statements, as 
well as the highest ranked distinguishing statements with z-scores for Factor 1. 
The z-scores of statements are the normal distribution curve of each array 
turned on its side, resulting in a composite (or idealised) Q sort for each factor. 
Proceeding tables represent how a hypothetical respondent with a 100% 
loading on that factor would have ordered all the statements of the Q-set for 
factor 1. Hypothetical respondents of factor 1 would have chosen their favoured 
CWLPS based upon payment motivation, targets set by the individual and 
wanting the weight loss to be rapid too. 
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Participants represented in Factor 1 ranked the following statements as "+5”; 
statements that I agree why I chose my favoured CWLPS: 
 
Table 25: +5 ranking of statements for factor 1 
 
Number (ranking) Statement Z-scores 
51 (+5) I chose this CWLPS, as I 
wanted to lose weight 
quickly. 
2.013 
56 (+5) I chose this CWLPS, as 
it looked easy to follow. 
1.926 
43 (+5) I chose this CWLPS as I 
could set my own 
realistic weight loss 
target to aim for. 
1.890 
 
The following were ranked in factor 1 as "+4”; statements that I agree why I 
chose my favoured CWLPS: 
Table 26: +4 ranking of statements for factor 1 
 
Number (ranking) Statement Z-scores 
28 (+4) I chose to pay for this CWLPS, as I 
knew that paying for it would motivate 
me into losing weight. 
1.588 
38 (+4) I chose to pay for this CWLPS because 
it is my responsibility to lose weight. If I 
do mess up, I fail. 
1.585 
60 (+4) I chose this CWLPS based upon the 
endorsement from friends who had 
successfully tried it themselves. 
1.466 
48 (+4) I chose this CWLPS based upon 
convenience. 
1.436 
 
At the other end of the composite Q sort array, Factor 1 participants placed 
these cards next to the positions marked "-5”, statements which they disagreed 
were not based upon the reasons why they chose their favoured CWLPS. 
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Table 27: -5 ranking of statements for factor 1 
 
Number (ranking) Statement Z-scores 
7 (-5) I chose this CWLPS as it was of a case 
of all or nothing. 
-2.144 
30 (-5) I chose this CWLPS as it was the last 
resort for me. 
-2.115 
15 (-5) I chose this CWLPS based upon the 
endorsement from celebrities who had 
successfully tried it themselves. 
-1.408 
 
 
The following were ranked in factor 1 as "-4”, statements which they disagreed 
with were ‘the opposite’ of the reasons why they chose their favoured CWLPS. 
 
Table 28: -4ranking of statements for factor 1 
 
Number (ranking) Statement Z-scores 
54 (-4) 54 I chose this CWLPS, as I did not 
want to talk about food at all. 
-1.405 
59(-4) 59 I chose this CWLPS, as I wanted 
the camaraderie from others who were 
also following the same CWLPS as me. 
-1.242 
10 (-4) I chose this CWLPS, as it was 
particularly important for me to be with 
others in a group setting, which I could 
get from this CWLPS. 
-1.203 
46 (-4) I chose this CWLPS, as I wanted to 
understand why I overeat so that I 
could change my relationship with food.  
-1.203 
 
 
Seven statements were distinguishing at p<0.01(Table 29). Therefore, 
statement scores on two factors have exceeded the difference score at p<0.01.  
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Table 29: Distinguishing statements for factor 1 
Number Statement Rank Z-
scores 
56 I chose this CWLPS, as it 
looked easy to follow. 
+5 +5 
41 I chose this CWLPS because 
I saw it advertised (online, 
TV, newspaper, radio). 
+3 +3 
12 I chose this CWLPS, as I 
wanted to buy the meals, and 
snacks provided by the 
commercial weight loss 
company that produces this 
CWLPS. 
+3 +3 
20 I chose this particular 
CWLPS as I thought it would 
encourage me to do new 
activities to help me lose 
weight (Great North Run, 
joining a gym). 
+2 +2 
49 I chose this CWLPS, as I did 
not want to try and lose 
weight with other people; I 
wanted to do it alone. 
+1 +1 
10 I chose this CWLPS, as it 
was particularly important for 
me to be with others in a 
group setting, which I could 
get from this CWLPS. 
-4 -4 
59 I chose this CWLPS, as I 
wanted the camaraderie from 
others who were also 
following the same CWLPS 
as me. 
-4 -4 
 
 
Table 30 demonstrates the consensus statements that were not distinguished 
amongst the factors at p>0.01, with respective z-score and ranking. 
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Table 30: Consensus statements for Factor 1 
 
 
 
Participants who subscribed to this factor chose their favoured CWLPS as it 
was simple, and it appeared that they had considered other others prior to 
choosing this CWLPS. The key statement that was distinguishing and also 
highly ranked (+5) amongst individuals who subscribed to “Effortless self-
management” was in relation to the CWLPS’s method of delivery: 
(56) I chose this CWLPS, as it looked easy to follow. 
 
5.3.10.1.2 Factor 1; Post-sort interviews 
Qualitative data from the post-sort interviews strengthens the statements listed 
in the tables above, further explaining the reasons why the subscribers of this 
factor chose their favoured CWLPS. 
 
5.3.10.1.3 Factor 1; Interpretation 
Participant 20, 114 and 100 clearly explained their reasons why they placed 
statements 43, 56, and 51 at +5. Even though these were not distinguishing 
statements for this factor, it is apparent that these statements were the core 
Number Statement Rank Z-
scores 
11 I chose this CWLPS, as I wanted to be able to buy the 
products associated with this CWLPS (scales, books). 
0 -0.23 
15 I chose this CWLPS based upon the endorsement from 
celebrities who had successfully tried it themselves. 
-5 -1.41 
47 I chose this CWLPS as it would help me to maintain my 
weight loss. 
3 1.30 
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reasons for choosing their favoured CWLPS; they were also highly ranked and 
common in the factor arrays too. 
“could motivate myself, I just wanted something as a guide really, so it let me 
set my target of what I wanted to lose, and I could chart it on a weekly basis, if I 
wanted too” (Participant 20: weight watchers online; statement 43; I chose this 
CWLPS as I could set my own realistic weight loss target to aim for.) 
 
“Hectic lifestyle like most people seem to have these days, erm I’m working long 
hours, 12 hour shifts, sometimes split shifts, and things like that so it basically 
didn’t need any extra decision making from myself in order to know what I was 
supposed to be eating….that’s it you can’t have anything else other than your 
black coffee or your water or whatever…your food packs you know”  
(Participant 114:LighterLife, statement 56; I chose this CWLPS, as it looked 
easy to follow.) 
 
“diet is quick and easy. It doesn't involve any faffing around and is simple to pick 
up”. (Participant 100: special k; statement 51: I chose this CWLPS, as I wanted 
to lose weight quickly. 
 
Even though statements 30 and 7 were not distinguishing statements for this 
factor at -5, it is apparent that these statements were not the reasons why 
participants (114, 100 and 20) subscribing to this factor chose their favoured 
CWLPS; they were also highly ranked and common in the factor arrays too. 
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“I didn’t think it was a last resort, I mean I’m fairly healthy anyway. If I wanted to 
do it that much and this wasn’t available, then I would of just had to increase the 
exercise and decrease the calorie intake, this obviously was a little bit more 
extreme” (Participant 114:LighterLife; statement 30; I chose this CWLPS as it 
was the last resort for me.) 
 
“ to be honest I wasn’t at an extreme of being massively overweight it was just 
wanting to nip it in the bud, I was a little bit overweight, so it wasn’t a last resort” 
(Participant 20;weight watchers online; statement 7;I chose this CWLPS as it 
was of a case of all or nothing.)   
 
5.3.10.2.1 Factor 2- Lifestyle adjustment counselling 
The Q-sorts of 6 participants all showed statistically significant loadings on 
factor 2, 5 of whom had chosen a very-low calorie diet (LighterLife & Cambridge 
diet), only one person was the exception to the choice of CWLPS for factor 
2;weight watchers. 
Proceeding tables demonstrate the highest and lowest ranked statements, as 
well as the highest ranked distinguishing statements with z-scores for Factor 2. 
The z-scores of statements are the normal distribution curve of each array 
turned on its side, resulting in a composite (or idealised) Q sort for each factor. 
Proceeding tables, represent how a hypothetical respondent with a 100% 
loading on that factor would have ordered all the statements of the Q-set for 
factor 2. Hypothetical respondents of factor 2 would have chosen their favoured 
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CWLPS based upon rapid weight loss, being healthier, and maintenance advice 
after discontinuing with the CWLPS.   
 
Participants represented in Factor 2 ranked the following statements as "+5”; 
statements that I agree why I chose my favoured CWLPS: 
 
 
Table 31: +5 ranking of statements for factor 2 
Number (ranking) Statement Z-scores 
51 (+5) I chose this CWLPS, as I wanted to 
lose weight quickly. 
2.197 
21 (+5) I chose this CWLPS as I wanted to be 
healthier - improving my appearance 
was not the main reason for choosing 
this particular CWLPS. 
1.870 
52(+5) I chose this CWLPS, as I wanted the 
‘coping/rebound’ advice after I came off 
the CWLPS. 
1.725 
 
 
The following were ranked in factor 2 as "+4”; statements that I agree why I 
chose my favoured CWLPS. 
 
Table 32: +4 ranking of statements for factor 2 
Number (ranking) Statement Z-scores 
53 (+4) I chose this particular CWLPS because 
I hoped the counselling would help me 
get to the root cause of why I overeat. 
1.533 
47 (+4) I chose this CWLPS as it would help 
me to maintain my weight loss. 
1.414 
3 (+4) I chose this CWLPS as I wanted 
something where there was a 
consistent guide to weight loss that did 
not change, which I could get from this 
CWLPS. 
1.383 
60 (+4) I chose this CWLPS based upon the 
endorsement from friends who had 
successfully tried it themselves. 
1.366 
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At the other end of the composite Q sort array, Factor 2 participants placed 
these cards next to the positions marked "-5”, statements which they disagreed 
were not based upon the reasons why they chose their favoured CWLPS. 
 
Table 33: -5 ranking of statements for factor 2 
Number (ranking) Statement Z-scores 
14 (-5) I chose this CWLPS, as I wanted to be 
able to compare my progress with 
others who were also using the same 
CWLPS as me. 
-0.673 
11 (-5) I chose this CWLPS, as I wanted to be 
able to buy the products associated 
with this CWLPS (scales, books). 
-0.533 
13 (-5) I chose this CWLPS, as I was aware 
that it would provide me with the 
element of competition about weight-
loss between others who were also 
using the same CWLPS as me. 
-0.514 
 
 
The following were ranked in factor 2 as "-4”, statements which they disagreed 
were not based upon the reasons why they chose their favoured CWLPS. 
 
Table 34: -4 ranking of statements for factor 2 
Number (ranking) Statement Z-scores 
49 (-4) I chose this CWLPS, as I did not want 
to try and lose weight with other 
people; I wanted to do it alone. 
-0.497 
28(-4) I chose to pay for this CWLPS, as I 
knew that paying for it would motivate 
me into losing weight. 
-0.416 
16 (-4) I did not choose this CWLPS based 
upon the endorsement from other 
people (group leaders and case studies 
of ‘real life’ people) who had 
successfully tried it themselves. 
-0.411 
41 (-4) I chose this CWLPS because I saw it 
advertised (online, TV, newspaper, 
radio). 
-0.367 
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Seven statements were distinguishing at p<0.01(Table 35). Therefore, 
statement scores on two factors have exceeded the difference score at p<0.01.  
 
Table 35: Distinguishing statements for Factor 2 
Number Statement Rank Score 
52 I chose this 
CWLPS, as I 
wanted the 
‘coping/rebound’ 
advice after I came 
off the CWLPS. 
5 1.73 
53 I chose this 
particular CWLPS 
because I hoped 
the counselling 
would help me get 
to the root cause of 
why I overeat. 
4 1.53 
46 I chose this 
CWLPS, as I 
wanted to 
understand why I 
overeat so that I 
could change my 
relationship with 
food. 
3 1.22 
30 I chose this CWLPS 
as it was the last 
resort for me. 
3 1.13 
40 I chose this CWLPS 
to lose weight for 
an event (wedding, 
holiday etc.). 
0 -0.23 
39 I chose this CWLPS 
as someone 
suggested that I 
could do with losing 
some weight. 
-2 -0.77 
22 I chose this 
CWLPS, as I was 
aware that it would 
not be a massive 
lifestyle change in 
following it. 
-4 -1.24 
 
 
 
Chapter Five Results 
 
187 
 
Table 36 demonstrates the consensus statements that were not distinguished 
amongst the factors at p>0.01, with respective z-score and ranking. 
 
Table 36: Consensus statements for Factor 2 
 
 
 
 
 
 
 
 
 
Participants who subscribed to this factor chose their favoured CWLPS based 
upon core counselling techniques, used for behaviour cognitive therapy. The 
key statement that was distinguishing and also highly ranked (+5 and +4) 
amongst individuals who subscribed to “lifestyle adjustment counselling” was in 
relation to the CWLPS’s cognitive behaviour therapy techniques: 
52) I chose this CWLPS, as I wanted the ‘coping/rebound’ advice after I came 
off the CWLPS. 
53) I chose this particular CWLPS because I hoped the counselling would help 
me get to the root cause of why I overeat. 
 
Number Statement Rank Z-
scores 
11 I chose this CWLPS, as I wanted to 
be able to buy the products 
associated with this CWLPS 
(scales, books). 
-1 -0.57 
15 I chose this CWLPS based upon 
the endorsement from celebrities 
who had successfully tried it 
themselves. 
-5 -1.45 
47 I chose this CWLPS as it would 
help me to maintain my weight loss. 
4 1.41 
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5.3.10.2.2 Factor 2; Post-sort interviews 
Qualitative data from the post-sort interviews strengthens the statements listed 
in the tables above, further explaining the reasons why the subscribers of this 
factor chose their favoured CWLPS. 
 
5.3.10.2.3 Factor 2; Interpretation 
Participants 109, 11, 0, 57 and 110 clearly explained their reasons why they 
placed statements 51, 21, and 52 at +5. Even though these were not 
distinguishing statements for this factor, it is apparent that these statements 
were the core reasons for choosing their favoured CWLPS; they were also 
highly ranked and common in the factor arrays too. 
 
“I think when you are very obese, I mean I was about five stones overweight, 
and you know and I got to the stage, because it’s a big decision to make 
because it is a lot of money, and I thought right I’m going to crack this and it 
does come off quickly, and you get lots of compliments pretty quickly because 
people are seeing the results and your clothes are fitting, and you think ‘oh yes’ 
I’ll keep going here”.  (Participant 0; LighterLife: statement 51 I chose this 
CWLPS, as I wanted to lose weight quickly). 
 
LighterLife participant 57 chose this product, as they wanted the 
‘coping/rebound’ advice after they came off the CWLPS to  
“Nail it” for the “long lasting effect” 
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Participant 11, was an interesting subscriber, as they believed that all 
statements fell below the +5 column when Q-sorting. Therefore, even though 
this participant had a significant loading onto this factor, I am wary of their data, 
due to their postal explanation of the placement of +5 and -5 statements. 
“Most of the question warrant answering correctly and most of all the answers 
were truly below 5+” 
Even though statements 14,11 and 13 were not distinguishing statements for 
this factor at -5, it is apparent that statement 13 was not one of the reasons why 
participants (109, 110 and 0) subscribing to this factor chose their favoured 
CWLPS; they were also common in the factor arrays too. 
 
Participants (110,109 and 0) did not choose their CWLPS based upon an 
element of competition (statement 13 I chose this CWLPS, as I was aware that 
it would provide me with the element of competition about weight-loss between 
others who were also using the same CWLPS as me), this was one of the key 
factors that did not interest the subscribers to factor 2  
“you need an element of competition, sometimes it can be counterproductive 
really, if someone’s losing weight faster than you, and if someone’s not losing it, 
and all you think, well all you think is she’s not doing it properly or the persons 
not doing it properly”.  (Participant 110; LighterLife). 
“Not interested in competition about weight loss, it’s about myself, my own 
targets my own health, competition not an issue whatsoever.” (Participant 109; 
LighterLife) 
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“No, that wasn’t there, not at all” (Participant 0; Cambridge diet) 
 
5.3.10.3.1 Factor 3- Celeb support 
The Q-sorts of five participants all showed statistically significant loadings on 
factor 3, five of whom had chosen a programme based commercial weight loss 
intervention (Weight Watchers and Slimming World). 
Proceeding tables demonstrate the highest and lowest ranked statements, as 
well as the highest ranked distinguishing statements with z-scores for Factor 3. 
The z-scores of statements are the normal distribution curve of each array 
turned on its side, resulting in a composite (or idealised) Q sort for each factor. 
Proceeding tables represent how a hypothetical respondent with a 100% 
loading on that factor would have ordered all the statements of the Q-set for 
factor 3. Hypothetical respondents of factor 3 would have chosen their favoured 
CWLPS based the support given from this CWLPS, maintenance, and knowing 
that choosing the CWLPS would not affect their lifestyle.   
 
Participants represented in Factor 3 ranked the following statements as "+5”; 
statements that I agree why I chose my favoured CWLPS. 
 
Table 37: +5 ranking of statements for factor 3 
Number (ranking) Statement Z-scores 
6 (+5) I chose this CWLPS, as I knew it would 
give me the support that I needed in 
assisting me to lose weight. 
1.766 
47(+5) I chose this CWLPS as it would help 
me to maintain my weight loss. 
1.595 
 22 (+5) I chose this CWLPS, as I was aware 
that it would not be a massive lifestyle 
change in following it. 
1.547 
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The following were ranked in factor 2 as "+4”; statements that I agree why I 
chose my favoured CWLPS. 
 
Table 38: +4 ranking of statements for factor 3 
Number (ranking) Statement Z-scores 
 3 (+4) I chose this CWLPS as I wanted 
something where there was a 
consistent guide to weight loss that did 
not change, which I could get from this 
CWLPS. 
1.434 
1 (+4) I chose this CWLPS, as I wanted a 
better choice of clothes that I would be 
able to buy, in losing weight from this 
particular CWLPS. 
1.332 
 57 (+4) I chose this CWLPS, as I wanted 
regular weigh-ins. 
1.299 
43 (+4) I chose this CWLPS as I could set my 
own realistic weight loss target to aim 
for. 
1.247 
 
 
At the other end of the composite Q sort array, Factor 2 participants placed 
these cards next to the positions marked "-5”, statements which they disagreed 
were not based upon the reasons why they chose their favoured CWLPS. 
 
Table 39: -5 ranking of statements for factor 3 
Number (ranking) Statement Z-scores 
45 (-5) I chose this CWLPS, as I wanted 
advice from celebrities to help me 
make better choices. 
-1.994 
39 (-5) I chose this CWLPS as someone 
suggested that I could do with losing 
some weight. 
-1.780 
4 (-5) I chose this CWLPS, as I did not want 
to get to the stage whereby I would be 
needing weight-loss surgery. 
-1.610 
 
The following were ranked in factor 2 as "-4”, statements which they disagreed 
were not based upon the reasons why they chose their favoured CWLPS. 
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Table 40: -4 ranking of statements for factor 3 
Number (ranking) Statement Z-scores 
15 (-4) I chose this CWLPS based upon the 
endorsement from celebrities who had 
successfully tried it themselves. 
-1.522 
 29 (-4) I chose this CWLPS as I thought it 
would be more socially accepted 
amongst my peers. 
-1.485 
7 (-4) I chose this CWLPS as it was of a case 
of all or nothing. 
-1.419 
30 (-4) I chose this CWLPS as it was the last 
resort for me. 
-1.366 
 
Three statements were distinguishing at p<0.01(Table 41). Therefore, 
statement scores on two factors have exceeded the difference score at p<0.01.  
 
Table 41: Distinguishing statements for factor 3 
Number Statement Rank Z-
scores 
42 I chose this 
CWLPS as I 
thought it would 
help me to give 
my family a 
healthier diet too. 
2 0.78 
39 I chose this 
CWLPS as 
someone 
suggested that I 
could do with 
losing some 
weight. 
-5 -1.78 
45 I chose this 
CWLPS, as I 
wanted advice 
from celebrities to 
help me make 
better choices. 
-5 -1.99 
 
Table 42 demonstrates the consensus statements that were not distinguished 
amongst the factors at p>0.01, with respective z-score and ranking. 
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Table 42: Consensus statements for Factor 3 
 
 
 
 
 
 
 
 
 
The key statement that was not distinguishing but was highly ranked (+5) 
amongst individuals who subscribed to celeb support was in relation to the 
changes that were required to their lifestyle: 
22) I chose this CWLPS, as I was aware that it would not be a massive lifestyle 
change in following it. 
 
5.3.10.3.2 Factor 3; Post-sort interviews 
Qualitative data from the post-sort interviews strengthens the statements listed 
in the tables above, further explaining the reasons why the subscribers of this 
factor chose their favoured CWLPS.
Number Statement Rank Z-
scores 
11 I chose this CWLPS, as I 
wanted to be able to buy 
the products associated 
with this CWLPS (scales, 
books). 
-2 -0.53 
15 I chose this CWLPS based 
upon the endorsement 
from celebrities who had 
successfully tried it 
themselves. 
-4 -1.52 
47 I chose this CWLPS as it 
would help me to maintain 
my weight loss. 
5 1.60 
Chapter Five Results 
 
194 
 
5.3.10.3.3 Factor 3; Interpretation 
Participants 67 and 51 clearly explained her reasons why they placed statement 
22 at +5. Even though these were not distinguishing statements for this factor, it 
is apparent that these statements were the core reasons for choosing their 
favoured CWLPS, were also highly ranked and common in the factor arrays too. 
 
“it was more or less a normal way of eating, you just needed to be more aware 
of how much…your quantities really” “its just being organised really, and having 
a bit more of a plan of what I’m going to eat, and generally it tends to work” 
(Participant 67) 
Slimming world participant 51 did not clearly explain why they ranked statement 
22 so highly (+5), however, they did clearly justify the placement of statements 
6 (+5) and 3 (+4). 
“The diet was straightforward (not counting calories) rather eating a lot of a wide 
range of foods. The support from slimming world was vital in the first months. 
Now it is second nature though. I enjoy the food and have kept to the healthy 
eating plan. My tastes have changed completed e.g. I actually crave fruit when 
hungry” (Slimming world; participant 51) 
Participant 11, was an interesting subscriber, as they believed that all 
statements fell below the +5 column when Q-sorting. Therefore, even though 
this participant had a significant loading onto this factor, I am wary of their data, 
due to their postal explanation of the placement of +5 and -5 statements. 
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““Most of the question warrant answering correctly and most of all the answers 
were truly below 5+” 
 
Statements 39 and 45 were distinguishing statements for this factor at -5, and 
were also common in the factor arrays too. In relation to the z-scores of 
statements 45 and 39, statement 45 was -1.99, 1.99 standard deviations below 
the mid-point of the distribution, and statement 39 was -1.78, 1.78 standard 
deviations below the mid-point of the distribution. Based upon the rank ordering 
of these statements (Table 41), participants did not choose their favoured 
CWLPS based upon celebrity advice, or someone telling them that they needed 
to lose weight.. Typically, a celebrity does not offer advice for a CWLPS, a 
celebrity will endorse a CWLPS after their success and how they stuck to the 
CWLPS. Celebrities would not give advice that was not related to the CWLPS. 
However, subconsciously, a participant could have purchased their favoured 
CWLPS, based upon the advertising of the CWLPS via a celebrity’s success. 
 
Participants (67, 92 and 51) did not choose their CWLPS due to someone 
saying that they needed to lose weight (statement 39; I chose this CWLPS as 
someone suggested that I could do with losing some weight). Also celebrity 
endorsement was not a factor for participant 88 in choosing their favoured 
CWLPS (statement 45; I chose this CWLPS, as I wanted advice from celebrities 
to help me make better choices.) 
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“No one suggested I needed to lose weight” (Participant 51; statement 39; I 
chose this CWLPS as someone suggested that I could do with losing some 
weight). 
    
“Nobody’s told me I need to lose some, but maybe in the past someone should 
have “(Participant 67; statement 39; I chose this CWLPS as someone 
suggested that I could do with losing some weight). 
“No one’s ever said that to me in my life, because I would kill them *laughs “. 
(Participant 92; statement 39; I chose this CWLPS as someone suggested that I 
could do with losing some weight). 
 
“That’s the least its more about my healthy, and how I look and buying nice 
clothes” CWLPS” (Participant 88; statement 45; I chose this CWLPS, as I 
wanted advice from celebrities to help me make better choices.) 
 
5.3.10.4.1 Factor 4- Men don’t get help 
The Q-sorts of 1 participant showed a high statistically significant loading on 
factor 4 (0.8445), choosing Slimming World for men. 
Proceeding tables demonstrate the highest and lowest ranked statements, as 
well as the highest ranked distinguishing statements with z-scores for Factor 4. 
The z-scores of statements are the normal distribution curve of each array 
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turned on its side, resulting in a composite (or idealised) Q sort for each factor. 
Proceeding tables represent how a hypothetical respondent with a 100% 
loading on that factor would have ordered all the statements of the Q-set for 
factor 4. Hypothetical respondents of factor 4 would have chosen their favoured 
CWLPS based upon it being gender specific, being healthier, and the GP being 
of little assistance in relation to losing weight.   
 
Participants represented in Factor 4 ranked the following statements as "+5”; 
statements that I agree why I chose my favoured CWLPS. 
 
Table 43: +5 ranking of statements for factor 4 
Number (ranking) Statement Z-scores 
21 (+5) I chose this CWLPS as I wanted to be healthier - 
improving my appearance was not the main reason 
for choosing this particular CWLPS. 
1.835 
27 (+5) I chose this CWLPS, as my GP was not helpful in 
providing any weight loss advice. 
1.835 
50 (+5) I chose this CWLPS as it was gender specific (men 
only or women only). 
1.835 
 
The following were ranked in factor 2 as "+4”; statements that I agree why I 
chose my favoured CWLPS. 
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Table 44: +4 ranking of statements for factor 4 
Number (ranking) Statement Z-scores 
6 (+4) I chose this CWLPS, as I knew it would give me 
the support that I needed in assisting me to lose 
weight. 
1.468 
 18 (+4) I chose to use this particular CWLPS because I 
could see other people (group leaders and case 
studies of ‘real life’ people) who had been 
through the process themselves, and could 
understand what I was going through. 
1.468 
39 (+4) I chose this CWLPS as someone suggested 
that I could do with losing some weight. 
1.468 
48 (+4) I chose this CWLPS based upon convenience. 1.468 
 
 
At the other end of the composite Q sort array, Factor 2 participants placed 
these cards next to the positions marked "-5”, statements which they disagreed 
were not based upon the reasons why they chose their favoured CWLPS. 
 
Table 45: -5 ranking of statements for factor 4 
Number (ranking) Statement Z-scores 
30 (-5) I chose this CWLPS as it was the last resort for me. -1.835 
40 (-5) I chose this CWLPS to lose weight for an event 
(wedding, holiday etc.). 
-1.835 
17 (-5) I chose to use this particular CWLPS because I 
could see celebrities who had been through the 
process themselves and could understand what I 
was going through. 
-1.835 
 
The following were ranked in factor 2 as "-4”, statements which they disagreed 
were not based upon the reasons why they chose their favoured CWLPS. 
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Table 46: -4 ranking of statements for factor 4 
Number (ranking) Statement Z-
scores 
57 (-4) I chose this CWLPS, as I wanted regular weigh-ins. -1.468 
24 (-4) I did not chose this CWLPS because of seeing 
advertisements which showed lots of people who have 
succeeded from this CWLPS. 
-1.468 
42 (-4) I chose this CWLPS as I thought it would help me to 
give my family a healthier diet too. 
-1.468 
37 (-4) I chose this CWLPS to educate me about what 
exercise I was supposed to do. 
-1.468 
 
Five statements were distinguishing at p<0.01(Table 47). Therefore, statement 
scores on two factors have exceeded the difference score at p<0.01.  
 
Table 47: Distinguishing statements for factor 4 
Number Statement Rank Z-
scores 
27 I chose this CWLPS, as my GP was not helpful in 
providing any weight loss advice. 
5 1.84 
50 I chose this CWLPS as it was gender specific (men 
only or women only). 
5 1.84 
18 I chose to use this particular CWLPS because I 
could see other people (group leaders and case 
studies of ‘real life’ people) who had been through 
the process themselves, and could understand 
what I was going through. 
4 1.47 
43 I chose this CWLPS as I could set my own realistic 
weight loss target to aim for. 
-3 -1.10 
40 I chose this CWLPS to lose weight for an event 
(wedding, holiday etc.). 
-5 -1.84 
 
 
 
Table 48 demonstrates the consensus statements that were not distinguished 
amongst the factors at p>0.01, with respective z-score and ranking. 
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Table 48: Consensus statements for Factor 4 
 
 
The only participant who subscribed to this factor chose their favoured CWLPS 
as it was gender specific. The key statements that was distinguishing and also 
highly ranked (+5) amongst this individual who subscribed to “Men don’t get 
help” was in relation to negative experiences at a GP’s, and it being for men 
only. 
27) I chose this CWLPS, as my GP was not helpful in providing any weight loss 
advice. 
50) I chose this CWLPS as it was gender specific (men only or women only). 
 
5.3.10.4.2 Factor 4; Post-sort interviews 
Qualitative data from the post-sort interviews strengthens the statements listed 
in the tables above, further explaining the reasons why the subscriber of this 
factor chose their favoured CWLPS. 
 
Number Statement Rank Z-
scores 
11 I chose this CWLPS, as I wanted to be able to buy the 
products associated with this CWLPS (scales, books). 
-3 -1.10 
15 I chose this CWLPS based upon the endorsement from 
celebrities who had successfully tried it themselves. 
-2 -0.73 
47 I chose this CWLPS as it would help me to maintain my 
weight loss. 
3 1.10 
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5.3.10.4.3 Factor 4; Interpretation 
Participant 1  clearly explained his reasons why they placed statements 50 and 
27 at +5, which were also distinguishing statements for this factor, it is apparent 
that these statements were the core reasons for choosing their favoured 
CWLPS, were also highly ranked and common in the factor arrays too. 
 
“I found that slimming world were the only ones that had done a gender specific 
class, aimed solely at men, and that’s the reasons why I chose that product” 
(Participant 1; statement 50 I chose this CWLPS as it was gender specific (men 
only or women only). 
 
“When I saw my GP I got no help, and from the sleep clinic at James Cook, they 
just give you the machine and say get on with it, there is no advice with regards 
to diet, exercise things like that “ 
(Participant 1; statement 27; I chose this CWLPS, as my GP was not helpful in 
providing any weight loss advice.) 
 
Distinguishing statement 40 for this factor at -5, was one of the reasons why 
participant 1 subscribing to this factor did not choose their favoured CWLPS, 
and were also common in the factor arrays too. 
“It wasn’t for a specific event; it was purely for health reasons”      
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(Participant 1; statement 40 I chose this CWLPS to lose weight for an event 
(wedding, holiday etc.). 
 
5.3.11 Summary 
The Q-methodology study identified a variety of reasons why the participants of 
my study chose purchase of CWLPS, and which CWLPS they chose to 
purchase. 
Participants (n=4) of Factor 1 had chosen different favoured CWLPS when 
conducting the Q-sort; LighterLife, Special K, Slim fast, and Weight Watchers 
online. These CWLPS vary in price and method of delivery. If an ideal 
intervention was to be produced for the respondents of Factor 1, the key 
components of it would need to be a) ease of use, b) setting specific individuals 
targets, and b) quick weight loss. Realistically the NHS could commission a 
weight loss programme for respondents who load onto Factor 1. 
The majority of participants of Factor 2 had chosen a very low-calorie diet (n=5); 
one had chosen a commercial weight loss programme that would be more 
suited to Factor 3 (weight watchers).  Lighterlife and the Cambridge diet are 
‘high end’ CWLPS, and known for rapid weight loss. If an ideal intervention was 
to be produced for the respondents of Factor 2, the key component of it would 
need to be a focus upon cognitive behaviour therapy techniques, specifically in 
relation to the maintenance advice after discontinuing with the CWLPS. These 
participants also wanted to be healthier, and to lose weight quickly. Realistically 
the NHS could not implement a weight loss programme that mirrors participant 
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loadings of Factor 2; counsellors trained in weight loss would be required, other 
health professionals would be required to ensure that the patient is in ketosis 
and that blood pressure is normal. As discussed in chapter 2 (2.10.4) rapid 
weight loss can lead to problems, including psychological distress which would 
require a psychologist to be involved if this intervention was utilised. 
All participants of Factor 3 (n=5) had chosen a programme-based commercial 
weight loss intervention (Weight Watchers and Slimming World). If an ideal 
intervention was to be produced for the respondents of Factor 3, it would need 
to a) be support based, b) not involve a massive lifestyle, and c) factor in weight 
maintenance after discontinuation. Realistically the NHS already utilises this 
weight loss intervention in their 12 week referral schemes. Referral would only 
work for respondents that load onto Factor 3, a patient that wanted to lose 
weight quickly and did not want to talk about calories (Factor 2) would not 
benefit from referral to a commercial weight loss programme. 
Only one participant loaded onto factor 4.However, this gentleman’s loading 
onto factor 4 (0.8445X) was too high to ignore. This gentleman had chosen 
Slimming World for men as his favoured CWLPS. If an ideal intervention was to 
be produced for respondents that load onto Factor 4, the key component would 
be in relation to the intervention being delivered in single sex groups. 
Realistically the NHS could provide male only weight loss interventions through 
their 12 week referral scheme (Slimming World for men). Or another alterative 
option would be for the NHS to pay for individuals to use Weight Watchers 
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online, and to take baseline, end point and follow up measures to assess 
maintenance. 
In relation to the Q-methodology study it is apparent that there is not one 
specific reason why the participants involved chose their favoured CWLPS. 
Dependent upon a person’s circumstance, and how much weight they want to 
lose, delivery of the CWLPS, and what support they require varies from person 
to person. No two people sorted the statements identically, which further shows 
that there is not one size that fits all. There is a considerable number and range 
of CWLPS for people to choose from, each varying in cost and characteristics. 
However, unless the person chooses an intervention which includes the most 
important components which suit them, they are unlikely to comply with the diet 
and lose weight. My findings show that people are very different in what they 
want from a CWLPS, and perhaps that it why there are so many products and 
services available. 
As a neophyte researcher I had assumptions about what I would find out from 
my study; I felt that marketing and cost would be the key features why 
participants chose their favoured CWLPS. However, my assumptions were 
proven incorrect, marketing and cost were not the key influencers for a person 
choosing their favoured CWLPS. I believe that marketing could have been one 
of the influencing factors for the choice of a participants CWLPS, though this 
was in the participant’s subconscious. If marketing did not play a part in the 
choice of CWLPS, commercial weight loss companies would not spend so 
much on advertising their product/service. Commercial weight loss companies 
Chapter Five Results 
 
205 
 
know their consumers very well, and spend vast amounts of money on when 
(before Christmas, and before summer), and where (prime time TV and 
Groupon) to marketing their CWLPS. Cost was secondary, in the sense that 
participants felt that if they were paying for it, they would make the most out of 
it; it was a motivator. Again, I believe that cost was a factor in the choice of 
CWLPS, as a participant would not spend all of their monthly outgoings 
(mortgage, council tax, water, TV licence, gas, electric etc.)  on a CWLPS, a 
participants would chose a CWLPS that would be within their budget. 
 In relation to health inequalities, it could be argued that the sample of Q-
methodology participants (high SES) could afford to lose weight and look after 
their health, in comparison to lower SES individuals. However, this is an 
assumption, and not based upon evidence.  Table 20 shows that the 
participants involved in the Q-methodology study spent on average 1.6% of 
their annual earnings on CWLPS alone, and spent 96.9% of their year using a 
CWLPS. As previously mentioned in 2.9.6, education plays an important role in 
relation to obesity prevalence, and also effects income. 60% of the participants 
involved in the Q-methodology study were in receipt of a postgraduate degree, 
degree or AS/A levels. However, it could be questioned why these individuals 
were using CWLPS, when research (Cutler and Lleras-Muney, 2006) suggests 
that additional schooling reduces the likelihood of obesity and overweight 
status. One can only assume that the individuals involved in the Q-methodology 
study gained their job prior to becoming overweight or obese, as their wage 
would be lower than it is, and they possibly would be able to afford CWLPS, and 
would not be involved in my research. As mentioned earlier in 2.8.2, an obese 
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person could suffer a wage penalty in the range of 0.7%-6.3% Baum and Ford 
(2004). Therefore, individuals in the Q-methodology study potentially could be 
using a CWLPS as they know that ‘thinner’ colleagues have a higher wage than 
them. However, I believe that that is not true as their average annual wage  
(£20,618 after housing costs) is £3614 higher than the North East average 
(Office for National Statistics, 2012). 
  
Additional research amongst a variety of socioeconomic groups is required to 
establish whether cost influences the choice of CWLPS amongst high and low 
SES individuals.  
 
  
5.4 Cochrane Review 
 
5.4.1 Results of the search 
The database searches for my review were conducted in September 2012. All 
hits were downloaded into Endnote on the 24th September 2012.  
 
The results of my searches in different databases yielded 25,484 hits before de-
duplication and 23,723 after de-duplication. I screened all titles of these hits, 
and 92 of them appeared relevant to the review. After assessing the abstracts 
of these 92 studies, I excluded 55 of them quite easily against my inclusion and 
exclusion criteria of my review. These studies were excluded because of the 
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type of participants (under 16), type of study design (not evaluations), or type of 
intervention (not using a CWLPS). I ordered full papers for the remaining 26 
hits. 
 
5.4.2 Excluded studies 
After reading the full papers of 26 hits, I excluded 9 papers (Bye et al, 2005; 
Furlow et al, 2009; Goldstein et al,1996; Hamilton and Greenway, 2004; 
Hession et al, 2009; Hyman et al, 1993; Mycroft, 2008; Pallister et al, 2009; 
Tsai et al, 2005) against my inclusion and exclusion criteria for various reasons; 
the date of publication (before 1980), not a CWLPS (self-help), type of study 
design (not evaluations), and CWLPS focusing on other outcomes (not weight 
related). 
I included 17 studies in my review (Anderson et al, 1991;  Anderson et al, 
1994a; Anderson et al, 1994b; Ditschuneit et al, 1999; Djuric et al, 2002; Gold et 
al, 2007; Gosselin and Cote,  2001; Heshka et al, 2003; Heshka et al, 2000; 
Jolly et al, 2011; Lowe et al, 2001; Morgan et al, 2008; Rippe et al, 1998; Rock 
et al, 2007; Rolland et al, 2009; Truby et al, 2006;  Womble et al, 2004). 
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Figure 21: Flowchart of the selection process for included studies 
 
5.4.3 Description of included studies 
See Appendices 25-41 for a full description and summary of each of the 17 
studies which were included in my review. The data extraction sheet which was 
used for my review (Appendix 42) was based on that which was recommended 
by Cochrane.  
 
5.4.5 Risk of bias in included studies 
The majority of studies had a high risk of bias, especially those which were 
funded by a commercial weight loss company. The majority of studies were 
RCT’s (n=13); the other studies were controlled before and after studies (n=4). 
 
Hits before de-duplication 25,484 
Included studies 17 
Hits after de-duplication 23,723 
 
Initial screening 92 
Papers excluded 55 
Papers ordered 26 
Papers excluded against inclusion and exclusion criteria 9 
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5.4.6 Allocation and blinding 
Due to the type of intervention assessed (CWLPS) all participants in the RCT'S 
knew which intervention they were assigned to and were not blind to the 
intervention. This is the case for most dietary intervention studies. However, it is 
possible to blind the outcome assessor for dietary intervention studies, and this 
should be done if at all possible. Only one study which I included in my review 
did this (Jolly et al, 2011). One study reported that participants were instructed 
not to mention their participation in the study to others (Heshka et al, 2000).  
 
5.4.7 Drop out and compliance 
Three CBA's (Anderson et al, 1994b; Gosselin and Cote, 2001; Lowe et al, 
2001) did not list whether there had been any dropouts in their studies. In one 
RCT (Womble et al, 2004), a significant amount of participants dropped out of 
the study (65% in the ediets group and 67% in the LEARN group). Where drop 
out was reported, this ranged from 17.74%-94.3%. Three studies resulted in a 
>50% dropout rate; a CBA of a meal replacement drink (Anderson et al, 1991); 
a multicentre RCT with 5 arms - two commercial face to face weight loss groups 
(Weight Watchers and Rosemary Conley), a low carbohydrate diet (Atkins), a 
liquid meal replacement (Slimfast) and a control group (Morgan et al, 2008); 
and an RCT of a commercial internet weight loss programme (Womble et al, 
2004). 
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In the multicentre RCT (Morgan et al, 2008) the highest dropout rate was 
observed in the Atkins group (81.8%) and the lowest dropout rate was observed 
in the weight watchers group (69%).  
 
Anderson et al (1991) did not comment on the high dropout rate (51%) in their 
study.  
 
One could argue that studies which include a high burden for the participant (for 
example in a lot of assessments being required during the study period) or 
studies which fail to engage with the participant (e.g. online programmes) may 
result in higher dropout rates. This will be discussed further in Chapter 6.  
 
Womble et al’s (2004) RCT of a commercial internet weight loss programme did 
report the reasons for drop out at 52 weeks (study end point). Participants in the 
ediet group dropped out due to family issues (n=1), and lack of 
interest/unknown (n=7). Participants in the LEARN group dropped out due to 
lack of interest/unknown (n=5), medical reasons (n=2), and family issues (n=1). 
However, this study did not report the reasons why dropout occurred at 16 
weeks. It is unknown whether the participants dropped out as they were bored, 
had severe side effects (which is not reported) and were not able to continue 
with the programme, or whether the research team could not get in contact with 
the participants. 
It is extremely important that studies report dropout rates. No study stated that 
anyone had died from using a CWLPS; however side effects were reported in 
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some studies, but not all. The reasons why dropout occurred is significant to 
any study, even more so in relation to the CWLPS that are prescribed on 
referral through the NHS (Slimming World/Weight Watchers). Studies that have 
used Weight Watchers and/or Slimming World as the intervention and not 
reported the reasons for dropout (Heshka et al, 2000; Heshka et al, 2003; 
Morgan et al, 2008) have shown that the intervention was effective in relation to 
weight loss. However, the dropouts of these studies could have had severe 
reactions to the diet, did not understand the diet, felt weight loss was not 
significant enough and stopped, or got tired of the intervention. Within studies of 
this nature, it is vital to report the differences between groups and reasons for 
drop out between the groups.  
One study (Jolly et al, 2011) included a qualitative component to their study 
which provides some insight into reasons for dropout. Jolly et al’s (2011) study 
team sent participants who had dropped out of their allocated programme an 
open ended question asking for their views about the weight loss programme to 
which they had been allocated, participants allocated (n=10)  to Rosemary 
Conley reported difficulties with completing the exercise part of the classes due 
to arthritis and other musculoskeletal problems. Participants could have 
dropped out due to their physical problems. 
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5.4.8 Other factors which affect the quality rating of studies 
 
5.4.8.1 Analysis 
Only 35% of the studies included in my review used an intention to treat 
analysis.  
 
5.4.8.2 Power 
Only four studies reported the statistical power of their study, and how they 
calculated this (Heshka et al, 2003; Jolly et al, 2011; Rolland et al, 2009; 
Womble et al, 2004); two further studies reported that they had calculated 
statistical power, but did not provide any information on how they had calculated 
it (Morgan et al, 2008; Rock et al, 2007). 
 
5.4.9 Funding source  
Nine of the 17 included studies were funded by industry  (Ditschuneit et al, 
1999;  Djuric et al, 2002; Heshka et al, 2000; Heshka et al, 2003; Morgan et al, 
2008; Rippe et al, 1998; Rock et al, 2007; Rolland et al, 2009; Truby et al, 
2006), seven of which were all or in part funded by a commercial weight loss 
company whose product was being researched (Ditschuneit et al, 1999;  Djuric 
et al, 2002; Heshka et al, 2000; Heshka et al, 2003; Rippe et al, 1998; Rock et 
al, 2007; Rolland et al, 2009). 
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Table 49: Funding source  
Study Funding source 
Anderson et al, 1991 Authors do not report this 
Anderson et al, 1994a Supported in part by Health Management 
Resources and the HCF Nutrition 
Research Foundation in Lexington, 
Kentucky. 
Anderson et al, 1994b Authors do not report this 
Ditschuneit et al, 1999 Slim fast 
Djuric et al, 2002 This study was supported in part by grant 
RO3 CA89761 from NIH, The Weight 
Watchers Group, Inc, Farmington Hills, 
Michigan, and the Ford Motor Company 
Fund. 
Gold et al, 2007 This study was supported by U.S. 
Department of Agriculture Hatch Act 
Funds (Grant VT-NS-00,904) 
Gosselin and Cote, 2001 Author do not report this 
Heshka et al, 2000 Supported by a grant from the Weight 
Watchers Foundation. 
Heshka et al, 2003 This study was supported by a grant from 
Weight Watchers International 
(Woodbury, NY) to the New York Obesity 
Research Center at St Luke’s/ Roosevelt 
Hospital. 
Jolly et al, 2011 The study was funded by NHS South 
Birmingham. 
Lowe et al, 2001 Authors do not report this 
Morgan et al, 2008 British Broadcasting Corporation 
Rippe et al, 1998 Weight Watchers International. 
Rock et al, 2007 This study was supported by Jenny Craig, 
Inc. 
Rolland et al, 2009 LighterLife UK 
Truby et al, 2006 British Broadcasting Corporation 
Womble et al, 2004 Pilot Study Grant from the North American 
Association for the Study of Obesity (to 
Dr. Womble) and by NIH Grant K24-DK- 
065,018 (to Dr. Wadden). 
 
Four studies did not report who funded their study (Anderson et al, 1994b; 
Anderson et al, 1991; Gosselin and Cote, 2001; Lowe et al, 2001).  
 Of interest, the studies which I included in my review which had the smallest 
(n=40; Anderson et al, 1994a) and the largest (n=1002; Lowe et al, 2001) 
sample sizes did not report who funded their research. The funding of an 
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evaluation of a CWLPS, by that CWLPS, could be considered a conflict of 
interest.  
 
5.4.10 Patient outcome incentives 
Gosselin and Cote (2001) reported that a penalty of $7 would have been 
charged at weighing sessions if the participant in their study had gained weight. 
This form of incentive is not uncommon in weight loss programmes, and it could 
improve patient compliance and the final results. Participants who wanted to be 
involved in the study conducted by Lowe et al (2001) were given an incentive of 
$25 at the end of the study if they turned up for all of their measurement 
assessment appointments, regardless of whether or not they had lost weight. 
This latter type of assessment is much better in terms of trial design in that, in 
real life, people do not get incentivised to lose weight. Results from studies 
where patients get incentivised to lose weight when they are on a CWLPS diet, 
compared with patients in a control group who do not receive incentives, are not 
a true reflection of how the diet might work in real life.  
 
5.4.11 Confounders 
Jolly et al (2011) reported that a small percentage of patients in their trial were 
using weight loss drugs at baseline (between 1 and 4 %). The authors do not 
state whether these drugs were continued throughout the duration of the study. 
The use of weight loss drugs could have impacted on the results. 
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5.4.12 Effects of interventions 
Although the studies included in my review varied in the type and number of 
outcome measurements taken and reported, and the methodological quality of 
the studies, all studies favoured the CWLPS intervention vs. control. However, 
when studies assessed whether one CWLPS intervention was better or worse 
compared with another, some types of CWLPS were clearly better than others. 
 
5.4.13 Types of interventions 
 
Table 50: Studies included and type of intervention 
Comparison N Included studies 
CBA study (patents were their own 
control) 
4 Anderson et al, 1991 
Anderson et al, 1994b 
Gosselin and Cote, 2001 
Lowe et al, 2001 
RCT's: Intervention A vs. 
Intervention B 
5 Anderson et al,1994a 
Ditschuneit et al, 1999 
Gold et al, 2007 
Rolland et al, 2009 
Womble et al, 2004 
RCT's: Intervention vs. control 4 Heshka et al, 2000 
Heshka et al, 2003 
Rippe et al, 1998 
Rock et al, 2007 
RCT's including more than 2 arms 
and more than 1 intervention group 
 
4 Djuric et al 2002 
Jolly et al, 2011 
Morgan et al, 2008 
Truby et al, 2006  
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5.4.13.1 CBA studies (n=4) 
Four of the included studies in my review were CBA studies (Anderson et al, 
1991; Anderson et al, 1994b; Gosselin and Cote, 2001; Lowe et al, 2001). Two 
of these studies included participants that had taken part in a commercial 
weight loss programme previously, and presented the follow up/maintenance 
results (Gosselin and Cote, 2001; Lowe et al, 2001).   
Five to eleven years after discontinuation of the Mincavi programme, Gosselin 
and Cote (2001) found that 29.1% of women who started the programme had 
maintained a weight loss of at least 5%, while 14.3% had maintained a loss of 
at least 10%. The Mincavi programme is similar to other commercial weight loss 
programmes, but is more ‘hands-on’; sampling takes place, and specific topic 
subjects are covered in the programme sessions. Clients are also able to gain 
support from a dietician and psychologist via using a free phone line and 
internet link. In this programme, clients were penalised if they gained weight, by 
needing to pay $7. 291 participants took part in this study, but measured 
weights were only available for 31 of these participants; the rest (n=260) had to 
have their weight adjusted (+2.9%) as it was self-reported via the telephone, 
and so there is a potential element of error in the findings of this study. 
 
Lowe et al (2001) randomly selected male and female participants (n=1002) 
who had completed a Weight Watchers programme in the past, and found that 
they had regained (after they had lost weight during the programme) between 
31.5% and 76.5% of their weight after one to five years. However, 42.6% had 
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maintained a loss of 5%, 18.8% had maintained a loss of 10%, and 70.3% were 
below their initial weight, when assessed at follow up. 
 
Anderson et al (1991 & 1994b) conducted studies to test the effectiveness of a 
commercial weight loss product called Slimfast. Although I have included them 
as two studies (of 17) in my review, one might view them as just one study. The 
1991 paper reported the results at the end of the intervention, and the 1994b 
paper reported the follow up results at two years post intervention. Given that 
the 1991 paper was assessing weight loss during the intervention, and the 
1994b paper was assessing follow-up/maintenance, I decided to keep these 
papers as separate studies. All patients (n=80) were obese at baseline, and 
62% of females and 69% of males had reduced their weight at the end of the 
intervention to a point where they were no longer obese (Anderson et al, 1991). 
36% of females and 39% of males maintained their weight loss at 1 year follow 
up (Anderson et al, 1994b), and 19.7% maintaining their weight loss at two year 
follow up.  
 
The participants in the in the Slimfast studies (Anderson et al, 1991; Anderson 
et al, 1994b) had a variety of co-morbidities at baseline; hypertension (n= 68), 
hypercholesterolemia (n=28), degenerative joint disease (n =21), 
hypertriglyceridemia (n =15), and type II diabetes (n=10). Anderson and 
colleagues do not report whether participants were receiving drugs to manage 
their co-morbidities during the course of the intervention or follow up. 
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5.4.13.2 RCT: Intervention vs. intervention (n=5) 
Five studies assessed the effectiveness of one CWLPS against another 
(Anderson et al, 1994a; Ditschuneit et al, 1999; Gold et al, 2007; Rolland et al, 
2009; Womble et al, 2004).  
 
Ditschuneit et al (1999) compared the effects a controlled diet vs. slim fast meal 
replacements. I found it difficult to assess what the results of this study were 
from reading the paper. The two arms of the study, I think, remained separate 
for 3 months (Phase 1). Those participants using slim fast (n=50) lost 7.1 kg ± 
3.5 kg, and those in the controlled diet group (n=50) lost 1.3 kg ± 2.2 kg. In 
terms of % weight loss, participants using slim fast lost 11.3% ± 6.8%, and 
those in the controlled diet group lost 5.9% ± 5.0%.  During Phase 2 (where I 
think both groups were prescribed Slim fast), both groups lost, on average, an 
additional 0.07% of their initial body weight. Both male and female participants 
were involved in this study. Attrition rates were quite high; 62% of participants in 
the slim fast group finished the study, compared with 64% of the control 
participants.  
 
Gold et al (2007) compared the effects of two online diets programmes; the 
VTrim diet vs. the eDiets.com diet. Both males and females were recruited to 
this study. Participants in the VTrim group lost significantly more weight than 
those in the eDiets.com group at 6 months (8.3 ± 7.9 kg vs. 4.1± 6.2 kg), and 
maintained a greater weight loss at 12 months (7.8 ± 7.5 kg vs. 3.4 ± 5.8 kg). In 
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terms of dropout, 77.4% of participants in eDiets.com group, and 64.5% of 
participants in the VTrim group, remained in the study until the end. 
 
One of the most expensive CWLPS is a VLCD called LighterLife. Rolland et al 
(2009) compared Lighterlife (n = 38) against a low carbohydrate, high protein 
diet (LCHP) (n = 34). Both men and women were recruited to the study. A 
greater weight loss was observed for participants in the LighterLife group vs. the 
LCHP diet at 3 months (11.6 ± 12.9 kg vs. 2.8 ± 4.5 kg) and 9 months (15.1 ± 
21.1 kg vs.1.9 ± 5.0 kg), p<0.0001 for both. However, only 41.2% of participants 
in the LighterLife group, and 52.6% in the LCHP, completed the study. 
Therefore, although Lighterlife appeared to work very well for those participants 
who remained in the study, for the majority of them (59%) it did not work. 
 
Another relatively small study (n=47, all females), conducted by Womble et al 
(2004), compared the effects of a weight loss manual vs. ediets. The manual 
featured information about diet and recommended the consumption of 1200-
1500 kcal per day, and physical activity. Those in the weight loss manual group 
lost more weight than those in the ediets group. At week 16, participants in 
eDiets.com lost 0.9% ± 3.2% of their initial weight compared with those in the 
manual diet group who lost 3.6% ± 4.0%. At week 52, losses were reported to 
have increased a little to 1.1% ± 4.0% (ediets group) and 4.0% ± 5.1% (manual 
group), and I think these weights must have been the last weight recorded for 
each participant. The authors state that only eight participants remained in each 
group at 16 weeks, and all participants were lost to follow up at 52 weeks. 
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Participants in Anderson et al (1994a) study, another relatively small study (n = 
40), compared a 800 kcal dietary supplement diet with the same 800 kcal 
dietary supplement diet plus an evening meal. Both arms received an intensive 
behavioural education program. Weight loss for the two groups is not clearly 
stated in the paper, but the authors report that the weight loss did not differ 
significantly between the two groups, and that the average weight loss for all 
participants was 15.7kg. Both male (n=21) and female participants (n=19) took 
part in this study, and drop out was minimal (92.5% of participants completed 
the study). Of note, Anderson et al (1994a) report the co-medications that the 
participants were taking during the study, including insulin (n=5), insulin and 
oral hypoglycaemic agents (n=3), oral hypoglycaemic agents (n=24), and diet 
alone (n=7). These medications could have had an effect on the results of this 
study. 
 
5.4.13.3 RCT's: One CWLPS vs. control (n=4) 
Four RCT's assessed the effectiveness of a CWLPS vs. controls (Heshka et al, 
2000; Heshka et al, 2003; Rippe et al, 1998; Rock et al, 2007). Three of these 
studies assessed the effectiveness of Weight Watchers as the CWLPS, and the 
other study assessed the effectiveness of the Jenny Craig programme (Rock et 
al, 2007).  
 
I have included the two studies by Heshka and colleagues (2000 and 2003) as 
separate studies, although they might be viewed as just one study. The studies 
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were funded by Weight Watchers. Heshka and colleagues report the findings of 
their study at 26 weeks (2000 paper) and at 2 years (2003 paper); both 
demonstrated significant decreases in body weight and BMI for both the control 
and intervention group (Weight Watchers). However, at 26 weeks, Weight 
Watchers participants (n=211) lost more weight, and reduced their BMI more 
than the control participants (n=212); -4.8 ± 5.6 kg vs. -1.4 ± 4.7 kg, and -1.7 ± 
1.9 vs. -0.5 ± 1.6 kg/m², respectively, in intention-to-treat analyses. Female 
(n=358) and male (n=65) participants took part in the study, and dropout rates 
were average; 17.5% in the Weight Watchers group and 18.9% in the control 
group.  
After 2 years, attrition was low (Heshka et al, 2003); 71% of Weight Watchers 
participants and 75% of control participants remained in the study at 2 years. 
Weight Watchers participants lost more weight than the control participants at 
one year; 4.3 ± 6.1 kg vs. 1.3 ± 6.1 kg, and two years 2.9 ± 6.5 kg vs. 0.2 ± 6.5 
kg.  At 2 years, BMI decreased more in the Weight Watchers group than the 
control group; 1.6 ± 0.2 vs. 0.5 ± 0.2 kg/m².   
 
Another study which assessed the effectiveness of Weight Watchers was 
conducted by Rippe et al (1998). This study only included female participants 
(n=80), who were randomised to a control or intervention (Weight Watchers) 
group for 12 weeks (thus mirroring the standard 12 weeks GP referral system in 
England). The intervention group (Weight Watchers) lost significantly more body 
weight (kg) and body fat (%) compared with controls (-6.07 ± 4.01 kg vs. 1.31 ± 
1.28 kg; 36.8% ± 32.5 vs. 36.2% ± 36.0%). However, one should be cautious 
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when reading these results. Three times more participants remained in the 
intervention group (75%) at study end vs. control participants (35%). If an ITT 
had been conducted, conclusions could have been more accurate.  
 
Rock et al (2007) assessed the effectiveness of the Jenny Craig programme. 
This study gave pre-packaged foods to the participants, along with programme 
materials, and extra support which addressed food-related components (mind, 
body, and food issues). Of note, this CWLPS also included advice to complete 
30 minutes of physical activity on 5 or more days of each week. Only female 
participants (n=70, 35 in each group) took part in this study. This study had 
minimal dropout rates; 5.7% control vs. 8.6% in the intervention group. Using an 
intent-to-treat (ITT) analysis, at six months, weight loss was 7.2 ± 6.7 kg and 
7.8% ± 7.2% in the intervention group vs. 0.3 ± 3.9 kg and 0.3% ± 4.5% in the 
control group. Using ITT analysis, at one year, weight loss was greater in the 
intervention group (n=32)  7.3 ± 10.4 kg vs. controls (n=33) 0.7 ± 5.6 kg, as was 
% weight loss,  7.8% ± 11.1% in the intervention group vs. 0.7% ± 6.2% in the 
control group.  
 
5.4.13.4 RCT's including more than 2 arms and more than 1 intervention 
group (n=4) 
Four studies compared the effect of one CWLPS with at least two other groups 
(Djuric et al 2002; Jolly et al, 2011; Morgan et al, 2008; Truby et al, 2006).  
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Djuric et al (2002) conducted a relatively small study in 48 female patients with 
Stage I or II breast cancer who had been diagnosed within the past 4 years, and 
a physician had confirmed that they were free of any recurrence. Chemotherapy 
or radiation therapy was to have been completed at least 3 months previously. 
The study had three arms; Weight Watchers with counselling (the 
Comprehensive group), an individualised arm (dietetic support, monthly group 
meetings, a monthly package of written information on various weight-loss 
topics), and a control group.  
The greatest weight loss (at 12 months of intervention) was found in the 
comprehensive group; 9.4 ± 8.6 kg compared with 8.0 ± 5.5 kg in the 
individualised group and 0.85 ± 6.0 kg in the control group. Weight loss relative 
to control was statistically significant in the comprehensive group at 3, 6, and 12 
months after randomisation, whereas weight loss in the individualised group 
was significant only significantly greater than controls at 12 months .Overall, the 
comprehensive group demonstrated the greatest improvements; a weight loss 
of 10% or more of initial body weight was observed in six of the 10 women in 
this group at 12 months.  
 
This study did not report the dropout rates per group, but an overall dropout rate 
and reason for drop out were given. 81% of participants remained in the study 
until the end.  Two participants were asked to leave the study for non-
compliance after 3 and 6 months, respectively. Reasons for drop out were; 
medical problems (n = 1), too busy (n= 2), emotional distress (n =3), and lost 
interest (n = 1). Attendance at the sessions was higher in the comprehensive 
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group compared with other groups; 93% (baseline to three months), 79% (3 
months to six months), and 52% (six to 12 months).   
 
The results of this study should be viewed in context, given that the participants 
in this study were breast cancer survivors and their medication could have had 
an impact on the overall results of the study. For example, three women were 
taking oestrogen replacement therapy and, of these, one was taking both 
tamoxifen and hormone replacement therapy. Three other participants were 
taking diabetes medication. 
 
Jolly et al (2011) conducted a trial with a number of programme arms; Weight 
Watchers, Slimming World, Rosemary Conley, Size down, General Practice, 
Pharmacy, Choice, and a control group. The study was funded by Birmingham 
PCT. 640 intervention, and 100 control participants took part in the study; both 
males and females were recruited to the study. At 12 weeks, participants in all 
programmes achieved significant weight loss, ranging from an average of 1.4 kg 
in the General Practice group to 4.4 kg in the Weight Watchers group. At one 
year, participants in all arms, except the General Practice and Pharmacy 
groups, had significant weight loss. At one year, only those in the Weight 
Watchers group had significantly greater weight loss (3.5kg) compared with the 
control group (1.1kg); mean difference 2.5 kg, 95% CI 0.8 to 4.2. Overall, 
participants in the commercial weight loss programmes lost significantly more 
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weight than the primary care programmes (mean difference 2.3 kg, 95% CI 1.3 
to 3.4). 
 
In this study conducted by Jolly et al (2001), a few participants in all of the 
groups were taking weight loss drugs; 3% Weight Watchers, 4% slimming 
world, 3% Rosemary Conley, 2% Size down, 1% General Practice, 4% 
Pharmacy, 3% choice, and 3% control. The study does not report whether the 
weight loss drugs were continued for the duration of the study. 
 
Morgan et al (2008) conducted a study with a number of programme arms; 
Weight Watchers, Rosemary Conley, Slim Fast, Atkins, and a control group. 
Participants (n=293) were stratified by gender (30% of participants were male) 
and randomly allocated to one of the five groups. Significant weight loss was 
achieved by those in all programmes (an average of between 5 and 9 kg at 6 
months), but no significant difference was observed between weight loss at 6 
months. 28% of participants dropped out of the study at six months. 
 
The BBC funded the study which was conducted and reported by Truby et al 
(2006). It is identical in design to the study of Morgan et al (2008) mentioned 
above, but Truby et al (2006) used ITT analysis. 71.7% of participants, including 
control participants, finished the study. Using ITT, all diet programmes resulted  
in a significant loss of body fat and weight over six months compared with the 
control group, but the loss of body fat and weight between programme groups 
was not significantly different; average weight loss was 5.9 kg and average fat 
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loss was 4.4 kg over six months. The Atkins diet resulted in significantly higher 
weight loss during the first four weeks, but by the end of the study it was not 
significantly more effective than the other programmes.  
 
The Atkins and Rosemary Conley groups appeared to perform best; average 
weight loss in the Atkins group was 6.3 kg, and 6.1 kg in the Rosemary Conley 
group. However, those in the Rosemary Conley group had the greatest % 
weight loss (6.6%), and greatest % fat loss (3.5%), at 6 months. Those in the 
Atkins group had a greater average reduction in their waist circumference 
compared with those in the Rosemary Conley group; 7.4 cm vs. 7.2 cm. 
 
5.4.14 Summary 
17 studies were included in this review, all of which had similar aims; some of 
the studies which I included were in fact papers from the same study that had 
presented results at different time points (e.g. at end of intervention and at 
follow up) and/or different analysis. When I convert my review into a Cochrane 
review I will discuss with my co-authors how best to manage these data. 
Sample size, design, quality, duration, and types of outcome measures varied 
considerably amongst the studies I included in my review. Because of the 
heterogeneity between studies, I did not conduct a meta-analysis. However, the 
majority of studies reported that the CWLPS they were testing performed better 
than the control. In the table below (Table 51), I have summarised the main 
weight loss results of the included studies.  It is clear that the CWLPS 
interventions, particularly commercial weight loss programmes perform the best. 
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Where the effectiveness of commercial weight programmes have been 
compared within the same study, Weight Watchers appears to perform the best. 
  
Table 51: Summary of main weight loss findings from the 17 included 
studies 
 
Study Main results 
Anderson et al, 1991 Of the 100 subjects, 49 stayed on the diet until reaching their 
desired weight. The average weight loss was 19.2 kg for 
females and 18.6 kg for males. At the end of the study period, 
62% of the females and 69% of the males had reduced their 
weight to the point that they were no longer obese. At follow-
up, 36% of females had maintained their weight loss and 39% 
of males had maintained their weight loss. 
Anderson et al, 1994a Both groups lost significant amounts of weight, and weight 
losses did not differ significantly between groups. Weight loss 
averaged 15.7 kg. 
Anderson et al, 1994b 35kg was lost at 25 weeks.  
20 kg was maintained of their weight loss at 2 year follow up. 
Ditschuneit et al,1999 The study favoured group B (meal replacement). Group B lost 
11.3% (± 6.8) vs. Controls 5.9% (± 5.0%) (as a percentage of 
initial body weight (p < 0.0001). During phase 1, mean weight 
loss in group B (n = 50) was 7.1 ± 3.5 kg. 
Group A patients (n = 50) lost an average of 1.3 ± 2.2 kg. 
During phase 2, both groups lost on average an additional 
0.07% of their initial body weight every month (p < 0.01). 
Djuric et al, 2002 The most successful group (at 12 months of intervention) was 
Weight Watchers combined with counselling (the 
comprehensive group) -9.4 ±8.6 kg, then the individualised 
group -8.0 ± 5.5kg. Weight loss relative to control was 
statistically significant in the comprehensive group 3, 6, and 12 
months after randomisation, whereas weight loss in the 
individualised group was significant only at 12 months. Weight 
loss of 10% or more of initial body weight was observed in 6 of 
the 10 women in the comprehensive group at 12 months 
Gold et al, 2007 The participants in the VTrim group lost significantly more 
weight than those in the eDiets.com group at 6 months (8.3 ± 
7.9 kg vs. 4.1 ± 6.2 kg) and maintained a greater loss at 12 
months (7.8 ±7.5 kg vs. 3.4 ±5.8 kg).  More participants in the 
VTrim group maintained a 5% weight loss goal; 65% vs. 37.5% 
at 12 months 
Gosselin and Cote, 
2001 
Five to eleven years after they had participated in the Mincavi 
programme 29.1% of all women maintained a weight loss of at 
least 5%, while 14.3% maintained a loss of at least 10%. The 
percentage of women who maintained at least 5% of their 
initial weight loss are as follows; 2 years = 43.6% (n = 55), 3 
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years = 33.3% (n = 42), 4 years = 23.8% (n = 42), 5–6 years = 
38.2% (n = 55), 7–8 years = 29.4% (n = 51), and 9–11 years; 
19.6% (n= 46). 
Heshka et al, 2000 After 26 weeks, subjects in the commercial program (weight 
watchers), as compared with those in the self-help program, 
had greater decreases in body weight (-4.8 ± 5.6 kg vs. -1.4 
±4.7 kg) and BMI (-1.7 ± 1.9 vs. -0.5 ± 1.6 kg/m2), both p< 
0.001, in intention-to-treat analyses. 
 
Heshka et al, 2003 In ITT analysis, mean (SD) weight loss of participants in the 
commercial group (weight watchers) was greater than in the 
self-help group at 1 year (4.3 ± 6.1 kg vs. 1.3 ± 6.1 kg) and at 
2 years (2.9 ± 6.5 kg vs. 0.2 ± 6.5 kg).  BMI also decreased 
more in the commercial group (1.6 ± 0.2 vs. 0.5 ± 0.2) 
compared with the self-help group. 
Jolly et al, 2011 Participants on all programmes achieved significant weight 
loss from baseline to programme end; range 1.37 kg (general 
practice) to 4.43 kg (Weight Watchers), and all except general 
practice and pharmacy provision resulted in significant weight 
loss at one year. At one year, only the Weight Watchers group 
had significantly greater weight loss than the control group (2.5 
kg, 95% CI 0.8 to 4.2). The commercial programmes achieved 
significantly greater weight loss compared with the primary 
care programmes at programme end (mean difference 2.3 kg, 
95% CI 1.3 to 3.4. 
Lowe et al, 2001 Based on corrected weights, weight regain from 1 to 5 y 
following weight loss ranged between 31.5 and 76.5%. At 5 
years, 19.4% were within 5 lb. of their goal weight, 42.6% 
maintained a loss of 5% or more, 18.8% maintained a loss of 
10% or more, and 70.3% were below initial weight. 
Morgan et al, 2008 Significant weight loss was achieved by all dieting groups 
(Atkins, Weight Watchers, Slimfast, Rosemary Conley); (5–9 
kg at 6 months) but no significant difference was observed 
between the different diets at 6 months. 
Rippe et al, 1998 The intervention group (Weight Watchers) lost significantly 
more body weight (kg) and body fat (%) compared with 
controls (-6.07 ± 4.01 kg vs. 1.31 ± 1.28 kg; 36.8% ± 32.5 vs. 
36.2% ± 36.0%). 
Rock et al, 2007 At 6 months, change in weight using ITT analysis was 7.2 ± 
6.7 kg and 7.8% ± 7.2% in the intervention group (Jenny 
Craig) vs. 0.3 ± 3.9 kg and 0.3% ± 4.5% in the control group (n 
=35 for each; p <0.01). One-year ITT analysis revealed 
significantly greater change in weight, present weight, BMI, 
and waist and hip circumferences in the intervention vs. control 
group. Completers at 1 year exhibited weight loss of 7.3 
(±10.4) kg for the intervention group (n =32) vs. 0.7 ± 5.6 kg 
for controls (n =33), p < 0.01, and 7.8% ± 11.1% weight loss 
for the intervention group vs. 0.7% ± 6.2% for controls, p < 
0.01. 
Rolland et al, 2009 Significantly greater weight loss was seen for patients using 
LighterLife compared with the Low Carbohydrate High Protein 
group at 3 (11.6 ± 12.9 vs. 2.8 ± 4.5 kg) and 9 months (15.1 ± 
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21.1 vs. 1.9 ± 5.0 kg), both p < 0.0001. 
Truby et al, 2006 All diets resulted in significant loss of body fat and weight over 
six months. Groups did not differ significantly but loss of body 
fat and weight was greater in all groups compared with the 
control group. In an intention to treat analysis, average weight 
loss was 5.9 kg and average fat loss was 4.4 kg over six 
months. The Atkins diet resulted in significantly higher weight 
loss during the first four weeks, but by the end was no more or 
less effective than the other diets. 
Womble et al, 2004 At week 16, participants in eDiets.com lost 0.9 ±3 .2% of their 
initial weight compared with 3.6 ± 4.0% for women assigned to 
the weight loss manual. At week 52, losses increased to 1.1 ± 
4.0% and 4.0 ± 5.1%, respectively. 
Results of a last-observation-carried-forward analysis found 
that women in the manual group lost significantly (p< 0.05) 
more weight (at both time points) than those using eDiets.com. 
(Results, however, of baseline-carried-forward and completers 
analyses did not reach statistical significance.) 
 
 
I did not formally assess the quality of the studies in my review, but I will do that 
as part of the conversion process for the Cochrane review. However, I do 
understand the concept of quality, and the different ways in which it can be 
assessed. When I have done this informally for the studies I included in my 
review, four of the studies stood out as being of good quality; Heshka et al 
2000; Heshka et al 2003; Jolly et al, 2011; Truby et al, 2006.   
 
Finally, approximately half of the studies included in my review were funded by 
a commercial weight loss company, or a non-academic based organisation. 
About a quarter of the studies were funded by a research grant, and about a 
quarter of studies did not state the source of funding. 
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Chapter Six 
Discussion and Conclusions 
 
6.1 Introduction 
In this chapter I have explained what I set out to achieve by doing this research, 
what I have learnt along the way, and the findings from my research. 
I set out to find out about the use, popularity and efficacy of CWLPS, particularly 
in relation to health inequalities. Much of what I have learnt by doing this 
research relates to methods. I learnt a lot about the various issues associated 
with recruiting people to a study like mine, including the issues associated with 
recruiting people from deprived areas. I also learnt about Q-methodology, which 
I found very exciting, and the Cochrane review process. I now appreciate the 
value of using a mixed methods approach. In addition, I learnt a lot about the 
issues involved with sensitive commercial data. 
My research did produce findings which help better understand the choice and 
efficacy of CWLPS. The novel use of Q-methodology to this topic area revealed 
some very interesting findings. Sadly, I found out very little about the use and 
efficacy of CWLPS in relation to health inequalities from the survey and the 
review, but I did find out some useful facts about whether the cost of a CWLPS 
influences the decision as to whether to buy it, or a cheaper CWLPS, in my Q-
method study.    
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At the end of this chapter, I make some suggestions for further research in this 
area 
 
6.2 What I set out to achieve 
The primary aim of my research was to establish why people chose certain 
CWLPS over others, and whether this depends on how much money they have. 
I also wanted to know about the efficacy of the different CWLPS, and whether 
this matched the views of the people using them. I was interested to know 
whether the choice of CWLPS was determined by their price. In theory, one 
could imagine that the most efficacious CWLPS might be the most expensive, 
and poorer people with less money may have no choice but to buy the cheaper 
CWLPS. If this was true, then the cost of CWLPS could contribute to health 
inequalities. 
 
I understand that I was asking a difficult but important question. Given the 
complexity of the topic, I decided it would be best to try and approach the 
question using different methods, in the hope that I would get a richer set of 
findings which I could then look at. I used a mixed method study design using 
three components; a survey, Q-methodology, and a systematic review. Each 
method had distinctive but overlapping aims which mapped onto my research 
question.  
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6.3 Why I chose to investigate CWLPS 
My interest in this topic came from a number of sources, including an interesting 
paper from Lowe et al (2001) which found that an increasing number of 
individuals who want to lose weight avoid clinical programmes, and instead 
seek assistance in commercial alternatives. This is not surprising, given the 
clever and persuasive marketing of CWLPS by commercial companies. 
 
6.4 What I have learnt through my PhD: Methods 
 
6.4.1 Recruiting people to the survey 
As I set out on my PhD journey, I honestly thought that I would have no trouble 
at all in getting participants to take part in my survey (or Q-method study). I 
thought this because of the data in the literature on the numbers of people in 
the UK who, at any one time, are trying to lose weight. Although these numbers 
vary, they have been estimated at about almost 37% women were dieting most 
of the time, compared to around 18% of men (BBC, 2004). In addition, the 
amount of marketing and exposure of CWLPS in magazines, TV commercials, 
etc., led me to believe that a lot of people would be interested in taking part in 
my study. I could not believe it when I got such a poor response rate to the 
initial advert in the Middlesbrough Gazette. 
Although I was disappointed with the level of interest, it did force me to think 
very carefully about recruitment, and different recruitment methods. I expanded 
the geographical area for recruitment, and went on the radio, which required 
additional ethical approvals (which caused a delay), and I learnt a lot from these 
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experiences. I have done a lot of reading on recruitment of participants to 
surveys and trials, and it does seem that, particularly for public health research 
(rather than clinical research), most studies struggle with recruitment issues 
these days. Before I did my PhD, I was a research assistant for a study called 
the ‘Community Challenge Project’ (CCP), and this study also had major 
problems in recruiting participants. I am co-author on a paper which we wrote 
about this issue (Hillier et al, 2011), and I intend to write a similar paper from my 
PhD work.   
To be able to answer my research question, I not only needed to recruit enough 
participants, but also recruit enough participants from different SES groups. At 
the start of my PhD, I simply thought that by advertising in a local newspaper I 
would be able to do this. I now appreciate that a more targeted recruitment 
strategy would have helped me do this. During the CCP study, we certainly 
found that recruiting people from deprived areas of the North East was better 
done face to face, and best of all done by local champions who the participants 
knew and trusted. In hindsight, I think it is possible that many people who we 
invited to take part in the survey were suspicious about ‘Ivory Tower’ 
researchers, and perhaps cynical about what they, the participant, would get out 
of the study. I now realise that I probably shouldn’t have told them I was a PhD 
student and needed the data for my PhD. It is possible that most potential 
participants for studies like mine are not very interested in helping a researcher 
in a University, but they may take part in a study if they think it is going to 
benefit them. I didn’t offer potential participants any benefits, except the 
opportunity to talk to others in the same situation as them. I now realise that this 
was probably a mistake, 
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6.4.2 Q-methodology 
Q-Methodology is not a novel method. It is a popular method of choice in some 
disciplines. However, to my knowledge it is not commonly used in health 
behaviour type research, and I have not been able to find a study using this 
method in the obesity research literature. I was a little nervous, but excited, 
about using this method. The Q-method part of my PhD work was certainly the 
part that I found most rewarding. One of the drawbacks of using a novel method 
is not being able to talk to others who have used it previously. However, I found 
out about, and joined, a discussion group for people doing Q-method, which 
was incredibly helpful. I also identified another (Fuse) PhD student at Newcastle 
University who was using it for her PhD, and also a lecturer at Teesside 
University; both were a great support. There was definitely something exciting 
about using a new method. 
The method itself is quite complicated, but I thoroughly enjoyed the complex 
nature of the method. I had never done any qualitative work before my PhD, 
and I didn’t think I was going to enjoy it. I couldn’t have been more wrong.  
 
6.4.3 The Cochrane review process 
I now understand that Cochrane reviews are all of good quality because of the 
rigorous peer review process which Cochrane insists upon. However, it can 
take such a long time for the Review Group to respond to queries and process 
reviews. I had to wait more than 6 months at one stage to get comments back 
on my protocol, and each time it came back for edits I revised it and sent it back 
in, but had to wait for months for them to reply. I can now understand why it 
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would be too risky to say that you will do a Cochrane Review by X date, 
because you are not in control – they are – and you might miss a deadline. 
In discussion with my supervisors, we made a decision during the course of my 
PhD that I would just get on and complete the review, and ‘Cochranise’ it after I 
had submitted my thesis. This was a good decision I think, but I am committed 
to Cochranise my review at a later date. I understand that the Cochrane Library 
is an important and valued source of best evidence, and can be accessed by 
people from all over the world. I particularly like the fact that it can be accessed 
free of charge by people from poor countries.   
   
6.4.4 The value of using a mixed methods approach 
One of the most important things I have learnt in doing my PhD is the value of 
asking the same question from different angles (using different methods). This 
provides a richer, and I would think truer, answer to the question. For example, I 
was particularly interested in the popularity and efficacy of CWLPS. From the 
survey (quantitative) results, there weren’t any associations between the cost of 
a CWLPS and its popularity, particularly for poorer people. The primary reason 
for this was because very few of the participants in my survey were from low 
SES backgrounds. I also didn’t find any useful (quantitative) data to help me 
answer the question from my review; included studies had not targeted 
particular groups by SES, or had presented analysis of effectiveness by SES.  
However, the Q-method study, because it was a qualitative method, did allow 
me to drill down and ask questions about the cost of CWLPS and whether that 
has an influence of people’s choice of CWLPS.  
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I think that a mixed methods approach may be particularly helpful when you are 
asking complex questions in a topic area where there isn’t much existing 
evidence. 
 
6.4.5 Issues involved with sensitive commercial data 
I was initially very surprised at the negative response I got from commercial 
companies when I asked them for data about the use of and efficacy of their 
weight loss product or service. I did think that they would be very happy to give 
me this data. When I met representatives from these companies at conferences 
and meetings, they seemed very interested in my research, and very keen to be 
involved in some way. However, they were not. I now understand the 
sensitivities associated with data on use and efficacy of CWLPS. Personally, I 
don’t think that this is right. These companies do hold a lot of data on their 
products and services, but they don’t release it.    
 
6.5 Findings from my research 
 
6.5.1 The survey 
The findings of the survey confirmed that there is a wide range of CWLPS which 
people in the UK use, and that slimming groups such as Weight Watchers and 
Slimming World are by far the most popular.  However, what I was most 
interested to find out from the survey was whether the SES of an individual was 
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a factor in determining which CWLPS they used. Sadly, because of the profile 
of the sample, I was not able to answer this question.  
 
6.5.2 The Q-methodology study  
The Q-method study which I conducted produced a plethora of interesting 
information, which I did not expect. The participants told me about the many 
reasons they choose CWLPS which support why a variety of CWLPS should be 
available (and offered, in the NHS) to the public. 
The Q-method study revealed four different groups of participants who had 
similar needs for their preferred weight loss product or service, which mapped 
onto the different types of CWLPS available; marketing and cost did not feature 
strongly in participant’s choice of CWLPS.  
The first group (Factor 1) I labelled as ‘effortless self-management’. This group 
of participants chose a CWLPS primarily because 1) it promised quick weight 
loss, 2) it was easy to follow, and 3) it allowed them to set their own realistic 
weight loss targets. Although the participants in this group chose different 
CWLPS, they each perceived the CWLPS they used as meeting these 
requirements. 
The second group (Factor 2) I labelled as ‘lifestyle adjustment counselling’. This 
group of participants chose a CWLPS primarily because 1) it promised quick 
weight loss, 2) it was healthy, and 3) it provided advice on maintenance after 
the participant had stopped using the CWLPS. Although the participants in this 
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group chose different CWLPS, five (of the six) had chosen a VLCD. Each 
participant perceived the CWLPS they used as meeting these requirements. 
The third group (Factor 3) I labelled as ‘Celeb support’. This group of 
participants chose a CWLPS primarily because 1) it offered support in losing 
weight, 2) it offered support in maintaining weight loss, and 3) sticking to the 
diet would not be a big change to their lifestyle. All participants in this group 
chose either Weight Watchers or Slimming World. Each participant perceived 
the CWLPS they used as meeting these requirements. 
The fourth group (Factor 4) included just one person, a man, and I labelled this 
group as ‘Men don’t get help’. This participant chose Slimming World for Men 
primarily because 1) it was gender specific, and 2) it was healthy. This 
participant perceived the CWLPS they used as meeting these requirements. 
 
Within the NHS, there is little flexibility to match patients who seek to lose 
weight with programmes, products and services, because only a limited number 
of options are commissioned and thus on offer. Rather than focus future 
research on finding the one most effective weight loss method for everybody, I 
think it would be more useful to try and identify different groups of people based 
on their needs from a weight loss method, and look to see whether this 
matching produces better results for everybody. The simplest case in point, 
identified from my research, is the provision of gender specific weight loss 
services. 
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Certainly, in the studies included in the systematic review, there was a high 
dropout rate in most studies. I think it is more than possible that those who 
dropped out were not a random sample, but those whose needs for a weight 
loss method did not match the CWLPS to which they were allocated.    
 
6.5.3 The review 
The systematic review showed that the use of CWLPS resulted in weight loss, 
although attrition rates were sometimes quite high. Most of the studies included 
in the systematic review were underpowered, and very few could be considered 
as good quality. None of the studies reported SES within their analysis, or 
feature any in-depth qualitative analysis about the reasons for drop out and 
participant experiences of the CWLPS.  
Where studies assessed the effectiveness of one type of CWLPS against a 
control diet, those in the CWLPS lost more weight over time. Where studies 
assessed the effectiveness of one type of CWLPS with another, results were 
mixed but slimming groups, such as Weight Watchers, appeared the most 
effective. A high quality study (Jolly et al, 2011) found that CWLPS such as 
Weight Watchers performed very well, compared with groups who were 
allocated to General Practice or Pharmacy weight loss service provision. A 
caveat needs to be attached to these results, in addition to the quality issues 
raised in the previous paragraph. One can only say something positive (or 
negative) about the effectiveness of a CWLPS if a study or trial has been 
conducted on this CWLPS. For many of the CWLPS which participants in my 
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survey listed as using, there are no CBA's or RCT's of effectiveness reported in 
the literature 
The effectiveness of a CWLPS did not appear to be related to its cost and, 
because of a lack of data collected and reported in these studies, I was unable 
to assess whether the effectiveness of a CWLPS was related to the SES of 
those taking part in the studies. 
 
6.6 Suggestions for further research in this area 
 
a) Future research on public health should include work which identifies the 
best ways of recruiting people from low SES backgrounds to various studies. 
b) Further research on mapping peoples preferred needs for their weight loss 
method with the available range of weight loss programmes; products and 
services (including CWLPS) would be helpful for both users and commissioners 
of services. The development of a screening to tool which facilitated a user 
being offered the most appropriate weight loss method would, most likely, 
improve an individual’s chances of success. 
c) Future trials to assess the efficacy of CWLPS should ensure they are 
statistically powered and that participants from a wide range of social 
backgrounds, including people from low SES groups, are recruited. Analysis of 
effectiveness by SES should be conducted and presented in research papers. 
Qualitative research should also be included as part of these studies, which 
Chapter Six Discussion and Conclusions 
 
241 
 
should include the exploration of reasons why people dropped out of the trial, 
and views from both men and women. 
 
6.7 Conclusions 
It is clear that most CWLPS are used, preferred, and effective for some people, 
at least for a short period of time. However, different users have different needs 
for their preferred CWLPS. A screening tool, which identified the needs of 
somebody who is considering using a CWLPS, might be helpful in signposting 
them to a CWLPS which would best suits them.  
 
From the data available to me, it appears that the cost of a CWLPS is not a 
critical factor in its use, popularity, or effectiveness. Also, I found no evidence 
that the cost of CWLPS fuels inequalities (i.e. that poorer people buy cheaper 
types of CWLPS, which in turn are less effective). However, the data available 
to me was limited; participants who took part in the survey (and Q-method) were 
mostly middle income, and the studies included in the systematic review did not 
target particular groups by SES, or present analysis of effectiveness by SES.  
 
Additional research on the uptake of CWLPS and its impact upon health 
inequalities would be useful, given our current knowledge that obesity is 
associated with health inequalities. It is important to try and work out where and 
how obesity drives health inequalities, and there is some logic behind the 
hypothesis that the use of CWLPS may be a contributing factor.  In theory, for 
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example, if an individual of low SES chooses to purchase and use a CWLPS to 
help them lose weight, rather than access support from the primary care team, 
then their available income would be reduced. We know that poverty is strongly 
associated with health inequalities (reference the nice book I lent to you), thus 
buying CWLPS could contribute to health inequalities via this route. 
 
Research to better understand the uptake and reasons for choice of CWLPS 
across the socioeconomic spectrum should be conducted. Indeed, this is what I 
set out to do for my PhD, but sadly I was unable to recruit a large enough or 
socioeconomically diverse sample. Future research in this area should be 
designed using the learning from my research. Targeting particular groups in 
society, e.g. via community groups and talking to people face to face, might be 
a more effective sampling strategy. Other target groups might be community 
weight loss groups which could be visited in person by the researcher. Such a 
study would require a significant resource, and is beyond the scope of a PhD 
study.    
 
Whilst undertaking my PhD I assumed that the cost of a CWLPS would play an 
important role in choice of CWLPS (with those individuals of greatest means 
been able to afford the more, and the most effective, CWLPS). The annual 
salary for the NE region in 2012 was £17,004. If an individual was to purchase 
the most expensive CWLPS from the survey (LighterLife), 25% of their salary 
would be accounted for on a CWLPS alone. Whilst I was intrigued to find, from 
my research, that the cost of a CWLPS did not appear to influence the choice of 
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CWLPS, my results should be interpreted with caution since most of the 
participants in my study were middle-income. The related issue of targeted 
marketing (to certain SES groups) of certain CWLPS is an issue which I have 
discussed with other academics during the course of my PhD, and one which I 
feel deserves further research. A study which identified, from magazines, 
newspapers, and TV adverts, whether certain CWLPS were targeted at certain 
SES groups, would be very useful in helping us to understand any relationship 
between the reasons of choice of CWLPS and SES was fuelled by company 
marketing strategies.  
 
In addition, research to better understand the effectiveness of CWLPS 
commonly used would be useful. Currently, there is limited information, and the 
best evidence is restricted to just a few types of CWLPS. A best practice model 
whereby the company paid for the research, but the management of the trial 
and evaluation of the results was conducted independently by a research team 
(based in Universities), and peer reviewed by other researchers, should be 
championed. The rationale for funding such studies is perhaps unconvincing for 
some companies for two reasons. First, such studies are very expensive. 
Second, such studies run the risk of concluding that the CWLPS under 
investigation is not significantly effective compared with controls. Why, when the 
company can produce relatively cheap marketing based on compelling 
‘personal stories’, would a company decide to spend a lot of money on a full 
trial. I understand the difficulties associated with the funding of good quality 
evidence in this area, and I think this needs addressing. One possible lever 
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might be for NICE to only include evidence on CWLPS where that company had 
funded such a trial. 
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Consent Form 
Please read the following consent form carefully then tick the Yes or No boxes, and initial all 
boxes. If you have ticked any of the No boxes to questions 1-7, your data will be securely 
destroyed when received.  If you tick the No box to question 8, but tick the Yes boxes to 
questions 1-7 you will still be included in this survey. 
 
 
 
 
  
 
  
  
 
 
  
 
 
 
 
 
 
--------------------------------------  --------------------  --------------------- 
1. I confirm that I have read and understood the participant information 
sheet for this study (version 3.0) and am aware of what it will involve.  
2. I have been able to contact the researcher about any questions or 
concerns that I have about this study using the details provided in the 
information sheet. 
3. I understand that my participation is voluntary and that I can withdraw 
from the research at any point before 28th February 2011 when data 
analysis will be complete. I am aware that if I choose to withdraw I will 
not be required to give a reason. 
 
4. I am 16 years of age or older 
 
5. I have used a commercial weight loss product or/and service in the last 
twelve months 
6. I understand that the information that I provide will be anonymised, will 
be kept strictly confidential, and will be kept in locked filing cabinets and 
password-protected files on computers at Durham University in 
accordance with the Data Protection Act (1998). My information will not 
be shared with anyone who is not part of the research team. After the 
study has finished, data will be securely saved and destroyed before the 
1st June 2015. 
7. I agree to take part in this study. 
 
8. I agree to be contacted to discuss my willingness to participate in the 
next stages of the overall study. 
 
ID Number: 
 Yes   No Initial 
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Volunteers needed to assess diet plans 
10:48am Monday 3rd January 2011 in News 
A UNIVERSITY research team is hoping to recruit volunteers to help in a study of weight-loss 
programmes.  
With an estimated 14 million people across the UK about to embark on a new year diet, the 
scientists are hoping they will have no shortage of applicants.  
The Durham University team is hoping to recruit 1,000 people to complete an anonymous 20-
minute postal survey telling researchers about their experience of commercial diet and weight-loss 
programmes.  
They hope to build up a scientific picture of which are popular and why, information which will be 
fed back to public health policy and may eventually lead to GPs having the option of referring 
patients to a diet plan, rather than a medical procedure.  
Researchers, based at the university’s school of medicine and health, in Stockton, want to recruit 
people from County Durham, Northumberland, Tyne and Wear and the Tees Valley.  
The only stipulation is that they must be over the age of 16 and must have used a commercial 
weight-loss product in the past year, such as Slimming World, WeightWatchers, LighterLife, 
Rosemary Conley, Diet Chef and Slim- Fast, as well as weight loss books, DVDs and websites.  
Lead researcher Alisha Crayton said: “There are so many commercial weightloss programmes 
available, but we don’t yet fully know how effective they are, what people think of them, and 
whether they provide good value for money.  
“In order for us to get a good idea of why people choose particular programmes and products, we 
are looking for at least 1,000 volunteers to complete the survey.  
“That way, we can identify some patterns and get a good picture of the market place.  
“We will then feed the findings into public health policy through primary care trusts.”  
Some of the volunteers will be invited to take part in a second stage of research, which will involve 
focus groups ranking programmes.  
Anyone interested is asked to send their name and address, including their postcode, either by 
emailing cwl.orbresearchgroup@durham.ac.uk, calling 0191-334- 0820 or by writing to R-Weight, 
Obesity Related Behaviours Research Group, School of Medicine and Health, Durham University, 
Queens Campus, Wolfson Research Institute, Stockton-on-Tees, TS17 6BH. 
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Teessiders wanted for Durham University student’s weight loss 
products survey 
Nov 18 2010 by Sarah Judd, Evening Gazette  
 
A GROUNDBREAKING study into the use of commercial weight loss products like meal 
supplement shakes and diet clubs is to take place on Teesside. 
Volunteers are being sought for the research by Durham University PhD student Alisha Crayton, 
who is based at the Wolfson Research Institute on Stockton Riverside. 
The research will form part of an international project to identify the effectiveness of products for 
consumers, while informing local health authorities - who could potentially offer them on the NHS - 
on the best weight loss methods available. 
Alisha, who is carrying out the study alongside Durham University professor Carolyn Summerbell, 
believes local health trusts could benefit financially compared with the cost of treating obesity-
related conditions. 
Alisha was previously involved with the Evening Gazette’s Get a Better Life Campaign, to 
encourage people across Teesside to improve eating and exercise habits, in conjunction with 
Teesside University and NHS Middlesbrough. 
She said: “At the moment, we don’t really know why some people choose commercial weight loss 
products. We want to get an idea of what products and services are being chosen on Teesside and 
what benefits people here see. In future, it could be that we put it to the Primary Care Trusts 
(PCTs) to say, ‘these products and services are being used, what do you think?’” 
The research, entitled R-Weight, is expected to be published across the world. 
It takes the form of a simple survey. 
Anybody who has used a commercial weight loss product or service in the past 12 months and is 
over 16 can take part by calling 0191 3340820, emailing cwl.orbresearchgroup@durham.ac.uk 
or writing to R-Weight, ORB research group, Durham University, School of Medicine and Health, 
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Queen’s Campus, Wolfson Research Institute - E106, TS17 6BH, including a name, address and 
postcode. 
 
 
Read More http://www.gazettelive.co.uk/news/teesside-news/2010/11/18/teessiders-wanted-for-
durham-university-student-s-weight-loss-products-survey-84229-27670980/#ixzz1iU1LLKW9 
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Dieters wanted for uni study  
RESEARCHERS are still recruiting dieters for a groundbreaking study into commercial weight loss 
products. 
PhD student Alisha Crayton, based at Durham University’s Wolfson Research Institute at Stockton 
Riverside, is analysing everything from meal supplement shakes to diet clubs. To take part, contact 
the research team with your name, address and postcode by email at 
cwl.orbresearchgroup@durham.ac.uk, telephone 0191 334 0820, or by writing to R-Weight, 
Obesity Related Behaviours Research Group, School of Medicine and Health, Durham University- 
Queens Campus, Wolfson Research Institute - E106, Stockton-on-Tees, TS17 6BH. 
 
 
Read More http://www.gazettelive.co.uk/gazette-communities/ts17-ingleby-barwick-and-
thornaby/ts17-ingleby-barwick-and-thornaby-news/2011/03/12/dieters-wanted-for-uni-study-84229-
28331104/#ixzz1iU1fN4F8 
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Useful contact details 
 
If you are concerned about weight loss, eating disorders, or any other health related issues, 
seek advice from your GP. Alternatively please see below for general advice and support 
groups. 
 
B-eat 
Beat is the leading UK charity for people with eating disorders and their families, providing 
helplines for adults and young people, online support and a UK-wide network of self-help 
groups to help people beat their eating disorder. 
Telephone: 0845 634 1414  Email: help@b-eat.co.uk 
 
Eating Disorders Carers Group for Teesside, Co. Durham and North Yorkshire 
Email goodwincath@googlemail.com 
 
Alliance Psychological Services 
Alliance Psychological Services is an independent provider of counselling and psychological 
solutions with a clinically proven record of delivering therapeutic and specialist services.  
Tel: (01642) 352747 
Fax: (01642) 614870 
Email: info@alliancepsychology.com  
 
Mind 
The largest Mental Health Charity in the UK with branches all over the UK offering various 
services and support. 
Website: http://www.mind.org.uk/  Telephone: 0845 766 0163 
 
Samaritans 
Samaritans provides confidential non-judgemental emotional support, 24 hours a day for people 
who are experiencing feelings of distress or despair, including those which could lead to suicide 
Telephone: 08457 90 90 90.  
ID Number: 
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Additional Information 
 
Please tick (✔) the questions that apply to you: 
 
Gender 
Male         Female   
 
 
Date of birth (day/month/year)         
 
Ethnicity - Which of the following best describes you? 
White       Black Caribbean       Black African       Bangladeshi        Black other         Asian other         
Chinese         Indian       Pakistani           
Other (please state)       
Occupation - Which of the following best describes you? 
Employed full-time       Full-time education        Employed part-time         Full-time carer
           Self-employed         Homemaker         Unemployed         Retired   
Other (please state)          
Marital status - Which of the following best describes you? 
Single         Living with parent(s)/Guardian(s)   Married        Divorced/separated                  
Co-habiting    
Other (please state)         
     
What is your highest level of educational achievement? 
Secondary School       BTEC/SCOTVEC         NVQ  HNC or HND        CSE       Degree        
GCSE       Postgraduate degree            AS or A Level   
Other (please state)          
What is your religion- Which of the following best describes you? 
 Judaism        Muslim       Sikh    Buddhism       Christianity       Roman Catholic        None  
Other (please state)         
Where do you buy the most of your bulk food shopping? (please state one answer only)  
            
ID Number: 
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Please indicate your choices by ticking (✔) the box(es) in the table below  
What commercial weight loss product(s) or/and service(s) have you used in the last 
twelve months?, how long did you use it/them for and, what was the approximate 
cost(s) of using this/these product(s) or services)? 
 1 day 1 
week 
1 
month 
3 
month 
6 
month 
1 
year 
Approximat
e Cost(s) 
Slimming World        
Weight 
Watchers 
       
Lighter Life        
Rosemary 
Connelly 
       
Diet Chef        
Tony Ferguson        
Alli        
Slim Fast        
Special K        
Lipobind        
Adios        
Weight Loss 
book(s) 
       
DVD(s)        
Magazine(s)        
Website(s)        
CD(s)        
 
Example: If you have only used Alli in the last twelve months for two weeks you would 
complete the survey as shown below: 
 1 day 1 week 1 
month 
3 
months 
6 
months 
1 year Cost 
Slimming 
World 
 
✔✔ 
    £32.95 
 
If you have used a commercial weight loss product or service that is not listed above, 
please complete the table below 
 
What commercial weight loss product or 
service have you used in the last twelve 
months? 
How long did you use the product or service 
for and, what was the approximate cost? 
  
  
  
ID Number: 
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If your GP has prescribed you with any commercial weight loss products or services in 
the last 12 months, please complete the table below 
 
What commercial weight loss product or 
service was prescribed? 
How long was the product or service 
prescribed for? 
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Participant Information Sheet 
 
What is R-Weight, and why are we doing it? 
R- Weight is a study that will find out how popular commercial weight loss products and 
services are in the Tees Valley area. The research team is conducting this study, as we do 
not know if commercial weight loss products and services are common, and if they are, has 
there been a preferred one in the last twelve months. This study is funded by Durham 
University, as part of a PhD researching commercial weight loss products and services. 
 
Who can take part? 
You can take part if you: 
(i) Have used a commercial weight loss product or service in the last twelve months 
And 
(ii) Live in the Tees Valley area (TS1-TS18) 
And 
(iii) Are 16 years old or over 
 
What are commercial weight loss products and services? 
Commercial weight loss products and/or services involve a one-off or continuous 
payment/subscription to lose weight.  
 
Examples include: 
• Weight loss programmes or clubs (Slimming World, Weight Watchers, Lighter Life, 
Rosemary Connelly, Diet Chef, Tony Ferguson etc) 
• Products (Alli, Slim Fast, Special K, Lipobind, Adios etc) 
• Other (Weight loss books, DVDs, magazines, websites, CDs etc) 
 
How do I take part? 
To take part in this study the research team would like you to complete a survey about 
commercial weight loss products and services that you have used in the last twelve 
months, and a consent form. We will also ask you to supply additional information (sex, 
date of birth, ethnicity, marital status, highest level of education achievement, religion and 
where you buy the most of your bulk food shopping). Additional information will give more 
answers, helping us to understand if this information may affect the reasons for choosing 
commercial weight loss products and services. After you have completed the survey, 
consent form and additional information please return in the pre-paid envelope. The survey 
will take approximately 20 minutes to complete. 
 
Do I have to take part? 
No. It is entirely up to you if you want to take part in this study after reading this information 
sheet. You can withdraw up to the 28th February 2011; you will not have to explain why. If 
you do wish to withdraw, contact Alisha Crayton (full contact details listed below) with your 
unique identification number (displayed in the top right-hand box).  
 
How do I consent? 
Your written consent will be required to participate in this study (see the consent form for 
details). Please read the enclosed consent form carefully then tick the Yes or No boxes and 
initial all boxes. If you have ticked any of the No boxes to questions 1-7, your data will be 
securely destroyed when received.  If you tick the No box to question 8, but tick the Yes 
boxes to questions 1-7 you will still be included in this survey. 
 
ID Number: 
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What will happen to the findings of this study? 
Findings from this study will be printed in scientific magazines and reports and will be 
presented at conferences both in the UK and abroad. Overall study results will be printed in 
the Evening Gazette. Information that you provide will not identify you. Results from this 
study will be submitted to Durham University for Alisha Crayton’s PhD thesis. If you wish to 
be given a report of this study, contact Alisha Crayton after October 2012. 
 
Will my data be kept confidential? 
All personal information that you provide will be kept confidential and anonymised with a 
unique identification number linked to your name. Your data will be kept in locked filling 
cabinets and password protected files at Durham University inline with the Data Protection 
Act (1998); this will not be shared with anyone who is not part of the research team. After 
the study has finished, data will be saved securely until the 1st June 2015, after this date, all 
data will be destroyed. Any information that you provide will be confidential. Exceptional 
circumstances could require us to reveal this information in a court of law. The research 
team will follow ethical and legal practice, protecting your identity and information from this 
study.  
 
How will this study benefit me? 
Participation in this research may not benefit you personally, though the research team 
would be grateful if you could take 20 minutes of your time for us to find out if commercial 
weight loss products and services have been popular in the last twelve months in the Tees 
Valley.  
 
Are there any risks to taking part? 
Taking part in this study is unlikely to affect you. If you are concerned about weight loss, 
eating disorders, or any other health related issues, seek advice from your GP.  General 
advice and support is enclosed on a separate ‘useful contact details’ sheet.  
 
Who has reviewed the study? 
This study was given a favourable ethical opinion by the School of Medicine and Health 
Ethics Committee at Durham University. 
 
Who should I contact if I have any concerns or questions? 
If you have any questions or concerns please contact Alisha Crayton (PhD student):  
Telephone: 0191 3340820 
Email: cwl.orbresearchgroup@durham.ac.uk 
Postal address:  
R- Weight 
Obesity Related Behaviours Research Group 
School of Medicine and Health 
Durham University- Queens Campus 
Wolfson Research Institute- E106 
Stockton-on-Tees 
TS17 6BH 
 
Alternatively contact Professor Carolyn Summerbell (Supervisor): 
Postal address: Obesity Related Behaviours Research Group 
School of Medicine and Health 
Durham University- Queens Campus 
Wolfson Research Institute- E106 
Stockton-on-Tees 
TS17 6BH 
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If you wish to take part in the study, please keep a copy of the participant information, and 
useful contact details sheets for your personal use 
 
Thank you for taking the time to read the participant information sheet 
 
Appendix 8: Survey; covering letter 
280 
 
 
 
 
Alisha Crayton  
R- Weight 
Obesity Related Behaviours Research Group (ORB)  
School of Medicine and Health  
Durham University-Queens Campus  
Wolfson Research Institute- E106 
TS17 6BH  
Email: cwl.orbresearchgroup@durham.ac.uk 
Telephone: 01913340820  
Dear Sir/Madam, 
Thank you for registering your interest in this study. For your convenience, a 
participant information sheet has been provided. 
 
If you wish to participate after carefully reading the participant information sheet 
please complete the survey, consent form, and additional information sheet, 
and return to the researcher (Alisha Crayton) in the pre-paid envelope before 
the date stated in the top left-hand box. Documents returned after this date will 
be securely destroyed when received: 
 
The study will take approximately 20 minutes of your time. This study is 
voluntary, it is your decision to decline or participate. All personal information 
that you provide will be kept confidential and anonymised with a unique 
identification number linked to your name. Your data will be kept in locked filling 
cabinets and password protected files at Durham University in accordance with 
the Data Protection Act (1998); which will not be shared with anyone who is not 
part of the research team. After the study has finished, data will be securely 
saved until the 1st June 2015, after this date, all data will be destroyed. 
 
 
 
 
Thank you for taking the time to read this information. 
 
Alisha Crayton (PhD Student)  Professor Carolyn Summerbell 
(Supervisor) 
 
 
 
ID Number: 
Return before: 
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1000 Tees Valley participants required for commercial weight loss survey 
 
 
Volunteers in the North East are being invited to take part in a study about their experiences 
and use of commercial weight loss products and services in the past twelve months. 
 
This study is being conducted by Alisha Crayton and Professor Carolyn Summerbell at 
Durham University, Queen’s Campus. Research is important in providing more information 
that will help shape public health policy and practice. 
 
Alisha explains that “the study is being conducted to provide additional information about the 
popularity of commercial weight loss methods in the region, and whether these options could 
be seen as a more cost effective treatment method for Primary Care Trust’s than current 
provisions”. 
  
 
“Commercial weight loss products and/or services involve a one-off or continuous 
payment/subscription to lose weight. For example; Slimming World, Weight Watchers, Lighter 
Life, Rosemary Connelly, Diet Chef, Tony Ferguson, Alli, Slim Fast, Special K, Lipobind, Adios 
,Weight loss books, DVDs, magazines, websites, CDs etc. This survey will require a similar 
amount of participants as the Get a Better Life Campaign, ideally 1000. Only one percent of 
people who read the Evening Gazette would reach this number. I am confident that  
people in the North East will provide much needed assistance to this research, as they did for 
the Get a Better Life Campaign.” explains Alisha. 
 
Alisha was one of the research team involved with the Get a Better Life Campaign, 
encouraging Teesside adults to make one dietary and one physical activity pledge, in 
partnership with Evening Gazette, Teesside University and NHS Middlesbrough. The Get a 
Better Life Campaign recruited over 1000 people to make healthy lifestyle changes.  
 
 
This research will involve a survey about commercial weight loss products and services that 
have been used in the last twelve months, and a consent form. The researchers also ask for 
additional information (sex, date of birth, ethnicity, marital status, highest level of education 
achievement, religion and where the majority of food items are bought). Additional information 
will give more answers, helping the researchers to understand if this information may affect the 
reasons for choosing commercial weight loss products and services. 
 
 
Participants who live in County Durham, Northumberland, Teesside, Tyne and Wear and parts 
of North Yorkshire, who have used a commercial weight loss product or service in the past 12 
months and are over 16 can take part by providing a name, address, postcode and contact 
telephone number via calling 0191 3340820, emailing 
cwl.orbresearchgroup@durham.ac.uk or writing to R-Weight, ORB research group, Durham 
University, School of Medicine and Health, Queen’s Campus, Wolfson Research Institute - 
E106, TS17 6BH. 
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Researchers at Durham University would like to know how popular commercial weight loss 
products and services are in County Durham, Northumberland, Tees Valley, and Tyne and 
Wear.  
At least 1000 volunteers are required to complete a 20 minute postal survey about commercial 
weight loss products and services purchased within the last twelve months. 
The research team at Durham University, Queen’s Campus, are conducting this study, as it is 
not known if commercial weight loss products and services are common, which is the most 
popular, and the average cost spent. Researchers will feed the findings into public health policy, 
informing Primary Care Trusts about alternative cost effective methods of weight loss. 
 
Who can take part? 
You can take part if you: 
(i) Have used a commercial weight loss product or service in the last twelve months And 
(ii) Live in County Durham, Northumberland, Tees Valley or  Tyne and Wear And (iii) Are 16 
years old or over 
 
What are commercial weight loss products and services? 
Commercial weight loss products and/or services involve a one-off or continuous 
payment/subscription to lose weight.  
Examples include: 
• Weight loss programmes or clubs (Slimming World, Weight Watchers, Lighter Life, 
Rosemary Connelly, Diet Chef, Tony Ferguson etc) 
• Products (Alli, Slim Fast, Special K, Lipobind, Adios etc) 
• Other (Weight loss books, DVDs, magazines, websites, CDs etc) 
 
If you are interested in taking part in this study, please send your name and address, including 
your postcode, and contact telephone number*,  either by emailing 
cwl.orbresearchgroup@durham.ac.uk, calling 0191-334- 0820 or by writing to R-Weight, 
Obesity Related Behaviours Research Group, School of Medicine and Health, Durham 
University, Queens Campus, Wolfson Research Institute, Stockton-on-Tees, TS17 6BH 
*Details required are only needed to post the survey to you, these details will not be used for 
analysis. All personal information that you provide will be kept confidential and anonymised with 
a unique identification number linked to your name. Your data will be kept in locked filling 
cabinets and password protected files at Durham University in line with the Data Protection Act 
(1998); this will not be shared with anyone who is not part of the research team. After the study 
has finished, data will be saved securely until the 1st June 2015, after this date, all data will be 
destroyed. 
 
 
  
Volunteers required for a regional commercial 
weight loss survey 
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• Consent forms, take information sheet 
 
Hi everyone I’d firstly like to thank you for attending today. If we could all introduce ourselves 
would be great. I’m Alisha, Alisha Crayton.  The research that you are involved in is about 
commercial weight loss for my PhD thesis, you have all taken part in the survey.  I will be 
conducting other focus groups like this one over the next month with other survey participants, 
just to make sure that we are capturing as many viewpoints about the reasons for buying 
commercial weight loss products and services as possible. 
 
Everyone who is here today has used one or more methods of commercial weight loss in the 
last twelve months, so everyone has a shared experience. By commercial weight loss I mean 
products and services that have been paid for to help you lose weight. Everything that is said 
here today is confidential, so if I could ask everyone to keep our discussions within these four 
walls would be appreciated. 
 
As you might of gathered from the information sheets that have been sent to you previously, this 
research is not affiliated by commercial weight loss companies. So this is not a test, there are 
no right or wrong answers, as you would normally do, please respect peoples opinions, 
and we will hear everyone’s views today.  
 
Our aim is to find out why you have chosen commercial weight loss products and 
services, and why you chose these over other commercial weight loss services and 
products. Weight loss is an important health concern for the NHS, and we’ll inform them 
about what is said today, to help them develop better services for people who want to 
lose weight. 
 
Briefly, we will talk about diet and exercise, weight loss and commercial weight loss.  
 
Just a couple of quick house keeping rules, the toilets are out of the door and to the right and 
the nearest fire exit is just opposite this door, whereby we would take the stairs, and at the 
bottom turn right if there is an evacuation. 
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Does anyone have any questions so far?. Ok, so without further adieu we will begin. 
 
Questions 
 
Diet/physical activity 
• Thinking back to before using a commercial weight loss products or service, what were 
your views on diet and physical activity? 
• Has your opinion about diet and physical activity changed at all since using a 
commercial weight loss product or service? 
Government 
• With regards to diet and exercise has anyone seen the NHS/Government guidelines 
about physical activity and diet?, 
 If yes, what was your opinions of them/, were they difficult or easy to 
understand? 
  If No, can anyone briefly talk about what they think is the amount of 
exercise required to stay fit and healthy on a weekly and/or daily 
basis?, and a quick summary about what is considered to be a healthy 
diet?.  
We all know if we reduce the amount we eat and exercise a little more, we will lose weight. 
 
Weight loss 
 So, has anyone tried any other weight loss options before paying to lose weight through 
a commercial intervention? 
  If yes, can you share with the group the impact it had on you 
socially/emotionally/physically?.  
 If, no-Ok we’ll move onto the subject at hand, commercial weight loss 
 
Moving nicely on, we’ve talked about weight loss, but not the reasons for choosing commercial 
weight loss. 
 
Commercial weight loss-reasons 
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• Does anyone feel that they can share their commercial weight loss experiences with the 
group? 
 For example, why you chose a commercial weight loss method?, was 
there anything in particular that attracted you to it? 
 Did you have any reasons for choosing these commercial weight loss 
products and services over other commercial weight loss products and 
services?  
 
There appears to be quite a few reasons why commercial weight loss has been chosen,  
Experiences 
• Would anyone like to share their experiences of using a commercial weight loss 
method?  
o For example did it have any impact on you physically/emotionally/socially?  
o Positive and negative  
 
Thinking about experiences  
GP 
• Has anyone been to the doctor to talk about weight loss options?,  
o What experience did you have?  
o Was the doctor helpful/or not? 
 
Linking on from the GP, to the NHS and the GP 
 
NHS-GP 
• Hypothetically if commercial weight loss options were available for 8 or 12 weeks for 
free on the NHS, do you think you would have visited the GP to talk about weight loss?. 
If your GP were to offer you a commercial weight loss method, how do you think you 
would respond? 
 
With commercial weight loss it appears that it can be done with others, or on your own. 
Family/friends 
• Support wise, did anyone feel able that they could tell their friends and family?  
 What was their initial reactions? 
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Stereotypes 
• Just to round up, do you think that there is a stereotype of a typical person who would 
use commercial weight loss products and services? 
 
Thank you all for attending, your input is greatly appreciated. 
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Consent Form 
Please read the following consent form carefully then tick the Yes or No boxes and initial all boxes. If you 
have ticked any of the No boxes to questions 1-7, your data will be securely destroyed.  
 
 
 
  
 
  
  
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
--------------------------------------  --------------------  --------------- 
Name of Participant (please print)   Date   Signature 
--------------------------------------  --------------------  ---------------------- 
Name of Researcher (please print)   Date   Signature 
--------------------------------------  --------------------  --------------------- 
 
   Yes     No Initial 
1. I confirm that I have read and understood the participant 
information sheet for this study (version 4.0) and am 
aware of what it will involve.  
2. I have had the opportunity to ask questions and have been 
provided with sufficient answers. 
3. I understand that my participation is voluntary and that I 
can withdraw from the research at any point before 15th 
October 2011 when data analysis will be complete. I am 
aware that if I choose to withdraw I will not be required to 
give a reason. 
4. I am 16 years of age or older 
5. I am aware that my participation in the group discussion 
will be audio-recorded for data analysis purposes. 
6. I understand that the information that I provide will be kept 
confidential and anonymised with an identification number 
linked to my name, kept in locked filing cabinets and 
password protected files on computers at Durham 
University in accordance with the Data Protection Act 
(1998). My anonymous information will not be shared with 
anyone who is not part of the research team. After the Q-
Weight study has finished, data will be securely saved 
until the 1st June 2015, after this date, all data will be 
destroyed. 
7. I agree to take part in this study. 
8. I agree to be contacted to discuss my willingness to 
participate in the next stages of the overall study. 
9. I wish to be sent a copy of the final results in the post after 
October 2012. 
 
ID Number: 
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Registration of interest form 
 
Name: …………………………………………………………………………………………………. 
 
Contact telephone number: ……………………………………………………………………….. 
 
If you are interested in taking part in the Q-Weight study, please complete the information below 
and return in the pre-paid envelope.  
Suitable day/s and time/s available (please ✔) 
Monday  
7-8pm 
Wednesday 
2-3pm 
Friday 
10-11am 
   
 
If the above days and times are not suitable, please specify a suitable date/day and time that is 
suitable 
………………………………………………………………………………………………………………
…………….. 
Suitable location/s (please ✔) 
Durham 
University- 
Queens 
Campus; 
Stockton 
Durham 
University 
Durham 
Teesside 
University 
   
 
If the above location’s are not suitable, please specify a suitable location 
………………………………………………………………………………………………………………
…………….. 
 
Please complete the registration of interest form, and return in the pre-paid envelope 
before the 15th October 2011 
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Participant Information Sheet 
 
What is Q-Weight study, are why are we doing it? 
Q-Weight is a study that will find out what are the reasons of 16 year olds and over in 
County Durham, Northumberland, Tees Valley or  Tyne and Wear for choosing 
commercial weight loss products or services within the last twelve months. This study 
is funded by Durham University, as part of a PhD researching commercial weight loss 
products and services. This is one stage of the full Q-Weight study; stage two involves 
a focus group discussion and stage three will involve a ranking exercise of statements 
related to commercial weight loss.  All stages will take approximately 30 minutes. 
 
Who can take part? 
You can take part if you: 
(i) Have used a commercial weight loss product or service in the last twelve 
months 
And 
(ii) Live in County Durham, Northumberland, Tees Valley or  Tyne and Wear 
And 
(iii) Are 16 years old or over 
 
What are commercial weight loss products and services? 
Commercial weight loss products and/or services involve a one-off or continuous 
payment/subscription to lose weight.  
 
Examples include: 
• Weight loss programmes or clubs (Slimming World, Weight Watchers, Lighter 
Life, Rosemary Connelly, Diet Chef, Tony Ferguson etc) 
• Products (Alli, Slim Fast, Special K, Lipobind, Adios etc) 
• Other (Weight loss books, DVDs, magazines, websites, CDs etc) 
 
How do I take part? 
You have been invited to take part in a group discussion with other people who have 
also used commercial weight loss products and/or services within the last twelve 
months. The group discussion will take place at a convenient time for all participants in 
the group at various suitable locations. The group will consist of 6-10 participants, 
taking approximately 30 minutes. You will be asked informal questions about your 
experiences of commercial weight loss methods, weight loss and issues surrounding 
obesity. Group discussions will be recorded on an audio device (Dictaphone). If you 
wish to take part, please complete the registration of interest slip, and in the pre-
paid envelope. 
 
Do I have to take part? 
No. It is entirely up to you if you want to take part in this study after reading this 
information sheet. You can withdraw up to the 15th October 2011; you will not have to 
explain why. If you do wish to withdraw, contact Alisha Crayton (full contact details 
listed below) with your unique identification number (displayed in the top right-hand 
box).  
 
Will my travel costs be reimbursed? 
ID Number: 
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Yes. Second class rail fare, standard bus fare or mileage costs. 
 
How do I consent? 
Your written consent will be required before the group discussion starts; you will have 
the opportunity to ask the researcher about any concerns or questions that you have 
about the study and your participation.  
 
What will happen to the data? 
The group discussion will be transcribed (excluding identifiable details), creating 
statements from key quotes about the different reasons of choice for choosing 
commercial weight loss products and/or services. These anonymous statements will 
not identify you; they will be used at the later stages of the Q-Weight study. Findings 
from this study will be printed in scientific magazines and reports and will be presented 
at conferences both in the UK and abroad. Overall study results will be printed in the 
Evening Gazette. Information that you provide will not identify you. Results from this 
study will be submitted to Durham University for Alisha Crayton’s PhD thesis.  
 
Will my data be kept confidential? 
All personal information that you provide will be kept confidential and anonymised with 
a unique identification number linked to your name. Your data will be kept in locked 
filling cabinets and password protected files at Durham University inline with the Data 
Protection Act (1998); this will not be shared with anyone who is not part of the 
research team. After the study has finished, data will be saved securely until the 1st 
June 2015, after this date, all data will be destroyed. Any information that you provide 
will be confidential. Exceptional circumstances could require us to reveal this 
information in a court of law. The research team will follow ethical and legal practice, 
protecting your identity and information from this study.  
 
How will this study benefit me? 
Participation in this research may not benefit you personally; the group discussion will 
inform the next stages of the Q- Weight Study.   
 
Are there any risks to taking part? 
Taking part in this study is unlikely to affect you. If you are concerned about weight 
loss, eating disorders, or any other health related issues, seek advice from your GP.  
General advice and support is enclosed on a separate ‘useful contact details’ sheet.  
 
Who has reviewed the study? 
This study was given a favourable ethical opinion by the School of Medicine and Health 
Ethics Committee at Durham University. 
 
Who should I contact if I have any concerns or questions? 
If you have any questions or concerns please contact Alisha Crayton (PhD student):  
Telephone: 0191 3340820 
Email: cwl.orbresearchgroup@durham.ac.uk 
Postal address:  
Q- Weight 
School of Medicine and Health  
Durham University-Queens Campus  
Holliday Building-A100 
TS17 6BH 
 
Alternatively contact Professor Carolyn Summerbell (Supervisor): 
Postal address: Obesity Related Behaviours Research Group 
School of Medicine and Health 
Durham University- Queens Campus 
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Wolfson Research Institute- E106 
Stockton-on-Tees 
TS17 6BH 
 
If you wish to take part in the study, please keep a copy of the participant information 
sheet for your personal use 
 
   
Thank you for taking the time to read the participant information sheet 
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                               Consent Form 
 
Please read the following consent form carefully then tick the Yes or No boxes 
and initial all boxes. If you have ticked any of the No boxes to questions 1-7, 
your data will be securely destroyed.  
 
 
 
  
 
  
  
 
 
  
 
 
 
  
 
 
 
 
--------------------------------------  --------------------  ---------------- 
Name of Participant (please print)   Date    Signature 
--------------------------------------  --------------------  ---------------- 
Name of Researcher (please print)  Date    Signature 
   Yes     No Initial 
1. I confirm that I have read and understood the participant 
information sheet for this study (version 4.0) and am aware of 
what it will involve.  
2. I have had the opportunity to ask questions and have been 
provided with sufficient answers. 
3. I understand that my participation is voluntary and that I can 
withdraw from the research at any point before 11 March 2012 
when data analysis will be complete. I am aware that if I 
choose to withdraw I will not be required to give a reason. 
4. I am 16 years of age or older 
5. I am aware that my participation in the group discussion will be 
audio-recorded for data analysis purposes. 
6. I understand that the information that I provide will be kept 
confidential and anonymised with an identification number 
linked to my name, kept in locked filing cabinets and password 
protected files on computers at Durham University in 
accordance with the Data Protection Act (1998). My 
anonymous information will not be shared with anyone who is 
not part of the research team. After the Q-Weight study has 
finished, data will be securely saved until the 1st June 2015, 
after this date, all data will be destroyed. 
7. I agree to take part in this study. 
8. I agree to be contacted to discuss my willingness to participate 
in the next stages of the overall study. 
9. I wish to be sent a copy of the final results in the post after 
October 2012. 
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Participant Information Sheet 
What is the Q-Weight study, and why are we doing it? 
Q-Weight is a study that will find out what are the reasons of 16 year olds and over in 
the Tees Valley choosing commercial weight loss products or services within the last 
twelve months. This study is funded by Durham University, as part of a PhD 
researching commercial weight loss products and services. This is one stage of the full 
Q-Weight study; your participation will only be required for this stage. 
 
Who can take part? 
You can take part if you: 
(i) Have used a commercial weight loss product or service in the last twelve 
months 
And 
(ii) Live in the Tees Valley area (TS1-TS18) 
And 
(iii) Are 16 years old or over 
 
What are commercial weight loss products and services? 
Commercial weight loss products and/or services involve a one-off or continuous 
payment/subscription to lose weight.  
 
Examples include: 
• Weight loss programmes or clubs (Slimming World, Weight Watchers, Lighter 
Life, Rosemary Connelly, Diet Chef, Tony Ferguson etc) 
• Products (Alli, Slim Fast, Special K, Lipobind, Adios etc) 
• Other (Weight loss books, DVDs, magazines, websites, CDs etc) 
 
How do I take part? 
You have been invited to take part in a group discussion with other people who have 
also used commercial weight loss products and/or services within the last twelve 
months. The group discussion will take place at a convenient time and location for all 
people in the group (4-6 participants); this will take approximately 30 minutes. Each 
member of the group will be given a set of statements about the reasons for choosing 
commercial weight loss products and/or services, each statement will be printed on 
9x5cm cards. You will be asked to look through the statements, roughly sorting them 
into agree, disagree and neutral/not relevant piles. The group will be asked if the 
statements are easy to understand, and if they feel that there are any missing 
statements about the reasons for choosing commercial weight loss products and 
services. Group discussions will be recorded on an audio device (Dictaphone). If you 
wish to take part, please complete the registration of interest form and return in 
the pre-paid envelope. 
 
Do I have to take part? 
No. It is entirely up to you if you want to take part in this study after reading this 
information sheet. You can withdraw up to the 1st May 2011; you will not have to 
explain why. If you do wish to withdraw, contact Alisha Crayton (full contact details 
listed below) with your unique identification number (displayed in the top right-hand 
box).  
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Appendix 18: Q-Methodology pilot study information sheet 
320 
 
How do I consent? 
Your written consent will be required before the group discussion starts; you will have 
the opportunity to ask the researcher about any concerns or questions that you have 
about the study and your participation. You will carefully then tick the Yes or No boxes 
and, initial all boxes on the consent form. If you have ticked any of the No boxes to 
questions 1-7, your data will be securely destroyed.   
 
What will happen to the data? 
The research team will make any suggested changes about the statements before the 
fifth stage of the Q-Weight study. Your participation is only required for this stage. 
Findings from this study will be printed in scientific magazines and reports and will be 
presented at conferences both in the UK and abroad. Overall study results will be 
printed in the Evening Gazette. Information that you provide will not identify you. 
Results from this study will be submitted to Durham University for Alisha Crayton’s PhD 
thesis. If you wish to be given a report of this study, contact Alisha Crayton after 
October 2012. 
 
Will taking part be kept confidential? 
All personal information that you provide will be kept confidential and anonymised with 
a unique identification number linked to your name. Your data will be kept in locked 
filling cabinets and password protected files at Durham University inline with the Data 
Protection Act (1998); this will not be shared with anyone who is not part of the 
research team. After the study has finished, data will be saved securely until the 1st 
June 2015, after this date, all data will be destroyed. Any information that you provide 
will be confidential. Exceptional circumstances could require us to reveal this 
information in a court of law. The research team will follow ethical and legal practice, 
protecting your identity and information from this study.  
 
How will this study benefit me? 
Participation in this research may not benefit you personally; the group discussion will 
inform the next stage of the Q- Weight Study. Your participation is only required for this 
stage. 
 
Are there any risks to taking part? 
Taking part in this study is unlikely to affect you. If you are concerned about weight 
loss, eating disorders, or any other health related issues, seek advice from your GP.  
General advice and support is enclosed on a separate ‘useful contact details’ sheet.  
 
Who has reviewed the study? 
This study was given a favourable ethical opinion by the School of Medicine and Health 
Ethics Committee at Durham University. 
 
Who should I contact if I have any concerns or questions? 
If you have any questions or concerns please contact Alisha Crayton (PhD student):  
Telephone: 0191 3340820 
Email: cwl.orbresearchgroup@durham.ac.uk 
Postal address:  
Q- Weight 
Obesity Related Behaviours Research Group 
School of Medicine and Health 
Durham University- Queens Campus 
Wolfson Research Institute- E106 
Stockton-on-Tees 
TS17 6BH 
 
Alternatively contact Professor Carolyn Summerbell (Supervisor): 
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Postal address: Obesity Related Behaviours Research Group 
School of Medicine and Health 
Durham University- Queens Campus 
Wolfson Research Institute- E106 
Stockton-on-Tees 
TS17 6BH 
 
If you wish to take part in the study, please keep a copy of the participant information 
sheet for your personal use 
Thank you for taking the time to read the participant information sheet 
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Registration of interest form 
 
Name: 
…………………………………………………………………………………………………. 
Contact telephone number: 
……………………………………………………………………….. 
If you are interested in taking part in the Q-Weight study, please complete the 
information below and return in the pre-paid envelope.  
 
Suitable day/s and time/s available (please ✔) 
 Monday Tuesday Wednesday Thursday Friday 
9am      
10am      
11am      
12pm      
1pm      
2pm      
3pm      
4pm      
5pm      
6pm      
7pm      
 
Please complete the registration of interest form, and return in the pre-paid 
envelope before the date stated in the top left-hand box of the form 
ID Number: 
Return before: 
………………………. 
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Participant Information Sheet 
 
What is the Q-Weight study, and why are we doing it? 
Q-Weight is a study that will find out what are the reasons of 16 year olds and over in 
County Durham, Northumberland, Tees Valley or  Tyne and Wear for choosing 
commercial weight loss products or services within the last twelve months. This study 
is funded by Durham University, as part of a PhD researching commercial weight loss 
products and services. This is the final stage of the Q-Weight study. 
 
Who can take part? 
You can take part if you: 
(i) Have used a commercial weight loss product or service in the last twelve 
months 
And 
(ii) Live in County Durham, Northumberland, Tees Valley or  Tyne and Wear 
And 
(iii) Are 16 years old or over 
 
What are commercial weight loss products and services? 
Commercial weight loss products and/or services involve a one-off or continuous 
payment/subscription to lose weight.  
 
Examples include: 
• Weight loss programmes or clubs (Slimming World, Weight Watchers, Lighter 
Life, Rosemary Connelly, Diet Chef, Tony Ferguson etc) 
• Products (Alli, Slim Fast, Special K, Lipobind, Adios etc) 
• Other (Weight loss books, DVDs, magazines, websites, CDs etc)  
 
How do I take part? 
You have been invited to take part in an exercise where you will be given a set of cards 
(9x5cm) which contain statements about the reasons for choosing commercial weight 
loss products and/or services. You will be asked to look through the statements, then 
sort them into three piles: agree, disagree and neutral/not relevant.  You will be asked 
to take the statements in your agree pile and place them onto a sorting sheet (see 
figure 1) which shows how strongly you agree with each of the statements. You will 
then be asked to do the same for your disagree pile, placing them on the sorting sheet 
to show how strongly you disagree with each of the statements. Statements that were 
placed in the neutral/not-relevant pile will be placed in the remaining boxes on the 
sorting sheet. Please be aware that the exercise will be audio-recorded (sound only) 
and your participation will involve the researcher conducting an informal interview with 
you to explain your placement of the statements at opposite ends. The exercise will be 
conducted at a convenient time and location for you and will take approximately 30 
minutes.  If you wish to take part, please complete the registration of interest slip, 
and return in the pre-paid envelope. 
 
Do I have to take part? 
 No. It is entirely up to you if you want to take part in this study after reading this 
information sheet. You can withdraw up to the 1st December 2011; you will not have to 
explain why. If you do wish to withdraw, contact Alisha Crayton (full contact details 
listed below) with your unique identification number (displayed in the top right-hand 
box).  
ID Number: 
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Will my travel costs be reimbursed? 
Yes. Second class rail fare, standard bus fare or mileage costs. 
 
 
 
 
How do I consent? 
Your written consent will be required before the group discussion starts; you will have 
the opportunity to ask the researcher about any concerns or questions that you have 
about the study and your participation..   
 
What will happen to the data? 
Findings from this study will be printed in scientific magazines and reports and will be 
presented at conferences both in the UK and abroad. Overall study results will be 
printed in the Evening Gazette. Information that you provide will not identify you. 
Results from this study will be submitted to Durham University for Alisha Crayton’s PhD 
thesis.  
 
Will taking part be kept confidential? 
All personal information that you provide will be kept confidential and anonymised with 
a unique identification number linked to your name. Your data will be kept in locked 
filling cabinets and password protected files at Durham University inline with the Data 
Protection Act (1998); this will not be shared with anyone who is not part of the 
research team. After the study has finished, data will be saved securely until the 1st 
June 2015, after this date, all data will be destroyed. Any information that you provide 
will be confidential. Exceptional circumstances could require us to reveal this 
information in a court of law. The research team will follow ethical and legal practice, 
protecting your identity and information from this study.  
 
How will this study benefit me? 
Participation in this research may not benefit you personally; your participation will give 
a better understanding about the reasons why commercial weight loss products and 
services might be chosen.   
 
Are there any risks to taking part? 
Taking part in this study is unlikely to affect you. If you are concerned about weight 
loss, eating disorders, or any other health related issues, seek advice from your GP.  
General advice and support is enclosed on a separate ‘useful contact details’ sheet.  
 
Who has reviewed the study? 
This study was given a favourable ethical opinion by the School of Medicine and Health 
Ethics Committee at Durham University. 
 
Who should I contact if I have any concerns or questions? 
If you have any questions or concerns please contact Alisha Crayton (PhD student):  
Telephone: 0191 3340820 
Email: cwl.orbresearchgroup@durham.ac.uk 
Postal address:  
Q-Weight 
School of Medicine and Health  
Durham University-Queens Campus  
Holliday Building-A100 
TS17 6BH 
 
Alternatively contact Professor Carolyn Summerbell (Supervisor): 
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Postal address: Obesity Related Behaviours Research Group 
School of Medicine and Health 
Durham University- Queens Campus 
Wolfson Research Institute- E106 
Stockton-on-Tees 
TS17 6BH 
 
If you wish to take part in the study, please keep a copy of the participant information 
sheet for your personal use 
Thank you for taking the time to read the participant information sheet 
 
Appendix 21: Q-Methodology q-sort registration form 
326 
 
 
 
 
 
 
Registration of interest form 
 
Name: …………………………………………………………………………………………………. 
 
Contact telephone number: ……………………………………………………………………….. 
 
If you are interested in taking part in the Q-Weight study, please complete the information below 
and return in the pre-paid envelope.  
Suitable day/s and time/s available (please ✔) 
Monday  
7-8pm 
Wednesday 
2-3pm 
Friday 
10-11am 
   
 
If the above days and times are not suitable, please specify a suitable date/day and time that is 
suitable 
………………………………………………………………………………………………………………
…………….. 
Suitable location/s (please ✔) 
Durham 
University- 
Queens 
Campus; 
Stockton 
Durham 
University 
Durham 
Teesside 
University 
   
 
If the above location’s are not suitable, please specify a suitable location 
………………………………………………………………………………………………………………
…………….. 
 
Please complete the registration of interest form, and return in the pre-paid envelope 
before the 12th February 2012 
ID Number: 
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                               Consent Form 
 
Please read the following consent form carefully then tick the Yes or No boxes 
and initial all boxes. If you have ticked any of the No boxes to questions 1-7, 
your data will be securely destroyed.  
 
 
 
  
 
  
  
 
 
  
 
 
 
  
 
 
 
--------------------------------------  --------------------  ---------------- 
Name of Participant (please print)   Date    Signature 
--------------------------------------  --------------------  ---------------- 
Name of Researcher (please print)  Date    Signature 
   Yes     No Initial 
1. I confirm that I have read and understood the participant 
information sheet for this study (version 4.0) and am aware of 
what it will involve.  
2. I have had the opportunity to ask questions and have been 
provided with sufficient answers. 
3. I understand that my participation is voluntary and that I can 
withdraw from the research at any point before 1st May 2012 
when data analysis will be complete. I am aware that if I 
choose to withdraw I will not be required to give a reason. 
4. I am 16 years of age or older 
5. I am aware that my participation will be audio-recorded for data 
analysis purposes. 
6. I understand that the information that I provide will be kept 
confidential and anonymised with an identification number 
linked to my name, kept in locked filing cabinets and password 
protected files on computers at Durham University in 
accordance with the Data Protection Act (1998). My 
anonymous information will not be shared with anyone who is 
not part of the research team. After the Q-Weight study has 
finished, data will be securely saved until the 1st June 2015, 
after this date, all data will be destroyed. 
7. I agree to take part in this study. 
8. I wish to be sent a copy of the final results in the post after 
October 2012. 
ID Number: 
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1. 
 
I chose this CWLPS, as I wanted 
a better choice of clothes that I 
would be able to buy, in losing 
weight from this particular 
CWLPS. 
 
2. 
 
I chose this CWLPS, as I wanted 
to have fun during the process 
of losing weight. 
 
3. 
 
I chose this CWLPS as I wanted 
something where there was a 
consistent guide to weight loss 
that did not change, which I 
could get from this CWLPS. 
 
4. 
 
I chose this CWLPS, as I did not 
want to get to the stage 
whereby I would be needing 
weight-loss surgery.  
 
5. 
 
I chose this CWLPS, as it would 
allow me to go out for meals, 
which was important for me as I 
like the social side of eating. 
 
6. 
 
I chose this CWLPS, as I knew it 
would give me the support that 
I needed in assisting me to lose 
weight.  
 
7. 
 
I chose this CWLPS as it was of a 
case of all or nothing. 
 
8. 
 
I chose this particular CWLPS, as 
I wanted to know how many 
calories are in different foods, 
which was particularly 
important for me to 
understand.  
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9. 
 
I chose this CWLPS, as I wanted 
it to show me how to 
understand the health value in 
different foods. 
 
10. 
 
I chose this CWLPS, as it was 
particularly important for me to 
be with others in a group 
setting, which I could get from 
this CWLPS. 
 
11. 
 
I chose this CWLPS, as I wanted 
to be able to buy the products 
associated with this CWLPS 
(scales, books). 
 
12. 
 
I chose this CWLPS, as I wanted 
to buy the meals, and snacks 
provided by the commercial 
weight loss company that 
produces this CWLPS. 
 
13. 
 
I chose this CWLPS, as I was 
aware that it would provide me 
with the element of 
competition about weight-loss 
between others who were also 
using the same CWLPS as me. 
 
14. 
 
I chose this CWLPS, as I wanted 
to be able to compare my 
progress with others who were 
also using the same CWLPS as 
me. 
 
15. 
 
I chose this CWLPS based upon 
the endorsement from 
celebrities who had successfully 
tried it themselves. 
 
16. 
 
I did not chose this CWLPS 
based upon the endorsement 
from other people (group 
leaders and case studies of ‘real 
life’ people) who had 
successfully tried it themselves. 
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17. 
 
I chose to use this particular 
CWLPS because I could see 
celebrities who had been 
through the process themselves 
and could understand what I 
was going through. 
 
18. I chose to use this particular 
CWLPS because I could see 
other people (group leaders 
and case studies of ‘real life’ 
people) who had been through 
the process themselves, and 
could understand what I was 
going through. 
 
19. 
 
I chose this particular CWLPS, as 
I knew it would allow me to 
share hints, tips and 
experiences with others who 
were also using the same 
CWLPS as me.   
 
20. 
 
I chose this particular CWLPS as 
I thought it would encourage 
me to do new activities to help 
me lose weight (Great North 
Run, joining a gym). 
 
21. 
 
I chose this CWLPS as I wanted 
to be healthier - improving my 
appearance was not the main 
reason for choosing this 
particular CWLPS.  
 
22. 
 
I chose this CWLPS, as I was 
aware that it would not be a 
massive lifestyle change in 
following it. 
 
23. 
 
I chose this CWLPS as I had 
confidence in its results, 
because the CWLPS shows 
people who have lost three 
stone.  
 
24. 
 
I did not chose this CWLPS 
because of seeing 
advertisements which showed 
lots of people who have 
succeeded from this CWLPS. 
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25. 
 
I did not chose this CWLPS 
because of the cost. 
 
26. 
 
I chose this particular CWLPS, as 
I knew I would be able to 
identify with people in a similar 
position to me.  
 
27. 
 
I chose this CWLPS, as my GP 
was not helpful in providing any 
weight loss advice.  
 
28. 
 
I chose to pay for this CWLPS, 
as I knew that paying for it 
would motivate me into losing 
weight. 
 
29. 
 
I chose this CWLPS as I thought 
it would be more socially 
accepted amongst my peers.  
 
30. 
 
I chose this CWLPS as it was the 
last resort for me. 
 
31. 
 
I chose this CWLPS to educate 
me about what sorts of foods I 
was supposed to eat. 
 
32. 
 
I chose this CWLPS to support a 
friend or family member to lose 
weight.  
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33. 
 
I chose this CWLPS as I knew it 
would allow me to view weight-
loss as being a challenge, 
something that I wanted to 
conquer. 
 
34. 
 
I chose this CWLPS as losing 
weight was beneficial for my 
job. 
 
35. 
 
I chose this CWLPS, as I wanted 
the ‘pat on the back’ from 
someone telling me that I had 
lost weight.  
 
36. 
 
I chose this CWLPS, as I knew it 
would allow me to meet new 
people, and make new friends; 
which I wanted to do.  
 
37. 
 
I chose this CWLPS to educate 
me about what exercise I was 
supposed to do. 
 
38. 
 
I chose to pay for this CWLPS 
because it is my responsibility 
to lose weight. If I do mess up, I 
fail. 
 
39. 
 
I chose this CWLPS as someone 
suggested that I could do with 
losing some weight. 
 
40. 
 
I chose this CWLPS to lose 
weight for an event (wedding, 
holiday etc).  
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41. 
 
I chose this CWLPS because I 
saw it advertised (online, TV, 
newspaper, radio). 
 
42. 
 
I chose this CWLPS as I thought 
it would help me to give my 
family a healthier diet too.  
 
43. 
 
I chose this CWLPS as I could set 
my own realistic weight loss 
target to aim for.  
 
44. 
 
I chose this CWLPS as I wanted 
advice from people (group 
leaders and case studies of ‘real 
life’ people) to help me make 
better choices. 
 
45. 
 
I chose this CWLPS, as I wanted 
advice from celebrities to help 
me make better choices. 
 
46. 
 
I chose this CWLPS, as I wanted 
to understand why I overeat so 
that I could change my 
relationship with food.  
 
47. 
 
I chose this CWLPS as it would 
help me to maintain my weight 
loss.  
 
48. 
 
I chose this CWLPS based upon 
convenience. 
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49. 
 
I chose this CWLPS, as I did not 
want to try and lose weight 
with other people; I wanted to 
do it alone. 
 
50. 
 
I chose this CWLPS as it was 
gender specific (men only or 
women only). 
 
51. 
 
I chose this CWLPS, as I wanted 
to lose weight quickly. 
 
52. 
 
I chose this CWLPS, as I wanted 
the ‘coping/rebound’ advice 
after I came off the CWLPS. 
 
53. 
 
I chose this particular CWLPS 
because I hoped the counselling 
would help me get to the root 
cause of why I overeat. 
 
54. 
 
I chose this CWLPS, as I did not 
want to talk about food at all. 
 
55. 
 
I chose this CWLPS because of 
the short duration of the 
CWLPS. 
 
56. 
 
I chose this CWLPS, as it looked 
easy to follow. 
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57. 
 
I chose this CWLPS, as I wanted 
regular weigh-ins. 
 
58. 
 
I chose this CWLPS, as I wanted 
the meal replacements 
provided by this CWLPS (food 
packs, shakes etc). 
 
59. 
 
I chose this CWLPS, as I wanted 
the camaraderie from others 
who were also following the 
same CWLPS as me. 
 
60. 
 
I chose this CWLPS based upon 
the endorsement from friends 
who had successfully tried it 
themselves. 
 
-3 
5 statements 
below 
 
 
-2 
7 statements 
below 
 
 
-1 
7 statements 
below 
 
 
+4 
4 statements 
below 
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+5 
3 statements 
below 
 
 
0 
8 statements 
below 
 
 
-5 
3 statements 
below 
 
 
-4 
4 statements 
below 
 
 
+1 
7 statements 
below 
 
 
+2 
7 statements 
below 
 
 
+3 
5 statements 
below 
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PQMethod2.20               cwlps                                                                                 
PAGE   24 
Path and Project Name: c:/Program Files/pqm220win/pqmethod/cwlps                                                 
May 21 12 
 
Factor Q-Sort Values for Statements sorted by Consensus vs. Disagreement (Variance across Factor Z-Scores) 
 
                                                                             Factor Arrays 
 
No.  Statement                                                    No.        1      2      3 
  
 36  i chose this cs as i knew it would allow me to meet new peop  36       -4     -4     -3 
 39  i chose this cs as someone suggested that i could do with lo  39       -2     -2     -2 
 47  i chose this cs as it would help me to maintain my weight lo  47        3      4      4 
 24  i did not chose this cs bse of seeing advertisements which s  24        0      1      0 
  3  i chose this cs as i wnted something where there was a cnst    3        4      4      3 
 15  i chose this cs based upon the endorsement from celebrities   15       -4     -5     -5 
 23  i chose this cs as i had confidence in its results because t  23        2      1      2 
 37  i chose this cs to educate me about what exercise i was supp  37       -3     -3     -1 
 25  i did not chose this cs bse of the cost                       25        1      0      0 
 38  i chose to pay for this cs because it is my responsibility t  38        4      2      3 
 28  i chose to pay for this cs as i knew that paying for it woul  28        3      3      1 
 19  i chose the ptr cs as i knew it would allow me to share hint  19        1      1      2 
 32  i chose this cs to support a friend or family member to lose  32       -1     -3     -3 
  2  i chose this cs as i wanted to have fun during the process o   2        0     -2      0 
 26  i chose this ptr cs as i knew i would be able to identify wi  26        1      1      2 
 50  i chose this cs as it was gender specific (men only or women  50       -1     -4     -2 
 45  i chose this cs as i wanted advice from celebrities to help   45       -5     -3     -5 
 17  i chose to use this ptr cs because i cld see cts who had bee  17       -3     -4     -5 
  4  i chose this cs as i did not want to get to the stage whereb   4       -3     -1     -4 
 48  i chose this cs based upon convenience                        48        4      2      4 
 20  i chose this ptr cs as i thought it wld encourage me to do n  20        2      0      0 
 16  i did not chose this cs based upon the edt from other ple (g  16        0     -2     -2 
 14  i chose this cs as i wntd to be able to compare my pgs with   14       -1     -1      1 
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 34  i chose this cs as losing weight was beneficial for my job    34        0     -2     -4 
 13  i chose this cs as i was awe that it wld pve me with the emt  13       -2     -5     -2 
 56  i chose this cs as it looked easy to follow                   56        5      2      4 
  9  i chose this cs as i wntd it to show me how to understand th   9       -1      1      1 
 44  i chose this cs as i wanted advice from people (grp leaders   44        0      0      2 
 42  i chose this cs as i thought it would help me to give my fam  42        0     -3     -1 
 18  i chose this ptr cs bse i cld see other ple (grp lds & cs of  18        1      0      3 
  8  i chose this ptcr cs as i wntd to know how many cals are in    8       -1     -2      1 
  6  i chose this cs as i knew it would give me the support that    6        2      3      5 
 11  i chose this cs as i wntd to be able to buy the products ass  11        0     -1     -3 
 59  i chose this cs as i wanted the camaraderie from others who   59       -3      0      0 
 35  i chose this cs as i wanted the pat on the back from someone  35        0     -2      1 
 43  i chose this cs as i could set my own realistic weight loss   43        5      2      2 
 60  i chose this cs based upon the endorsement from friends who   60        4      3      0 
  1  i chose this cs as i wanted a better choice of clothes that    1        1      1      5 
 33  i chose this cs as i knew it would allow me to view wl as be  33        2      0      4 
 49  i chose this cs as i did not want to try and lose weight wit  49        1     -3     -2 
 41  i chose this cs because i saw it advertised (onlne,tv,newspa  41        2     -1     -3 
 40  i chose this cs to lose weight for an event (wedding,holiday  40        3      0     -1 
 29  i chose this cs as i thought it would be more socially accep  29       -2     -5     -1 
 54  i chose this cs as i did not want to talk about food at all   54       -3      1     -4 
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Bibliographic Details  
Study ID Anderson 1994b 
Author (first) Anderson JW, Brinkman-Kaplan, VL, Lee H, Wood CL. 
Journal  American College of Nutrition 
Year 1994b 
Volume 3 
Pages 256-261 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details 
James W. Anderson, MD, VA Medical Center, Cooper Drive Division (111C), Lexington, KY 40511 
 
Character of included studies  
Methods Controlled before and after 
Participants Exclusion criteria 
Authors do not report this 
Inclusion criteria 
BMI 40+ 
Interventions Number of study centres: Authors do not report this 
Country/location: US 
Setting: Authors do not report this 
Treatment before study Authors do not report this 
Titration period: Authors do not report this 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Authors do not state what the primary and secondary outcomes are. Outcome measures for weight, lipids and BP are 
listed. 
Primary outcome(s) 
Secondary outcome (s) 
Other outcome (s) 
Study details Run-in period: Authors do not report this 
Study terminated before regular end: Authors do not report this 
Publication details Language of publication:  English 
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Commercial funding: Authors do not report this 
Non-commercial funding: Authors do not report this 
Publication status (peer review journal): yes 
Publication status (journal supplement):  Authors do not report this 
Publication status (abstract): Authors do not report this 
Stated aim for study Quote “this study critically examined the relationships between weight loss and changes in serum lipid and blood 
pressure levels” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
High risk 
No randomisation 
Allocation concealment  (selection bias) High risk 
Authors do not report this  
Blinding (performance & detection bias) High risk 
Authors do not report this 
Blinding of participants and personnel 
(performance bias) 
High risk 
Authors do not report this 
Blinding of outcome assessment (detection 
bias) 
High risk  
Authors do not report this 
Incomplete outcome data (attrition bias) Low risk 
10 dropped out in-between 6 and 12 months, 2 additional participants dropped out at 18, and five additional 
participants dropped out at 24 months 
Selective reporting (reporting bias) Authors do not report this 
Other bias  
Comments  
 
Overview of study populations Anderson 1994b 
Number invited 80 participants in total 
Number screened Authors do not report this 
Number randomised Authors do not report this 
Number ITT Authors do not report this 
Number finishing the study 63 
(%) of randomised patients finishing study This was not an RCT 
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Description of interventions Anderson 1994b 
Intervention(s) [route, frequency, total 
dose/day] 
Control(s) [route, frequency, total dose/day] Participants were instructed to consume at least five packages of supplement, abstain from food, and drink 2L of non-alcoholic drinks per day. Two vitamin tablets were also taken. 
 
Baseline characteristics Anderson 1994b 
Number of intervention participants 
Number of control participants 
80 patients in total, not randomised 
Participating population 80 patients with a BMI above 40 
Sex [female %] 68.75% female 
Age [mean years (SD)] 42±1.5 females     44±2.0 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] 45.5±0.6 
Ethnic groups [%] Authors do not report this 
Duration of intervention [mean ... (SD)] 14 week core curriculum 
Duration of follow-up [mean ... (SD)] follow up data for  12, 18 and 24 months 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Anderson 1994b 
Intervention(s) Not an RCT. Authors do not report this 
Control (s) Not an RCT. Authors do not report this 
Primary endpoint(s) Authors do not specifically report  what the primary and secondary endpoints are, though BP and lipids are factored in 
the aim 
 
Weight 
93.9±2.4* 
BMI 
33.1±0.7* 
Cholesterol mmol/L 
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4.76±1.09 
                    Mg/dl 
184±4.2* 
LDL Cholesterol mmol/L 
3.15±0.098 
                    Mg/dl 
122±3.8* 
HDL Cholesterol mmol/L 
1.04±0.028 
                    Mg/dl 
40.2±1.1* 
LDL:HDL Cholesterol ratio 
3.21±0.13* 
Triglycerides  mmol/L 
1.35±0.078 
                    Mg/dl 
120±6.9* 
Systolic bp (mmHg) 
124±1.7* 
Diastolic bp (mmHg) 
81.4±0.8* 
 
 
Secondary endpoint(s) Authors do not report this 
Other endpoint(s) Authors do not report this 
Effect size 35.3kg was lost at 25.6 weeks.  
19.7 kg were maintained of their weigh loss at 2 year follow up. 
 
Cholesterol (15.1%), LDL cholesterol (17.0%), triglycerides (14.2%), systolic BP (8.8%) and diastolic BP (10.2%) 
decreased significantly. lipids and BP were significantly correlated with baselines values and change in BMI after 
adjustment for baselines values.  
 
Adverse events Anderson 1994b 
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All adverse events Authors do not report this 
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Bibliographic Details  
Study ID Truby 2006 
Author (first) Truby H, Baic S, deLooy A, Fox KR, Livingstone MBE, Logan CM, Macdonald, IA, Morgan, LM, Taylor, MA, Millward, 
DJ. 
Journal  BMJ 
Year 2008 
Volume Authors do not report this 
Pages 1-6 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper        See Morgan et al (2008) 
Corresponding author and contact details Authors do not report this. Email the author listed in the Morgan paper 
 
Character of included studies  
Methods 
Multicentre randomised unblended controlled trial. 
Participants Exclusion criteria 
Coronary heart disease; type 1 or type 2 diabetes; renal, liver, or respiratory failure; gout; obesity with known cause 
(Cushing’s disease, hypothyroidism); previous gastric or weight loss surgery; clinical depression; eating disorders; 
drug or alcohol misuse; any malabsorptive state (including lactose intolerance); taking lipid lowering or anti-
hypertensive drugs; taking any drugs (including orlistat and sibutramine) for weight loss; being treated for cancer; and 
being pregnant or breastfeeding. 
Inclusion criteria 
Participants were chosen from people who lived within 30 miles of a test centre, were aged between 18 and 65, and 
had a self reported body mass index between 27 and 40. 
Interventions Number of study centres: five 
Country/location:  UK 
Setting: community based 
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Treatment before study: Authors do not report this   
Titration period: Authors do not report this   
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
 
Main weight and body fat changes over six months  
 
Primary outcome(s) Authors do not report this. They state the main outcome measures were body fat and weight 
changes over six months   
Secondary outcome (s) Authors do not report this   
Other outcome (s) Authors do not report this   
Study details Run-in period: Authors do not report this   
Study terminated before regular end: Authors do not report this   
Publication details Language of publication: English 
Commercial funding: BBC 
Non-commercial funding: Authors do not report this   
Publication status (peer review journal): Yes 
Publication status (journal supplement): Authors do not report this   
Publication status (abstract): Authors do not report this   
Stated aim for study 
Quote “To compare the effectiveness of four commercial weight loss diets available to adults in the United Kingdom.” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
Low  
At each test centre, they stratified participants by sex and allocated them to a group using random number generation. 
Allocation concealment  (selection bias) High risk 
Authors do not report this   
Blinding (performance & detection bias) High risk 
Participants and staff were not blind, this is stated in the paper 
Blinding of participants and personnel 
(performance bias) 
High risk 
Authors do not report this   
Blinding of outcome assessment (detection 
bias) 
High risk 
Authors do not report this   
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Incomplete outcome data (attrition bias) Low  
83 dropped out 
Selective reporting (reporting bias) Authors do not report this   
Other bias  
Comments  
 
Overview of study populations Truby 2006 
Number invited 300 participants were contacted 
(number screened 300, 7 were excluded 
Number randomised 293 
Number ITT 292 (one was excluded due to pregnancy) 
 
The primary analysis was on an intention to treat basis, with baseline values carried forward to replace missing values 
(one participant was not used in this analysis as she withdrew because of pregnancy). 
(n) finishing study 
Intervention 
Control 
Total 
210 
 
158 at 12 months with return data 
(%) of randomised patients finishing study 
 
71.7% including control 
 
Description of interventions Truby 2006 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
Control(s) [route, frequency, total dose/day] 
For the group based programmes (weight Watchers and Rosemary Conley), participants attended the most 
convenient class and they reimbursed the costs of joining and attending one class each week. Both parent companies 
signed a contract committing to the provision of standard care. For Slim-Fast, they reimbursed the cost of up to two 
meal replacements each day and provided a copy of the Slim-Fast support pack. They gave participants in the Atkins 
group a copy of Dr Atkins’ New Diet Revolution. 
They asked the members of the control group to maintain their current diet and exercise pattern and offered them any 
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of the diets for six months at the end of study (free of charge). 
It doesn’t state if all participants or just those receiving a commercial programme (see below) 
Participants completed a seven day diet and activity diary at baseline, eight week, and 24 week. They gave no dietary 
or exercise advice so as not to compromise the study. When they analysed the food diaries at two months they found 
that some of the participants on the Atkins diet were not taking supplements of micronutrients as advised in the book. 
Therefore, from week 10 they offered free daily supplements of multivitamins. All participants who withdrew completed 
a short exit questionnaire. At 12 months, they recorded the weight and dieting behaviour from six to 12 months of all 
participants still willing to attend test centres. 
 
Baseline characteristics Truby 2006 
Number of intervention participants 
Number of control participants 
232 
61 
Participating population Participants who lived within 30 miles of a test centre, aged between 18 and 65, and had a self-reported body mass 
index between 27 and 40. 
Sex [female %] 73.7% Atkins   
72.4%weight watchers   
71.2% slim fast  
72.4% rosemary Connelly  
75.4% control 
Age [mean years (SD)] 40.9 (9.7)  Atkins   
39.9 (10.9)  weight watchers  
38.9 (10.7) slim fast  
40.6 (10.3)  rosemary Connelly   
40.8 (9.6) control 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] 31.9 (2.2) Atkins  31.2 (2.7)weight watchers  32.2 (3.0) slim fast  31.6 (2.6) rosemary Connelly 31.5 (2.9) control 
Ethnic groups [%] Authors do not report this 
Duration of intervention [mean ... (SD)] 24 weeks 
Duration of follow-up [mean ... (SD)] Authors do not report this 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
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Co-morbidities Authors do not report this 
 
Matrix of study endpoints Truby 2006 
Intervention(s) SD in brackets Atkins   weight watchers   slim fast   rosemary Connelly   control 
 
0-2 months 
Weight kg 
5.2 (4.4) 4.7 (3.2) 3.7 (3.5) 4.0 (3.3) 0.4 (1.8) 
Weight loss % 
5.5 (4.2) 5.1(3.5) 3.8 (3.4) 4.5 (3.6) 0.4 (2.2) 
Fat loss  
3.5† (3.0) 3.1 (2.4) 2.3† (2.3) 2.5 (2.1) 0.2 (1.3) 
Fat loss % 
1.9† (1.9) 1.6 (1.9) 1.0† (1.4) 1.5 (1.5) 0.1 (1.4) 
Reduction in waist circumference 
6.7 (6.1) 5.5 (5.1) 4.8 (4.6) 4.5 (5.3) 1.0 (4.0) 
 
 
2-6 month 
Weight kg 
1.3 (3.1) 2.2 (3.0) 1.4 (2.8) 2.4 (3.4) −0.9 (1.6) 
Weight loss % 
1.3 (3.1) 2.4 (3.4) 1.3 (2.9) 2.7 (3.7) −1.2 (1.9) 
Fat loss 
1.2 (2.3) 2.0 (2.3) 1.2 (2.6) 2.1 (2.5) −0.5 (1.2) 
Fat loss % 
1.3 (1.9) 2.0 (2.0) 1.2 (2.4) 2.1 (2.4) −0.0 (1.0) 
Reduction in waist circumference 
2.4 (4.0) 3.0 (3.5) 2.1 (3.4) 3.0 (4.2) −0.3 (2.4) 
 
 
0-6 months 
Weight loss 
6.0 (6.4) 6.6 (5.4) 4.8 (5.6) 6.3 (6.1) −0.6 (2.2) 
Weight loss % 
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6.2 (6.2) 7.3 (6.1) 4.9 (5.5) 7.0 (6.6) −0.6 (2.7) 
Fat loss kg 
4.6 (4.8) 5.0 (4.3) 3.4 (4.3) 4.5 (4.3) −0.3 (4.4) 
Fat loss % 
3.1 (3.3) 3.6 (3.3) 2.1 (2.9) 3.4 (3.5) 0.1 (1.6) 
Reduction in waist circumference 
8.1 (7.4) 8.3 (7.0) 6.4 (6.3) 7.2 (7.2) 0.8 (3.8) 
 
For all variables reported, the control group was significantly different from all other groups (P<0.001). 
*Not measured in all participants: 57 for Weight Watchers, 56 for Rosemary Conley, 60 for controls. 
†Pairwise comparison of group means with post hoc Tukey’s HSD (honestly significantly different) test found a 
significant difference between the Atkins and Slim-Fast groups 
 
 
0-2 months 
Fall in blood pressure systolic  
5.7* (12.7) 3.5 (9.6) 0.5* (11.4) 2.4 (11.2) 3.3 (11.0) 
Diastole 
3.6 (8.4) 4.1 (6.8) 3.1 (7.8) 2.8 (7.1) 2.0 (7.0) 0.61 
Fall in total glucose 
0.04 (0.4) 0.14 (0.5) 0.13 (0.5) 0.15 (0.5) 0.02 (0.4) 0.44 
Fall in cholesterol 
0.08 (0.7) 0.44* (0.6) 0.26* (0.6) 0.35* (0.8) 0.08 (0.5) 0.001 
 
2-6 months 
Fall in systolic blood pressure 
1.3 (9.8) 0.9 (10.3) 2.9 (12.4) 2.1 (9.2) −0.9 (8.3) 0.23 
Fall in diastolic blood pressure 
1.1 (6.3) 0.8 (6.7) −0.3 (8.6) 1.0 (5.5) −0.4 (5.7) 0.51  
Fall in total glucose 
0.13 (0.5) 0.29 (0.6) 0.12 (0.5) 0.17 (0.5) 0.13 (0.4) 0.34 
Fall in cholesterol 
0.19 (0.5) 0.11 (0.5) 0.07 (0.5) 0.08 (0.6) 0.24 (0.24) 0.24 
 
0-6 months 
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Systolic 7.2 (11.6) 4.1 (11.7) 2.7 (10.7) 4.5 (9.8) 2.8 (11.8) 0.19 
Diastolic 4.9 (8.1) 4.4 (8.6) 2.5 (8.6) 3.6 (6.0) 1.6 (7.4) 0.13 
Fall in total glucose 
0.19 (0.5) 0.46* (0.6) 0.19 (0.6) 0.27 (0.5) 0.14* (0.5) 0.013 
Fall in cholesterol 
0.29 (0.8) 0.55* (0.7) 0.35 (0.6) 0.5 (0.5) 0.5* (0.18) 0.013 
 
 
Control (s) See above for control data. 
Primary endpoint(s)  
Secondary endpoint(s)  
Other endpoint(s)  
Effect size 
All diets resulted in significant loss of body fat and weight over six months. Groups did not differ significantly but loss 
of body fat and weight was greater in all groups compared with the control group. In an intention to treat analysis, 
average weight loss was 5.9 kg and average fat loss was 4.4 kg over six months. The Atkins diet resulted in 
significantly higher weight loss during the first four weeks, but by the end was no more or less effective than the other 
diets. 
 
Adverse events Truby 2006 
All adverse events  Authors do not report this 
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Bibliographic Details  
Study ID Anderson 1991 
Author (first) Anderson JW, Hamilton, CC, Crown-Weber E, Riddlemoser M, Gustafson NJ. 
Journal  American Dietetic Association 
Year 1991 
Volume 1582(3) 
Pages Authors do not report this six pages in total 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details 
J.W. Anderson (corresponding author) is chief of the Metabolic and Endocrinology, Section VA Medical Center, 
Lexington, KY 40511. 
 
Character of included studies  
Methods  
Before and after study 
Participants 
Exclusion criteria 
Body weight less than 120% of desirable, recent surgery or myocardial infarction (< 6 weeks), unstable heart disease, 
pregnancy, lactation, severe psychological disturbance, alcohol abuse, or drug abuse. 
Inclusion criteria 
Authors do not report this 
Interventions Number of study centres: No study centre, Slim Fast or something similar was used, and does not require attending 
specific locations. 
Country/location: US 
Setting:  No study centre, Slim Fast or something similar was used, and does not require attending specific locations. 
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Treatment before study: Authors do not report this 
Titration period: Authors do not report this 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
 
Does not state the specific outcome measures. At the beginning of the weight loss phase, a complete blood chemistry, 
lipid profile, complete blood cell count, differential blood cell count, urinalysis, and 12-lead electrocardiogram (ECG) 
were obtained. Thereafter, a blood chemistry panel was obtained every 2 weeks, a complete blood cell count and 
serum high-density-lipoprotein (HDL) cholesterol value every 4 weeks, and a differential blood cell count every 8 
weeks. 
 
Primary outcome(s): Authors do not report this 
Secondary outcome (s): Authors do not report this 
Other outcome (s): Authors do not report this 
Study details Run-in period None reported 
Study terminated before regular end None reported 
Publication details Language of publication:  English 
Commercial funding: Authors do not report this 
Non-commercial funding: Authors do not report this 
Publication status (peer review journal):  yes 
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Publication status (journal supplement): Authors do not report this 
Publication status (abstract): Authors do not report this 
Stated aim for study 
Quote “  “ No specific aim stated. 
This study examined the safety and effectiveness of a VLCD regimen being followed by 100 subjects. 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
High  
Authors do not report this, all participants received the same product 
Allocation concealment  (selection bias) 
High 
Authors do not report this. A trained physician and nurse monitored weight, blood pressure, and changes in medical 
status weekly. 
Blinding (performance & detection bias) High 
None reported 
Blinding of participants and personnel 
(performance bias) 
High 
None reported 
Blinding of outcome assessment (detection 
bias) 
High 
None reported 
Incomplete outcome data (attrition bias) High 
None reported 
Selective reporting (reporting bias) High 
None reported 
Other bias None reported 
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Comments All received the same liquid supplement. However, participants were not told how much activity to do. Certain 
participants could have done more activity than others and could have altered the results. Participants were told not to 
eat anything else, however, as this was not monitored, they could have consumed additional food. 
 
Overview of study populations Anderson 1991 
Number invited Only one group 
After completing an initial medical and laboratory evaluation, individuals attended the first group session and entered 
the weight loss program. Patients were monitored weekly by trained physicians and nurses. Patients also attended 90-
minute group classes conducted by trained behavioural health educators. 
Number screened Authors do not state this 
Number randomised 100 subjects 
(n) ITT 
Intervention 
Control 
Total 
Authors do not state this 
Number finishing study 49 
(%) of randomised patients finishing study 
Intervention 
Control 
Total 
49% 
 
Description of interventions Anderson 1991 
Intervention(s) [route, frequency, total 
dose/day] 
Control(s) [route, frequency, total dose/day] Five chocolate or vanilla liquid supplements plus two vitamin-mineral tablets daily. 
There was no comparison group 
 
Baseline characteristics Anderson 1991 
Number of intervention participants 
Number of control participants 
100 in total, no comparison group 
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Participating population Authors do not report this. The report only states the exclusion criteria, not the participant characteristics 
Sex [female %] Authors do not report this 
Age [mean years (SD)] Authors do not report this 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] Authors do not report this 
Duration of disease [mean years (SD)] Authors do not report this 
Ethnic groups [%] Authors do not report this 
Duration of intervention [mean ... (SD)] Authors do not report this 
Duration of follow-up [mean ... (SD)] Authors do not report this 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
Co-morbidities 
When they entered the program, many patients had obesity-related diseases such as hypertension (n = 68), 
hypercholesterolemia (n = 28), degenerative joint disease (n = 21), hypertriglyceridemia (n = 15), and type II diabetes 
(n = 10). 
 
Matrix of study endpoints Anderson 1991 
Intervention(s) 
At the end of the weight loss period (when desired eight was achieved), female lost a mean of 19.2 kg, or 20%, of 
initial body weight in 17 weeks (range=1 to 39 week). Males lost a mean of 18.6 kg, or 16%, of initial body weight in 12 
weeks (range=1 to 22 weeks). 62 % of females and 69% of males had a non-obese body mass index 
(kg[m.sup.2]<30) by the end of the VLCD weight loss phase. 
Total serum cholesterol decreased a mean of 14% (P<.001) for both females and males during the weight loss phase. 
Final mean cholesterol values for females. 
Mean HDL-cholesterol levels decreased 17% (P<.001) for females and did not significantly change for males. Mean 
triglyceride values decreased 8% for females and 24% for males (P<.05). Fasting serum glucose values decreased a 
mean of 12% (P<.001) for females and 16% (P<.05) for males during the weight loss phase. Of the 10 patients (6 
females, 4 males) with type II diabetes, 5 patients had serum glucose decreases of 32% or more and 4 patients had 
decreases of 44% or more. 
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Mean systolic blood pressure decreased 12.5% (P<.001) for females and 11% (P<.001) for males during weight loss. 
Mean diastolic blood pressure decreased 9% (P<.001) for both females and males. Fifty-six patients who were initially 
taking antihypertensive/diuretic medications were able to discontinue them during the VLCD phase. 
Control (s) Authors do not report this. There is no comparison group. 
Primary endpoint(s)  
Secondary endpoint(s)  
Other endpoint(s)  
Effect size 
Of the 100 subjects, 49 stayed on the diet until reaching their desired weight. The average weight loss was 19.2 kg for 
females and 18.6 kg for males. At the end of the study period, 62 % of the females and 69 % of the males had body 
masses outside the obese range. At follow-up, females had maintained 36 % of the weight loss and males had 
maintained 39 % of the weight loss. 
 
Adverse events Anderson 1991 
 
Two patients required antigout medication, and 27 patients were started on iron supplements during the weight loss 
phase. 
Patients reported the following side effects at least once during the weight loss phase: fatigue (n-47), orthostatic 
dizziness (n=41), constipation (n=35), headaches (n=25), palpitations (n=7), hair loss (n=5), cold intolerance (n=5), 
irregular menses (n=4), and dry skin (n=1). 
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Bibliographic Details  
Study ID Anderson 1994a 
Author (first) Anderson JW, Brinkman-Kaplan V, Hamilton CC, Logan JE, Collins RW, Gustafson NJ. 
Journal  Diabetes Care 
Year 1994a 
Volume 17 (6) 
Pages 602-604 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Short report 
Corresponding author and contact details James W. Anderson, MD, VA Medical Center, 
Cooper Drive Division (111C), Lexington, KY 40511. 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
 
Participants Exclusion criteria 
If participants do not have the expressed inclusion criteria 
Inclusion criteria 
non-insulin-dependent diabetes mellitus of > 1-year duration, 40-70 years of age, BMI 30-40 kg/m2, serum creatinine 
levels ^176 /xM, serum cholesterol levels ^7.8 mM, serum triglycerides <22.6 mM, and no recent cardiovascular 
events. 
Diagnostic criteria 
Interventions Number of study centres: Authors do not report this. No particular study centre, this study researched Slim Fast (or 
something similar), which can be consumed anywhere 
Country/location: US 
Setting:  Authors do not report this No particular study centre, this study researched Slim Fast (or something similar), 
which can be consumed anywhere 
Treatment before study:  Authors do not report this 
Titration period: Authors do not report this 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
This study was designed to determine if food-containing hypocaloric diets are as effective as liquid-supplement diets in 
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promoting weight loss for obese individuals with non-insulin-dependent diabetes mellitus (NIDDM). 
Primary outcome(s) Authors do not report this Outcome measures are weight, BP, Serum glucose (mM) ,Glycosylated 
hemoglobin (%), Serum cholesterol (mM), Serum LDL cholesterol (mM), Serum HDL cholesterol (mM), Serum 
triglycerides (mM) 
Secondary outcome (s)  
Other outcome (s) 
Study details Run-in period: Authors do not report this 
Study terminated before regular end : Authors do not report this 
Publication details Language of publication English 
Commercial funding: Authors do not report this 
Non-commercial funding:  Supported in part by Health Management Resources and the HCF Nutrition Research 
Foundation in Lexington, Kentucky. 
Publication status (peer review journal):  Yes 
Publication status (journal supplement): Authors do not report this 
Publication status (abstract) 
Stated aim for study 
Quote “This study was designed to determine if food-containing hypocaloric diets are as effective as liquid-supplement 
diets in promoting weight loss for obese individuals with non-insulin-dependent diabetes mellitus (NIDDM).” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) Low 
Forty subjects (19 women and 21 men) entered the study and were assigned to one of two diets using a stratified 
randomization based on gender, body mass index (BMI), and insulin use. 
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Allocation concealment  (selection bias) 
High  
Authors do not report this. Twenty subjects (10 women and 10 men) were assigned to liquid supplement, and 20 
subjects (9 women and 11 men) were assigned to liquid supplement plus food. 
Blinding (performance & detection bias) High  
Authors do not report this 
Blinding of participants and personnel 
(performance bias) Low  
90-min group classes conducted by a trained behavioral health educator. Both groups received an intensive 
behavioural programme.  It does not state is the groups were mixed, which could have meant that participants were 
telling one another about what they were doing, and could have contaminated the results (participants could have 
decided to swap the programme that they were assigned too, to the other programme that another participant had told 
them about). This would not have been blind to personnel either, which could have meant that the sessions picked out 
specific people and ensured that they received better behavioural messages (i.e. group a). 
Nurses and physicians were not blind to who had received what. Participants could have discussed what they were 
doing during consultations. This would not affect the results massively as it would only be a person’s weight that could 
be tampered with, other outcome measures related to bloods, and BP which could not be tampered with.  
Blinding of outcome assessment (detection 
bias) 
Low  
Nurses and physicians were not blind to who had received what. Participants could have discussed what they were 
doing during consultations. This would not affect the results massively as it would only be a person’s weight that could 
be tampered with, other outcome measures related to bloods, and BP, which could not be tampered with. 
Incomplete outcome data (attrition bias) Low 
Three subjects data were not available for 1 year follow up 
Selective reporting (reporting bias) High 
Authors do not report this. 
Other bias  
Comments  
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Overview of study populations Anderson 1994a 
Number invited 
Low  
Forty subjects (19 women and 21 men) entered the study and were assigned to one of two diets using a stratified 
randomization based on gender, body mass index (BMI), and insulin use. Twenty subjects (10 women and 10 men) 
were assigned to liquid  supplement, and 20 subjects (9 women and 11 men) were assigned to liquid supplement plus 
food. 
Number screened  
Low  
Authors do not report this. 
Interested subjects attended an orientation session and underwent careful medical and laboratory screening. 
Number randomised 
Low  
Forty subjects (19 women and 21 men) entered the study and were assigned to one of two diets using a stratified 
randomization based on gender, body mass index (BMI), and insulin use. 
(n) ITT 
Intervention 
Control 
Total 
Authors do not report this. 
Number finishing study 37 were available for follow up. Does not state which group the dropouts were from 
(%) of randomised patients finishing study 
 
92.5% 
 
Description of interventions Anderson 1994a 
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Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
Control(s) [route, frequency, total dose/day] 
 
For the weight-loss diet program, group A subjects were instructed to consume at least five liquid supplements a day, 
which provide 800 kcal and 80 g of high-quality protein, and take two vitamin/mineral tablets. 
Group B subjects were instructed to consume at least three liquid supplements a day, which provide 320 kcal and 32 g 
of high-quality protein, take one vitamin/mineral supplement, and consume a recommended evening meal containing 
~500 kcal and 50 g of high-quality protein. 
 
Baseline characteristics Anderson 1994a 
Number of intervention participants 
Number of control participants 
40 
 
Participating population NIDDM subjects with body mass indexes (BMIs) of 30-40 kg/m2 
Sex [female %] 50% and 45% 
Age [mean years (SD)] Authors do not report this. They state 40-70 years of age 
HbA1c [mean % (SD)] 8.2 ± 0.5 
8.6 ± 0.5 
BMI [mean kg/m2 (SD)] Authors do not report this.  
Duration of disease [mean years (SD)] Authors do not report this.  
Ethnic groups [%] Authors do not report this.  
Duration of intervention [mean ... (SD)] 12 weeks intervention 
Duration of follow-up [mean ... (SD)] Follow up after one year 
Co-medications 
Initial treatment regimens included insulin, 5 subjects; insulin and oral hypoglycemic agents, 3 subjects; oral 
hypoglycemic agents, 24 subjects; and diet alone, 7 subjects. 
Co-interventions Authors do not report this. 
Co-morbidities Authors do not report this. 
 
Matrix of study endpoints Anderson 1994a 
Intervention(s) Body weight (kg) 88.6 ± 2.8 
Systolic blood pressure (mmHg) 124.2 ± 3.6 
Diastolic blood pressure (mmHg) 76.3 ± 1.8 
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Serum glucose (mM) 7.6 ± 0.5 
Glycosylated hemoglobin (%)6.2 ± 0.2 
Serum cholesterol (mM) 4.6 ± 0.2 
Serum LDL cholesterol (mM) 2.8 ± 0.2 
Serum HDL cholesterol (mM) 1.0 ±0.1 
Serum triglycerides (mM) 1.7 ± 0.2 
 
Control (s) Body weight (kg)  89.4 ± 2.7 
Systolic blood pressure (mmHg) 123.8 ± 3.9 
Diastolic blood pressure (mmHg) 75.3 ± 2.2 
Serum glucose (mM) 8.9 ± 0.8 
Glycosylated hemoglobin (%)6.8 ± 0.3 
Serum cholesterol (mM) 4.7 ± 0.2 
Serum LDL cholesterol (mM) 2.7 ± 0.2 
Serum HDL cholesterol (mM) 1.1 ±0.0 
Serum triglycerides (mM) 2.0 ± 0.2 
Primary endpoint(s) Authors do not report this. 
Secondary endpoint(s) Authors do not report this. 
Other endpoint(s)  
Effect size 
Both groups lost significant amounts of weight, and weight losses did not differ significantly between groups. Weight 
loss averaged 15.7 kg for the entire group. 
 
Adverse events Anderson 1994a 
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All adverse events The authors do not state which group suffered the events below 
Frequently reported side effects during the weight-loss phase included constipation (56% of subjects), diarrhea (31%), 
dizziness (31%), fatigue (31%), flu/sore throat (13%), headache (10%), vomiting (10%), blurred vision (10%), muscle 
cramps (8%), and syncope (5%). 
 
One woman in group B discontinued the study because of coronary bypass surgery for pre-existing coronary heart 
disease. 
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Bibliographic Details  
Study ID Ditschuneit 1999 
Author (first) Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G 
Journal  American Journal of Clinical Nutrition 
Year 1999 
Volume 69 
Pages 198-204 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details 
HH Ditschuneit, University Hospital, Department of Medicine, University Ulm, Robert-Koch-Strasse 8, D-89081 Ulm, 
Germany. E-mail: herwig.ditschuneit@medizin.uni-ulm.de. 
 
Character of included studies   
Methods Prospective, randomized, parallel intervention study 
 
Participants Exclusion criteria 
Individuals with a history or presence of significant disease, endocrine disorders, psychiatric diseases, alcohol or drug 
abuse, or abnormal laboratory test results of clinical significance were excluded. In addition, women were excluded if 
they were lactating, pregnant, or wished to become pregnant. 
Inclusion criteria 
Patients were men and women aged >18 y whose body mass indexes were > 25.0 and 40.0 and who gave their 
informed consent to participate. Patients indicated their willingness to be randomly assigned to study groups and to 
follow the program protocol, which included monthly hospital visits for physical examinations and review of diet 
records. One hundred patients met the inclusion criteria, agreed to be randomly assigned to study groups, and 
adhered to the study protocol. 
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Interventions Number of study centres: Authors do not report this  
Country/location: US 
Setting: Authors do not report this No particular setting, slim fast allows participants to consume the shake wherever 
they wish to. 
Treatment before study: Authors do not report this 
Titration period: Authors do not report this 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
 
Authors do not report this. The authors do not specifically state what the primary outcomes were, but tables state 
weight (kg), weight loss(%),SBP (mm Hg),  DBP (mm Hg),  
Triacylglycerol (mmol/L),  Cholesterol (mmol/L),  HDL cholesterol (mmol/L),  Glucose (mmol/L),  Insulin (pmol/L) 
Primary outcome(s) Authors do not report this 
Secondary outcome (s) Authors do not report this 
Other outcome (s) 
Study details Run-in period: Authors do not report this 
Study terminated before regular end: Authors do not report this 
Publication details Language of publication: English 
Commercial funding: Slim fast 
Non-commercial funding: Authors do not report this 
Publication status (peer review journal): yes 
Publication status (journal supplement): Authors do not report this 
Publication status (abstract): Authors do not report this 
Stated aim for study 
Quote “We assessed the long-term effects of an energy restricted diet combined with 1 or 2 daily meal replacements 
on body weight and biomarkers of disease risk in 100 obese patients.” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
Low  
Computer-generated identification number. 
Allocation concealment  (selection bias) High  
Participants would have known what they were receiving, the dietician would not have been blind as they were to 
prescribe diet plans according to the participant and what they were receiving 
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Blinding (performance & detection bias) High  
Authors do not report this 
Blinding of participants and personnel 
(performance bias) 
High 
Authors do not report this 
Blinding of outcome assessment (detection 
bias) 
High  
Authors do not report this. It does not state whether many participants had their anthropometrics done at the same 
time. If they were, this could have had an impact on the results, especially if the answers were read out (element of 
completion) 
Incomplete outcome data (attrition bias) 
Low 
All patients completed the first three months (phase 1)  
During the next 24 mo (phase 2), patient attrition occurred and at the end of this phase 37 patients had dropped out 
(n=63) 
Selective reporting (reporting bias) Authors do not report this 
Other bias  
Comments It is not stated whether the dietician also assisting in data collection. The dietician could have pulled the waist measure 
tighter for slim fast participants it does not state whether inter and intra reliability was done for the waist 
measurements. If various researchers did these they could be quite a large margin of error 
 
Overview of study populations Ditschuneit 1999 
Number invited 
Low  
Authors do not report this 
50 participants were randomly assigned to group A (control group) and 50 patients to group B (meal-replacement 
group). The study patients were referred to the Obesity Center at the University Hospital of Ulm for obesity 
management. All patients had been treated by the referring practitioner with energy restricted diets for ³3 mo. 
Dissatisfaction with the degree of weight loss was the primary reason for transfer to the University Center 
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Number screened 
Low  
Screening was initially carried out by the Obesity Center at the University Hospital of Ulm for obesity management. 
Patients were referred. 
Number randomised 
 
 
Low 50 and 50 
(n) ITT 
Intervention 
Control 
Total 
High  
Authors do not report this 
Number finishing study Low  
All finished the study, however at 24 months dropouts started to occur.  
(%) of randomised patients finishing study 
 
62% finished the study control 
64% finished the study intervention 
 
Description of interventions Ditschuneit 1999 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group B was prescribed similar self-selected diets, except that 2 of the 3 main meals (breakfast, lunch, or dinner) 
were replaced with meal-replacement shakes, soups, or hot chocolate (Slim•Fast). Each meal replacement contained 
0.84–1.05 MJ energy, 14.0–17.0 g protein, 27.0–33.5g carbohydrate, 5.0–6.6 g fat, and 4.5–6.5 g fiber and was 
supplemented with essential vitamins and minerals. In place of snacks, patients were provided with 2 nutrition snack 
bars (Slim•Fast) per day containing 0.38–0.46 MJ energy, 1.4–1.7 g protein, 16.1–18.1 g carbohydrate, 2.4–3.9 g fat, 
and 1.1 g fiber.  
In phase 2, all patients were seen monthly and continued to receive the same instructions while following their food 
plans. The energy content of the prescribed diet was the same in both groups, and all patients were instructed to 
replace one meal and one snack with the energy-controlled, nutrient-dense meal and snack replacements. 
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Control(s) [route, frequency, total dose/day] 
 
 
The dietary intervention during phase 1 was structured such that a staff nutritionist explained the diet plan in detail and 
counselled participants by using personalized sample menus and recipes and instruction in maintenance of a food 
diary. Throughout the study, patients were prescribed a balanced diet providing 5.2–6.3 MJ/d (1200–1500 kcal/d) and 
19–21% of energy as protein, 48–54% of energy as carbohydrate, and 25–34% of energy as fat. Three meals 
(breakfast, lunch, and dinner) and 2 snacks (1 between breakfast and lunch and 1 between lunch and dinner) were 
recommended. The nutritionist provided monthly, personalized instructions by using food exchange lists and food 
diaries to equalize the prescribed energy intakes between groups A and B. Individual preferences for various food 
items were integrated into the diet plan. During phase 1, the 3-mo weight-loss period, group A was prescribed a diet in 
which all meals and snacks were prepared from self-selected, conventional foods. 
In phase 2, all patients were seen monthly and continued to receive the same instructions while following their food 
plans. The energy content of the prescribed diet was the same in both groups, and all patients were instructed to 
replace one meal and one snack with the energy-controlled, nutrient-dense meal and snack replacements. 
 
Baseline characteristics Ditschuneit 1999 
Number of intervention participants 
Number of control participants 
50 
50 
Participating population Patients were men and women 18+  years, between 25-40 BMI 
Sex [female %] 82% control     
76% intervention 
Age [mean years (SD)] Control 
Age (y) women 46.8 ±11.2           men 45.5 ±12.0 
Intervention 
Women 44.3 ±9.8               men 46.5 ±9.5 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] Control  
Women   33.9 ±3.0            men 33.1 ±4.1 
Intervention 
Women 33.1 ±4.1                   men 33.0 ±3.7 
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Duration of disease [mean years (SD)] Authors do not report this 
Ethnic groups [%] Authors do not report this 
Duration of intervention [mean ... (SD)] 3 months 
Duration of follow-up [mean ... (SD)] 24 month follow up 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Ditschuneit 1999 
Intervention(s) Weight 
89.1 ±12.1    women;baseline       82.3 ±12.0         women;3 months        104.1 ±13.1        men;baseline             95.2 
±13.1 men;three months 
Waist:hip ratio 
0.86 ±0.15     women;baseline    0.84 ±0.13    women;3 months            0.95 ±0.09    men;baseline           0.93 ±0.11 
men;3 months 
Systolic blood pressure 
139 ±18     women;baseline        130 ±14          women;3months        142 ±15   men;baseline                    132 ±10   
women;3 months 
Diastolic blood pressure 
82 8     women;baseline          80 5       women;3 months          83 7    men;baseline           82 ±3   men;3 months 
Triglycerol 
2.00 ±1.07     women;baseline            1.57 ±0.74    women;3 months    2.94 ±1.48        men;baseline        2.29 ±1.70  
men;3 months 
Chloestrol 
5.75 ±1.02     women;baseline       5.70 ±0.94     women;3months          6.07±0.97    men;baseline        6.09 ±0.66        
men;3 months 
HDL 
1.40 ±0.41     women;baseline               1.34 ±0.46     women;3 months              1.04 ±0.28         men;baseline          
1.15 ±0.33     men;3 months 
Blood glucose 
4.96 ±0.28    women;baseline            4.55 ±0.69         women;3 months        5.11 ±1.02      men;baseline            4.74 
±0.99      men;3 months 
Insulin 
128.5 ±51.7    women;baseline                 78.9 ±23.4     women;3 months                143.5 ±53.6  men;baseline                   
100.8 ±34.9    men;3 months 
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Phase 1 
Body weight (kg) 
Group B 92.6 ±13.7         baseline   85.5 ±13.4  3 months 
Waist-to-hip ratio 
Group B 0.89 ±0.12 baseline     0.86 ±0.18  3months 
SBP (mm Hg)  
Group B 139 ±15   baseline 130 ±13         3months 
DBP (mm Hg) 
Group B 82 6   baseline  80 5 3months 
Triacylglycerol (mmol/L) 
Group B 2.23 ±1.24 baseline   1.75 ±1.09 3months 
Cholesterol (mmol/L) 
Group B 5.83 ±1.01      baseline   5.79 ±0.89 3 months 
HDL cholesterol (mmol/L) 
Group B 1.31 ±0.41 baseline   1.30 ±0.44 3 months 
Glucose (mmol/L) 
Group B 4.97 ±0.87 baseline   4.58 ±0.74 3 months 
Insulin (pmol/L)  
Group B 132.0 ±53.1       baseline  84.9 ±30.4   3months 
 
 
Phase 2 
Body weight (kg) 
Group B 84.3 ±13.8 15months       82.2 ±13.4   27 months 
Waist-to-hip ratio 
Group B 0.85 ±0.20 15 months       0.85 ±0.19     27 months 
SBP (mm Hg) 
Group B 123 ±11          15months    124 ±12          27months 
DBP (mm Hg) 
Group B  76 5     15months    78 ±5   27months 
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Triacylglycerol (mmol/L) 
Group B 1.58 ±0.41 15months      1.40 ±0.49        27months 
Cholesterol (mmol/L) 
Group B  5.51 ±0.53      15months     5.35 ±0.95       27months 
HDL cholesterol (mmol/L) 
Group B 1.24 ±0.30     15months        1.39 ±0.77      27months 
Glucose (mmol/L) 
Group B 4.75 ±0.63   15months      4.40 ±0.39     27months 
Insulin (pmol/L) 
Group B 96.2 ±48.0    15months       81.8 ±30.2         27months 
Control (s) Weight 
90.6 ±9.4    women;baseline       89.4 ±10.4      women;3months            101.7 ±12.3     men;baseline              100.5 
±13.0     men;3 months 
Waist hip ratio 
0.86 ±0.15    women;baseline       0.84 ±0.13     women;3 months        0.95 ±0.09       men;baseline         0.93 ±0.11        
men;3 months 
Systolic BP 
141 ±16       women;baseline       142 ±16     women;3 months       136 ±15     men;baseline    134 ±14      men;3 
months 
Diastolic BP 
84 8    women;baseline    82 6     women;3 months          82 8     men;baseline         80 ±4         men;3 months 
Triacylglycerol 
1.96 ±1.10     women;baseline          1.93 ±1.10   women;3 months          2.92 ±2.03  men;baseline             3.16 ±2.50    
men;3 months 
Chloestrol 
5.97 ±1.00        women;baseline      5.78 ±1.01      women;3 months          6.17 ±0.61      men;baseline            6.12 
±0.97men;3 months 
HDL 
1.33 ±0.34      women;baseline    1.30 ±0.30    women;3 months      1.02 ±0.15     men;baseline      0.96 ±0.16 men;3 
months 
Blood glucose 
5.05 ±0.78     women;baseline       5.08 ±0.77     women;3 months            5.01 ±1.05    men;baseline     5.06 ±0.88        
men;3 months 
Insulin 
129.5 ±45.8   women;baseline         128.6 ±59.7      women;3 months          172.3 ±60.3    men;baseline           171.6 
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±65.9            men;3 months 
 
 
Phase 1 
 
 
 
Body weight (kg) 
Group A 92.7 ±10.8         baseline   91.4 ±11.6  3months 
Waist-to-hip ratio 
Group A 0.90 ±0.10     baseline  0.86 ±0.21  3months 
SBP (mm Hg)  
Group A 140 ±14 baseline     141 ±16  3months 
DBP (mm Hg) 
Group A 83 6 baseline  82 5  3months 
Triacylglycerol (mmol/L) 
Group A 2.13 ±1.34 baseline   2.15 ±1.50  3months 
Cholesterol (mmol/L) 
Group A 6.01 ±0.94 baseline 5.84 ±1.00  3months 
HDL cholesterol (mmol/L) 
Group A 1.27 ±0.33  baseline  1.24 ±0.31 3 months 
Glucose (mmol/L) 
Group A 5.05 ±0.85     baseline  5.07 ±0.79 3 months 
Insulin (pmol/L)  
Group A 134.6 ±50.4 baseline   139.1 ±63.2 3months 
 
 
Phase 2 
Body weight (kg) 
Group A  87.5 ±12.1        15months    85.0 ±11.8     27months 
Waist-to-hip ratio 
Group A 0.85 ±0.24    15 months      0.84 ±0.18       27months 
SBP (mm Hg) 
Group A  135 ±12     15months         138 ±13      27months 
DBP (mm Hg) 
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Group A  78 5       15months    80 ±6     27months 
Triacylglycerol (mmol/L) 
Group A 1.65 ±0.53    15months    1.77 ±0.62      27months 
Cholesterol (mmol/L) 
Group A  5.45 ±0.93       15months     5.69 ±0.60    27months 
HDL cholesterol (mmol/L) 
Group A 1.24 ±0.26    15months         1.18 ±0.17     27months 
Glucose (mmol/L) 
Group A 4.55 ±0.40   15months     4.52 ±0.42     27months 
Insulin (pmol/L) 
Group A  93.1 ±28.4   15months        98.8 ±30.0     27months 
 
 
 
Primary endpoint(s) Authors do not report this 
Secondary endpoint(s) Authors do not report this 
Other endpoint(s)  
Effect size 
The study favoured group B (meal replacement). Group B lost 11.3 ± 6.8% vs  5.9 ± 5.0% (as a percentage of initial 
body weight, (P < 0.0001). During phase 1, mean weight loss in group B (n = 50) was 7.1 ± 3.5 kg, with significant 
reductions in plasma triacylglycerol, glucose, and insulin concentrations (P < 0.0001). 
Group A patients (n = 50) lost an average of 1.3 ± 2.2 kg with no significant improvements in these biomarkers. During 
phase 2, both groups lost on average an additional 0.07% of their initial body weight every month (P < 0.01). During 
the 27-mo study, both groups experienced significant reductions in systolic blood pressure and plasma concentrations 
of triacylglycerol, glucose, and insulin (P < 0.01). 
 
Adverse events Ditschuneit 1999 
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All adverse events 
 Patient complaints included headache (n = 10), loss of hair (n = 4), abdominal discomfort (diarrhoea, gas, and 
constipation; n = 7), back pain (n = 3), depressed mood (n = 2), cold intolerance (n = 2), and influenza syndrome (n = 
32). 
 
The paper states that these were not due to the intervention; headache and abdominal discomfort might be due to 
using slim fast in my opinion. 
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Bibliographic Details  
Study ID Djuric 2002 
Author (first) Djuric Z, DiLaura NM, Jenkins I, Darga L, Jen CK, Mood D, Bradley E, Hryniuk WM. 
Journal  Obesity Research 
Year 2002 
Volume 10 
Pages 657-655 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details Zora Djuric djuricz@karmanos.org 
 
Character of included studies  
Methods Randomised pilot study  
 
Participants Exclusion criteria 
Opposite of the below 
Inclusion criteria  
Eligible subjects were ages 18 to 70 years. They had stage I or II breast cancer that was diagnosed within the past 4 
years and were free of any recurrence as confirmed by a physician. Chemotherapy or radiation therapy was to have 
been completed at least 3 months previously with the exception of tamoxifen. Recruitment sources were direct mail to 
“Race for the Cure” participants, press releases, and brochures at breast clinics.  
Interventions Number of study centres:  Authors do not report this. 4 different arms, does not specifically state where the 
interventions were held 
Country/location: US 
Setting: Authors do not report this.  4 different arms, does not specifically state where the interventions were held 
Treatment before study: Authors do not report this.  
Titration period: Authors do not report this. 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Authors do not report what these are. However, data at 12 month follow up is available for Numbers of women 
achieving 10% weight loss, Energy intake (kcal/d)*, Fat intake (% of energy). 
Primary outcome(s) Authors do not report this. 
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Secondary outcome (s) Authors do not report this. 
Other outcome (s) 
Study details Run-in period: Authors do not report this. 
Study terminated before regular end: Authors do not report this. 
Publication details Language of publication: English 
Commercial funding: This study was supported in part by grant RO3 CA89761 from NIH, The Weight Watchers Group, 
Inc, Farmington Hills, Michigan, and the Ford Motor Company Fund. 
Non-commercial funding: Authors do not report this. 
Publication status (peer review journal): yes 
Publication status (journal supplement): Authors do not report this. 
Publication status (abstract): Authors do not report this. 
Stated aim for study 
Quote “The objective was to develop effective weight loss methods for women who have had breast cancer, because 
obesity may result in an adverse prognosis” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
High  
Authors do not report how they were randomised to each of the four arms 
Allocation concealment  (selection bias) High  
Authors do not report this. 
Blinding (performance & detection bias) High  
Authors do not report this. 
Blinding of participants and personnel 
(performance bias) 
High  
Authors do not report this. 
Blinding of outcome assessment (detection 
bias) 
High 
Authors do not report this. 
Incomplete outcome data (attrition bias) 
High 
Nine of the 48 women did not complete 12 months of participation. Two were dropped for noncompliance after 3 and 6 
months, respectively. Seven women withdrew from the study, and all but two did so before 3 months. After 12 months, 
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subjects assigned to any intervention arm were given the option of continuing with the program. 
Selective reporting (reporting bias) Authors do not report this. 
Other bias  
Comments It does not state whether the participants in the weight watchers arm and the comprehensive arm mixes (e.g. did they 
both attend the weight watchers meetings at the same time). There could be contamination of data, if these two arms 
met at the same time and the comprehensive arm discussed what they were doing with the weight watchers only arm. 
 
Overview of study populations Djuric 2002 
Number invited 
Authors do not report this. 
Number screened 
 
Authors do not report this. 48 women too part, there was no screening, just to meet the criteria set out. 
Number randomised  Authors do not report this, or how many were randomised to each arm, it can only be assumed that 12 were 
randomised to each arm, given equal distribution. 
(n) ITT 
Intervention 
Control 
Total 
None reported 
Number finishing study 
Nine of the 48 women did not complete 12 months of participation. Two were dropped for noncompliance after 3 and 6 
months, respectively. Seven women withdrew from the study, and all but two did so before 3 months. Reasons for 
withdrawal were medical problems (n = 1), too busy (n = 2), emotional distress (n= 3), and lost interest (n =1). 
(%) of randomised patients finishing study 
 
81.25% 
 
Description of interventions Djuric 2002 
 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
Weight watchers arm 
For the WW arm, women were encouraged to attend WW meetings but received no other dietary or exercise 
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instruction. These meetings were conveniently available throughout the Detroit area at various times during the day. 
Coupons for weekly attendance were provided free of charge. The “weigh-in” data card from the WW meetings was 
faxed or mailed to the dietician as proof of attendance, and this also provided additional data to assess weight-loss 
patterns and attendance. The WW program is designed for weekly attendance. 
Individualized Arm 
Contacts by the dietician were scheduled to be weekly for the first 3 months, biweekly for months 3 to 6, and monthly 
thereafter. Women were accommodated if they needed a greater or lesser frequency of contacts at any given time. 
They were also free to call the dietician, and some women enjoyed sharing their successes as they occurred. Apart 
from the quarterly data collection visits, all of the individual contacts were by telephone appointment. A monthly group 
meeting was held during the lunch hour, and women were encouraged, but not required, to attend. A monthly packet 
of written information was prepared on various weight-loss topics (environmental control, serving-size control, 
exercise, motivation, goal setting, holiday, eating, seasonal foods) and either presented to the women at the monthly 
meeting or mailed to their homes. One-on-one counselling was provided regarding diet and exercise by a registered 
dietician. 
Comprehensive Arm 
For the comprehensive arm, subjects received the individualized counselling described above and were asked to 
attend weekly WW meetings using free coupons. Because the subjects had group meetings with WW, and it was felt 
that adding the dietician-led monthly group might be an overly burdensome time commitment, the monthly meeting 
was omitted. The WW program has dietary guidelines that coincide well with cancer-prevention guidelines and with 
the dietary-exchange goals that were presented to the participants and this was explained in detail. The women 
learned how the “points” system of WW, which takes into account energy, fat, and fibre contents of foods, coincides 
well with the food-group exchanges that were assigned for each individualized diet plan. It was requested that 
exercise and dietary logs be kept daily. 
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Control(s) [route, frequency, total dose/day]  
Subjects randomized to the control arm received the National Cancer Institute’s “Action Guide to Healthy Eating” and 
the “Food Guide Pyramid” pamphlets, but they received no other dietary or exercise instructions or help. They met 
with the dietician at baseline, 3, 6, and 12 months for the required assessments. Controls were allowed to follow a 
weight-reduction diet on their own if desired. 
 
 
 
Baseline characteristics Djuric 2002 
Number of intervention participants 
Number of control participants 
Authors do not report this. all reported  as one 
Participating population All females aged 18 to 70 years. They had stage I or II breast cancer that was diagnosed within the past 4 years and 
were free of any recurrence as confirmed by a physician. Chemotherapy or radiation therapy was to have been 
completed at least 3 months previously with the exception of tamoxifen 
Sex [female %] 100 
Age [mean years (SD)] 51.7 ± 8.4 
(range, 36 to 70) 
HbA1c [mean % (SD)] Authors do not report this. 
BMI [mean kg/m2 (SD)] 35.5 ± 3.9 
Duration of disease [mean years (SD)] Authors do not report this. 
Ethnic groups [%] 12 (25%) 
35 (73%) One study subject was Native American. 
Duration of intervention [mean ... (SD)] 3 months 
Duration of follow-up [mean ... (SD)] 6 months, 9 months, 12 months 
Co-medications 
Three women were taking estrogen replacement therapy, and of those, one was taking both tamoxifen and hormone 
replacement therapy. 
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Three were taking diabetes medication (6%) 
Co-interventions  
Co-morbidities 
They had stage I or II breast cancer that was diagnosed within the past 4 years and were free of any recurrence as 
confirmed by a physician. Chemotherapy or radiation therapy was to have been completed at least 3 months 
previously with the exception of  tamoxifen. 
 
4 were smokers (8%) 
19 had arthritis (40%) 
 
Matrix of study endpoints Djuric 2002 
Intervention(s) Weight change after 12 months  
-2.6 ± 5.9 kg in the Weight Watchers group, -8.0 ±5.5 kg in the individualized group, and -9.4 ± 8.6 kg in the 
comprehensive group that used both individualized counselling and Weight Watchers 
 
Comprehensive arm 
Weight loss was most rapid in the comprehensive arm, with mean weight losses of 7.4, 9.3, and 9.4 kg at 3, 6, and 12 
months, respectively 
individualized counselling group 
All women in this arm exhibited weight loss at 6 months, ranging from 1.4 to 17.7 kg. After 6 months, six of nine 
women continued to lose weight, whereas three women regained 30% to 39% of their lost weight. At 12 months, the 
range of weight loss from baseline was 3.2 to 20.9 kg, indicating a loss in every woman who completed 12 months on 
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the individualized arm. 
Weight watchers only 
Weight change at 6 months ranged from a loss of 14.5 kg to a gain of 10 kg, and six of nine women lost %1 kg. The 
weight change from baseline to 12 months ranged from a loss of 11.4 kg to a gain of 4.8 kg, and five of eight women 
lost %1 kg, indicating that some women can benefit from a WW-only approach. 
12 Months Numbers of women achieving 10% weight loss 
Control 0% 
Weight Watchers 25% 
Individualized 22% 
Comprehensive 60% 
 Control (s)  
Weight change after 12 months 
0.85 ± 6.0 kg in the control group 
 
12 months, mean body weight increased by 0.85 kg 
 
12 Months Numbers of women achieving 10% weight loss 
Control 0% 
 
Primary endpoint(s) Authors do not report this. Does not specifically state what the primary end point was, though it does state The main 
goal of the interventions tested in this study was weight loss 
Secondary endpoint(s) Authors do not report this. 
Other endpoint(s)  
Effect size 
Data indicated that the most successful (at 12 months of intervention ) was  weight watchers combined with 
counselling -9.4 ±8.6 kg the individualised group -8.0 ± 5.5kg. Weight loss relative to control was statistically 
significant in the comprehensive group 3, 6, and 12 months after randomization, whereas weight loss in the 
individualized group was significant only at 12 months. Weight loss of 10% or more of initial body weight was observed 
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in 6 of 10 women in the comprehensive group at 12 months. 
 
Adverse events Djuric 2002 
All adverse events Authors do not report this 
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Bibliographic Details  
Study ID Gold 2007 
Author (first) Gold BC, Burke S, Pintauro S, Buzzell P, Harvey-Berino J. 
Journal  Obesity 
Year 2007 
Volume 15(1) 
Pages 155-164 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details 
Jean Harvey-Berino, Department of Nutrition and Food Sciences, University of Vermont, 250 Carrigan Wing, 109 
Carrigan Drive, Burlington, VT 05405. 
E-mail: jharvey@uvm.edu 
 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
Participants Exclusion criteria 
Opposite of the below 
 
Inclusion criteria 
18 years+ 
BMI >25 and≤ 39.9 kg/m2 
Regular access to a computer (not more than 3 years old with CD-ROM drive, Internet connection, at least 64 
Megabytes of RAM, 350 MHz processor speed, and Windows 98 or higher as a computer operating system) 
Ineligible if they planned to move from the area or get pregnant within the next 12 months, had a history of major 
medical or psychiatric problems, smoked or had been a non-smoker for less than 1 year, took medications known to 
affect weight, were unable to participate in a mild to moderate exercise program, or were unable to regularly attend 
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weekly meetings. 
Interventions Number of study centres: Authors do not report this.  This was an online study. 
Country/location:  US 
Setting; Authors do not report this.  This was an online study. 
Treatment before study: Authors do not report this.   
Titration period   n/a 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Primary outcome(s) The primary purpose of this study was to compare weight losses achieved through a behavioral 
on-line intervention vs. a  commercial self-help website. A second aim was to evaluate the use of web components 
and their relationship to weight loss between groups and within groups to identify which web components correlated 
with weight loss. 
 
Secondary outcome (s) 
Other outcome (s) 
Study details Run-in period:    Authors do not report this.   
Study terminated before regular end: Authors do not report this.   
Publication details Language of publication: English 
Commercial funding: Authors do not report this.   
Non-commercial funding; This study was supported by U.S. Department of Agriculture Hatch Act Funds (Grant VT-NS-
00,904) 
Publication status (peer review journal):  yes 
Publication status (journal supplement): Authors do not report this.   
Publication status (abstract): Authors do not report this.   
Stated aim for study 
Quote “This study aimed to investigate the effectiveness of a structured behavioural weight loss website (VTrim) vs. a 
commercial weight loss website (eDiets.com).” 
Notes  
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Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
 
High 
Authors do not report this.   
Allocation concealment  (selection bias) High 
Authors do not report this.   
Blinding (performance & detection bias) High 
Authors do not report this.   
Blinding of participants and personnel 
(performance bias) 
High 
Authors do not report this.  Staff would have known which website the participant was to be directed too 
Blinding of outcome assessment (detection 
bias) 
High 
Authors do not report this.  It does not state if the same researchers who told participants what website they were to 
use, were the same for carrying out the measures. This could have impacted on the results 
Incomplete outcome data (attrition bias) Low  
14 were lost from ediets (n=62-14) 
22 were lost from v trim (n=62-22) 
48 included in completers analysis e diets 
40 included in completers analysis vtrim  
Selective reporting (reporting bias) Authors do not report this.   
Other bias  
Comments  
 
Overview of study populations Gold 2007 
Number invited  595 
(n) screened 
Intervention 
Control 
Total 
595 
(n) randomised 
Intervention 
Control 
Total 
185 
62 
62 
61 allocated to an arm not related to the study 
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(n) ITT 
Intervention 
Control 
Total 
An intention-to-treat analysis examined weight change using baseline carried forward. 
Number finishing study 48 e diets 
40 v trim 
(%) of randomised patients finishing study 
 
77.4% e diets 
64.5% v trim 
 
Description of interventions Gold 2007 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
 
 
Control(s) [route, frequency, total dose/day] 
The eDiets.com program provided a calorie-controlled meal plan tailored to individual preferences. Participants were 
encouraged to follow their meal plan (“my diet”); recipe instructions and menu-specific grocery lists were offered as 
aids. The program encouraged exercise (“my fitness”). Participants tailored their program on the basis of their exercise 
abilities and their likes and dislikes. An on-line exercise journal was provided to track weekly progress. There were 
check-in points interactively but no direct accountability to a therapist. Although the website did not include a 
structured behavioural curriculum (lessons, activities), fundamental behavioural weight loss concepts were present. 
“Support central,” monitored by experts and peers, offered opportunities for social support. 
Subjects randomized to VTrim participated in a 6-month on-line therapist-led weight loss program and a subsequent 6-
month on-line weight maintenance program. A unique username and password were established for each subject so 
that web use could be tracked throughout the study. 6-month Weight Loss Phase. The weight loss phase focused on 
the modification of eating and exercise habits through the use of behavioural strategies and self-management skills. 
The program layout was similar to a workbook in that specific behaviour modification lessons, such as “Eating in 
Social Situations,” were featured each week, and the leader focused on the topic during the weekly on-line meeting. 
The instruction and support were delivered solely online. Participants self-reported their weight each week online, and 
they participated in hour-long weekly on-line chats, led by a trained therapist. 
 
Baseline characteristics Gold 2007 
Number of intervention participants 
Number of control participants 
62 
62 
Participating population Participants aged 18 years +, BMI >25 and≤ 39.9 kg/m2, and with access to a pc less than 3 years of age. 
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Sex [female %] 48 (77) v trim 
53 (86) e diets 
Age [mean years (SD)] 46.5 (10.7) v trim 
48.9 (9.9) e diets 
HbA1c [mean % (SD)] Authors do not report this. 
BMI [mean kg/m2 (SD)] 32.3 (3.9)  vtrim       
32.5 (4.2)    ediets 
Duration of disease [mean years (SD)] Authors do not report this. 
Ethnic groups [%] 61 (98)    vtrim    61 (98) ediets 
Duration of intervention [mean ... (SD)] 0-6 months 
Duration of follow-up [mean ... (SD)] 6-12 months 
Co-medications Authors do not report this. 
Co-interventions Authors do not report this. 
Co-morbidities Authors do not report this. 
 
Matrix of study endpoints Gold 2007 
Intervention(s) 4.1 ±6.2 kg e diet 6 months weight loss 
3.4 ±5.8 e diets weight maintained at 12 months 
Control (s) 7.8 ±7.5 v trim weight maintained at 12 months 
8.3 ± 7.9 kg v trim 6 month weight loss 
Primary endpoint(s) 8.3 ± 7.9 kg v trim 6 month weight loss 
4.1 ±6.2 kg e diet 6 months weight loss 
7.8 ±7.5 v trim weight maintained at 12 months 
3.4 ±5.8 e diets weight maintained at 12 months 
 
65% of participants in the VTrim group lost 5% or more of initial body weight, compared with 37.5% of participants in 
the eDiets.com group at 12 months 
Secondary endpoint(s)  
Other endpoint(s)  
Effect size 
VTrim group lost significantly more weight than the eDiets.com group at 6 months (8.3 ± 7.9 kg vs. 4.1±6.2 kg) and 
maintained a greater loss at 12 months (7.8 ±7.5 kg vs. 3.4 ±5.8 kg).  More participants in the VTrim group maintained 
a 5% weight loss goal  65% vs. 37.5% at 12 months 
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Adverse events Gold 2007 
All adverse events 
 
Authors do not report this. 
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Bibliographic Details  
Study ID Gosselin 2001 
Author (first) Gosselin C, Cote G. 
Journal  Women’s Health (biomed central) 
Year 2001 
Volume 1:2 
Pages Not stated, 7 pages in total 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details Caroline Gosselin* - gosselin.cabanac@sympatico.ca 
 
Character of included studies  
Methods Controlled before and after study 
Participants Exclusion criteria 
Pregnant women at the time of interview and individuals who had followed the program for less than a month were 
excluded from the analysis. 
Inclusion criteria 
 
Participants had to of entered the Mincavi program at least two years prior to the study 
 
Interventions Number of study centres: Authors do not report this. 
Country/location: Quebec 
Setting:  The study was done via the telephone (weight maintenance, and weights were adjusted according to 
previous studies on self-reporting) 
Treatment before study: Authors do not report this.    
Titration period: Authors do not report this. 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
 
Does not state the exact primary or secondary outcomes, however, data was collected in relation too BMI, weight and 
% weight loss 
Primary outcome(s) Authors do not report this. 
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Secondary outcome (s) Authors do not report this. 
Other outcome (s) 
Study details Run-in period: Authors do not report this. 
Study terminated before regular end; Authors do not report this. 
Publication details Language of publication: English 
Commercial funding: Authors do not report this. 
Non-commercial funding: Authors do not report this. 
 
Does not state who the funders were, but data was obtained from the commercial weight loss company. 
Publication status (peer review journal);  yes 
Publication status (journal supplement): Authors do not report this. 
Publication status (abstract): Authors do not report this. 
Stated aim for study 
Quote Authors do not report this.. However, the study reports weight maintenance in women 2 to 11 years after their 
participation in a popular commercial program in the province of Quebec, Canada. 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
High 
Authors do not report this.. It states that clients were randomly picked from the programs client list. 
Allocation concealment  (selection bias) High  
Authors do not report this. 
Participants had already used the programme and were in the maintenance phase. All participants should have been 
the same, though some could have lost 5% of their body weight at baseline to programme end, and some could have 
lost 10% at baseline to the end of the programme. It does not state that any form of clustering of participants was used 
i.e. 5% weight loss vs 10% weight loss 
Blinding (performance & detection bias) High  
Data had already been collected at the various time points. However, there was only data available for 11% of the 
subjects. The other participants had to have their weight adjusted with a 2.9% increase, as their was self-reported over 
the telephone 
Blinding of participants and personnel 
(performance bias) 
High  
Personnel were not blind at all. Specific participants could have been picked to participant in the study. even though it 
states it was randomly done, there was no science behind this (i.e. participants were not inputted into a computer 
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programme and the first 291 selected were those to be contacted). 
Blinding of outcome assessment (detection 
bias) 
High  
Start date data was available for all participants, though only 31 participants had complete records. It does not state 
why data was only available for these participants. There are no statistical tests to show the data available participants 
vs the adjusted weight data for the other participants. 
Incomplete outcome data (attrition bias) High  
Attrition not as such. Participants had already completed the programme, the study was a follow up to assess weight 
maintenance. However, data was only available for 31 participants, the rest (260) had to have their weight adjusted 
(+2.9%) as it was self-reported via the telephone. 
Selective reporting (reporting bias) Authors do not report this. 
Other bias  
Comments The programme that the participants were involved in had a penalty of $7 if weight was gained when attaining the 
sessions; this could have had quite an impact of the results overall, and for weight maintenance. Participants could 
have subconsciously thought that every time they weighed themselves at home, that they would be penalised, and 
therefore were more strict with the diet that other commercial programmes. Within the group sessions, the numbers 
were very large (50-100), and would group leaders would not be able to answer all client questions. This could have 
impacted on weight loss, or it could have meant that weight loss should be the same with all participants as they all 
received the same treatment . Though others could have responded better than others in a large group case scenario, 
other clients could have assisted other clients to reach their weight loss goals. 
 
Overview of study populations Gosselin 2001 
Number invited 323 were originally contacted if 90% took part in the present study. it does not state why they did not want to take part. 
Number screened 
 
291 participants participated in the present study. 323 were originally contacted if 90% took part in the present study. it 
does not state why they did not want to take part. 
Number randomised Authors do not report this. This was a CBA study. No randomisation 
(n) ITT 
Intervention 
Control 
Total 
Authors do not report this. 
Number finishing study 291 
All participants had originally took part in the Mincavi programme 
(%) of randomised patients finishing study 
 
Authors do not report this. This is a CBA.  
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Description of interventions Gosselin 2001 
Intervention(s) [route, frequency, total 
dose/day] 
 
Control(s) [route, frequency, total dose/day] 
Initially a recipe book was given ,stating the importance of three meals a day using the specific food groups. Recipes 
are given in the book that are cheap, readily available and focus on the specific food groups. The participant decided 
on how much they want to lose (it does not state if they are ever advised that they have set an unrealistic goal). Meals 
at 1400kcal (for women) 1800kcal (for men) are encouraged in the weight loss phase, and in the weight maintenance 
phase participants are to increase their intake by 50kcal. Large groups of women (50-100) attend their session every 
week with their food diary for feedback (it does not state what percentage of diaries are looked at each week).  Topics 
of specific subjects are addressed each week 30-45mins, and recipe sampling takes place. Additional support from a 
dietician and a psychologist is available through a toll-free phone line and internet. Participating in the program 
involves a one-time fee of 25$ (Canadian dollars), and a 7$ fee per week during the weight loss phase. Once a 
participant has reached her goal weight, she is given free access to weekly sessions for as long as she maintains her 
goal weight. A fee of 7$ will be charged on weighing sessions if she is found to have gained weight. 
  
 
Baseline characteristics Gosselin 2001 
Number of intervention participants 
Number of control participants 
Authors do not report this. This was a CBA 
Participating population Participants had to of entered the Mincavi program at least two years prior to the study 
 
Sex [female %] 100% 
Age [mean years (SD)] 43,0 ±12,8 (all 2-11 years) 
HbA1c [mean % (SD)] Authors do not report this. 
BMI [mean kg/m2 (SD)] 29,8 ±4,7 (all 2-11 years) 
Duration of disease [mean years (SD)] Authors do not report this. 
Ethnic groups [%] Authors do not report this. 
Duration of intervention [mean ... (SD)] The intervention had already taken place. 
Duration of follow-up [mean ... (SD)] 11 years 
Co-medications Authors do not report this. 
Co-interventions Authors do not report this. 
Co-morbidities Authors do not report this. 
 
Matrix of study endpoints Gosselin 2001 
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Intervention(s) 25 ±45   bmi after program (all 2-11 years)   29.5 ±5.4    bmi at follow up (all 2-11 years)  4.5 ±6.6  weight loss 
maintained (all 2-11 years) 
Control (s) Authors do not report this. There was not a control. It was a CBA. 
Primary endpoint(s) Authors do not report this. 
Secondary endpoint(s) Authors do not report this. 
Other endpoint(s)  
Effect size 
Five to eleven years after they had participated in the program 29.1% of all women maintained a weight loss of at least 
5%, while 14.3% maintained a loss of at least 10%. Percentage of women who maintained at least 5% of their initial 
weight loss are as following; 2 years = 43.6% (n = 55), 3 years = 33.3% (n = 42), 4 years = 23.8% (n = 42), 5–6 years 
= 38.2% (n = 55), 7–8 years = 29.4% (n = 51), and 9–11 years; 19.6% (n= 46). 
 
Adverse events Gosselin 2001 
All adverse events Authors do not report this. 
 
 
 
 
  
Appendix 33: Data extraction sheet; Heshka 2000 
 
394 
 
Bibliographic Details  
Study ID Heshka 2000 
Author (first) Heshka S, Greenway F, Anderson JW, Atkinson RL, Hill JO, Phinney SD, Miller-Kovach K, Pi-Sunyer FX. 
Journal  The American Journal of Medicine 
Year 2000 
Volume 109 
Pages 282-287 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details 
Stanley Heshka, PhD, New York Obesity Research Center, St. Luke’s/Roosevelt Hospital Center, 1090 Amsterdam 
Avenue, 14C, New York, New York 10025. 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
Participants Exclusion criteria 
Those with a fasting glucose level greater than 140 mg/dL, a triglyceride level greater than 1,000 mg/dL, a serum 
aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase, gamma 
glutamyltransferase, or bilirubin level that was more than twice the upper limit of normal, or a serum creatinine level 
greater than 1.4 mg/dL were excluded, as were those using systemic or inhaled corticosteroids or lithium. We 
excluded persons with a history of alcohol abuse within the past year or any significant psychiatric disorder or other 
condition that, in the investigator’s judgment, would interfere with participation in the trial. Candidates who initiated a 
new drug therapy within 30 days of randomization, who were in a weight-loss program, or who took prescription 
weight-loss or investigational medications within 90 days of randomization were also excluded. 
Inclusion criteria 
Men and women with a body mass index of 27 to 40 kg/m2, age 18 to 65 years, including those who had health 
problems for which weight reduction is a medically accepted therapy, were eligible. 
Diagnostic criteria 
Interventions Number of study centres: six  
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Country/location: US 
Setting: Clinical research centres 
Treatment before study: Authors do not report this. 
Titration period: Authors do not report this. 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Outcome measures were changes in body weight, body mass index, waist circumference, and body fat. Changes in 
serum homocysteine levels were measured in a subsample of participants during the first 12 weeks. 
Primary outcome(s) Authors do not report this. 
Secondary outcome (s) Authors do not report this. 
Other outcome (s) 
Study details Run-in period: Authors do not report this. 
Study terminated before regular end: Authors do not report this. 
Publication details Language of publication: English 
Commercial funding: Supported by a grant from the Weight Watchers Foundation. 
Non-commercial funding: Authors do not report this. 
Publication status (peer review journal): yes 
Publication status (journal supplement): Authors do not report this. 
Publication status (abstract): Authors do not report this. 
Stated aim for study 
Quote “The principal objective of this 2-year trial is to compare weight loss and health benefits achieved and 
maintained by moderately overweight and obese men and women in a structured commercial weight-loss program 
with that achieved through self-help, which includes the use of books, manuals, and brief consultations with a 
dietitian.” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) Low  
A randomization envelope prepared by the data-coordinating center was opened, and the candidate was assigned to 
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the self-help or the commercial program. A blocked randomization scheme was used, such that within the overall 
randomization of 70 subjects per site, assignment was constrained to an equal number of self-help and commercial 
assignments within blocks of size 2 to 10. Block size, and assignment within each block, was determined by a random 
number table. A different randomization sequence was prepared for each site. 
Allocation concealment  (selection bias) High 
Participants would have know which arm they were assigned too, based on the methods used (self-help vs 
commercial) 
Blinding (performance & detection bias) Low  
Subjects in the commercial arm were instructed not to mention their participation in a research study to other group 
participants or staff at the program site. However, participants were given vouchers, so the group leaders could have 
realised that they were not ordinary clients. It does not state whether the dietician in the self-help group knew that their 
new clients were involved in a research project. The dietician could have given additional advice during the 20 minute 
consultation 
Blinding of participants and personnel 
(performance bias) 
Low  
Subjects in the commercial arm were instructed not to mention their participation in a research study to other group 
participants or staff at the program site. However, participants were given vouchers, so the group leaders could have 
realised that they were not ordinary clients. It does not state whether the dietician in the self-help group knew that their 
new clients were involved in a research project. The dietician could have given additional advice during the 20 minute 
consultation 
Blinding of outcome assessment (detection 
bias) 
High  
Authors do not report this. 
Incomplete outcome data (attrition bias) 
Low  
Three hundred eighty-one subjects (90%) attended the week 12 visit and 347 (82%) attended the week 26 visit to the 
clinical research centers. The numbers of dropouts were similar in the two groups (commercial 37, self-help 40), and 
dropouts were not different from subjects who continued to participate, except for a small difference in age (41.5 6 1.2 
years for dropouts vs 45.5 6 0.5 years for participants). 
Selective reporting (reporting bias) High  
Authors do not report this. 
Other bias  
Comments  
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Overview of study populations Heshka 2000 
Number invited 
484 went through screening. Authors do not report this. 
Number screened 
Of the 484 candidates who went through screening, 423 (87%) were enrolled in the trial (358 women, 65 men).  
Number randomised Randomization of 70 subjects per site, assignment was constrained to an equal number of self-help and commercial 
assignments within blocks of size 2 to 10. Block size, and assignment within each block, was determined by a random 
number table. A different randomization sequence was prepared for each site. 67 to 73 subjects at each of six clinical 
research centres. Of the 484 candidates who went through screening, 423 (87%) were enrolled in the trial (358 
women, 65 men). 211commercial 212 self-help 
(n) ITT 
Intervention 
Control 
Total 
An intention-to-treat analysis, with missing data replaced by last observation carried forward, was applied to measures 
of body weight and body mass index. Data were also analysed on an available-cases basis [i.e., using subjects who 
provided data at both week 12 and week 26, because intention-to-treat analyses may underestimate the effect of the 
actually administered treatment (14)]. Analysis of variance or covariance models were used to test the hypotheses of 
greater changes in the commercially treated subjects than in the self-help subjects. Statistical significance was set at 
0.05 (two sided). The chi-squared test was used to compare proportions; if overall differences were observed, 
binomial tests were used within categories to compare the commercially treated and self-help groups. Unless 
otherwise specified, continuous results are presented as mean 6 SD. Analyses were conducted using SAS version 
6.12 (SAS Institute, Inc., Cary, North Carolina) and SPSS version 8.0 (SPSS, Inc., Chicago, Illinois) statistical 
software. 
Number finishing study 174 commercial 172 self-help 
(%) of randomised patients finishing study 
 
82.46% commercial  
81.13% self help 
 
Description of interventions Heshka 2000 
Intervention(s) [route, frequency, total 
dose/day] 
 
Subjects assigned to the commercial program were given vouchers entitling them to attend Weight Watchers 
sessions, and the locations of publicly available Weight Watchers sites were reviewed with them. They were then left 
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Control(s) [route, frequency, total dose/day] 
to make their own choice of meeting location and time. 
Subjects assigned to self-help had 20-minute consultations with a dietician at the week 0 (randomization) and week 12 
visits and were given publicly available printed material orienting them to dietary principles and exercise guidelines for 
weight loss (10,11). Other resources, such as public library materials, web sites on the Internet, and telephone 
numbers of health promotion organizations offering free weight-control information, were drawn to their attention. 
 
Baseline characteristics Heshka 2000 
Number of intervention participants 
Number of control participants 
211 
212 
Participating population Men and women with a body mass index of 27 to 40 kg/m2, age 18 to 65 years, including those who had health 
problems for which weight reduction is a medically accepted therapy, were eligible. 
Sex [female %] Does not state the split between groups. 84.6% were women overall 
Age [mean years (SD)] 45 ±10 commercial 
44 ± 10 self-help 
HbA1c [mean % (SD)] Authors do not report this. 
BMI [mean kg/m2 (SD)] 33.8 ± 3.4 commercial 
33.6 ± 3.7 self-help 
Duration of disease [mean years (SD)] Authors do not report this. 
Ethnic groups [%] 
74% white, 13% African-American, 8% Hispanic, 1% Asian, and 4% other. 
Duration of intervention [mean ... (SD)] 26 weeks 
Duration of follow-up [mean ... (SD)] Authors do not report this. See other heshka study 
Co-medications Authors do not report this. 
Co-interventions Smokers 21 (10) commercial 
Smokers 19 (9) self-help 
Co-morbidities Authors do not report this. 
 
Matrix of study endpoints Heshka 2000 
Intervention(s) Commercial 
Weight loss 
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-4.8 ± 5.6kg 
Bmi 
-1.7±1.9 
Waist 
-4.3 ± 10.5 
Fat mass 
-3.8 ± 7.0 
serum homocysteine 
-0.5 ± 1.3 
Control (s) Weight loss 
-1.4±4.7 kg 
Bmi 
-0.5±1.6 
Waist 
-0.7 ± 12.7 
Fat mass 
-1.5 ± 7.6 kg, 
serum homocysteine 
0.9 6 1.8 mM, 
 
Primary endpoint(s) Authors do not report this. 
Secondary endpoint(s) Authors do not report this. 
Other endpoint(s)  
Effect size 
After 26 weeks, subjects in the commercial program, as compared with those in the self-help program, had greater 
decreases in body weight [mean (± SD) 24.8 6 5.6 vs 21.464.7 kg] and body mass index (21.761.9 vs20.561.6 kg/m2, 
both P ,0.001) in intention-to-treat analyses. 
 
Adverse events Heshka 2000 
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All adverse events Authors do not report this.  
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Bibliographic Details  
Study ID Heshka 2003 
Author (first) Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, Kolotkin RL, Miller-Kovach K, Pi-Sunyer 
FX. 
Journal  JAMA 
Year 2003 
Volume 289 
Pages 
1792-1798 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details Stanley Heshka  
sh311@columbia.edu 
 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
 
Participants Exclusion criteria 
Fasting glucose higher than 140 mg/dL (7.8 mmol/L), triglycerides higher than 1000 mg/dL (11.3 mmol/L), liver 
function test results (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, lactate 
dehydrogenase, -glutamyltransferase, and bilirubin) more than 2 times the upper normal limit, and serum creatinine 
higher than 1.4 mg/dL (124 mol/L). Also excluded were potential participants using systemic or inhaled 
corticosteroids or lithium, having a history of alcohol abuse within the past year, or having a history or presence of a 
significant psychiatric disorder or any condition that, in the investigator’s judgment, would interfere with participation in 
the trial. Potential participants who initiated a new drug therapy within 30 days of randomization, who were already 
participating in a weight loss program, or who took prescription weight loss or investigational medications within 90 
days of randomization were also excluded. 
Inclusion criteria 
  
 
Appendix 34: Data extraction sheet; Heshka 2003 
402 
 
Men and women with a BMI of 27 to 40, aged 18 to 65 years, including persons with health problems for which weight 
reduction is a medically accepted therapy, were eligible for the study. 
Diagnostic criteria 
Interventions Number of study centres: 6 US clinical centers 
Country/location :US 
Setting: Authors do not report this. Research centres (doesn’t specifically state where the self-help or commercial 
interventions were held, i.e. community centre etc) 
Treatment before study: Authors do not report this. 
Titration period: Authors do not report this. 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Primary outcome(s) Weight change 
Secondary outcome (s) Waist circumference, body mass index, blood pressure, serum lipids, glucose, and insulin 
levels. 
Other outcome (s) 
Study details Run-in period: Authors do not report this. 
Study terminated before regular end: Authors do not report this. 
Publication details Language of publication:  English 
Commercial funding: This study was supported by a grant from Weight Watchers International (Woodbury, NY) to the 
New York Obesity Research Center at St Luke’s/ Roosevelt Hospital. 
Non-commercial funding: Authors do not report this. 
Publication status (peer review journal):  Yes 
Publication status (journal supplement): Authors do not report this. 
Publication status (abstract): Authors do not report this. 
Stated aim for study Quote “To compare weight loss and health benefits achieved and maintained through self-help weight loss vs with a 
structured commercial program.” 
Notes  
 
Risk of bias unclear / low / high risk 
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Random sequence generation (selection 
bias) Low  
randomization envelope prepared by the data coordinating center was opened and the participant was assigned to 
self-help or the commercial program 
Allocation concealment  (selection bias) High  
Authors do not report this. 
Blinding (performance & detection bias) Low 
Participants and investigators at each site were blind to the assignment condition until the envelope was opened. 
Blinding of participants and personnel 
(performance bias) 
Low  
Participants and investigators at each site were blind to the assignment condition until the envelope was opened. 
Blinding of outcome assessment (detection 
bias) 
High  
Authors do not report this. 
Incomplete outcome data (attrition bias) High  
Authors do not report this. 
Selective reporting (reporting bias) High  
Authors do not report this. 
Other bias  
Comments  
 
Overview of study populations Heshka 2003 
Number invited  Authors do not report how many were invited, only that 484 assessed for eligibility 
 
Number screened 484 assessed for eligibility 
 
Number randomised 423 randomised 
211 intervention group (commercial) 
212 (self-help) 
(n) ITT 
Intervention 
Control 
Total 
Three analyses were performed on weight change and related outcome variables: an intent-to-treat (ITT) analysis 
including all randomized participants (missing values were imputed by last-observation-carried-forward or linear 
interpolation and participants who made no follow-up visits were assumed to remain at baseline value); a modified ITT 
analysis including all participants who made at least 1 clinic visit after randomization; and a completers analysis using 
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only participants who completed the study. 
Number finishing study Commercial 
Follow-up Measurement Visits 
198 at Week 12 
175 at Week 26 
176 at Week 52 
154 at Week 78 
 
Self-help 
183 at Week 12 
172 at Week 26 
170 at Week 52 
156 at Week 78 
 
Commercial 
61 Lost to Follow-up or Withdrew Consent 
Self-help 
53 Lost to Follow-up or Withdrew Consent 
 
Commercial 
150 Completed Week 104 
Self-help 
159 Completed Week 104 
 
Commercial 
211 Included in Intent-to- Treat Analysis 
198 Included in Modified Intent-to-Treat Analysis 
148 Included in Completers Analysis 
2 Excluded From Completers Analysis (Lymphoma) 
Self-help 
212 Included in Intent to- Treat Analysis 
188 Included in Modified Intent-to-Treat Analysis 
159 Included in Completers Analysis 
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(%) of randomised patients finishing study After two years 71% of commercial  participants had completed the study, and 75% of self-help participants had 
completed the study 
 
Description of interventions Heshka 2003 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
 
 
 
Control(s) [route, frequency, total dose/day] 
Participants assigned to the commercial program were given vouchers entitling them to attendance at sessions of 
Weight  Watchers, and the locations of available sites of this commercial program were reviewed with them. The 
vouchers enabled participants to attend sessions at no cost and, during the study period. Weekly group meetings of 
approximately an hour’s duration are led by successful program graduates who act as role models and provide written 
educational materials, a weekly weigh-in, and social support. 
 
Participants assigned to the self-help group received 20-minute consultations with a dietitian at the week 0 (baseline) 
and week 12 visits and were given publicly available printed material orienting them to dietary principles and exercise 
guidelines for safe weight loss.16,17 Other resources such as public library materials, Web sites, and telephone 
numbers of health promotion organizations  offering free weight control information were drawn to their attention. 
 
 
Baseline characteristics Heshka 2003  
Number of intervention participants 
Number of control participants 
 211 
212 
Participating population Overweight and obese men (n=65) and women (n=358) (body mass 
index, 27-40) aged 18 to 65 years. 
Sex [female %] 82% commercial 
87% self-help 
Age [mean years (SD)] 46 (10) commercial 
44(10) self-help 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] 33.8 (3.4) commercial 
33.6 (3.7) self-help 
Duration of disease [mean years (SD)] Authors do not report this 
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Ethnic groups [%] Authors do not report this 
Duration of intervention [mean ... (SD)] 26 weeks 
Duration of follow-up [mean ... (SD)] 52, 78, and 104 weeks follow up 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Heshka 2003 
Intervention(s) See below 
Control (s) See below 
Primary endpoint(s) Commercial 
1year weight change 
(−4.3 [6.1] kg,  
2 year weight change 
(−2.9 [6.5] kg 
Self-help 
1 year weight change 
−1.3 [6.1] kg 
2 year weight change 
 −0.2 [6.5] kg 
 
Secondary endpoint(s) Commercial Waist change year 1 
−4.1 (0.6)  
Self-help Waist change year 1 
−1.6 (0.6) 
Commercial Waist change year 2 
−2.4 (0.6)  
Self help Waist change year 2  
−0.6 (0.6) 
Commercial 1year Blood pressure, mm Hg Systolic 
 −0.6 (0.9) 
Self-help 1 year Blood pressure, mm Hg Systolic 
0.2 (0.8) 
Commercial systolic year 2 
−2.2 (1.1)*  
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Self-help systolic year 2 
−2.4 (1.0)* 
Commercial 1 year Diastolic −0.4 (0.6)  
Self-help 1 year diastolic 
1.4 (0.6)* 
Commercial diastolic year 2 
−0.6 (0.7)  
Self-help diastolic year 2 
0 (0.6) 
Commercial year 1 Glucose, mg/dL  
3.5 (0.6)*  
Self year year 1 Glucose, mg/dL 
3.6 (0.6)* 
Commercial year 2 Glucose, mg/dL 
5.2 (0.7)*  
Self-help year 2 Glucose, mg/dL 
4.6 (0.7)* 
Commercial Insulin, IU/L year 1 
−2.0 (0.5)* 
Self help Insulin, IU/L  year 1 
−0.3 (0.5) 
Commercial Insulin, IU/L year 2 
0.6 (0.6) 
Self-help Commercial Insulin, IU/L year 2 
2.3 (0.6)* 
Cholesterol, mg/dL Total year 1commercial 
l −8.7 (1.7)* 
Cholesterol, mg/dL Total year 1self-help 
 −9.5 (1.7)*  
Cholesterol, mg/dL Total year 2commercial 
 −10.4 (2.0)* 
Cholesterol, mg/dL Total year 2 self-help 
 −11.3 (1.9)* 
HDL commercial year 1 
2.0 (0.7)* 
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HDL self-help year 1 
 0.8 (0.7)  
HDL commercial year 2 
 0.5 (0.8) 
HDL self-help year 2 
 0.6 (0.8) 
HDL/total cholesterol ratio commercial year 1 
 0.02 (0.003)*self-help year 1 
HDL/total cholesterol ratio 
 0.020 (0.003)*  
HDL/total cholesterol ratio commercial year 2 
 0.02 (0.003)* 
HDL/total cholesterol ratio self-help year 2 
 0.02 (0.003)* 
Triglycerides, mg/dL  commercial year 1 
−7.8 (3.7)* 
Triglycerides, mg/dL  self-help year 1 
 1.5 (3.8)  
Triglycerides, mg/dL  commercial year 2 
 −0.3 (4.0) 
Triglycerides, mg/dL  self-help year 2 
 −0.1 (3.9)  
 
 
Other endpoint(s)  
Effect size 
In ITT analysis, mean(SD) weight loss of participants in the commercial group was greater than in the self-help group 
at 1 year (−4.3 [6.1] kg vs −1.3 [6.1] kg) and at 2 years (−2.9 [6.5] kg vs −0.2 [6.5] kg).  Body mass index also 
decreased more in the commercial group −1.6 (0.2)  vs −0.5 (0.2) self-help 
 
Adverse events Heshka 2003 
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All adverse events 2 Lymphoma participants excluded from the study (possibly not due to the study) 
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Bibliographic Details  
Study ID Lowe 2001 
Author (first) Lowe MR,  Miller-Kovach K,  Phelan S. 
Journal  International journal of obesity 
Year 2001 
Volume 25 
Pages 325-331 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details 
MR Lowe, Department of Clinical and Health Psychology, Mail Stop 626, MCP Hahnemann University, Philadelphia, 
PA 19102, USA. E-mail: lowe@drexel.edu 
 
Character of included studies  
Methods  
Controlled before and after 
Participants Exclusion criteria 
Over 61 000 were ineligible due to incorrect telephone or zip code numbers 
Inclusion criteria 
All participants had formerly been Weight Watchers members and reached goal weight while in the program.  
Interventions Number of study centres: Authors do not report this. This study was after participants had used Weight Watchers 
Country/location: US 
Setting: Authors do not report this. This study was after participants had used Weight Watchers 
Treatment before study: Authors do not report this. 
Titration period: Authors do not report this. 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Maintained a loss of 5% or more 
Maintained a loss of 10% or more 
Primary outcome(s): Authors do not report this. 
Secondary outcome (s): Authors do not report this. 
Other outcome (s) 
Study details Run-in period: Authors do not report this. 
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Study terminated before regular end: Authors do not report this. 
Publication details Language of publication: English 
Commercial funding: Authors do not report this. 
Non-commercial funding: Authors do not report this. 
Publication status (peer review journal): yes 
Publication status (journal supplement): Authors do not report this. 
Publication status (abstract): Authors do not report this. 
Stated aim for study 
Quote “To determine weight loss maintenance among participants in a commercial weight loss program (Weight 
Watchers) who had reached their goal weights 1 - 5 y previously. “ 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
Low 
Not randomised, study had already been carried out 
Allocation concealment  (selection bias) Low 
Authors do not report this. 
Blinding (performance & detection bias) Low 
Authors do not report this. 
Blinding of participants and personnel 
(performance bias) 
Low  
Authors do not report this. 
Blinding of outcome assessment (detection 
bias) 
Low 
Authors do not report this. 
Incomplete outcome data (attrition bias) Low 
Authors do not report this. 
Selective reporting (reporting bias) Low 
Authors do not report this. 
Other bias Self-report was used. However, a second sample (oversample) was used using a stratification procedure to adjest for 
self-reporting. Money was given as an incentive to take part in an additional survey 
Comments  
 
Overview of study populations Lowe 2001 
Number invited First sample was 189 780 participants, 61000 were not eligible. 1002 randomly selected lifetime members. 
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(number screened 
First sample was 189 780 participants, 61000 were not eligible. 1002 randomly selected lifetime members. 
Number randomised Not applicable 
(n) ITT 
Intervention 
Control 
Total 
Not applicable 
Number finishing study Not applicable 
(%) of randomised patients finishing study 
 
Not applicable 
 
Description of interventions Lowe 2001 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
 
 
 
 
 
 
Control(s) [route, frequency, total dose/day] 
The Weight Watchers program includes a food plan, an activity plan, and a behaviour modification plan focused 
primarily on cognitive restructuring. The food plan is a nutritionally balanced, moderate deficit diet designed to produce 
a weight loss of up to 0.9 kg per week. The activity plan involves the recommendation to accumulate 30 min of 
physical activity on most (preferably all) days of the week. Weekly group meetings, led by successful program 
graduates who act as role models, provide written educational materials, a weekly weigh-in, and social support. Goals 
weights are determined by the individual member and must be at least 5 lb less than the member's joining weight. 
Members are encouraged to select a weight goal within the BMI range of 20 ± 25. Because lifetime status comes with 
free services and most members have a substantial amount to lose, the vast majority choose a weight goal equivalent 
to a BMI of 25. In addition, Weight Watchers confers lifetime member eligibility to members who provide a weight goal 
from a qualified health professional who has stated that the prescribed weight (even if above a BMI of 25) is deemed 
healthy based on an individual assessment of the member. 
 
Baseline characteristics Lowe 2001 
Number of intervention participants 
Number of control participants 
1002 in total 
Participating population All participants had formerly been Weight Watchers members and reached goal weight while in the program. 
Sex [female %] 96% in national sample 95.0% in oversample 
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Age [mean years (SD)] Not in mean but in age groups 
18-24 0.7% national sample 0.4% oversample 
25-29 3.0%   national sample   2.7%   oversample 
30-34  8.7% national sample   10.9%   oversample 
35 - 44 31.9%   national sample   32.2%   oversample 
45 - 54 31.5%    national sample  30.2%   oversample 
55 -64 15.7%     national sample  14.0%   oversample 
65 and over 8.6%    national sample   9.7%   oversample 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] Authors do not report this 
Duration of disease [mean years (SD)] Authors do not report this 
Ethnic groups [%] Authors do not report this 
Duration of intervention [mean ... (SD)] Authors do not report this 
Duration of follow-up [mean ... (SD)] 1-5 years follow up 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Lowe 2001 
Intervention(s) 1992 (50) 70.2±11.5 self reported weight 72.3±12.2    measured weight 0.03 Discrepancy between reported and 
actual weight 
1993 (50) 67.9±10.7 self reported weight 70.7±11.4 measured weight 0.04 Discrepancy between reported and actual 
weight 
1994 (56) 67.1±10.5 self-reported weight 69.0±11.4 measured weight 0.03 Discrepancy between reported and actual 
weight 
1995 (66) 64.5±7.4 self reported weight 66.4±8.1measured weight  0.03 Discrepancy between reported and actual 
weight 
1996 (36) 65.8±7.2 self reported weight 66.8±7.8 measured weight 0.02 Discrepancy between reported and actual 
weight 
Average 67.0±9.8 self reported weight 69.0±10.5  measured weight  0.03 Discrepancy between reported and actual 
weight 
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                                                    1992      1993      1994      1995      1996      Overall 
kg regain                                      7.4 5.8    8.4 8.3  6.0 5.6   5.7 5.4   2.9 5.1   5.7 6.1 
Percentage weight loss regained 76.5       61.2 77.9 60.1 59.8 57.9 53.7 54.8 31.5 44.3 56.4 57.1 
Percentage within 5 lb of goal      19.4       14.7        27.0        25.9      47.6       28.3 
Percentage maintained _5% loss 42.6       46.0       54.3       60.1       69.6       56.8 
Percentage maintained _10% loss 18.8     30.2       32.4       35.0      51.6        35.4 
Percentage below initial weight       70.3     60.2       80.0      82.7      92.5        79.6 
Percentage below goal weight         3.9      4.7        11.1      11.5      17.8         10.9 
Control (s)  
Primary endpoint(s) Authors do not report this 
Secondary endpoint(s) Authors do not report this 
Other endpoint(s)  
Effect size 
Based on corrected weights, weight regain from 1 to 5 y following weight loss ranged between 31.5 and 76.5%. At5 y, 
19.4% were within 5 lb of goal weight, 42.6% maintained a loss of 5% or more, 18.8% maintained a loss of 10% or 
more, and 70.3% were below initial weight. 
 
Adverse events Lowe 2001 
All adverse events Authors do not report this 
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Bibliographic Details  
Study ID Morgan 2008 
Author (first) Morgan LM, Griffin BA, Millward DJ, DeLooy A, Fox KR, Baic S, Bonham MP, Wallace JM, MacDonald I, Taylor MA, 
Truby H. 
Journal  Public Health Nutrition 
Year 2008 
Volume 12 (6) 
Pages 799–807 
Language ENGLISH 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details L.Morgan@surrey.ac.uk 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT)    multicentred 
 
Participants Exclusion criteria 
prior history of CHD, known type 1 or 2 diabetes, liver or respiratory failure, gout, lipid-lowering or anti-hypertensive 
medication, history of obesity with known cause (i.e. Cushing’s syndrome, hypothyroidism), previous gastric or weight-
loss surgery, taking any weight-losing drugs (including Orlistat or Sibutramine), clinical depression, eating disorders, 
drug or alcohol abuse, any  malabsorptive state (including lactose intolerance), treatment for a malignancy, pregnancy 
or breast-feeding.  
Inclusion criteria 
18 to 65 years 
Who lived within 30 miles of a test centre and had a self reported BMI between 27 and 40 kg/m2. 
Interventions Number of study centres: five 
Country/location: UK 
Setting: testing at five different universities 
Treatment before: Authors do not report this 
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Titration period: Authors do not report this 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
A range of outcomes were collected. However, plasma lipids and lipoproteins appear to be the key measures, related 
to cvd risk for this study. 
Primary outcome(s) Authors do not report this 
Secondary outcome (s) Authors do not report this 
Other outcome (s) 
Study details Run-in period none:       The control was a delayed treatment group which involved no dietary intervention until after 6 
months. 
Study terminated before regular end none 
Publication details Language of publication: English 
Commercial funding: British Broadcasting Corporation 
Non-commercial funding: Authors do not report this 
Publication status (peer review journal): yes 
Publication status (journal supplement): Authors do not report this 
Publication status (abstract): Authors do not report this 
Stated aim for study 
Quote “To investigate the relative efficacy of four popular weight-loss programmes on plasma lipids and lipoproteins 
as measures of CVD risk.” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) Low  
Participants were stratified by gender (only 30% of participants were male) and randomly allocated to any of the five 
groups (four diets and control). 
Allocation concealment  (selection bias) High 
Participants would have known what they were assigned too 
Blinding (performance & detection bias) Low 
Group leaders did not take any measures.  
Blinding of participants and personnel High 
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(performance bias) Authors do not report this 
Blinding of outcome assessment (detection 
bias) 
High  
Authors do not report this 
Incomplete outcome data (attrition bias) Low  
28% dropped out 
Selective reporting (reporting bias) High 
Authors do not report this 
Other bias High  
Money to attend the classes was reimbursed. This therefore did not arise suspicion, in that pre paid vouchers were not 
given. Receipts could be required for tax purposes. Travel costs were also reimbursed. 
Comments  
 
Overview of study populations Morgan 2008 
Number invited 
 
300 obese men and women were recruitment via a BBC advertising campaign 
Number screened Authors do not report this 
Number randomised 
 
Each centre aimed to recruit a cohort of sixty participants, to allow twelve in each diet group plus a further twelve in a 
control group 
(n) ITT 
Intervention 
Control 
Total 
Authors do not report this 
Number finishing study 
 
52 
(%) of randomised patients finishing study 
 
Data was available for 17.74% of participants at 6 months 
 
The authors report 28% 
 
Description of interventions Morgan 2008 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
For the group-based programmes (Weight Watchers and Rosemary Conley), participants arranged to attend the most 
geographically convenient class and the costs of joining and attending one class per week for 6 months were 
reimbursed on presentation of receipts. Both parent companies of Weight Watchers (www.weightwatchers.co. uk) and 
Rosemary Conley (www.rosemary-conley.co.uk) signed a contract committing to the provision of standard care. For 
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Control(s) [route, frequency, total dose/day] 
Slim-Fast, the cost of up to two meal replacements per day was reimbursed on presentation of receipts, and a copy of 
the Slim-Fast Support Pack was provided. The Atkins group was given a copy of Dr Atkins’ New Diet Revolution. 
 
 
Control group subjects were asked to maintain their current diet and exercise pattern and were offered any of the diets 
for 6 months at the end of study, free of charge. 
 
Baseline characteristics Morgan 2008 
Number of Intervention participants  
 
 
 
Number of Control participants 
Atkins 57 
Weight watchers 58 
Slim fast 59 
Rosemary Connelly 58 
Control 61 
Participating population 18 to 65 years. Who lived within 30 miles of a test centre and had a self reported BMI between 27 and 40 kg/m2. 
Sex [female %] 73.1% 
Age [mean years (SD)] Atkins 40.9 (9.7)  weight watchers 39.9(10.9) slim fast 38.9(10.7)  rosemary conelly 40.6(10.3) whole cohort 40.3(10.2) 
control  40.8(9.6) 
 
HbA1c [mean % (SD)] Authors did not report 
BMI [mean kg/m2 (SD)] 31.7 (2.7) 
Duration of disease [mean years (SD)] Authors did not report 
Ethnic groups [%] Authors did not report 
Duration of intervention [mean ... (SD)] 6 months 
Duration of follow-up [mean ... (SD)] Authors did not report 
Co-medications Authors did not report 
Co-interventions Authors did not report 
Co-morbidities Authors did not report 
 
Matrix of study endpoints Morgan 2008 
Intervention(s) 2 months 
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Weight  
85.1** (10.9) atkins  84.2** (13.2) weight watchers  87.2** (12.4)slim fast  82.8** (12.4)  rosemary Connelly  86.9 
(14.8) control 
TAG mmol/l 
1.07** (0.44)atkins  1.25** (0.47) weight watchers  1.47 91.04) slim fast  1.34** (0.58) rosemary Connelly  1.50  control 
(0.65) 
LDL-C mmol/L 
3.59 (0.73) atkins 3.12**( 0.71) weight watchers 3.29**( 0.68) slim fast 3.21**( 0.66) rosemary Connelly 3.79( 0.78) 
control 
HDL-C mmol/L 
1.24 (0.25) atkins  1.04** (0.21) weight watchers 1.15**( 0.28) slim fast 1.07**( 0.24) rosemary Connelly 1.22 (0.24) 
control 
Glucose mmol/l 
5.52 (0.43) atkins  5.36 (0.51) weight watchers  5.41( 0.49) slim fast  5.50 (0.53) rosemary Connelly  5.42( 0.43) 
control 
Insulin pmol/l 
75.2 (83.6) atkins  57.2 (35.9) weight watchers  80.1( 67.1) slim fast  63.7( 31.8) rosemary Connelly 69.2 (41.0) control 
 
 
6 months 
Weight 
83.2** 10.6 81.4** 13.6 85.4** 12.2 79.4** 12.6 88.5 15.0 
Tag 
83.2** 10.6 81.4** 13.6 85.4** 12.2 79.4** 12.6 88.5 15.0 
Ldl-c 
3.56 0.76 3.13** 0.58 3.31** 0.70 3.15** 0.57 3.55 0.73 
Ldl peak density (g/l) 
1.0280** 0.0021 1.0281** 0.0021 1.0286** 0.0030 1.0285** 0.0031 1.0287** 0.0032 
Hdl-c 
1.14 0.32 0.98** 0.15 1.09** 0.27 1.02** 0.25 1.04** 0.20 
Glucose 
5.30* 0.61 4.95** 0.65 5.23* 0.60 5.23** 0.54 5.18* 0.51 
Insulin 
54.8 32.4 52.9 30.2 64.6** 39.6 58.5 34.8 75.9 45.0 
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Control (s) See above for control data 
Primary endpoint(s) Authors did not report 
Secondary endpoint(s) Authors did not report 
Other endpoint(s)  
Effect size 
Significant weight loss was achieved by all dieting groups (5–9 kg at 6 months) but no significant difference was 
observed between diets at 6 months. 
 
Adverse events Morgan 2008 
All adverse events Authors did not report 
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Bibliographic Details  
Study ID Rippe 1998 
Author (first) Rippe JM, Price JM, Hess SA, Kline G, DeMers KA, Damitz S,Kreidieh I, Freedson P. 
Journal  Obesity research 
Year 1998 
Volume 6 (3) 
Pages 208-218 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details 
James M. Rippe, M.D., Director, The Center for Clinical and Lifestyle Research, 21 North Quinsigamond Avenue, 
Shrewsbury, MA 01545.. 
 
Character of included studies  
Methods  
randomized prospective trial 
Participants Exclusion criteria 
Potential subjects were excluded if they had participated in a weight loss or exercise program during the previous 
three months. Individuals who reported orthopaedic or cardiovascular problems which would prevent participation in 
an exercise program were also excluded. Potential subjects were excluded if they were undergoing psychological 
counselling or taking any psychotropic medications or medications known to affect heart rate response to exercise or 
metabolic rate. Not pregnant or lactating and agreed to use adequate birth control while participating in the study. 
 
Inclusion criteria 
Overweight women 
Table of desirable weight for height participated in the study. 
 
Interventions Number of study centres: single centre 
Country/location: US 
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Setting: Authors do not report this. The setting would be at the commercial weight loss setting (community 
centre/school etc) 
Treatment before study: Before and after the 12-week study intervention all subjects underwent a graded maximal 
exercise test with direct measurement of maximal oxygen consumption (Vojmax).Psychological inventories were 
administered before and after the 12-week study period. 
Titration period: Authors do not report this. 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
 
Primary outcome(s) Primary outcome of interest in this investigation was the interaction between pre-to-post change 
and group identification (treatment or control). 
Secondary outcome (s) 
Other outcome (s) 
Weight change 
VO2 max 
Heart rate 
Systolic BP 
Diastolic BP 
Activity score 
Percentage change in body fat 
 
Study details Run-in period: Authors do not report this. 
Study terminated before regular end: Authors do not report this. 
Publication details Language of publication: English 
Commercial funding: Grant from Weight Watchers International. 
Non-commercial funding: Authors do not report this. 
Publication status (peer review journal): yes 
Publication status (journal supplement): Authors do not report this. 
Publication status (abstract): Authors do not report this. 
Stated aim for study 
Quote “To study the effects of a 12-week weight loss strategy involving increased physical activity, self-selected 
hypocaloric diet, and group support on psychological wellbeing, quality of life, and health practices in moderately 
obese women.” 
Notes  
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Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
High  
Women were assigned to control or intervention; it does not state how this was done. 
Allocation concealment  (selection bias) High  
Authors do not report this. 
Blinding (performance & detection bias) High  
Participants knew what they were assigned too, it does not state if they were told not to discuss with the researchers 
taking their measures. 
Blinding of participants and personnel 
(performance bias) 
High 
It does not state whether the researchers knew what arm the participants were assigned too. If they did know, this 
could have impacted on the results if other measures were used (e.g. waist)  
Blinding of outcome assessment (detection 
bias) 
Authors do not report this. 
Incomplete outcome data (attrition bias) 10 withdrew from the intervention (n=30) and 26 withdrew from the control group (n=14). 14 out of the 26 who 
withdrew were unhappy that they were not in the intervention group. Therefore, they must of known what the 
intervention was. 
Selective reporting (reporting bias) Authors do not report this. 
Other bias  
Comments  
 
Overview of study populations Rippe 1998 
Number of intervention participants 
Number of control participants  
Authors do not report if there were more participants initially than those listed. 
Number screened Authors do not report if there were only the 80 who took part, or if there were more participants, and after screening 
there were 80. 
Number randomised 40 
40 
 
(n) ITT 
Intervention 
Control 
Total 
Authors do not report this. 
Number finishing the study 44 in total  
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30 intervention 
14 control 
(%) of randomised patients finishing study 
 
75% intervention 
35% control 
 
 
Description of interventions Rippe 1998 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
 
 
 
 
Control(s) [route, frequency, total dose/day] 
Weight watchers participants received no further supervision or nutritional counselling other than that provided as a 
standard part of this program. The nutrition portion of the program consisted of a self-selected, hypo caloric diet with a 
caloric range of 33,258 to 41,462 kJ. The emphasis of the nutritional portion of the program is on food that is self-
selected. The food plan is designed to be hypo caloric while nutritionally balanced and in line with public health 
guidelines. This program also requires members to take a multiple vitamin/nutritional supplement that provides no 
more than 100% of the U.S. recommended daily allowance (RDA). Subjects were instructed to increase weekly 
physical activity to 4184 kJ during the second week, to 5232.5 kJ during the third week, and 6379 kJ each week 
thereafter. Most of the subjects obtained this increased physical activity through walking of moderate intensity, 
although a wide variety of other activities was allowed. 
 
 
 
Dietary intake was recorded by all subjects for four days immediately before the intervention, at the midpoint of the 
intervention, and immediately after the 12 weeks of the intervention using standard techniques. Subjects recorded 
everything they ate and drank for four consecutive days with one day falling on a weekend. They were instructed to 
measure the volume and size of foods and drink and to estimate weight of meats by comparison with sample pictures 
provided of actual sizes. Subjects who did not provide appropriate detail about their intake were questioned further for 
the needed information. Data were analysed for nutrient content using a commercially available software package. 
Control subjects were requested to maintain prior activity levels throughout the study period and not to initiate any new 
exercise program. 
 
 
Baseline characteristics Rippe 1998 
Number of intervention participants 
Number of control participants 
40 
40 
Participating population Overweight women 
Table of desirable weight for height participated in the study. 
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Sex [female %] 100% 
Age [mean years (SD)] Intervention 37.4(7.9) control    35.6(5.9) 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] Authors do not report this 
Duration of disease [mean years (SD)] Authors do not report this 
Ethnic groups [%] Authors do not report this 
Duration of intervention [mean ... (SD)] 12 weeks 
Duration of follow-up [mean ... (SD)] Authors do not report this 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Rippe 1998 
Intervention(s) See below 
Control (s) See below 
Primary endpoint(s) See below 
Secondary endpoint(s) See below  
Other endpoint(s) Weight 
6.07 ± 4.01 intervention 1.31 ± 1.28 kg control  
Body fat 
4.3% reduction in body fat (intervention) 0.2% reduction in body fat 
Activity level from baseline to endpoint 
+4.4(2.3) intervention    +0.7(0.3) control 
VO2 max change from baseline to endpoint 
+3.8(3.3) intervention        -2.7(3.5) control  
Diastolic blood pressure change from baseline to end point 
-4.3(9.6) intervention   -2.1(7.9) control 
Heart rate change from baseline to endpoint 
+2.2(11.1) control   -6.2(11.6) intervention 
Systolic BP baseline change to endpoint 
-3.2(11.8) control -6.5(13.1)  intervention 
Psychological data (significant differences) change from baseline to endpoint 
Body cathexis 
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0.7(8.6)      control   18.6(16.7)   intervention 
Sonstroem 
0.9(5.9)  control   8.1(7.1)   intervention 
Rosenberg 
-0.4(2.6)       control  3.5(3.3)    intervention 
Stati trait 
0.3(3.7)    control  5.7(7.4)    intervention 
Poms-vigor 
-0.8(4.2)         control -6.5(5.6)      intervention 
Quality of life subscales (significant differences) change from baseline to endpoint 
Physical function 
1.4(9.5)   control   13.5(16.7) intervention 
Vitality 
2.9(20.8)     control  21.7(17.9) intervention 
Mental health 
2.3( 10.1)   control   10.4(16.0)   intervention 
Effect size 
The intervention group lost significant body weight (kg) and body fat (%) compared to controls (-6.07 ± 4.01 kg vs. 
1.31 ± 1.28 kg; 36.8%-32.5% vs. 36.2%-36.0%). 
 
Adverse events Rippe 1998 
All adverse events Authors do not report this 
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Bibliographic Details  
Study ID Rolland 2009 
Author (first) Rolland C, Hession M, Murray S, Wise A, Broom I. 
Journal  Journal of Diabetes 
Year 2009 
Volume 1 
Pages 207-217 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Paper 
Corresponding author and contact details 
Catherine Rolland, Centre for Obesity Research and Epidemiology, Robert Gordon University, St Andrew Street, 
AB25 1HG Aberdeen, UK. 
Tel: +44 01224 262893 
Fax: +44 01224 262828 
Email: c.rolland@rgu.ac.uk 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
 
Participants Exclusion criteria 
Patients with a history of hepatic or renal disease, cancer, currently pregnant or lactating, on antidepressants or anti-
obesity medication, or those with eating disorders were excluded from the study. 
Inclusion criteria 
Patients referred to a Specialist Obesity Clinic were entered into a randomized controlled clinical trial (RCT) of differing 
dietary interventions in the management of their obesity. Men and women >18 years of age and with a body mass 
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index (BMI) ≥35 kg m2 were included in the study. 
Interventions Number of study centres: Authors do not report this 
Country/location: UK 
Setting: Authors do not report this 
Treatment before study : Authors do not report this  
Titration period not reported: Authors do not report this 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
 
Primary outcome(s) 
Weight loss 
Secondary outcome (s) 
Other outcome (s) 
Bmi 
% body fat 
Fat mass 
Fat free mass 
Waist circumference 
Study details Run-in period : Authors do not report this 
Study terminated before regular end: Authors do not report this  
Publication details Language of publication: English 
Commercial funding Lighter Life uk 
Non-commercial funding: Authors do not report this 
Publication status (peer review journal): yes 
Publication status (journal supplement): Authors do not report this 
Publication status (abstract): Authors do not report this 
Stated aim for study 
Quote. Authors do not report this. The closest aim is: The present study assesses the effectiveness of an LCHP, a 
commercial very low-calorie diet (VLCD; Lighter Life (LL)), and a 600 kcal-deficient (CDD) diet in an obese population. 
Notes  
 
Risk of bias unclear / low / high risk 
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Random sequence generation (selection 
bias) High  
Authors do not report this 
At the end of the screening period, patients who did not achieve a 5% weight loss were randomized to either LCHP or 
LL. Though it does not state how this was done, was it opaque envelopes given by an independent statistician???. 
It states that there were significant differences in BMI, weight and fat free mass of those who did not achieve 5% 
weight loss. However, it does not state how the randomisation was adjusted according to this, i.e. did they ensure that 
there were equal weights between groups 
Allocation concealment  (selection bias) It does not state if the allocation was blind to participants or researchers. Nor does it state if the same staff carried out 
the data collection procedures (this would not impact on the results anyhow, as methods to collect data would not 
have researcher error involved) 
Blinding (performance & detection bias) High 
Authors do not report if the allocation was blind to participants or researchers. Nor does it state if the same staff 
carried out the data collection procedures (this would not impact on the results anyhow, as methods to collect data 
would not have researcher error involved) 
Blinding of participants and personnel 
(performance bias) 
 
High 
Authors do not report if the allocation was blind to participants or researchers. Nor does it state if the same staff 
carried out the data collection procedures (this would not impact on the results anyhow, as methods to collect data 
would not have researcher error involved) 
Blinding of outcome assessment (detection 
bias) 
High 
Authors do not report if the anthropometrics at three months were told to the participants. This could have impacted on 
the results if participants wanted to lose more weight, they potentially could have free styled and done additional 
exercise to lose more weight. 
Incomplete outcome data (attrition bias) 20 out of 34 dropped out of lighter life, and 38 out of 38 dropped out of low carb high protein diet 
Selective reporting (reporting bias) Authors do not report this 
Other bias  
Comments  
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Overview of study populations Rolland 2009 
Number invited 254 patients contacted 
Number screened 120 
Number randomised 34 intervention 
38 control 
(n) ITT 
Intervention 
Control 
Total 
Not reported 
Number finishing the study 14 intervention 
20 control 
(%) of randomised patients finishing study 
 
41.2% intervention 
52.6% control 
 
Description of interventions Rolland 2009 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lighter life 
The LL is a VLCD that is administered in the shape of soups, shakes, and bars to replace conventional food and 
provide a daily average of 550 kcal (36% carbohydrate, 36% protein, and 28% fat and at least 100% of the 
recommended daily allowance (RDA) of vitamins and minerals). Patients are advised to remain adequately hydrated 
while on the diet. The LL has two distinctive stages: (i) weight loss; and (ii) on-going weight management. During each 
stage, patients attend weekly single sex group meetings with seven to 12 people that are delivered by a trained LL 
counsellor, enabling active management of motivation and concordance, using group support and counselling to 
encourage long-term behavioural modification and weight management. The groups consisted of a mix of research 
subjects and self-referred individuals. Patients were required to remain on the weight loss phase for a minimum of 3 
months, after which they were given a choice to continue for up to another 6 months or to be assigned to the 
management phase. On average, patients who finished the study remained on the diet for 6.9 months (range 4–9 
months). For the weight management phase, solid foods are reintroduced over a 12-week period, during which 
patients are slowly weaned off food packs while still receiving counselling and support. Advice on healthy eating and 
exercise and continual support are offered. LL patients also came monthly to the trial centre to be weighed for the first 
3 months and then every other month after screening, resulting in six visits over 9 months during which they discussed 
their on-going LL treatment. Telephone and email support was also available throughout. 
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Control(s) [route, frequency, total dose/day] 
 
 
 
Low carb high protein 
Patients on the LCHP were restricted to ≤40 g carbohydrate  day. The energy intake ranged from 800 to 1500 kcal, 
where an 800 kcal diet was composed of 20% carbohydrate, 40% protein, and 40% fat. Patients were given a booklet 
with information about which foods to eat and which to avoid. Examples of recipes were also provided. The diet was 
supplemented with multivitamins and minerals (Forceval; Alliance Pharmaceuticals, Chippenham, UK). This is one of 
the standard dietary treatments currently used at the Specialist Obesity Clinic in Aberdeen, Scotland. Patients came 
monthly to the trial centre to be weighed for the first 3 months and then every other month after screening, resulting in 
six visits over 9 months. Constant support was available via telephone and email. 
 
Baseline characteristics Rolland 2009 
Number of intervention participants 
Number of control participants 
34 
38 
Participating population Men and women >18 years of age and with a body mass index (BMI) ≥35 kg m2 were included in the study. 
Sex [female %] Authors do not report this 
Age [mean years (SD)] Authors do not report this 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] Low carb high protein 
41.63 ± 4.8 
Lighter life 
46.0 ± 7.0 
Duration of disease [mean years (SD)] Authors do not report this 
Ethnic groups [%] Authors do not report this 
Duration of intervention [mean ... (SD)] Time points are 3 and nine months 
Duration of follow-up [mean ... (SD)] Authors do not report this 
Co-medications Authors do not report this 
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Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Rolland 2009 
Intervention(s) 3 months 
Weight 
111.0 ± 18.4* 
Bmi 
41.8 ± 7.4* 
% body fat 
44.8 ± 8.5* 
Fat mass (kg) 
50.3 ± 15.1* 
Fat free mass (kg) 
60.5 ± 11.1* 
Waist circumference 
119.1 ± 16.4* 
Total cholesterol (mmol  L) 
4.6 ± 1.1* 
Low-density lipoprotein (mmol  L) 
2.9 ± 0.9* 
High-density lipoprotein (mmol  L) 
1.25 ± 0.22* 
Total cholesterol  high-density lipoprotein 
3.8 ± 1.0 
Triacylglycerols (mmol  L) 
1.2 ± 0.7 
Fasting glucose (mmol  L) 
4.8 ± 0.5* 
HbA1c (%) 
5.5 ± 0.3* 
Systolic blood pressure (mmHg) 
127.8 ± 15.2* 
Diastolic blood pressure (mmHg) 
81.8 ± 10.8* 
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9months 
Weight 
107.5 ± 20.1* 
Bmi 
40.3 ± 8.9* 
%body fat 
42.2 ± 11.9*_ 
Fat mass (kg) 
42.2 ± 11.9*_ 
Fat free mass (kg) 
60.7 ± 11.5* 
Waist circumference 
114.5 ± 16.0*_ 
Total cholesterol (mmol  L) 
4.8 ± 1.0*_ 
Low-density lipoprotein (mmol  L) 
2.9 ± 0.9* 
High-density lipoprotein (mmol  L) 
1.38 ± 0.25*_ 
Total cholesterol  high-density lipoprotein 
3.6 ± 1.0*_ 
Triacylglycerols (mmol  L) 
1.1 ± 0.7* 
Fasting glucose (mmol  L) 
4.9 ± 0.4* 
HbA1c (%) 
5.4 ± 0.4* 
Systolic blood pressure (mmHg) 
128.2 ± 18.0* 
Diastolic blood pressure (mmHg) 
83.2 ± 12.4* 
Control (s) 3 months 
Weight 
108.7 ± 15.6* 
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Bmi 
40.6 ± 5.3* 
% body fat 
47.6 ± 5.8* 
Fat mass (kg) 
52.0 ± 11.3* 
Free fat mass (kg) 
56.8 ± 9.1 
Waist circumference 
119.1 ± 10.0* 
Total cholesterol (mmol  L) 
5.4 ± 0.9 
Low-density lipoprotein (mmol  L) 
3.3 ± 0.8 
High-density lipoprotein (mmol  L) 
1.44 ± 0.32 
Total cholesterol  high-density lipoprotein 
3.8 ± 1.0 
Triacylglycerols (mmol  L) 
1.5 ± 0.8 
Fasting glucose (mmol  L) 
5.4 ± 0.8 
HbA1c (%) 
5.6 ± 0.4 
Systolic blood pressure (mmHg) 
132.0 ± 18.6 
Diastolic blood pressure (mmHg) 
87.7 ± 8.2 
 
 
9months 
Weight 
109.6 ± 16.3* 
Bmi 
40.9 ± 5.4* 
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Body fat % 
48.0 ± 6.1* 
Fat mass (kg) 
53.0 ± 12.2* 
Fat free mass (kg) 
55.5 ± 12.1 
Waist circumference 
119.0 ± 10.8* 
Total cholesterol (mmol  L) 
5.3 ± 1.0 
Low-density lipoprotein (mmol  L) 
3.2 ± 0.8_ 
High-density lipoprotein (mmol  L) 
1.44 ± 0.35 
Total cholesterol  high-density lipoprotein 
3.7 ± 1.0 
Triacylglycerols (mmol  L) 
1.5 ± 0.9 
Fasting glucose (mmol  L) 
5.3 ± 0.8_ 
HbA1c (%) 
5.6 ± 0.4 
Systolic blood pressure (mmHg) 
133.1 ± 16.6 
Diastolic blood pressure (mmHg) 
86.6 ± 8.4 
 
 
 
Primary endpoint(s)  
Secondary endpoint(s)  
Other endpoint(s)  
Effect size Significantly greater weight loss was seen for patients on the LL than the LCHP at 3 (mean (±SD) )11.6 ± 12.9 vs )2.8 
± 4.5 kg, respectively; P < 0.0001) and 9 months ()15.1 ± 21.1 vs )1.9 ± 5.0 kg, respectively; P < 0.0001) after 
screening. 
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Adverse events Rolland 2009 
All adverse events Authors do not report this 
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Bibliographic Details  
Study ID Womble 2004 
Author (first) Womble L, Wadden T, McGuckin BG, Sargent SL, Rothman RA, Krauthamer-Ewing SE 
Journal  Obesity research 
Year 2004 
Volume 12 (6) 
Pages 1011-1018 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details 
Leslie G. Womble, University of Pennsylvania, Weight and Eating Disorders Program, 3535 Market St., Suite 3029, 
Philadelphia, PA 19104. 
E-mail: womble@mail.med.upenn.edu 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
 
Participants Exclusion criteria 
Individuals had to be free of physical conditions including type 1 or 2 diabetes; uncontrolled hypertension (>140/90 
mm Hg); a history of cerebrovascular, cardiovascular, kidney, or liver disease; the use of medications known to affect 
body weight (e.g., steroids); pregnancy or lactation; and a weight loss 5% of initial weight and/or the use of anorectic 
agents in the previous 6 months. Psychosocial contraindications included bulimia nervosa, major depression, or other 
psychiatric illness that significantly disrupted daily functioning. 
Inclusion criteria 
Limited to women, ages 18–65 years, who had a BMI of 27–40 kg/m2. Participants also were required to have daily 
access to the Internet. 
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Interventions Number of study centres: Authors do not report this 
Country/location: US 
Setting: Internet and various locations (everyday life locations) whilst using the learn programme manual 
Treatment before study : Authors do not report this 
Titration period: Authors do not report this 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Primary outcome(s) 
Change in body weight 
Secondary outcome (s) 
Other outcome (s) 
 
Blood pressure 
Fasting biochemical profile that included triglycerides, glucose, total cholesterol, high-density lipoprotein (HDL), and 
low-density lipoprotein (LDL) 
Study details Run-in period: Authors do not report this 
Study terminated before regular end: Authors do not report this 
Publication details Language of publication : English 
Commercial funding: Authors do not report this 
Non-commercial funding : Pilot Study Grant from the North American Association for the Study of Obesity (to Dr. 
Womble) and by NIH Grant K24-DK- 065,018 (to Dr. Wadden). 
Publication status (peer review journal) : yes 
Publication status (journal supplement): Authors do not report this 
Publication status (abstract): Authors do not report this 
Stated aim for study 
Quote “To assess, in a 1-year randomized controlled trial, the efficacy of eDiets.com (a commercial Internet weight 
loss program) in improving weight, cardiovascular health, and quality of life.” 
Notes  
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Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
High  
Does not specifically state how they were randomised. It just stated that they were assigned to ediets or the manual 
program. No sequence generation, no opaque envelopes, no information given. 
Allocation concealment  (selection bias) High  
The assistants explained the two arms to potential participants, therefore those receiving the manual program knew 
what the other was receiving and vice versa. Assistants could have explained one of the arms more than another (i.e. 
the intervention). It does not state why this was done, especially when it is an RCT. The participants shouldn’t know 
what the other group is doing under rct controls. But telling the participants the two arms could have already interfered 
with the results. Participants who were keen to be involved in the intervention group, and received the manual 
program could have meant that they didn’t try as much, as they were disappointed with what they had received. 
Blinding (performance & detection bias) High  
Authors do not report this 
Blinding of participants and personnel 
(performance bias) 
High  
Participants would have known what they were receiving 
Blinding of outcome assessment (detection 
bias) 
High  
It does not state whether the assistants taking the outcome measures were blind to who had received what, or if the 
participants had been told not to tell the researchers what they were doing. it is doubtful that this would have had an 
impact on the results, as the project was not funded commercially, and it is very unlikely that researchers would try to 
tamper with the results especially when  the methods used could not be tampered with (bloods being taken, blood 
pressure cuff, scales and high stick) 
Incomplete outcome data (attrition bias) High 
15 were left at 16 weeks in the e diet group, 8 remained at 52 weeks  
16 were left at 16 weeks in the e diet group, 8 remained at 52 weeks  
 
Selective reporting (reporting bias) Authors do not report this 
Other bias  
Comments  
 
Overview of study populations Womble 2004 
Number invited 158 assessed for eligibility via phone, 65 ineligle 
Number screened 158 assessed for eligibility via phone, 65 ineligle  
Number randomised 47 
(n) ITT None reported 
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Intervention 
Control 
Total 
Number finishing study 16 in total, eight in each group 
(%) of randomised patients finishing study 
 
65-66% in each group finished the study (16 weeks) 
33-35% in each group finished the study (52 weeks) 
 
 
Description of interventions Womble 2004 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
 
 
 
 
 
Control(s) [route, frequency, total dose/day] 
1 year membership was paid for, with the ediets group, this also paid for a virtual visit with a dietician. A tailored 
programme of foods, and exercise were given to match their likes, needs etc. Women with a BMI of 27 to 35 kg/m2 
were provided meal plans that prescribed 1200 to 1300 kcal/d, whereas those with a BMI >35 kg/m2 were given 1300 
to 1400 kcal/d. grocery lists were provided and social online meetings with a professional. Find a buddy programme 
allowed members to email other members participating in the programme. A psychologist was met with a baseline, 8, 
16, 26 and 52 weeks for 20 minutes. The initial visit was to talk about goals and methods of treatment, log onto ediets 
every day, and to record and log the intake of foods. Remaining visits discuss weight loss, and satisfaction with the 
programme. 
 
243-page book that provided 16 step-by step lessons for modifying eating, activity, and thinking habits. 1200-1500kcal 
per day was required, and it was recommended that daily records of calories intake were kept. Physical activity was 
encouraged, and control behaviours to be practiced (i.e. slower eating). After 16 weeks, participants were given the 
Weight Maintenance Survival Guide (19) that reiterated concepts introduced in the LEARN Program (18). Participants 
in this group met with a psychologist on the same schedule (i.e., at baseline and four times over the year) as those in 
the eDiets.com group. 
 
Baseline characteristics Womble 2004 
Number of intervention participants 
Number of control participants 
23 ediets 
24 LEARN 
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Participating population 
Limited to women, ages 18–65 years, who had a BMI of 27–40 kg/m2. Participants also were required to have daily 
access to the Internet. 
Sex [female %] 100% 
Age [mean years (SD)] 44.2±9.3   ediets            43.3±11.1 manual 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] 33.9±3.2        ediets   33.0 ±3.0   manual 
Duration of disease [mean years (SD)] Authors do not report this 
Ethnic groups [%] Not reported 
Duration of intervention [mean ... (SD)] 1 year 
Duration of follow-up [mean ... (SD)] 
weight and blood pressure were scheduled for both groups at baseline and weeks 2, 4, 8, 12, 16, 20, 26, 34, 42, and 
52 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Womble 2004 
Intervention(s) See below 
Control (s) See below 
Primary endpoint(s) 0.7±2.7 kg of initial weight ediets weight loss at 16 weeks 
3.0 ± 3.1 kg of initial weight with manual at 16 weeks 
0.8 ±3.6 kg of baseline to 52 weeks with ediets 
3.3±4.1 kg of baseline to 52 weeks with manual 
Secondary endpoint(s) 
Significant within-subject changes over 52 weeks for completers (N = 31) 
Lipids 
  
Appendix 39: Data extraction sheet; Womble 2004 
 
442 
 
LDL 120.4±32.2  baseline           135.5±32.7*     16weeks       125.1 ±31.2   52weeks 
HDL/total      3.8± 1.0   baseline            4.1 ±0.9*   16weeks    3.8±0.8   52weeks 
 
 
Percent reduction in initial weight for participants assigned to eDiets.com or a weight loss manual 
eDiets.com 
Week 16 completers only (n=31) 1.3 ± 3.3% 
Week 52 completers only (n=31   2.1 ±3.9% 
Weight loss manual 
Week 16 completers only (n=31)  4.0 ± 3.7% 
Week 52 completers only (n=31)      4.6% 4.4 ± 5.0% 
 
 
 
 
 
 
triglycerides, glucose, and blood pressure are not stated for end point data, only baseline 
Other endpoint(s)  
Effect size 
At week 16, participants in eDiets.com lost 0.9 ±3.2% of initial weight compared with 3.6 ± 4.0% for women assigned 
to the weight loss manual. At week 52, losses increased to 1.1±4.0% and 4.0±5.1%, respectively. 
Results of a last-observation-carried-forward analysis found that women in the manual group lost significantly (p 0.05) 
more weight (at both times) than those treated by eDiets.com. (Results, however, of baseline-carried-forward and 
completers analyses did not reach statistical significance.) 
 
Adverse events Womble 2004 
All adverse events Authors do not report this 
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Bibliographic Details  
Study ID Jolly 2011 
Author (first) Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, Daley A, Aveyard P.  
Journal  BMJ 
Year 2011 
Volume 343 
Pages 1-16 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Full paper 
Corresponding author and contact details A.Daley@bham.ac.uk 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
 
Participants 
Exclusion criteria  
Patients were excluded if they were unable to understand English or were pregnant. 
Inclusion criteria  
Eligible participants were registered with general practices in South Birmingham Primary Care Trust, were aged at 
least 18 years, and had a raised body mass index recorded in their primary care notes within the previous 15 months. 
White Europeans and all ethnic groups apart from South Asians with no comorbidities: BMI ≥30 
• White Europeans and all ethnic groups apart from South Asians with comorbidities: BMI ≥28 
• South Asians with no comorbidities: BMI ≥25 
• South Asians with comorbidities: BMI ≥23 
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Interventions Number of study centres: 17 
Country/location: UK 
Setting: leisure centre, and pharmacy settings, community venues 
Treatment before study: Authors do not report this 
Titration period: Authors do not report this 
 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Primary outcome(s) weight loss at programme end (12 weeks) 
Secondary outcome (s) weight loss at one year, self reported physical activity, and percentage weight loss at 
programme end and one year 
Other outcome (s) 
Study details Run-in period: Authors do not report this 
Study terminated before regular end: Authors do not report this 
Publication details Language of publication: English 
Commercial funding: Authors do not report this  
Non-commercial funding: The study was funded by NHS South Birmingham. 
Publication status (peer review journal) :Yes 
Publication status (journal supplement): Authors do not report this 
Publication status (abstract): Authors do not report this 
Stated aim for study 
Quote “To assess the effectiveness of a range of weight management programmes in terms of weight loss.” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) Low 
An independent statistician prepared two separate randomisation sequences, and, to ensure blinding, the allocations 
  
Appendix 40: Data extraction sheet; Jolly 2011 
 
445 
 
were placed in opaque, consecutively numbered envelopes, which the call centre staff used in order 
Allocation concealment  (selection bias) Low 
opaque, consecutively numbered envelopes were used 
Blinding (performance & detection bias) Low 
Based upon the other bias 
Blinding of participants and personnel 
(performance bias) 
Low 
After attending the sessions, the participants would have known what arm they were allocated to. Participants 
allocated to the commercial providers were given vouchers for 12 free sessions; these would have been given to the 
group leaders, which could have meant that additional attention was given to these participants as they knew that their 
group was being researched. Weight date could have also been also reported inaccurately (so show larger 
improvements). 
Participants in the choice arm knew which arm they would receive as they had chosen it; women chose the 
commercial programmes, whereas men chose the size down programme. 
 
Blinding of outcome assessment (detection 
bias) 
Low 
A trained practice nurse, health trainer, or researcher blinded to the allocation group did the one year assessment at 
the participant’s general practice or home. 
Incomplete outcome data (attrition bias) Low 
Based upon the other bias 
Selective reporting (reporting bias) Low 
Based upon the other bias 
Other bias Low 
17.3% of weights were self reported at one year, 39.7% at 12 weeks. This could have impacted on the findings. 
The researchers felt this was not true, self reporters, had a smaller weight loss than those who had their weight taken 
by someone else. 
Comments 
Only 11.5% accepted the invitation, who could have already been motivated to change. This could have had an impact 
on the study results. The trial participants attended alongside people who paid to attend the programmes, this could 
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have caused conflict amongst members. 
Some participants were taking weight loss drugs; this could have had quite an impact on the results. 
 
Overview of study populations Jolly 2011 
Number invited 8810 
Number screened 8810 letters sent to patients who met criteria 
7799 no response 
 
Number randomised 740 randomised to the eight arms 
640 were randomised to commercial programmes, NHS led intervention, general practice or pharmacy led, or chose 
they wanted to attend 
100 were randomised to the minimal intervention comparator group 
(n) ITT 
Intervention 
Control 
Total 
All analyses according to intention to treat were done by using Stata v11.0 and SPSS v17.0. 
Number  finishing study 
 
575 intervention 
83 control 
 
 
(%) of randomised patients finishing study 
 
88.9% total 
85.8% intervention 
83% control 
 
Description of interventions Jolly 2011 
Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
Box 2 Description of interventions 
Weight Watchers is group based, and the participant was able to join at any time. One to one support is available for 
new members and during weighing. This is followed by a group talk from the leader, with discussion. Meetings took 
place in community venues and lasted one hour. Core programme material delivered over five weeks included a food 
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points system (based on age, sex, height, weight, and activity), beating hunger, taking more physical activity, eating 
out, and keeping motivated. Other sessions delivered to the whole group covered recipes, health and nutrition, and 
keeping active. The plan aims for 500 kcal (2.09 MJ) deficit/day, leading to 0.5-1.0 kg weight loss a week. Physical 
activity is encouraged; the objective is to gradually build up to 10 000 steps daily. Predominant strategies used to 
change behaviour included stages of change, food and activity diaries, goal setting, and evaluation of progress. 
Rewards are given for every 3.2 kg (7 lb) lost and for loss of 5% and 10% of body weight. 
Slimming World is group based, and the participant was able to join at any time. Meetings took place in community 
venues and lasted 90 minutes. Also included is access to a website, magazines, and one to one telephone support 
from a consultant or other members. Members are encouraged to eat mainly foods with low energy density to achieve 
satiety, plus some extras rich in calcium and fibre, with controlled amounts of high energy dense foods. Weight loss 
goals are set by the individual. Physical activity is encouraged, with gradual build up to 30 minutes of moderately 
intense activity five days a week. The theoretical background is based on transactional analysis and motivational 
interviewing. Predominant behaviour change strategies used included weekly weighing; group support; and group 
praise for weight loss, new decisions, and continued commitment even in the absence of weight loss. Awards are 
given for 3.2 kg (7 lbs) lost and loss of 10% of body weight. Individual support, if needed, uses self monitoring of food 
and emotions, for and against evaluations, visualisation techniques, and personal eating plans. 
Rosemary Conley is group based, and the participant was able to join at any time. Meetings took place in community 
venues and lasted 90 minutes. One to one support is offered during weighing and to establish a calorie allowance. 
Additional support is available by email and telephone. Goals are staged: either 1-1.5 kg/week with a goal of 6.35 kg 
(1 stone) loss or 0.5-1 kg/week with an initial goal of 3.2 kg (7 lb).Sessions include a 45 minute optional exercise 
class. Extra exercise sessions may be offered for an additional fee. The theoretical background is based on role 
modelling and group support and uses visualisation and reframing to support behavioural change. Predominant 
behaviour  change strategies used include rewards for slimmer’s who maintain or lose weight, slimmer of the week, 
and certificates for 3.2 kg and 6.35 kg milestones. 
The Size Down Programme was an NHS group based programme run in community venues by support workers 
trained by the dietetics service. This provided six weekly two hour sessions, with follow-up sessions at nine and 12 
weeks. All participants joined together in week one of the programme. Its particular focus was on long term changes in 
patterns of eating behaviour, achieving a balanced diet, and increasing physical activity in daily life, and it used an 
interactive style. Topics covered included managing behaviour around food and prevention of relapse, the eatwell 
plate, nutritional information, planning strategies to deal with lapses into previous dietary behaviours, interactive visual 
aids to show the fat and sugar content of foods, and adaptation of recipes. The theoretical background was based on 
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Control(s) [route, frequency, total dose/day] 
the cycle of change (Prochaska and Di Clemente). The benefits of physical activity, setting goals, and finding activities 
to fit into life were discussed. Predominant behaviour change strategies used included goal setting, stages of change, 
and self monitoring with a food diary. 
The general practice and pharmacy programmes comprised 12 one to one sessions in the general practice or 
pharmacy. The first session was planned to last 30 minutes, with follow-up sessions of 15-20 minutes. Sessions were 
client led and based around a problem solving approach. Sessions included weight and dieting history, exploration of 
goals and expectations of patients, the eatwell plate, setting goals to reduce calorie intake and increase physical 
activity, planning strategies to deal with challenging situations, use of food diaries, and maintaining weight loss. 
Weight loss goals were 5-10% of starting body weight, at a rate of 0.5-1 kg/week over three to six months, followed by 
maintenance. Physical activity goals were to aim to slowly increase activity levels to achieve 30 minutes of moderate 
activity on five days each week. The theoretical basis used stages of change and motivational interviewing. 
Predominant behaviour change strategies included goal setting, self monitoring with food diaries, hunger scale, waist 
measurements, and physical activity. Resources were provided as homework for discussion in the next session or for 
personal reflection. Participants were encouraged to reward themselves for success. 
 
Participants allocated to the comparator group were sent vouchers for 12 free sessions at a local authority run leisure 
centre (a council run facility open to all members of the public and usually consisting of a swimming pool, fitness suite, 
and other sports halls or courts). Participants were not given an appointment to attend and were given no individual 
advice or support on diet or physical activity 
 
Baseline characteristics Jolly 2011 
Number of intervention participants 
Number of control participants 
640 
100 
Participating population Eligible participants were registered with general practices in South Birmingham Primary Care Trust, were aged at 
least 18 years, and had a raised body mass index recorded in their primary care notes within the previous 15 months. 
The body 
mass index threshold for invitation was that which makes them eligible for primary care obesity management services 
in the 
NHS and varied according to ethnic group and the presence or absence of comorbidities (box 1). The threshold for 
invitation for people with no obesity 
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Sex [female %] 72 (weight watchers) 65 (slimming world) 69 (rosemary Connelly) 64 (size down) 67(general practice)  73 (pharmacy) 
70 (choice) 75 (comparator) 
Age [mean years (SD)] 50.71 (14.56 weight watchers) 48.84 (14.91;slimming world) 49.76 (14.51;rosemary Connelly) 48.75 (15.63;size down) 
50.48 (13.79;general practice) 48.94 (15.82;pharmacy) 47.45 (14.35;choice) 49.67 (13.83;comparator) 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] 33.96 (3.9;weight watchers) 33.83 (3.8;slimming world) 33.38 (3.5;rosemary Connelly) 33.77 (3.9;size down) 33.06 
(3.5;general practice) 33.44 (3.5; pharmacy) 33.41 (3.4;choice) 33.88 (4.4;choice) 
Duration of disease [mean years (SD)] Authors do not report this 
Ethnic groups [%] 1 (weight watchers) 3 (slimming world) 0 (rosemary Connelly) 3 (size down) 0 (general practice) 0 (pharmacy)  1 
(choice) 3 (comparator)  (south Asian) 
5 (weight watchers) 5(slimming world) 12(rosemary Connelly) 3(size down) 6(general practice) 9(pharmacy) 
10(choice) 9 (comparator) (black British/Caribbean/African) 
7 (weight watchers) 4(slimming world) 5(rosemary Connelly) 3(size down) 4(general practice) 4(pharmacy) 6(choice) 
4(comparator) (mixed and other) 
Duration of intervention [mean ... (SD)] 12 months 
Duration of follow-up [mean ... (SD)] Authors do not report this 
Co-medications Weight loss drug (%) 3 (3weight watchers) 4 (4 slimming world) 3 (3 rosemary Connelly) 2 (2 size down) 1 (1 general 
practice) 3 (4 pharmacy) 3 (3 choice) 3 (3 comparator) 
Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Jolly 2011 
Intervention(s)  
Control (s)  
Primary endpoint(s) Programme end 
Weight loss (95% CI) 12 week  
4.43 (3.6-5.3**; weight watchers) 3.56 (2.7-4.4**; slimming world) 4.23 (3.2-5.2**; rosemary Connelly) 2.38 (1.7-
3.1**;size down) 1.37 (0.4-2.3*; general practice) 2.11 (1.0-3.2**;pharmacy) 3.32(2.5-4.1; choice) 2.01(1.02-
2.8**;comparator) 
 
Secondary endpoint(s)  
Programme end 
 
Proportion of each group that achieved 5% loss (95% CI) percentage 
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46.0 (36.0 to 56.3;weight watchers) 35.0 (25.7 to 45.2; slimming world) 42.0 (32.2 to 52.3; rosemary Connelly) 18.0 
(11.0 to 26.9; size down) 15.7 (8.1 to 26.4; general practice) 21.4 (12.5 to 32.9; pharmacy) 35.0 (25.7 to 45.2; choice) 
22.0 (14.3 to 31.4;comparator) 
 
Median (IQR) physical activity (kcals/week) 
19.26 (12.25-2629**;weight watchers) 1899(1226-2571**;slimming world) 1801(1155-2447**;rosemary Connelly) 
1480(701-2259**; size down**) 1895(963-2826**; general practice) 2720(1790-3649**; pharmacy) 1986(1245-2727**; 
choice) 1608(988-2228; comparator) 
 
Change in physical activity to programme end (minutes/week)§ §Change from baseline in minutes/week using 
baseline observation carried forward. 
58(42-75;weight watchers) 60(42-79; slimming world) 49(33-65; rosemary Connelly) 55(35-75;size down) 47(25-
70;general practice) 73(59-94; pharmacy) 59(40-77; choice) 51(36-67; comparator)   
 
1 year 
Proportion of each group that achieved 5% loss (95% CI) percentage 
31.0 (22.1 to 41.0;weight watchers) 21.0 (13.5 to 30.3;slimming world) 26.0 (17.7 to 35.7;rosemary Connelly) 21.0 
(13.5 to 30.3;size down) 15.7 (8.1 to 26.4; general practice) 14.3 (7.1 to 24.7;pharmacy) 28.0 (19.5 to 37.9;choice) 
17.0 (10.2 to 25.8;comparator) 
 
Weight loss (95% CI) 
3.46(2.1-4.8**;weight watchers) 1.89(0.9-2.9**;slimming world) 2.12(0.9-3.4**;rosemary Connelly) 2.45(1.3-3.6**;size 
down) 0.83(-0.4-2.0**; general practice) 0.66(-0.4-1.7; pharmacy) 2.15(0.9-3.4**; choice) 1.08(0.1-2.1**;comparator) 
 
Physical activity change to one year (kcal/week) 
2048 (1262-2834**; weight watchers) 1362(645-2078**;slimming world) 1429(657-2202**;rosemary Connelly) 
1429(644-2213**;size down) 861(256-1467**; general practice) 1473(742-2203**;pharmacy) 1642(837-2448**;choice) 
1766(1044-2487**;comparator) 
 
Change in physical activity to one year (minutes/week)§ Change from baseline in minutes/week using baseline 
observation carried forward. 
60(40-79;weight watchers) 21(3-39; slimming world) 25(10-40;rosemary Connelly) 19(4-33;size down) 14(-4-
35;general practice) 27(3-51; pharmacy) 32(14-50; choice) 42(25-60;comparator) 
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Other endpoint(s)  
Effect size 
All programmes achieved significant weight loss from baseline to programme end (range 1.37 kg (general practice) to 
4.43 kg (Weight Watchers)), and all except general practice and pharmacy provision resulted in significant weight loss 
at one year. At one year, only the Weight Watchers group had significantly greater weight loss than did the comparator 
group (2.5 (95% confidence interval 0.8 to 4.2) kg greater loss,). The commercial programmes achieved significantly 
greater weight loss than did the primary care programmes at programme end (mean difference 2.3 (1.3 to 3.4) kg). 
 
Adverse events Jolly 2011 
All adverse events Authors do not report this 
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Bibliographic Details  
Study ID Rock 2007 
Author (first) Rock CL, Pakiz B, Flatt SW, Quintana EL. 
Journal  Obesity 
Year 2007 
Volume 15 
Pages 939 –949 
Language English 
Type (e.g. full paper, conference 
proceeding, unpublished report) 
Paper 
Corresponding author and contact details 
Cheryl L. Rock, University of California, San Diego, 9500 Gilman Drive, Dept. 0901, La Jolla, CA 92093-0901. 
E-mail: clrock@ucsd.edu 
 
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
 
Participants Exclusion criteria 
Those who were unable to be physically active because of severe disability (e.g., severe arthritic conditions) or who 
reported a history or presence of a comorbid disease for which diet modification and increased physical activity might 
be contraindicated were not included, as well as those who reported being currently pregnant or breastfeeding or 
planning a pregnancy within the next 2 years. Current active involvement in another diet intervention study or 
organized weight loss program; and having a history or presence of a significant psychiatric disorder or any other 
condition that, in the investigator’s judgment, would interfere with participation in the trial also disqualified women from 
participating. 
Inclusion criteria 
18 years and older; initial BMI 25.0 kg/m2 (overweight or obese)  and <40 kg/m2, and a minimum of 15 kg over ideal 
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weight as defined by the 1983 Metropolitan Life Insurance tables. willing and able to participate in clinic visits and JC 
facility interactions at specified intervals and to maintain contact with the investigators for two years; willing to allow 
blood collections; and capable of performing a simple step test for assessing cardiopulmonary fitness. 
 
Interventions Number of study centres: one 
Country/location: US 
Setting: clinic and community facility 
Treatment before study: Authors do not report this 
Titration period: Authors do not report this 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Does not specifically state what the primary and secondary outcome measures were. 
 
Change in weight (kg) 
 Change in percent weight 
Change in BMI (kg/m2) 
 Change in waist circumference (cm) 
Change in hip circumference (cm) 
Change in step test (heart rate per 30 seconds) 
Alpha-carotene (_M) 
Beta-carotene (_M) 
Lutein (_M)  
Lycopene (_M)  
Beta-cryptoxanthin  
Total carotenoids  
HDL cholesterol (mg/dL)  
LDL cholesterol (mg/dL)  
Total cholesterol (mg/dL)  
Triglycerides (mg/dL) 
Sex hormone binding globulin 
Insulin (_U/mL) 
 
Primary outcome(s) Authors do not report this 
Secondary outcome (s) Authors do not report this 
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Other outcome (s) 
Study details Run-in period: Authors do not report this 
Study terminated before regular end: Authors do not report this 
Publication details Language of publication: English 
Commercial funding: This study was supported by Jenny Craig, Inc. 
Non-commercial funding: Authors do not report this 
Publication status (peer review journal):  yes 
Publication status (journal supplement): Authors do not report this 
Publication status (abstract): Authors do not report this 
Stated aim for study 
Quote “To test whether a commercial weight loss program promotes greater weight loss in overweight or obese 
women compared with control conditions and to describe the effect on plasma lipids, carotenoids, hormones, and 
fitness.” 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) Unclear  
After enrolment and successful completion of the baseline data collection and assessment activities, participants were 
stratified by BMI (25.0 –29.9 vs. 30.0 kg/m2) and age (≤40 and >40 years) and randomly assigned to one of the two 
study groups. 
Allocation concealment  (selection bias) High  
Authors do not report this 
Blinding (performance & detection bias) High 
Authors do not report this 
It does not state if an independent person assigned the participants to the study groups, or whether many researchers 
were involved in assigning the participants to their group according to age and BMI 
Blinding of participants and personnel High 
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(performance bias) Authors do not report this 
Participants would have known that they were either control or intervention, one would attend the group, one would 
not 
Blinding of outcome assessment (detection 
bias) 
High 
Authors do not report this  
It does not state whether the researchers who were taking the measures were blind. Participants were not told not, not 
to tell the researchers what they were doing (which could have happened). As the study was funded by the 
commercial provider, subconsciously the researchers could have swayed the results (i.e. pulling the tape measure 
tighter) 
Incomplete outcome data (attrition bias) Low  
At six months two left (lost to follow up, decided to stop taking part) in the control group (n=33), and no more drop outs 
occurred. Three left in the commercial group (lost to follow up, decided to stop taking part, became pregnant), no more 
drop outs occurred 
Selective reporting (reporting bias) Authors do not report this 
Other bias It does not state whether the intervention participants joined current members of the JC programme, this could have 
impacted on the results if the counsellor was paying more attention to new clients. 
Comments  
 
Overview of study populations Rock 2007 
Number invited A total of 276 women were screened by telephone. 
Number screened A total of 276 women were screened by telephone. 
Number randomised 70 women were enrolled in the study and were randomized. 
(n) ITT 
Intervention 
Control 
Total 
an intent-to treat and completers analysis on the 12-month data, substituting baseline values for any subjects for 
whom 12-month data were missing.  
Number finishing the study 33 (control)  
32 (intervention) 
(%) of randomised patients finishing study 
 
94.3% control 
91.4% intervention 
 
Description of interventions Rock 2007 
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Intervention(s) [route, frequency, total 
dose/day] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control(s) [route, frequency, total dose/day] 
The intervention arm consisted of referral to a conveniently located community-based JC facility, including the 
establishment of an initial appointment to begin the program. Subjects assigned to the commercial weight loss 
program intervention received all program materials, including pre-packaged prepared foods as needed to achieve a 
meal plan, free-of-charge. The core components of the JC weight loss program are described as addressing food, 
body, and mind. Interactions between corporate-trained and supervised staff and the clients consist of weekly one-to-
one contacts with a counsellor who is described as a consultant, with follow-up telephone and e-mail contacts and 
web site/message board availability. The food component consists of prescribing an energy reduced diet (typically 
1200–2000 kcal/d, individualized based on energy requirements) that includes pre-packaged prepared food items that 
incorporate (and are accompanied by) increased vegetables, fruit, and other additional strategies to reduce the energy 
density of the diet. The goal is 30 minutes of physical activity on 5 or more days of the week. Finally, the mind 
component describes the cognitive aspects of promoting weight loss and maintenance, including self-acceptance, 
improved body image, and interpretation of one’s attitudes, behaviour, and thinking patterns, as these factors can be 
monitored and/or modified to promote successful weight loss and maintenance. 
 
The usual care control group were provided consultation, at baseline (after randomization) and again at 16 weeks, 
with a research staff dietician, who also provided publicly available print material that described dietary and physical 
activity guidelines to promote weight loss and maintenance. The dietician initially discussed the interpretation of the 
participant’s anthropometric data and the concepts of healthy weight and energy balance. Baseline energy 
requirements for weight maintenance were then calculated, and an energy intake level (accompanied by a menu plan 
based on food groups) to achieve a weight loss of 10% over a 6-month period was prescribed, involving a deficit of 
500 to 1000 kcal/d, as per current recommendations . Specific sample meal plans and recommendations to increase 
physical activity were provided to each participant. Written materials and resources for useful strategies and skills, 
such as reading food labels, estimating serving sizes, and eating outside the home, were provided, as well as 
information for healthy food choices (e.g., the U.S. Department of Agriculture Food Guide Pyramid). Progress was 
reviewed and concepts and strategies were further discussed in the follow-up counselling session. 
 
Baseline characteristics Rock 2007 
Number of intervention participants 
Number of control participants 
35 
35 
Participating population 
18 years and older; initial BMI 25.0 kg/m2 (overweight or obese)  and <40 kg/m2, and a minimum of 15 kg over ideal 
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weight as defined by the 1983 Metropolitan Life Insurance tables. willing and able to participate in clinic visits and JC 
facility interactions at specified intervals and to maintain contact with the investigators for two years; willing to allow 
blood collections; and capable of performing a simple step test for assessing cardiopulmonary fitness. 
 
Sex [female %] 100% 
Age [mean years (SD)] 42 (11) (intervention) 
40 (12) (control) 
HbA1c [mean % (SD)] Authors do not report this 
BMI [mean kg/m2 (SD)] 34.2 (3.7) (intervention) 
33.8 (3.4) (control) 
Duration of disease [mean years (SD)] Authors do not report this 
Ethnic groups [%] White non-Hispanic 20 (57) intervention     20 (57)  control 
Hispanic 5 (14)  intervention         11 (31)  control 
African-American 6 (17)         intervention 1 (3)     control 
Asian-American 1 (3) intervention    1 (3)    control 
Other 3 (9)   intervention    2 (6)    control 
Duration of intervention [mean ... (SD)] 6 months 
Duration of follow-up [mean ... (SD)] 12 months 
Co-medications Authors do not report this 
Co-interventions Authors do not report this 
Co-morbidities Authors do not report this 
 
Matrix of study endpoints Rock 2007 
Intervention(s) 
Change in weight (kg)† -7.2 (6.7)    6 months       -6.6 (10.2)    12 months 
Change in percent weight†-7.8 (7.2)    6 months      -7.1 (10.8)     12 months 
Change in BMI (kg/m2)†-2.6 (2.5)     6 months      -2.4 (3.8)   12 months 
Change in waist circumference (cm)† -7.1 (8.4)       6 months   -8.2 (10.5)    12 months 
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Change in hip circumference (cm)†-5.7 (5.1)   6 months     -6.2 (7.8)    12 months 
Change in step test (heart rate per 30 seconds)‡ -6.4 (6.4)      6 months -4.1 (6.8)     12 months 
Alpha-carotene (M)* 0.12 (0.14)   baseline    0.13 (0.11)    6 months    0.18 (0.15)†    12months 
Beta-carotene (M)* 0.48 (0.65)   baseline  0.73 (0.73)‡   6months    0.67 (0.57)†    12months 
Lutein (M) 0.36 (0.19)   baseline  0.38 (0.23)        6months            0.40 (0.23)      12months 
Lycopene (M) 0.71 (0.35)         baseline       0.69 (0.27)           6months          0.94 (0.35)†        12months 
Beta-cryptoxanthin (M) 0.15 (0.13)        baseline        0.20 (0.16)‡          6months         0.15 (0.07)     12months 
Total carotenoids (M)* 1.82 (1.2)      baseline      2.12 (1.18)      6months      2.33 (1.04)         12months 
HDL cholesterol (mg/dL)     50 (15)        baseline       51 (13)         6months         61 (15)†          12months 
LDL cholesterol (mg/dL) 113 (40)      baseline      109 (32)           6months     104 (26)      12 months 
Total cholesterol (mg/dL) 189 (37)    baseline   181 (33)              6months      188 (30)       12months 
Triglycerides (mg/dL)§ 112 (52) baseline       98 (42)          6months     107 (59)  12months 
Sex hormone binding globulin (nM) 56.4 (49.6)      baseline      72.7 (59.3)     12months    72.8 (50.7)    12months 
Insulin (U/mL)* 22.7 (12.3)     baseline      17.7 (9.9)‡        6 months      18.8 (10.8)   12months 
Control (s) 
Change in weight (kg)† -0.3 (3.9)    6 months   -0.7 (5.5)     12months 
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Change in percent weight† -0.3 (4.5)       6months               -0.7 (6.0)     12months 
Change in BMI (kg/m2)†  -0.2 (1.5)   6months              -0.3 (2.1)     12months 
Change in waist circumference (cm)†  -1.1 (6.5)        6months              -0.2 (7.0)    12months 
Change in hip circumference (cm)† - 0.3 (3.3)     6 months                  -0.3 (5.0)    12months 
Change in step test (heart rate per 30 seconds)‡  - 2.9 (6.3)  6 months      -3.4 (6.3)   12months 
Alpha-carotene (M)* 0.13 (0.11) baseline    0.09 (0.07)‡  6 months    0.16 (0.14)  12months 
Beta-carotene (M)* 0.46 (0.39)  baseline 0.42 (0.32)   6 months  0.50 (0.31)†   12 months 
Lutein (M) 0.37 (0.16) baseline 0.40 (0.16)  6 months 0.41 (0.17) 12 months 
Lycopene (M) 0.77 (0.24)  baseline   0.74 (0.23)    6 months   1.03 (0.32)†    12months 
Beta-cryptoxanthin (M) 0.16 (0.10) baseline  0.18 (0.15)   6months   0.16 (0.10)   12months 
Total carotenoids (M)* 1.90 (0.81)    baseline    1.81 (0.65)   6 months    2.26 (0.69)    12months 
HDL cholesterol (mg/dL) 52 (13)    baseline   53 (11)   6months    56 (17)    12months 
LDL cholesterol (mg/dL) 121 (35)   baseline 119 (26)    6months   120 (31)    12months 
Total cholesterol (mg/dL) 193 (42)  baseline   196 (34)    6months    196 (37)    12months 
Triglycerides (mg/dL)§ 99 (50)    baeline    102 (51)    6months   102 (50)    12months 
  
Appendix 41: Data extraction sheet; Rock 2007 
 
460 
 
Sex hormone binding globulin (nM) 68.9 (74.5)    baseline  79.4 (69.3)    6months    69.8 (43.2)   12months 
Insulin (U/mL)* 17.9 (8.4)    baseline   19.6 (10.0)    6 months  19.7 (9.2)    12months 
 
Primary endpoint(s)  
Secondary endpoint(s)  
Other endpoint(s)  
Effect size 
At 6 months, change in weight by intent-to-treat (ITT) analysis was -7.2 (6.7) kg and -7.8% (7.2%) in the intervention 
group vs. -0.3 (3.9) kg and -0.3% (4.5%) in the control group (n =35 for each; p <0.01). One-year ITT analysis 
revealed significantly greater change in weight, percent weight, BMI, and waist and hip circumferences in the 
intervention vs. control group. Completers at 1 year exhibited change in weight of -7.3 (10.4) kg for the intervention 
group (n =32) vs. -0.7 (5.6) kg for controls (n  33) (p < 0.01), and -7.8% (11.1%) weight change for the intervention 
group vs. -0.7% (6.2%) for controls (p < 0.01). 
 
Adverse events Rock 2007 
All adverse events 
 
Authors do not report this 
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Bibliographic Details  
Study ID  
Author (first)  
Journal   
Year  
Volume  
Pages  
Language  
Type (e.g. full paper, conference 
proceeding, unpublished report) 
 
Corresponding author and contact details  
 
Character of included studies  
Methods Randomised controlled clinical trial (RCT) 
Randomisation ratio 
Superiority design 
Non-inferiority design 
Equivalence design 
Parallel/ crossover/cluster/factorial RCT 
Controlled clinical trial (CCT) 
Participants Exclusion criteria 
Inclusion criteria 
Diagnostic criteria 
Interventions Number of study centres 
Country/location 
Setting 
Treatment before study 
Titration period 
Outcomes Outcome(s) (as stated in the protocol/registered trial documents or publication of study design) 
Primary outcome(s) 
Secondary outcome (s) 
Other outcome (s) 
Study details Run-in period 
Study terminated before regular end 
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Publication details Language of publication 
Commercial funding 
Non-commercial funding 
Publication status (peer review journal) 
Publication status (journal supplement) 
Publication status (abstract) 
Stated aim for study Quote “  “ 
Notes  
 
Risk of bias unclear / low / high risk 
Random sequence generation (selection 
bias) 
 
Allocation concealment  (selection bias)  
Blinding (performance & detection bias)  
Blinding of participants and personnel 
(performance bias) 
 
Blinding of outcome assessment (detection 
bias) 
 
Incomplete outcome data (attrition bias)  
Selective reporting (reporting bias)  
Other bias  
Comments  
 
Overview of study populations Study ID 
Intervention 
Control 
Total 
 
(n) screened 
Intervention 
Control 
Total 
 
(n) randomised 
Intervention 
Control 
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Total 
(n) safety 
Intervention 
Control 
Total 
 
(n) ITT 
Intervention 
Control 
Total 
 
(n) finishing study 
Intervention 
Control 
Total 
 
(%) of randomised patients finishing study 
Intervention 
Control 
Total 
 
Total 
I 
C 
T 
 
  
 
Description of interventions Study ID 
Intervention(s) [route, frequency, total 
dose/day] 
 
Control(s) [route, frequency, total dose/day]  
 
Baseline characteristics Study ID 
Intervention  
Control  
Participating population  
Sex [female %]  
Age [mean years (SD)]  
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HbA1c [mean % (SD)]  
BMI [mean kg/m2 (SD)]  
Duration of disease [mean years (SD)]  
Ethnic groups [%]  
Duration of intervention [mean ... (SD)]  
Duration of follow-up [mean ... (SD)]  
Co-medications  
Co-interventions  
Co-morbidities  
 
Matrix of study endpoints Study ID 
Intervention(s)  
Control (s)  
Primary endpoint(s)  
Secondary endpoint(s)  
Other endpoint(s)  
 
Adverse events Study ID 
I: Intervention (s) 
C: Control (s) 
T: Total 
Deaths [n] 
I: 
C: 
T: 
 
 
 
 
 
 
 
All adverse events [n] 
I: 
C: 
T: 
 
Severe / serious adverse events [n] 
I: 
C: 
T: 
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Drop-outs due to adverse events [n] 
I: 
C: 
T: 
 
Hospitalisation [n] 
I: 
C: 
T: 
 
Out-patient treatment [n] 
I: 
C: 
T: 
 
All hypoglycaemic episodes [n] 
I: 
C: 
T: 
 
Severe / serious hypoglycaemic episodes 
[n] 
I: 
C: 
T: 
 
Definition of severe / serious hypoglycaemia  
Nocturnal hypoglycaemic episodes [n] 
I: 
C: 
T: 
 
Definition of nocturnal hypoglycaemia  
Symptoms [n] 
I: 
C: 
T: 
 
 
Author survey unclear / low / high risk 
Intervention(s)  
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Control (s)  
study author contacted  
study author replied  
no communication possible  
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Exante Meal Replacement Packs: Two, Four or Six Week Plans from £37.59 With Free 
Delivery (Up to 70% Off) 
More Info!
 
Amount:  
from £37.59 
Discount67% You save£75.76 
 
Highlights 
• Two, four or six week meal replacement plan 
• Three packs per day 
• Packs consist of shakes, soup and carbonara 
• Calorie-controlled plan 
• Includes shaker 
• Suitable for vegetarians 
 
Fine Print 
Purchase: May buy up to 5; limit 1 per redemption.  
Further information: Valid on option purchased only. By purchasing a Groupon, you are purchasing a voucher for the 
underlying products or services described above. Orders fulfilled by Exante. Original values verified on 1 May 2013 at 
1.13pm.  
See the rules that apply to all deals.  
 
Delivery: Free. Allow up to 2 working days for delivery.  
 
Using Your Groupon: Place order by 18 May at  
www.exantediet.com/groupon-uk, by copying and pasting your Groupon code into required field.  
 
For more on Groupon Goods, pricing and delivery, see the FAQ. 
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Box of 84 Alli Weight Management Tablets from £31.99 (39% Off) 
mHnPaq9TQanxp
 
More Info!
 
Amount:  
from £31.99 
Discount39% You save£20.14 
 
Highlights 
• Designed to support weight management programmes  
• Three capsules per day, taken with meals  
• Recommended for those with a BMI of 28 or above  
• Each box contains 84 tablets, lasting up to four weeks 
• One, two or three boxes available 
 
Fine Print 
Purchase: May buy up to 2; limit 1 per redemption.  
Further information: Must be aged 18 or over. Suitable for those with a BMI of 28 or above. Consult a doctor before 
taking Alli if you are taking or have recently taken any other medicines, including medicines obtained without a 
prescription. Not suitable for pregnant or breast-feeding women, those taking Ciclosporin, Warfarin or other blood 
thinning medications, if allergic (hypersensitive) to orlistat or any of the ingredients of Alli, or those with cholestatis or 
with problems absorbing food (chronic malabsorbtion syndrome) as diagnosed by a doctor. Valid on option purchased 
only.By purchasing a Groupon, you are purchasing a voucher for the underlying products or services described above. 
Orders fulfilled by Golds Pharmacy.  
See the rules that apply to all deals.  
 
Delivery: £3.95. Allow up to 7 working days via Royal Mail or UK Mail. Signature required.  
 
Using Your Groupon: Place order by 24 November 2013 at http://www.goldspharmacy.co.uk/search/alli, by selecting 
your required product and copying and pasting your Groupon code into required field.  
 
For more on Groupon Goods, pricing and delivery, see the FAQ.  
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Figure 19 output data: 
 
Model Summaryb 
Model R R Square Adjusted R 
Square 
Std. Error of the Estimate 
1 .140a .020 .007 619.03122 
a. Predictors: (Constant), Age 
b. Dependent Variable: Total_cost_cwlps 
 
 
Coefficientsa 
Model Unstandardized 
Coefficients 
Standar
dized 
Coeffici
ents 
t Sig. 95.0% Confidence Interval for B 
B Std. 
Error 
Beta Lower 
Bound 
Upper Bound 
1 
(Cons
tant) 
114.38
1 
236.89
3 
 
.483 .631 
-
357.143 
585.904 
Age 6.435 5.108 .140 
1.26
0 
.211 -3.732 16.601 
a. Dependent Variable: Total_cost_cwlps 
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Figure 20 output data: 
 
Model Summaryb 
Model R R Square Adjusted R 
Square 
Std. Error of the Estimate 
1 .109a .012 -.001 621.50954 
a. Predictors: (Constant), imd_score 
b. Dependent Variable: Total_cost_of_cwlps 
 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B 
B Std. Error Beta Lower Bound Upper Bound 
1 
(Constant) 482.447 109.367  4.411 .000 264.756 700.137 
imd_score -4.115 4.231 -.109 -.973 .334 -12.537 4.307 
a. Dependent Variable: Total_cost_of_cwlps 
 
